{
  "meta": {
    "title": "Mission_Neet_Pg-Inicet_Grand_Test-31",
    "url": "https://brainandscalpel.vercel.app/mission-neet-pg-inicet-grand-test-31-7ebb5870.html",
    "scrapedAt": "2025-11-29T17:24:20.971Z"
  },
  "questions": [
    {
      "id": 96990,
      "choices": [
        {
          "id": 386068,
          "text": "<p><span style=\"font-size:14.0pt;\">Capnocytophaga canimorsus</span></p>"
        },
        {
          "id": 386069,
          "text": "<p><span style=\"font-size:14.0pt;\">Pasteurella multocida</span></p>"
        },
        {
          "id": 386070,
          "text": "<p><span style=\"font-size:14.0pt;\">Staphylococcus aureus</span></p>"
        },
        {
          "id": 386071,
          "text": "<p><span style=\"font-size:14.0pt;\">Bacteroides fragilis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 48-year-old man presents with rapidly developing, hemorrhagic bullous lesions on his hand 12 hours after a dog bite. He has no history of immunosuppression or splenectomy. Culture of the wound is pending. Which of the following organisms is the most likely cause of this skin presentation?</span></p>",
      "unique_key": "Q5520504",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Staphylococcus aureus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In immunocompetent individuals, <strong>bullous hemorrhagic lesions</strong> following a <strong>dog bite</strong> are classically associated with <strong>β-hemolytic streptococci</strong> and <strong>Staphylococcus aureus</strong>, particularly methicillin-resistant strains (MRSA).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">S. aureus is a common pathogen in animal bite wound infections and can cause <strong>rapidly progressive bullous skin lesions</strong> due to its potent toxins (e.g., exfoliative toxin).</span></li><li><span style=\"font-size:14.0pt;\">Although Capnocytophaga canimorsus is transmitted through dog bites and can cause serious systemic illness, its classic presentation is <strong>fulminant sepsis, DIC, and renal failure</strong>—especially in <strong>asplenic or immunocompromised</strong> hosts—not localized hemorrhagic bullae in healthy individuals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Capnocytophaga canimorsus:</strong> This is indeed part of the <strong>dog’s oral flora</strong> and can be transmitted via bites. However, it primarily causes <strong>sepsis and systemic complications</strong> (e.g., DIC, renal failure) in <strong>immunocompromised</strong> or <strong>asplenic</strong> patients, not localized hemorrhagic bullous lesions in healthy hosts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pasteurella multocida:</strong> More commonly associated with <strong>cat bites</strong>, though it can be found in dog bite wounds too. It typically causes <strong>rapid-onset cellulitis</strong> with purulent discharge, and necrotizing fascitis but is <strong>not characteristically linked to bullous hemorrhagic lesions</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bacteroides fragilis:</strong> An anaerobic organism found in polymicrobial infections following bite wounds but <strong>not a primary agent</strong> of hemorrhagic bullae or rapid skin necrosis. Typically involved in <strong>deep tissue anaerobic infections</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>immunocompetent individuals</strong>, <strong>hemorrhagic bullous skin lesions</strong> following <strong>dog bites</strong> are most commonly caused by <strong>Staphylococcus aureus</strong> or <strong>β-hemolytic streptococci</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Capnocytophaga is more commonly associated with <strong>systemic complications</strong> in <strong>immunosuppressed</strong> or <strong>asplenic</strong> patients.</span></li></ul>",
      "correct_choice_id": 386070,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96990/NEET_GT__11_NOV_2025_Microbiology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96990/NEET_GT__11_NOV_2025_Microbiology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96959,
      "choices": [
        {
          "id": 385944,
          "text": "<p><span style=\"font-size:14.0pt;\">Adduction</span></p>"
        },
        {
          "id": 385945,
          "text": "<p><span style=\"font-size:14.0pt;\">Flexion</span></p>"
        },
        {
          "id": 385946,
          "text": "<p><span style=\"font-size:14.0pt;\">Abduction</span></p>"
        },
        {
          "id": 385947,
          "text": "<p><span style=\"font-size:14.0pt;\">Extension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following actions is primarily affected due to injury to the muscle attached at the marked site?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111356.jpg\" width=\"319\" height=\"451\"></span></p>",
      "unique_key": "Q7608878",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Abduction</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The marked area in the image is the <strong>greater trochanter</strong> of the <strong>femur</strong>, which serves as the attachment site for muscles such as the <strong>gluteus medius</strong> and <strong>gluteus minimus</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These muscles are critical for the <strong>abduction</strong> of the thigh at the hip joint. They help to <strong>move the leg laterally</strong> and <strong>stabilize the pelvis</strong> during activities like walking.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111416.jpg\" width=\"952\" height=\"571\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Adduction:</strong> Incorrect. Adduction of the thigh involves muscles like the <strong>adductor longus</strong>, <strong>adductor magnus</strong>, and <strong>gracilis</strong>, which attach to the medial side of the thigh and not to the <strong>greater trochanter</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Flexion:</strong> Incorrect. Thigh flexion is primarily performed by muscles such as the <strong>iliopsoas</strong> and <strong>rectus femoris</strong>, not the <strong>gluteus medius</strong> or <strong>gluteus minimus</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Extension:</strong> Incorrect. Thigh extension involves muscles like the <strong>gluteus maximus</strong> and <strong>hamstrings</strong>, which are not attached to the <strong>greater trochanter</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>gluteus medius</strong> and <strong>gluteus minimus</strong> muscles, which attach to the <strong>greater trochanter</strong> of the femur, are responsible for <strong>abduction of the thigh</strong>.</span></li><li><span style=\"font-size:14.0pt;\">These muscles also play a crucial role in <strong>stabilizing the pelvis</strong> during ambulation.</span></li></ul>",
      "correct_choice_id": 385946,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96959/NEET_GT__11_NOV_2025_Anatomy_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96959/NEET_GT__11_NOV_2025_Anatomy_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96944,
      "choices": [
        {
          "id": 385884,
          "text": "<p><span style=\"font-size:14.0pt;\">Weight-for-height Z-score less than -3 SD</span></p>"
        },
        {
          "id": 385885,
          "text": "<p><span style=\"font-size:14.0pt;\">Mid-upper arm circumference (MUAC) less than 115 mm</span></p>"
        },
        {
          "id": 385886,
          "text": "<p><span style=\"font-size:14.0pt;\">Presence of bilateral pitting edema</span></p>"
        },
        {
          "id": 385887,
          "text": "<p><span style=\"font-size:14.0pt;\">Weight-for-age Z-score less than -3 SD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 15-month-old child is brought to the primary health center for nutritional assessment. The healthcare worker is evaluating the child for Severe Acute Malnutrition (SAM) using WHO criteria. All of the following are diagnostic criteria for SAM in children aged 6-59 months except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8900759",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)</strong> <strong>Weight-for-age Z-score less than -3 SD</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to WHO criteria for diagnosing Severe Acute Malnutrition (SAM) in children aged 6-59 months, the diagnostic criteria include: Weight-for-height Z-score &lt;-3 SD, MUAC &lt;115 mm, or presence of bilateral pitting edema.</span></li><li><span style=\"font-size:14.0pt;\">Weight-for-age Z-score &lt;-3 SD is a criterion for underweight, not specifically for SAM.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">SAM diagnosis focuses on wasting (acute malnutrition) rather than underweight, which can be due to both acute and chronic malnutrition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Weight-for-height Z-score less than -3 SD:&nbsp;</strong>Weight-for-height Z-score &lt;-3 SD is a standard WHO criterion for diagnosing SAM, indicating severe wasting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mid-upper arm circumference (MUAC) less than 115 mm:</strong> MUAC &lt;115 mm is a WHO criterion for SAM diagnosis and is widely used for community screening.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Presence of bilateral pitting edema:</strong> Bilateral pitting edema is a clinical sign of kwashiorkor type of SAM and is included in WHO criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">SAM diagnosis is based on wasting indicators (WHZ, MUAC) and edema, not underweight criteria</span></li><li><span style=\"font-size:14.0pt;\">Weight-for-age reflects both acute and chronic malnutrition, making it less specific for SAM</span></li><li><span style=\"font-size:14.0pt;\">MUAC &lt;115 mm is particularly useful for community-based screening and program admission criteria</span></li></ul>",
      "correct_choice_id": 385887,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96944/NEET_PG_11_Nov_2025_PSM_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96944/NEET_PG_11_Nov_2025_PSM_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97256,
      "choices": [
        {
          "id": 387120,
          "text": "<p><span style=\"font-size:14.0pt;\">Mesna</span></p>"
        },
        {
          "id": 387121,
          "text": "<p><span style=\"font-size:14.0pt;\">Amifostine</span></p>"
        },
        {
          "id": 387122,
          "text": "<p><span style=\"font-size:14.0pt;\">Dexrazoxane</span></p>"
        },
        {
          "id": 387123,
          "text": "<p><span style=\"font-size:14.0pt;\">Leucovorin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female with breast cancer is receiving doxorubicin therapy. After cumulative dose of 350 mg/m², she develops dyspnea and pedal edema. Echocardiography shows reduced ejection fraction. Which drug could have prevented this complication?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6165619",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Dexrazoxane</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has developed anthracycline-induced cardiomyopathy leading to congestive heart failure (CHF).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Doxorubicin produces cardiotoxicity as a unique adverse effect, which can manifest either acutely (within 2-3 days causing ECG changes, arrhythmias, hypotension - all reversible) or delayed (producing CHF related to total dose administered, usually at doses &gt;300 mg/m²).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The CHF is due to cardiomyopathy which may be fatal.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Dexrazoxane is an iron chelating agent which, when infused i.v. before doxorubicin, has been found to reduce risk of cardiotoxicity. Anthracyclines (doxorubicin, daunorubicin, epirubicin, idarubicin) generate quinone type free radicals which contribute to cardiotoxicity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, dexrazoxane may also compromise the anticancer efficacy of doxorubicin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Dexrazoxane can also be used to ameliorate anthracycline infusion site reaction due to extravasation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mesna:</strong> Mesna prevents cyclophosphamide/ifosfamide-induced hemorrhagic cystitis, not anthracycline cardiotoxicity</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Amifostine:</strong> Prevents cisplatin nephrotoxicity and radiation-induced xerostomia, not doxorubicin cardiotoxicity</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Leucovorin:</strong> Is used for Methotrexate toxicity rescue, not for anthracycline complications</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dexrazoxane pretreatment reduces anthracycline-induced dose-dependent cardiomyopathy and CHF but should be used judiciously as it may compromise anticancer efficacy.</span></p>",
      "correct_choice_id": 387122,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97256/NEET_GT__11_NOV_2025_Pharmacology_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97256/NEET_GT__11_NOV_2025_Pharmacology_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96929,
      "choices": [
        {
          "id": 385824,
          "text": "<p><span style=\"font-size:14.0pt;\">Pancreatic secretions become hypertonic at high flow rates</span></p>"
        },
        {
          "id": 385825,
          "text": "<p><span style=\"font-size:14.0pt;\">Cholecystokinin (CCK) primarily stimulates bicarbonate secretion</span></p>"
        },
        {
          "id": 385826,
          "text": "<p><span style=\"font-size:14.0pt;\">The major anion in pancreatic fluid is chloride (Cl⁻)</span></p>"
        },
        {
          "id": 385827,
          "text": "<p><span style=\"font-size:14.0pt;\">Pancreatic secretion is isotonic and has higher HCO₃⁻ than plasma at high flow rates&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding pancreatic secretion is most accurate under normal physiological conditions?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3804445",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Pancreatic secretion is isotonic and has higher HCO₃⁻ than plasma at high flow rates</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pancreatic secretions are composed of <strong>bicarbonate (HCO₃⁻)</strong> and <strong>enzymes</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These secretions are essential for <strong>neutralizing gastric acid</strong> entering the duodenum and for <strong>digestive enzyme activity</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>ductal cells</strong> of the pancreas secrete <strong>bicarbonate-rich fluid</strong>, while the <strong>acinar cells</strong> secrete digestive enzymes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Secretin</strong>, released from <strong>S cells</strong> in the duodenum in response to <strong>acidic chyme or fatty acids</strong>, stimulates <strong>bicarbonate secretion</strong> from pancreatic ductal cells.</span></li><li><span style=\"font-size:14.0pt;\">As pancreatic secretion flow rate increases, <strong>bicarbonate concentration rises</strong> and <strong>chloride concentration falls</strong>, due to an <strong>HCO₃⁻/Cl⁻ exchange mechanism</strong> in the ductal epithelium.</span></li><li><span style=\"font-size:14.0pt;\">Importantly, pancreatic secretions remain <strong>isotonic</strong> to plasma at all flow rates.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, at <strong>high flow rates</strong>, pancreatic juice contains <strong>high HCO₃⁻</strong> and <strong>low Cl⁻</strong>, maintaining isotonicity with plasma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pancreatic secretions become hypertonic at high flow rates:</strong> Incorrect. Pancreatic juice is <strong>always isotonic</strong>, regardless of the flow rate, due to active electrolyte transport and osmotic equilibration with plasma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cholecystokinin (CCK) primarily stimulates bicarbonate secretion:</strong> Incorrect. <strong>CCK</strong> mainly stimulates <strong>pancreatic enzyme secretion</strong> from acinar cells, not bicarbonate secretion. <strong>Secretin</strong> is the main regulator of <strong>HCO₃⁻</strong> output.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The major anion in pancreatic fluid is chloride (Cl⁻):</strong> Incorrect. While Cl⁻ predominates at low flow rates, <strong>HCO₃⁻</strong> becomes the major anion at <strong>high flow rates</strong>, especially after secretin stimulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Secretin</strong> stimulates <strong>bicarbonate-rich</strong>, <strong>isotonic pancreatic secretions</strong>, while <strong>CCK</strong> stimulates <strong>enzyme-rich secretions</strong>.</span></li><li><span style=\"font-size:14.0pt;\">At <strong>high flow rates</strong>, pancreatic juice contains <strong>more HCO₃⁻ and less Cl⁻</strong> compared to plasma, maintaining isotonicity across all flow conditions.</span></li></ul>",
      "correct_choice_id": 385827,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96929/NEET_GT__11_NOV_2025_Physiology_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96929/NEET_GT__11_NOV_2025_Physiology_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96920,
      "choices": [
        {
          "id": 385788,
          "text": "<p><span style=\"font-size:14.0pt;\">Dorsal horn of the left side of the spinal cord</span></p>"
        },
        {
          "id": 385789,
          "text": "<p><span style=\"font-size:14.0pt;\">Right dorsal column nucleus</span></p>"
        },
        {
          "id": 385790,
          "text": "<p><span style=\"font-size:14.0pt;\">Dorsal horn of the right side of the spinal cord</span></p>"
        },
        {
          "id": 385791,
          "text": "<p><span style=\"font-size:14.0pt;\">Left dorsal column nucleus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old construction worker sustains a puncture wound on the palmar surface of his right hand. He reports intact vibration and fine touch sensation in the injured region. The injured sensory nerve fibers are associated with Pacinian corpuscles. In the pathway that carries these sensations, the first synapse occurs at which of the following sites?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7070018",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Right dorsal column nucleus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pacinian corpuscles</strong> are rapidly adapting mechanoreceptors responsible for detecting <strong>vibration and deep pressure</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The sensory information they generate is carried by <strong>large myelinated Aβ fibers</strong> through the <strong>dorsal column–medial lemniscus pathway (DCML)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In the DCML pathway:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The <strong>first-order neuron cell body</strong> lies in the <strong>dorsal root ganglion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The axon enters the spinal cord and <strong>ascends ipsilaterally in the dorsal column</strong> (fasciculus cuneatus for upper limb, fasciculus gracilis for lower limb).</span></li><li><span style=\"font-size:14.0pt;\">The <strong>first synapse</strong> occurs in the <strong>ipsilateral dorsal column nucleus</strong> of the medulla (nucleus cuneatus for upper limb input like the hand, nucleus gracilis for lower limb).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Since this patient has an injury on the <strong>palmar surface of the right hand</strong>, the signal ascends in the <strong>right fasciculus cuneatus</strong> and first synapses in the <strong>right dorsal column nucleus (nucleus cuneatus)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the correct answer is the <strong>right dorsal column nucleus</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Dorsal horn of the left side of the spinal cord:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The dorsal horn is the site where <strong>pain and temperature fibers</strong> (spinothalamic tract) synapse.</span></li><li><span style=\"font-size:14.0pt;\">Fine touch and vibration fibers bypass the dorsal horn and ascend ipsilaterally.</span></li><li><span style=\"font-size:14.0pt;\">Left-sided dorsal horn involvement is incorrect because the pathway is still ipsilateral before crossing at the medulla.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dorsal horn of the right side of the spinal cord</strong>:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While this is ipsilateral, it is still incorrect.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>dorsal horn</strong> processes nociception and temperature sensations, not vibration and fine touch.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Left dorsal column nucleus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Incorrect because the <strong>crossing of fibers</strong> in the DCML pathway happens in the medulla after the first synapse.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the first synapse is always <strong>ipsilateral (right side for right hand input)</strong>, not contralateral.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Vibration and fine touch from Pacinian corpuscles travel via the dorsal column–medial lemniscus pathway, with the first synapse occurring in the ipsilateral dorsal column nucleus (nucleus cuneatus for the upper limb).</span></p>",
      "correct_choice_id": 385789,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96920/NEET_GT__11_NOV_2025_Physiology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96920/NEET_GT__11_NOV_2025_Physiology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97055,
      "choices": [
        {
          "id": 386328,
          "text": "<p><span style=\"font-size:14.0pt;\">Basic metabolic panel</span></p>"
        },
        {
          "id": 386329,
          "text": "<p><span style=\"font-size:14.0pt;\">Liver function tests</span></p>"
        },
        {
          "id": 386330,
          "text": "<p><span style=\"font-size:14.0pt;\">Complete blood counts</span></p>"
        },
        {
          "id": 386331,
          "text": "<p><span style=\"font-size:14.0pt;\">Urine microalbumin:creatinine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old man with cystic fibrosis is started on a cystic fibrosis transmembrane conductance regulator (CFTR) modulator. Which laboratory test is it most important to monitor closely during treatment with this drug?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6881396",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Liver function tests</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">CFTR modulators (such as ivacaftor, lumacaftor, and elexacaftor/tezacaftor/ivacaftor) are associated with hepatotoxicity, often manifesting as elevated liver enzymes.</span></li><li><span style=\"font-size:14.0pt;\">Regular monitoring of liver function tests (LFTs) is critical because drug-induced liver injury can occur, and early detection allows for timely management or modification of therapy.​</span></li><li><span style=\"font-size:14.0pt;\">Guideline recommendations suggest checking LFTs at baseline, then every 3 months during the first year of therapy, and annually thereafter, with more frequent monitoring if abnormalities are detected.​</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Basic metabolic panel</strong>: Not specifically indicated for CFTR modulator monitoring, unless there are other clinical concerns.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complete blood counts</strong>: Not directly affected by these drugs and not a priority for routine monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Urine microalbumin: creatinine</strong>: More relevant to monitoring renal or diabetic complications, not the effects of CFTR modulators.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Liver function tests must be closely monitored during treatment with CFTR modulators, as these medications can cause significant hepatotoxicity, and routine surveillance helps prevent serious complications.</span></p>",
      "correct_choice_id": 386329,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97055/NEET_GT__11_NOV_2025_Medicine_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97055/NEET_GT__11_NOV_2025_Medicine_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97041,
      "choices": [
        {
          "id": 386272,
          "text": "<p><span style=\"font-size:14.0pt;\">Switch to grid/focal laser photocoagulation</span></p>"
        },
        {
          "id": 386273,
          "text": "<p><span style=\"font-size:14.0pt;\">Add or switch to intravitreal aflibercept</span></p>"
        },
        {
          "id": 386274,
          "text": "<p><span style=\"font-size:14.0pt;\">Proceed to pan-retinal photocoagulation</span></p>"
        },
        {
          "id": 386275,
          "text": "<p><span style=\"font-size:14.0pt;\">Observe for another three months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old woman with center-involving diabetic macular edema (DME) receives monthly intravitreal ranibizumab. After six injections, OCT shows persistent thickening. What is the next best step?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7399898",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans</strong>. <strong>B) Add or switch to intravitreal aflibercept</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For patients with <strong>center-involving DME</strong> who do <strong>not respond adequately</strong> to initial anti-VEGF therapy (e.g., ranibizumab or bevacizumab), <strong>aflibercept</strong> is often used as the next line due to its superior drying effect and improved visual outcomes in <strong>poor responders</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clinical trials (e.g., DRCR.net Protocol T) have shown <strong>aflibercept to be more effective</strong> than ranibizumab or bevacizumab in patients with worse baseline vision or persistent edema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Switch to Grid/focal laser photocoagulation</strong>: While previously used, focal laser is <strong>no longer first-line</strong> for center-involving DME due to the proven superiority of anti-VEGF agents. It may be considered in <strong>non–center-involving DME</strong> or <strong>peripheral areas</strong>, but not at this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Proceed to Pan-retinal photocoagulation (PRP)</strong>: PRP is indicated for <strong>proliferative diabetic retinopathy</strong>, not for macular edema. This patient shows <strong>DME without PDR</strong>, making PRP inappropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Observe for another three months</strong>: Observation may lead to <strong>further visual decline</strong>. Persistent macular edema after six anti-VEGF injections is a sign of <strong>non-response</strong>, and early treatment optimization is warranted.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In cases of <strong>persistent center-involving DME</strong> after multiple ranibizumab injections, switching to <strong>aflibercept</strong> is a <strong>data-supported strategy</strong>. Aflibercept binds multiple VEGF isoforms and has shown <strong>greater efficacy</strong> in poor responders.</span></p>",
      "correct_choice_id": 386273,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97041/NEET_GT__11_NOV_2025_Opthalmology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97041/NEET_GT__11_NOV_2025_Opthalmology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96950,
      "choices": [
        {
          "id": 385908,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood-soaked gauze and cotton swabs</span></p>"
        },
        {
          "id": 385909,
          "text": "<p><span style=\"font-size:14.0pt;\">Items contaminated with cytotoxic drugs along with glass or plastic ampoules</span></p>"
        },
        {
          "id": 385910,
          "text": "<p><span style=\"font-size:14.0pt;\">Urine bags</span></p>"
        },
        {
          "id": 385911,
          "text": "<p><span style=\"font-size:14.0pt;\">Human anatomical waste from surgical specimens</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">According to Bio Medical Waste Management Rules 2016, which of the following waste items should not be discarded in the yellow bin?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2233018",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Urine bags</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to Bio Medical Waste Management Rules 2016, urine bags are discarded in the red bin and not in the yellow bin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20154712.jpg\" width=\"693\" height=\"583\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Blood-soaked gauze and cotton swabs:&nbsp;</strong>Blood-soaked gauze is infectious waste and correctly goes in yellow bins</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Items contaminated with cytotoxic drugs along with glass or plastic ampoules:</strong> All items used during preparation and administration of cytotoxic drugs (eg: glass and plastic bottles, ampoules, vials, iv sets, gloves, syringes without needle, dressing, cotton swabs, etc.) are discarded in yellow bin with cytotoxic label. The container is not the determining factor in the case of segregation of cytotoxic wastes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Human anatomical waste from surgical specimens:</strong> Human anatomical waste is correctly disposed of in yellow bins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Yellow bins are for infectious waste, anatomical waste, and expired pharmaceuticals as per BMW Rules 2016</span></li><li><span style=\"font-size:14.0pt;\">Proper segregation at source is crucial for effective biomedical waste management</span></li></ul>",
      "correct_choice_id": 385910,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96950/NEET_PG_11_Nov_2025_PSM_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96950/NEET_PG_11_Nov_2025_PSM_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97195,
      "choices": [
        {
          "id": 386880,
          "text": "<p><span style=\"font-size:14.0pt;\">Barrett’s esophagus</span></p>"
        },
        {
          "id": 386881,
          "text": "<p><span style=\"font-size:14.0pt;\">Schatzki ring</span></p>"
        },
        {
          "id": 386882,
          "text": "<p><span style=\"font-size:14.0pt;\">Eosinophilic esophagitis</span></p>"
        },
        {
          "id": 386883,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudo-achalasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old female patient came to the physician with complaints of heartburn and regurgitation of food. The symptoms have been present for 3 years but have worsened for the past 3 months. She took over-the-counter medications, but the symptoms did not subside. Upper GI endoscopy shows the following presentation. What is your probable diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20112032.jpg\" width=\"424\" height=\"399\"></span></p>",
      "unique_key": "Q6787153",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Barrett’s esophagus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The given image is an upper GI endoscopic image of Barrett's esophagus.</span></li><li><span style=\"font-size:14.0pt;\">It shows tongue shaped projections in the surrounding mucosa.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Schatzki ring:</strong> A Schatzki ring is a narrowing of the lower esophagus that can cause difficulty swallowing (dysphagia). It typically appears as a thin ring on endoscopy and wouldn't show the patchy red mucosa that is indicative of Barrett’s esophagus. The symptoms of heartburn and regurgitation are less specific to a Schatzki ring unless there is accompanying esophagitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Eosinophilic esophagitis:&nbsp;</strong>This is an allergic/immune condition that results in a buildup of eosinophils in the esophagus, leading to esophageal dysfunction. On endoscopy, it can show multiple rings, white specks of eosinophilic infiltrates, and longitudinal furrows, none of which are visible in the provided image.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pseudo-achalasia:</strong> This refers to symptoms of achalasia due to carcinoma of esophagus. It would not cause the visible changes seen in Barrett’s esophagus on endoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Barrett’s esophagus is the columnar metaplasia of lower esophagus.</span></p>",
      "correct_choice_id": 386880,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97195/NEET_GT__11_NOV_2025_Surgery_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97195/NEET_GT__11_NOV_2025_Surgery_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97009,
      "choices": [
        {
          "id": 386144,
          "text": "<p><span style=\"font-size:14.0pt;\">McArdle disease</span></p>"
        },
        {
          "id": 386145,
          "text": "<p><span style=\"font-size:14.0pt;\">Pompe disease</span></p>"
        },
        {
          "id": 386146,
          "text": "<p><span style=\"font-size:14.0pt;\">Von Gierke disease</span></p>"
        },
        {
          "id": 386147,
          "text": "<p><span style=\"font-size:14.0pt;\">Anderson disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 5-month-old infant is brought to the pediatrician due to failure to thrive, hepatosplenomegaly, and hypotonia. On examination, the infant appears irritable and has delayed motor milestones. A liver biopsy reveals glycogen with abnormally long, unbranched outer chains. Which of the following glycogen storage disorders is most likely in this patient?</span></p>",
      "unique_key": "Q8118508",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Anderson disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Anderson disease</strong> (Glycogen Storage Disease Type IV) is caused by a deficiency of the <strong>glycogen branching enzyme (GBE1)</strong>. This leads to the accumulation of <strong>abnormal glycogen with fewer branching points</strong>, forming long, amylopectin-like chains.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These abnormal glycogen structures are poorly soluble and tend to precipitate in tissues, especially in the liver, leading to inflammation, fibrosis, and cirrhosis.</span></li><li><span style=\"font-size:14.0pt;\">Clinically, Anderson disease presents in infancy with <strong>hepatosplenomegaly, failure to thrive, muscle hypotonia, and progressive liver dysfunction</strong>, often culminating in liver failure if untreated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike other GSDs, the structural abnormality in glycogen is a key diagnostic feature.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. McArdle disease (GSD Type V):&nbsp;</strong>Caused by <strong>muscle glycogen phosphorylase deficiency</strong>. It leads to muscle cramps and myoglobinuria after exercise but the <strong>glycogen structure is normal</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pompe disease (GSD Type II):&nbsp;</strong>Caused by <strong>acid alpha-glucosidase deficiency</strong>. Glycogen accumulates in lysosomes, particularly in the heart and skeletal muscles. The <strong>structure of glycogen is normal</strong>, but the location of accumulation is lysosomal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Von Gierke disease (GSD Type I):&nbsp;</strong>Due to <strong>glucose-6-phosphatase deficiency</strong>, leading to hypoglycemia, lactic acidosis, hyperlipidemia, and hepatomegaly. The <strong>structure of glycogen remains normal</strong>, although the quantity is excessive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Anderson disease (GSD Type IV)</strong> is characterized by accumulation of <strong>abnormal, poorly branched glycogen</strong> due to <strong>branching enzyme deficiency</strong>, leading to hepatosplenomegaly and progressive liver failure in infancy.</span></p>",
      "correct_choice_id": 386147,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97009/NEET_GT__11_NOV_2025_Biochemistry_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97009/NEET_GT__11_NOV_2025_Biochemistry_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97054,
      "choices": [
        {
          "id": 386324,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic dissection</span></p>"
        },
        {
          "id": 386325,
          "text": "<p><span style=\"font-size:14.0pt;\">Pericardial effusion</span></p>"
        },
        {
          "id": 386326,
          "text": "<p><span style=\"font-size:14.0pt;\">Pneumothorax</span></p>"
        },
        {
          "id": 386327,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary edema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man with a history of hypertension, hyperlipidemia, and tobacco use disorder presents with acute severe chest pain radiating to his back. On examination, he is diaphoretic and in moderate distress. His heart rate is 110 bpm and blood pressure is 172/94 mmHg. Oxygen saturation is 98% on room air. Chest X-ray is shown below. Which of the following pathologies is most likely based on his clinical findings and imaging?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20152055.jpg\" width=\"525\" height=\"431\"></strong></span></p>",
      "unique_key": "Q5850332",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Aortic dissection</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acute severe chest pain radiating to the back, in a patient with hypertension and smoking history, is highly suspicious for aortic pathology.</span></li><li><span style=\"font-size:14.0pt;\">Chest X-ray shows a widened mediastinum, which, while not diagnostic, is an important clue for aortic dissection.</span></li><li><span style=\"font-size:14.0pt;\">CXR findings support major thoracic vessel pathology but definitive diagnosis requires advanced imaging such as CTA or TEE.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pericardial effusion:</strong> Pericardial effusion typically presents with features of tamponade (muffled heart sounds, hypotension, and pulsus paradoxus), and CXR shows an enlarged, globular cardiac silhouette.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pneumothorax:</strong> Pneumothorax presents with unilateral absence of breath sounds and hyperresonance; CXR reveals a collapsed lung, not mediastinal widening.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pulmonary edema:</strong> Pulmonary edema presents with dyspnea and bilateral infiltrates or Kerley B lines on CXR, findings not present in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients presenting with acute severe chest pain and a widened mediastinum on CXR, aortic dissection must be considered; rapid diagnosis is essential for life-saving intervention.</span></p>",
      "correct_choice_id": 386324,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97054/Neet_Gt__11_Nov_2025_Medicine_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97054/Neet_Gt__11_Nov_2025_Medicine_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96942,
      "choices": [
        {
          "id": 385876,
          "text": "<p><span style=\"font-size:14.0pt;\">The event constitutes a public health risk to other States through international spread and potentially requires a coordinated international response</span></p>"
        },
        {
          "id": 385877,
          "text": "<p><span style=\"font-size:14.0pt;\">The event has caused more than 1000 deaths in the affected country within 30 days of onset</span></p>"
        },
        {
          "id": 385878,
          "text": "<p><span style=\"font-size:14.0pt;\">The event involves a pathogen with pandemic potential as listed in WHO's priority pathogen list</span></p>"
        },
        {
          "id": 385879,
          "text": "<p><span style=\"font-size:14.0pt;\">The event has spread to at least 3 countries across 2 different WHO regions</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">According to the International Health Regulations (2005), which of the following criteria must be met for the WHO Director-General to declare a Public Health Emergency of International Concern (PHEIC)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6581144",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)&nbsp;The event constitutes a public health risk to other States through international spread and potentially requires a coordinated international response</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A Public Health Emergency of International Concern (PHEIC) is defined under the International Health Regulations (2005) as \"an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response.</span></li><li><span style=\"font-size:14.0pt;\">\" Both criteria must be satisfied: the risk of international spread AND the need for coordinated international response.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The declaration is made by the WHO Director-General based on advice from the Emergency Committee, considering factors like the seriousness of the public health impact, unusual or unexpected nature of the event, risk of international spread, and risk of restrictions on international travel or trade.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The event has caused more than 1000 deaths in the affected country within 30 days of onset:</strong> There is no specific death threshold criterion for PHEIC declaration. The focus is on international spread risk and need for coordinated response, not mortality numbers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The event involves a pathogen with pandemic potential as listed in WHO's priority pathogen list:</strong> While priority pathogens are important for preparedness, PHEIC can be declared for any health event meeting the IHR criteria, not just those involving listed pathogens.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The event has spread to at least 3 countries across 2 different WHO regions:</strong> There is no specific requirement for spread across multiple countries or regions. A PHEIC can be declared even if the event is contained within one country but poses international risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PHEIC declaration requires both international spread risk AND need for coordinated international response</span></li><li><span style=\"font-size:14.0pt;\">The WHO Director-General makes the declaration based on Emergency Committee advice under IHR (2005)</span></li><li><span style=\"font-size:14.0pt;\">No specific mortality thresholds or geographical spread criteria are mandated for PHEIC declaration</span></li><li><span style=\"font-size:14.0pt;\">Examples of declared PHEICs include H1N1 pandemic (2009), Ebola outbreak(2014), Zika virus (2016), and COVID-19 (2020)</span></li></ul>",
      "correct_choice_id": 385876,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96942/NEET_PG_11_Nov_2025_PSM_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96942/NEET_PG_11_Nov_2025_PSM_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97207,
      "choices": [
        {
          "id": 386928,
          "text": "<p><span style=\"font-size:14.0pt;\">Superficial femoral artery</span></p>"
        },
        {
          "id": 386929,
          "text": "<p><span style=\"font-size:14.0pt;\">Popliteal artery</span></p>"
        },
        {
          "id": 386930,
          "text": "<p><span style=\"font-size:14.0pt;\">External iliac artery</span></p>"
        },
        {
          "id": 386931,
          "text": "<p><span style=\"font-size:14.0pt;\">Abdominal aorta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man presents to the vascular surgery clinic with complaints of progressive pain in his left thigh during walking, which is relieved by rest. He also notes coldness and numbness in the left lower extremity after prolonged exertion. On physical exam, the left femoral pulse is weak, while the right femoral is palpable. Ankle-brachial index (ABI) on the left is 0.6. Which of the following is the most likely site of arterial obstruction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2565450",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) External iliac artery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>external iliac artery</strong> is the most likely site of <strong>occlusion or significant stenosis</strong> in this patient.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It transitions into the <strong>femoral artery</strong> after passing under the inguinal ligament and supplies blood to the lower extremities.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A lesion in the <strong>external iliac artery</strong> would cause reduced <strong>perfusion to the thigh and distal leg</strong>, resulting in <strong>exercise-induced claudication</strong> in the <strong>unilateral lower thigh</strong>, with diminished <strong>femoral pulses</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The finding of a <strong>unilateral weak femoral pulse</strong> with normal contralateral and distal pulses suggests a <strong>proximal obstruction</strong>, specifically at the level of the <strong>external iliac artery</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The ABI value of <strong>0.61</strong> confirms <strong>moderate peripheral arterial disease</strong> on the affected side.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Superficial femoral artery:</strong> Incorrect. While femoral artery disease may cause lower extremity ischemia leading to calf claudication, it would typically result in <strong>preserved femoral pulse</strong> but <strong>distal pulse deficits</strong> (popliteal or pedal).&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Popliteal artery:</strong> Incorrect. Obstruction here would affect <strong>distal pulses</strong> (dorsalis pedis/posterior tibial), not the <strong>femoral pulse</strong>. The patient's <strong>popliteal pulses are symmetric</strong>, making this less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Abdominal aorta:</strong> Incorrect. Aortic occlusion or high-grade stenosis would typically present with <strong>bilateral symptoms</strong> and diminished <strong>bilateral femoral pulses</strong>, often seen in <strong>Leriche syndrome</strong>. This patient has <strong>unilateral symptoms</strong>, ruling this out.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Unilateral thigh claudication with diminished femoral pulse and preserved distal pulses suggests external iliac artery stenosis or occlusion; ABI helps quantify severity of peripheral arterial disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-11-10%20at%2012.50.21.jpeg\" width=\"458\" height=\"635\"></span></p>",
      "correct_choice_id": 386930,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97207/NEET_GT__11_NOV_2025_Surgery_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97207/NEET_GT__11_NOV_2025_Surgery_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96930,
      "choices": [
        {
          "id": 385828,
          "text": "<p><span style=\"font-size:14.0pt;\">Suppression of 1α-hydroxylase activity in the proximal tubule</span></p>"
        },
        {
          "id": 385829,
          "text": "<p><span style=\"font-size:14.0pt;\">Enhanced calcium reabsorption in the distal convoluted tubule</span></p>"
        },
        {
          "id": 385830,
          "text": "<p><span style=\"font-size:14.0pt;\">Binding of PTH to receptors on the luminal surface of proximal tubular cells</span></p>"
        },
        {
          "id": 385831,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduction in urinary cyclic AMP (cAMP) excretion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is a direct renal tubular effect resulting from the action of parathyroid hormone (PTH)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4965409",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Enhanced calcium reabsorption in the distal convoluted tubule</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Parathyroid hormone (PTH) acts on both the proximal convoluted tubule (PCT) and the distal convoluted tubule (DCT), but it produces different effects in each.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Actions in the distal convoluted tubule (DCT):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the DCT, PTH increases the reabsorption of calcium from the urine back into the blood.</span></li><li><span style=\"font-size:14.0pt;\">It regulates the transcellular calcium absorption by controlling the activity of specialized calcium channels in the DCT and connecting tubule cells.</span></li><li><span style=\"font-size:14.0pt;\">It also increases the expression of these calcium-transporting proteins, including TRPV5, the apical calcium channel.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Actions in the proximal convoluted tubule (PCT):</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>In contrast to its effects on calcium in the DCT, PTH has two main actions on the PCT:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Inhibits phosphate reabsorption:&nbsp;</strong>PTH decreases the reabsorption of phosphate,→ more phosphate excretion in the urine. It does this by reducing the number of sodium-phosphate cotransporters in the apical membrane of the PCT cells.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stimulates vitamin D activation:&nbsp;PTH upregulates the activity of the enzyme 1-alpha-hydroxylase in the PCT. This enzyme is responsible for converting inactive vitamin D into its active form, calcitriol. The active form of vitamin D then promotes calcium absorption in the intestines.&nbsp;</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Parathyroid hormone (PTH)</strong> regulates <strong>calcium and phosphate balance</strong> through its actions on <strong>bone</strong>, <strong>kidney</strong>, and <strong>intestine</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>In the kidney, PTH:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Increases calcium reabsorption</strong> in the <strong>distal convoluted tubule (DCT)</strong>, thereby reducing calcium excretion.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Decreases phosphate reabsorption</strong> in the <strong>proximal convoluted tubule (PCT)</strong> by inhibiting <strong>Na⁺/phosphate cotransporters</strong>, promoting <strong>phosphaturia</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Stimulates 1α-hydroxylase</strong> in the <strong>proximal tubule</strong>, increasing production of <strong>1,25-dihydroxyvitamin D (calcitriol)</strong>, which enhances intestinal calcium absorption.</span></li><li><span style=\"font-size:14.0pt;\">Activates <strong>adenylate cyclase</strong>, increasing <strong>cAMP</strong>, which is excreted in urine — so <strong>urinary cAMP levels rise</strong> during PTH action.</span></li></ol><ul><li><span style=\"font-size:14.0pt;\">Thus, the key renal tubular effect is <strong>enhanced calcium reabsorption in the distal tubule</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Suppression of 1α-hydroxylase activity in the proximal tubule:</strong> Incorrect. PTH <strong>stimulates</strong>, not suppresses, 1α-hydroxylase activity — leading to increased calcitriol synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Binding of PTH to receptors on the luminal surface of proximal tubular cells:</strong> Incorrect. PTH binds to <strong>basolateral membrane receptors</strong>, not luminal ones, initiating <strong>G-protein–mediated cAMP signaling</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Reduction in urinary cyclic AMP (cAMP) excretion:</strong> Incorrect. PTH <strong>increases adenylate cyclase activity</strong>, producing more cAMP, which diffuses into urine. Therefore, urinary cAMP <strong>increases</strong>, not decreases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Parathyroid hormone (PTH)</strong> enhances <strong>calcium reabsorption in the distal convoluted tubule</strong>, decreases <strong>phosphate reabsorption in the proximal tubule</strong>, and <strong>stimulates 1α-hydroxylase</strong> activity, resulting in elevated <strong>calcitriol production</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It acts via <strong>basolateral membrane receptors</strong> and increases <strong>urinary cAMP</strong> as a marker of renal PTH activity.</span></li></ul>",
      "correct_choice_id": 385829,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96930/NEET_GT__11_NOV_2025_Physiology_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96930/NEET_GT__11_NOV_2025_Physiology_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96948,
      "choices": [
        {
          "id": 385900,
          "text": "<p><span style=\"font-size:14.0pt;\">2 visits</span></p>"
        },
        {
          "id": 385901,
          "text": "<p><span style=\"font-size:14.0pt;\">3 visits</span></p>"
        },
        {
          "id": 385902,
          "text": "<p><span style=\"font-size:14.0pt;\">4 visits</span></p>"
        },
        {
          "id": 385903,
          "text": "<p><span style=\"font-size:14.0pt;\">5 visits</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 15-month-old child presents to a Primary Health Centre with incomplete vaccination status. The child has received BCG at birth, OPV-0 at birth, Pentavalent-1, OPV-1, and Rotavirus-1 at 6 weeks. No further vaccines were given due to family migration. The mother is concerned about catch-up vaccination. According to current immunization guidelines, what is the minimum number of visits required to complete the primary immunization schedule for this child, excluding the measles vaccines?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5205426",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)</strong> <strong>2 visits</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to catch-up immunization guidelines, the minimum visits required are: Visit 1 - OPV-2, fIPV-1, DPT-1 (given in place of Pentavalent as Hib and Hep B component are not recommended beyond one year); Visit 2 - OPV-3, DPT-2, fIPV-2 (after minimum 4-week interval).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hence, 2 visits are sufficient.</span></li><li><span style=\"font-size:14.0pt;\">If the question included measles vaccines, it would require 3 visits as MR-1 needs to be given, and booster doses would follow later.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Catch-up immunization allows simultaneous administration of multiple vaccines when there are no contraindications</span></li><li><span style=\"font-size:14.0pt;\">Minimum intervals between doses must be maintained even in catch-up schedules (4 weeks for most vaccines)</span></li></ul>",
      "correct_choice_id": 385900,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96948/NEET_PG_11_Nov_2025_PSM_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96948/NEET_PG_11_Nov_2025_PSM_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96957,
      "choices": [
        {
          "id": 385936,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 385937,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 385938,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3 only</span></p>"
        },
        {
          "id": 385939,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding snake envenomation and first aid are true?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Pressure immobilization is effective for elapid bites but contraindicated for viper bites.</span></li><li><span style=\"font-size:14.0pt;\">Severe local edema (&gt;30 cm) with respiratory failure indicates severe envenomation.</span></li><li><span style=\"font-size:14.0pt;\">Local incision and suction help remove venom effectively if performed early.</span></li><li><span style=\"font-size:14.0pt;\">Observation for 24 hours is advised in mild envenomation without systemic features.</span></li></ol>",
      "unique_key": "Q1139215",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Pressure immobilization is effective for elapid bites but contraindicated for viper bites:</strong> Pressure immobilization is indeed recommended for <strong>elapid and sea‑snake bites</strong>, where venom absorption primarily occurs via lymphatics. It is <strong>contraindicated in viper bites</strong>, as viper venom is tissue‑destructive and compression increases the risk of local necrosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Severe local edema (&gt;30 cm) with respiratory failure indicates severe envenomation: Severe envenomation</strong> is characterized by <strong>extensive edema (&gt; 30 cm)</strong>, marked pain, erythema, and systemic toxicity (e.g., hypotension, paresthesias, coma, or respiratory failure).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Observation for 24 hours is advised in mild envenomation without systemic features:</strong> If a patient presents several hours after a bite with only <strong>mild local swelling and no systemic findings</strong>, observation for <strong>at least 24 hours</strong> with vital sign and oxygen monitoring is warranted.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Local incision and suction help remove venom effectively if performed early:&nbsp;</strong>Incorrect. Incision, suction, or cryotherapy are obsolete and dangerous practices. They can cause <strong>local hemorrhage, infection, and nerve injury</strong>, and do not effectively remove venom.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Pressure immobilization</strong> delays venom spread through lymphatic compression and is indicated for <strong>elapid</strong> and <strong>sea‑snake</strong> bites, <strong>not for vipers</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Observation for 24 hours</strong> is adequate for mild envenomation without systemic toxicity.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Incision, suction, or cauterization</strong> should <strong>never</strong> be performed in snakebite management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Management of snake bite -&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111324.jpg\" width=\"769\" height=\"791\"></strong></span></p>",
      "correct_choice_id": 385936,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96957/NEET_GT__11_NOV_2025_FMT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96957/NEET_GT__11_NOV_2025_FMT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97201,
      "choices": [
        {
          "id": 386904,
          "text": "<p><span style=\"font-size:14.0pt;\">Mask ventilation</span></p>"
        },
        {
          "id": 386905,
          "text": "<p><span style=\"font-size:14.0pt;\">Laryngeal mask airway (LMA)</span></p>"
        },
        {
          "id": 386906,
          "text": "<p><span style=\"font-size:14.0pt;\">Tracheostomy</span></p>"
        },
        {
          "id": 386907,
          "text": "<p><span style=\"font-size:14.0pt;\">Nasotracheal intubation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male patient is brought to the casualty with maxillofacial trauma after a road traffic accident (RTA). He has altered consciousness and desaturation. A clear liquid discharge is coming from his nostrils. What is the preferred method of securing a definitive airway for this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3867582",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Tracheostomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients with severe maxillofacial trauma are highly likely to experience severe airway compromise or obstruction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In such cases, intubation is necessary to maintain airway competency. Given the presence of facial trauma, tracheostomy is the preferred method as it bypasses the obstructed upper airway by creating an opening and placing a stoma in the anterior wall of the trachea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mask ventilation:&nbsp;</strong>Mask ventilation is often difficult in patients with facial trauma due to structural damage and may not provide a secure airway.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Laryngeal mask airway (LMA):&nbsp;</strong>LMA can be used temporarily but is not ideal for long-term airway management in patients with facial trauma as it does not protect against aspiration and may be dislodged.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Nasotracheal intubation:&nbsp;</strong>Nasotracheal intubation is contraindicated in patients with facial trauma due to the risk of further injury to the nasal and facial structures. History is suggestive of CSF rhinorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tracheostomy</strong> is the preferred method for securing the airway in patients with severe maxillofacial trauma.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mask ventilation</strong> and <strong>LMA</strong> may be used temporarily but do not provide a secure airway.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Nasotracheal intubation</strong> is contraindicated in facial trauma due to the risk of further injury.</span></li></ul>",
      "correct_choice_id": 386906,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97201/NEET_GT__11_NOV_2025_Surgery_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97201/NEET_GT__11_NOV_2025_Surgery_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96925,
      "choices": [
        {
          "id": 385808,
          "text": "<p><span style=\"font-size:14.0pt;\">Acetylcholine released from myenteric fibers</span></p>"
        },
        {
          "id": 385809,
          "text": "<p><span style=\"font-size:14.0pt;\">Dopamine released from adrenergic fibers</span></p>"
        },
        {
          "id": 385810,
          "text": "<p><span style=\"font-size:14.0pt;\">Vasoactive intestinal peptide (VIP)</span></p>"
        },
        {
          "id": 385811,
          "text": "<p><span style=\"font-size:14.0pt;\">Substance P</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old man undergoes manometry to evaluate dysphagia. As the bolus moves through the lumen, the intestinal segment distal to the bolus shows relaxation before the advancing wave arrives. Which neurotransmitter is primarily responsible for mediating this relaxation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2651703",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Vasoactive intestinal peptide (VIP)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During <strong>peristalsis</strong>, a bolus of food causes two coordinated responses:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Contraction behind the bolus</strong> – mediated by excitatory neurotransmitters (acetylcholine, substance P).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Relaxation ahead of the bolus</strong> – mediated by <strong>inhibitory neurotransmitters</strong>, especially <strong>VIP (vasoactive intestinal peptide)</strong> and <strong>nitric oxide (NO)</strong> released from myenteric plexus neurons.</span></li></ol></li><li><span style=\"font-size:14.0pt;\">This relaxation ensures that the lumen distal to the bolus is open, allowing smooth propulsion of the food bolus through the gastrointestinal tract.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the neurotransmitter responsible for relaxation distal to the bolus is <strong>VIP</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Acetylcholine released from myenteric fibers:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Acetylcholine is an <strong>excitatory neurotransmitter</strong> in the gut.</span></li><li><span style=\"font-size:14.0pt;\">It mediates <strong>contraction behind the bolus</strong>, not relaxation distal to it.</span></li><li><span style=\"font-size:14.0pt;\">Hence, this statement is incorrect in the context of distal relaxation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dopamine released from adrenergic fibers:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Dopamine and adrenergic input generally <strong>decrease overall gut motility</strong>, but they are <strong>not responsible for the localized relaxation distal to the bolus during peristalsis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This option is incorrect.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Substance P:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Substance P is an <strong>excitatory neurotransmitter</strong> in the enteric nervous system, working with acetylcholine to cause contraction <strong>proximal to the bolus</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It does not mediate relaxation distal to the bolus.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Relaxation of the intestinal segment distal to a bolus of food during peristalsis is mediated by vasoactive intestinal peptide (VIP) released from inhibitory neurons of the myenteric plexus.</span></p>",
      "correct_choice_id": 385810,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96925/NEET_GT__11_NOV_2025_Physiology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96925/NEET_GT__11_NOV_2025_Physiology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96971,
      "choices": [
        {
          "id": 385992,
          "text": "<p><span style=\"font-size:14.0pt;\">ii and iv</span></p>"
        },
        {
          "id": 385993,
          "text": "<p><span style=\"font-size:14.0pt;\">i, ii, and iv</span></p>"
        },
        {
          "id": 385994,
          "text": "<p><span style=\"font-size:14.0pt;\">i and iii</span></p>"
        },
        {
          "id": 385995,
          "text": "<p><span style=\"font-size:14.0pt;\">iii and iv</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The fibers of the internal oblique and transversus abdominis muscles contribute to which specific walls of the inguinal canal?</span></p><p><br><span style=\"font-size:14.0pt;\">i. Anterior wall </span></p><p><span style=\"font-size:14.0pt;\">ii. Roof </span></p><p><span style=\"font-size:14.0pt;\">iii. Floor </span></p><p><span style=\"font-size:14.0pt;\">iv. Posterior wall</span></p>",
      "unique_key": "Q6489969",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) ii and iv</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>inguinal canal</strong> is an oblique passage in the lower anterior abdominal wall, extending from the <strong>deep inguinal ring</strong> to the <strong>superficial inguinal ring</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its boundaries are formed by several muscular and fascial structures:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>ii. Roof:</strong> Formed by the <strong>arching fibers of the internal oblique and transversus abdominis muscles</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>iv. Posterior wall:</strong> Formed primarily by the <strong>transversalis fascia</strong>, but reinforced medially by the <strong>conjoint tendon</strong>, which is derived from the <strong>lower fibers of the internal oblique and transversus abdominis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>i. Anterior wall:</strong> Formed mainly by the <strong>aponeurosis of the external oblique</strong> and reinforced laterally by the <strong>internal oblique</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>iii. Floor:</strong> Formed by the <strong>inguinal ligament</strong> and <strong>lacunar ligament</strong> medially.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thus, the <strong>fibers of the internal oblique and transversus abdominis muscles</strong> contribute to both the <strong>roof</strong> (by their arching fibers) and the <strong>posterior wall</strong> (through the conjoint tendon).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20131507.jpg\" width=\"867\" height=\"589\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>internal oblique and transversus abdominis muscles</strong> form the <strong>roof and posterior wall</strong> of the inguinal canal, reinforcing it and helping prevent inguinal hernia formation.</span></p>",
      "correct_choice_id": 385992,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96971/NEET_GT__11_NOV_2025_Anatomy_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96971/NEET_GT__11_NOV_2025_Anatomy_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97052,
      "choices": [
        {
          "id": 386316,
          "text": "<p><span style=\"font-size:14.0pt;\">BP of 169/100 mmHg</span></p>"
        },
        {
          "id": 386317,
          "text": "<p><span style=\"font-size:14.0pt;\">History of ischemic stroke &lt;3 months prior to admission</span></p>"
        },
        {
          "id": 386318,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspirin use</span></p>"
        },
        {
          "id": 386319,
          "text": "<p><span style=\"font-size:14.0pt;\">Prior history of peptic ulcer disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old man with hypertension, diabetes, and a recent ischemic stroke presents with chest pain and is found to have anterior STEMI at a non-PCI-capable hospital; he had a stroke 1 month ago and peptic ulcer disease 9 years ago. Which of the following is an absolute contraindication to fibrinolytic therapy?</span></p>",
      "unique_key": "Q5252969",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) History of ischemic stroke &lt;3 months prior to admission</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Fibrinolytic therapy is absolutely contraindicated in patients with an ischemic stroke within the past 3 months because of the high risk of life-threatening intracranial hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\">Hypertension can be lowered safely before fibrinolysis if below critical levels.</span></li><li><span style=\"font-size:14.0pt;\">Aspirin use is routine and not a contraindication.</span></li><li><span style=\"font-size:14.0pt;\">Prior peptic ulcer disease without recent bleeding is only a relative, not absolute, contraindication.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recent ischemic stroke (≤3 months) is an absolute contraindication to fibrinolytic therapy in STEMI. Such patients should be transferred for PCI even if it requires a substantial delay.</span></p>",
      "correct_choice_id": 386317,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97052/Neet_Gt__11_Nov_2025_Medicine_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97052/Neet_Gt__11_Nov_2025_Medicine_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97438,
      "choices": [
        {
          "id": 387848,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassure; gross motor delay is common and self-limited</span></p>"
        },
        {
          "id": 387849,
          "text": "<p><span style=\"font-size:14.0pt;\">Order brain MRI urgently</span></p>"
        },
        {
          "id": 387850,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer for early intervention and assess for neuromuscular disorder</span></p>"
        },
        {
          "id": 387851,
          "text": "<p><span style=\"font-size:14.0pt;\">Check plasma ammonia for urea cycle defect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-month-old infant cannot sit without support and continues to have head lag. Social smile was achieved at 2 months and babbling at 6 months. What is the most appropriate next step?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5253101",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Refer for early intervention and assess for neuromuscular disorder</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">By 9 months, a child should be able to sit without support.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Persistent head lag and inability to sit independently at this age are red flags for motor delay, suggesting possible neuromuscular weakness or central motor dysfunction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early referral for developmental evaluation and intervention is critical to prevent further delay.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A thorough neurological and neuromuscular examination should be performed, including assessment of tone, reflexes, and serum creatine kinase (CK) levels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Reassure; gross motor delay is common and self-limited:</strong> Incorrect. Isolated gross motor delay at 9 months is not normal and should not be dismissed as self-limited.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Order brain MRI urgently:</strong> Incorrect. Brain MRI is not the initial step unless there are focal neurological deficits or regression; clinical and neuromuscular assessment comes first.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Check plasma ammonia for urea cycle defect:</strong> Incorrect. Urea cycle disorders present earlier with encephalopathy, vomiting, or lethargy, not isolated gross motor delay.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Failure to sit unsupported and persistent head lag at 9 months are early signs of gross motor delay.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Prompt referral for early developmental intervention and evaluation for neuromuscular disorders is essential.</span></li></ul>",
      "correct_choice_id": 387850,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97438/NEET_GT__11_NOV_2025_Pediatrics_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97438/NEET_GT__11_NOV_2025_Pediatrics_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97012,
      "choices": [
        {
          "id": 386156,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucose 6-phosphate</span></p>"
        },
        {
          "id": 386157,
          "text": "<p><span style=\"font-size:14.0pt;\">Fructose 6-phosphate</span></p>"
        },
        {
          "id": 386158,
          "text": "<p><span style=\"font-size:14.0pt;\">Galactose 1-phosphate</span></p>"
        },
        {
          "id": 386159,
          "text": "<p><span style=\"font-size:14.0pt;\">UDP-glucose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man comes to the clinic for evaluation of fatigue and muscle weakness after prolonged fasting. The physician explains that during fasting, the body maintains blood glucose through glycogen breakdown and gluconeogenesis, while glucose utilization occurs via glycolysis during feeding. Which key metabolic intermediate acts as a central link between these three pathways — glycolysis, gluconeogenesis, and glycogenolysis — allowing smooth interconversion between glucose utilization and glucose production depending on the body’s energy needs?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1306539",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Glucose 6-phosphate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Glucose 6-phosphate (G6P) is the common metabolic intermediate that connects glycolysis, gluconeogenesis, and glycogenolysis.</span></li><li><span style=\"font-size:14.0pt;\">In glycolysis, G6P is converted to fructose 6-phosphate, eventually leading to pyruvate and ATP production.</span></li><li><span style=\"font-size:14.0pt;\">In gluconeogenesis, G6P is generated from non-carbohydrate precursors (like lactate, glycerol, amino acids) and can be converted back to free glucose by the enzyme glucose-6-phosphatase in the liver and kidney.</span></li><li><span style=\"font-size:14.0pt;\">In glycogenolysis, glycogen phosphorylase releases glucose-1-phosphate from glycogen, which is then converted to G6P by phosphoglucomutase.</span></li><li><span style=\"font-size:14.0pt;\">Hence, G6P serves as a crucial metabolic crossroad for carbohydrate metabolism.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Fructose 6-phosphate:&nbsp;</strong>Involved in glycolysis and gluconeogenesis, but not directly in glycogenolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Galactose 1-phosphate:&nbsp;</strong>Participates in galactose metabolism, not in the three main glucose pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. UDP-glucose:&nbsp;</strong>A key intermediate in glycogenesis (glycogen synthesis), not glycolysis or gluconeogenesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Glucose-6-phosphate is the central metabolic hub linking glycolysis, gluconeogenesis, and glycogenolysis—allowing rapid switching between glucose utilization and production.</span></p>",
      "correct_choice_id": 386156,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97012/NEET_GT__11_NOV_2025_Biochemistry_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97012/NEET_GT__11_NOV_2025_Biochemistry_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97027,
      "choices": [
        {
          "id": 386216,
          "text": "<p><span style=\"font-size:14.0pt;\">Cyclic progesterone therapy</span></p>"
        },
        {
          "id": 386217,
          "text": "<p><span style=\"font-size:14.0pt;\">Levonorgestrel-releasing intrauterine system (LNG-IUS)</span></p>"
        },
        {
          "id": 386218,
          "text": "<p><span style=\"font-size:14.0pt;\">Total hysterectomy with bilateral salpingo-oophorectomy</span></p>"
        },
        {
          "id": 386219,
          "text": "<p><span style=\"font-size:14.0pt;\">Endometrial ablation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old nulliparous woman on tamoxifen therapy for breast cancer presents with postmenopausal bleeding. Transvaginal ultrasound shows endometrial thickness of 12 mm. Endometrial biopsy reveals complex endometrial hyperplasia with atypia. What is the most appropriate management for this patient?&nbsp;</span></p>",
      "unique_key": "Q4961171",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Total hysterectomy with bilateral salpingo-oophorectomy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This <strong>42-year-old postmenopausal woman</strong> on <strong>tamoxifen therapy</strong> presents with <strong>postmenopausal bleeding</strong> and <strong>endometrial biopsy</strong> showing <strong>complex endometrial hyperplasia with atypia</strong> (also known as <strong>endometrial intraepithelial neoplasia</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key considerations:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Tamoxifen</strong> acts as a <strong>selective estrogen receptor modulator (SERM)</strong> — it is <strong>anti-estrogenic in breast tissue</strong> but <strong>estrogenic on the endometrium</strong>, predisposing to <strong>endometrial hyperplasia and carcinoma</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Complex hyperplasia with atypia</strong> carries a <strong>high risk (up to 30–40%) of progression to endometrial carcinoma</strong> or concurrent carcinoma.</span></li><li><span style=\"font-size:14.0pt;\">In a <strong>postmenopausal woman</strong> who has completed childbearing, the <strong>definitive and most appropriate management</strong> is <strong>total hysterectomy with bilateral salpingo-oophorectomy (BSO)</strong> to remove both the uterus and ovaries (which are the sources of estrogen).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Therefore, given her <strong>postmenopausal status</strong>, <strong>tamoxifen use</strong>, and <strong>hyperplasia with atypia</strong>, <strong>total hysterectomy with BSO</strong> is the best management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Cyclic progesterone therapy:&nbsp;</strong>Incorrect. Cyclic oral progesterone can be used in <strong>premenopausal women</strong> or those <strong>desiring fertility</strong>, to reverse <strong>simple or complex hyperplasia without atypia</strong>. However, in <strong>postmenopausal women with atypia</strong>, it is inadequate and unsafe, as it does not eliminate the malignancy risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Levonorgestrel-releasing intrauterine system (LNG-IUS):&nbsp;</strong>Incorrect. LNG-IUS may be considered for <strong>hyperplasia without atypia</strong> or for women wishing to <strong>preserve fertility</strong>. However, with <strong>atypical hyperplasia</strong> in a <strong>postmenopausal woman</strong>, surgical management (hysterectomy) is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Endometrial ablation:&nbsp;</strong>Incorrect. Endometrial ablation destroys the endometrial lining but <strong>does not remove the source of malignancy</strong> and <strong>precludes histologic follow-up</strong>. It is <strong>contraindicated</strong> in the presence of <strong>atypia or suspected malignancy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>postmenopausal women</strong> (especially those on <strong>tamoxifen</strong>) with <strong>complex endometrial hyperplasia with atypia</strong>, the <strong>most appropriate management</strong> is <strong>total hysterectomy with bilateral salpingo-oophorectomy</strong>, as there is a <strong>high risk of progression to or coexistence with endometrial carcinoma</strong>.</span></p>",
      "correct_choice_id": 386218,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97027/NEET_GT__11_NOV_2025_OBG_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97027/NEET_GT__11_NOV_2025_OBG_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97048,
      "choices": [
        {
          "id": 386300,
          "text": "<p><span style=\"font-size:14.0pt;\">Patient with known epilepsy</span></p>"
        },
        {
          "id": 386301,
          "text": "<p><span style=\"font-size:14.0pt;\">Focal neurologic findings</span></p>"
        },
        {
          "id": 386302,
          "text": "<p><span style=\"font-size:14.0pt;\">Altered mental status</span></p>"
        },
        {
          "id": 386303,
          "text": "<p><span style=\"font-size:14.0pt;\">Papilledema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following scenarios does not require head imaging prior to lumbar puncture?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4473565",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Patient with known epilepsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a patient with <strong>known epilepsy</strong>, if they present with a seizure that is consistent with their usual pattern, <strong>head imaging</strong> is generally <strong>not required</strong> prior to lumbar puncture (LP), as the seizure may be part of their pre-existing condition.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The lack of new or atypical findings in the clinical presentation typically makes imaging unnecessary.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In contrast, <strong>new-onset seizures</strong>, <strong>focal neurologic findings</strong>, and <strong>papilledema</strong> are all situations where head imaging is essential to rule out serious underlying causes, such as a space-occupying lesion, infection, or increased intracranial pressure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Focal neurologic findings</strong>: Focal neurologic signs (e.g., weakness, visual changes, speech difficulties) are often associated with structural lesions such as tumors or abscesses. <strong>Head imaging</strong> is crucial in such cases to identify potential intracranial pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Altered mental status:</strong> Patients with altered consciousness may have intracranial pathology, such as mass lesion, hemorrhage, or increased intracranial pressure; imaging is always indicated before LP.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Papilledema</strong>: <strong>Papilledema</strong> suggests increased intracranial pressure, which can result from space-occupying lesions, infections, or hemorrhage. Imaging is critical to assess the cause before performing an LP to avoid worsening of the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">While <strong>head imaging</strong> is routinely required before performing an LP in cases of new-onset seizure, focal neurologic findings, and papilledema, it is <strong>not always needed</strong> in patients with <strong>known epilepsy</strong> unless the seizure pattern is atypical or concerning for a new underlying cause.</span></p>",
      "correct_choice_id": 386300,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97048/NEET_GT__11_NOV_2025_Medicine_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97048/NEET_GT__11_NOV_2025_Medicine_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97031,
      "choices": [
        {
          "id": 386232,
          "text": "<p><span style=\"font-size:14.0pt;\">Central (GnRH-dependent) due to hypothalamic hamartoma</span></p>"
        },
        {
          "id": 386233,
          "text": "<p><span style=\"font-size:14.0pt;\">Peripheral (GnRH-independent) due to ovarian tumor</span></p>"
        },
        {
          "id": 386234,
          "text": "<p><span style=\"font-size:14.0pt;\">Peripheral (GnRH-independent) due to McCune-Albright syndrome</span></p>"
        },
        {
          "id": 386235,
          "text": "<p><span style=\"font-size:14.0pt;\">Central (GnRH-dependent) due to CNS pathology</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old girl presents with breast development, irregular vaginal bleeding, and multiple café-au-lait spots with irregular borders. X-ray shows polyostotic fibrous dysplasia. Which type of precocious puberty does this represent?&nbsp;</span></p>",
      "unique_key": "Q9254659",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Peripheral (GnRH-independent) due to McCune-Albright syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>6-year-old girl</strong> with <strong>breast development</strong>, <strong>irregular vaginal bleeding</strong>, and <strong>multiple café-au-lait spots with irregular borders</strong>, plus <strong>X-ray shows polyostotic fibrous dysplasia</strong>, fits the classic triad of <strong>McCune-Albright syndrome</strong> (GNAS activating mutation): (1) <strong>polyostotic fibrous dysplasia</strong>, (2) <strong>café-au-lait spots with irregular (“coast of Maine”) borders</strong>, and (3) <strong>endocrinopathies</strong> such as <strong>precocious puberty</strong> from autonomous ovarian estrogen production.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In McCune-Albright, sex-steroid production is <strong>Peripheral (GnRH-independent)</strong>—gonadotropin-releasing hormone (<strong>GnRH</strong>) is not the driver, so LH/FSH are low or suppressed, and a <strong>GnRH stimulation test</strong> is non-centrally responsive.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the presentation—<strong>breast development</strong>, <strong>irregular vaginal bleeding</strong>, <strong>multiple café-au-lait spots with irregular borders</strong>, and <strong>polyostotic fibrous dysplasia</strong> in a <strong>6-year-old girl</strong>—indicates <strong>Peripheral (GnRH-independent) due to McCune-Albright syndrome</strong>, matching option <strong>C</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Central (GnRH-dependent) due to hypothalamic hamartoma:&nbsp;</strong>Incorrect. While <strong>central (GnRH-dependent)</strong> causes (e.g., <strong>hypothalamic hamartoma</strong>) can produce <strong>precocious puberty</strong> with <strong>breast development</strong> and <strong>irregular vaginal bleeding</strong> in a <strong>6-year-old girl</strong>, the hallmark <strong>multiple café-au-lait spots with irregular borders</strong> and <strong>X-ray shows polyostotic fibrous dysplasia</strong> are not features of a hypothalamic hamartoma; these point instead to <strong>McCune-Albright syndrome</strong> and thus a <strong>Peripheral (GnRH-independent)</strong> mechanism, not <strong>Central</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Peripheral (GnRH-independent) due to ovarian tumor:&nbsp;</strong>Incorrect. An <strong>ovarian tumor</strong> can cause <strong>Peripheral (GnRH-independent)</strong> estrogen excess with <strong>breast development</strong> and <strong>irregular vaginal bleeding</strong> in a <strong>6-year-old girl</strong>, but it does <strong>not</strong> explain the characteristic <strong>multiple café-au-lait spots with irregular borders</strong> and <strong>polyostotic fibrous dysplasia on X-ray</strong>; that specific combination is typical of <strong>McCune-Albright syndrome</strong>, not an isolated tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Central (GnRH-dependent) due to CNS pathology:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:14.0pt;\">Generic <strong>CNS pathology</strong> (central lesions) causing <strong>Central (GnRH-dependent)</strong> pubertal activation could present with <strong>breast development</strong> and <strong>irregular vaginal bleeding</strong> at <strong>6 years</strong>, but the coexisting <strong>multiple café-au-lait spots with irregular borders</strong> and <strong>polyostotic fibrous dysplasia</strong> on <strong>X-ray</strong> identify <strong>McCune-Albright syndrome</strong>, which is <strong>Peripheral (GnRH-independent)</strong> rather than <strong>Central</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">McCune-Albright syndrome (café-au-lait spots with irregular borders + polyostotic fibrous dysplasia) causes peripheral, GnRH-independent precocious puberty.</span></p>",
      "correct_choice_id": 386234,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97031/NEET_GT__11_NOV_2025_OBG_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97031/NEET_GT__11_NOV_2025_OBG_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97250,
      "choices": [
        {
          "id": 387096,
          "text": "<p><span style=\"font-size:14.0pt;\">Oral vancomycin</span></p>"
        },
        {
          "id": 387097,
          "text": "<p><span style=\"font-size:14.0pt;\">Topical mupirocin</span></p>"
        },
        {
          "id": 387098,
          "text": "<p><span style=\"font-size:14.0pt;\">IV ceftriaxone</span></p>"
        },
        {
          "id": 387099,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhaled colistin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old healthcare worker in NICU is found to have MRSA colonization in the anterior nares during routine screening. She is asymptomatic. What is the most appropriate treatment for decolonization?</span></p>",
      "unique_key": "Q9210909",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Topical mupirocin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Topical mupirocin (or bacitracin) is the drug of choice for MRSA colonization prophylaxis in asymptomatic carriers, particularly nasal colonization.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It acts by inhibiting bacterial protein synthesis by blocking isoleucyl-tRNA synthetase.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For nasal MRSA carriers, especially healthcare workers, topical application to anterior nares effectively decolonizes and prevents transmission without systemic side effects.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This prevents progression to active MRSA infection and protects vulnerable patients in NICU settings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Oral vancomycin:</strong> Vancomycin is the drug of choice for active MRSA infections, not colonization. Oral vancomycin is primarily used for Clostridium difficile colitis (pseudomembranous colitis) as it is not absorbed systemically. For MRSA colonization, oral vancomycin would be ineffective and inappropriate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. IV ceftriaxone:</strong> Ceftriaxone is a third-generation cephalosporin that is ineffective against MRSA due to altered penicillin-binding proteins in methicillin-resistant strains. MRSA, by definition, is resistant to all beta-lactam antibiotics including cephalosporins except 5th generation cephalosporins like ceftaroline.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Inhaled colistin:&nbsp;</strong>Colistin (polymyxin E) is reserved for superbug infections caused by NDM (New Delhi metallo-beta-lactamase) producing bacteria and multidrug-resistant Gram-negative organisms. It is not indicated for MRSA colonization and would represent inappropriate antimicrobial use with risk of toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Topical mupirocin is the drug of choice for decolonization of asymptomatic MRSA nasal carriers, while vancomycin is reserved for active MRSA infections.</span></p>",
      "correct_choice_id": 387097,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97250/NEET_GT__11_NOV_2025_Pharmacology_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97250/NEET_GT__11_NOV_2025_Pharmacology_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97198,
      "choices": [
        {
          "id": 386892,
          "text": "<p><span style=\"font-size:14.0pt;\">Intravesical BCG</span></p>"
        },
        {
          "id": 386893,
          "text": "<p><span style=\"font-size:14.0pt;\">Systemic chemotherapy</span></p>"
        },
        {
          "id": 386894,
          "text": "<p><span style=\"font-size:14.0pt;\">Radical cystectomy</span></p>"
        },
        {
          "id": 386895,
          "text": "<p><span style=\"font-size:14.0pt;\">TURBT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old male smoker presents with painless hematuria. Further investigation reveals bladder cancer extending up to the muscle layer. What should be the treatment of choice for this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3492278",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Radical cystectomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Radical cystectomy is the standard treatment for muscle-invasive bladder cancer.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It involves the removal of the bladder and surrounding tissues/organs (such as prostate in men and uterus in women), and it provides the best chance for long-term survival and disease control.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Intravesical BCG:</strong> Intravesical BCG is typically used for non-muscle invasive bladder cancer (NMIBC). It is effective in reducing recurrence and progression of superficial bladder cancer but is not adequate for muscle-invasive disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Systemic chemotherapy:</strong> While systemic chemotherapy can be used as part of the treatment plan, especially in a neoadjuvant setting (before surgery) or for metastatic disease, it is not the primary treatment of choice for muscle-invasive bladder cancer without metastatic disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. TURBT:&nbsp;</strong>Transurethral resection of bladder tumours is used in non-muscle invasive tumors. It is not the first-line treatment for muscle-invasive bladder cancer when the patient is otherwise healthy and a surgical candidate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">For muscle-invasive bladder cancer, the treatment of choice is radical cystectomy, which involves the removal of the bladder and surrounding tissues to achieve the best long-term outcomes.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Painless hematuria in a smoker is highly suggestive of bladder carcinoma and should prompt thorough evaluation.</span></li></ul>",
      "correct_choice_id": 386894,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97198/NEET_GT__11_NOV_2025_Surgery_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97198/NEET_GT__11_NOV_2025_Surgery_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97234,
      "choices": [
        {
          "id": 387036,
          "text": "<p><span style=\"font-size:14.0pt;\">Second generation H₁ antihistamines cross the blood-brain barrier and cause significant sedation</span></p>"
        },
        {
          "id": 387037,
          "text": "<p><span style=\"font-size:14.0pt;\">Promethazine has the maximum anticholinergic action among first generation antihistamines</span></p>"
        },
        {
          "id": 387038,
          "text": "<p><span style=\"font-size:14.0pt;\">Terfenadine and Astemizole were withdrawn due to QT prolongation</span></p>"
        },
        {
          "id": 387039,
          "text": "<p><span style=\"font-size:14.0pt;\">First generation H₁ antihistamines are useful in drug-induced Parkinsonism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following are true about H₁ antihistamines,&nbsp;except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6496636",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Second generation H₁ antihistamines cross the blood-brain barrier and cause significant sedation.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Second generation H₁ antihistamines represent a significant pharmacological advancement over their predecessors precisely because they do not cross the blood-brain barrier to any appreciable extent.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This fundamental pharmacokinetic property eliminates the CNS depressant effects, allowing patients to use these medications without experiencing sedation, impaired psychomotor performance, or reduced alertness.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Drugs like cetirizine, loratadine, fexofenadine, and desloratadine maintain their peripheral antihistaminic efficacy while sparing central nervous system function, making them suitable for patients who need to drive vehicles or operate machinery requiring constant attention.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Promethazine has the maximum anticholinergic action among first generation antihistamines:</strong> Among first generation antihistamines, promethazine demonstrates the most pronounced anticholinergic activity. This property contributes to its side effect profile including dry mouth, urinary hesitancy, constipation, and blurred vision. The strong anticholinergic action also explains its utility beyond simple antihistaminic effects, including use as an antiemetic and in managing extrapyramidal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Terfenadine and Astemizole were withdrawn due to QT prolongation:</strong> Both terfenadine and astemizole were withdrawn from the market due to their propensity to cause QT interval prolongation, particularly when combined with CYP3A4 inhibitors such as ketoconazole, erythromycin, or ciprofloxacin. These drugs, remembered by the mnemonic \"CAT drugs\" (Cisapride, Astemizole, Terfenadine - \"Cat is cute = QT prolongation\"), posed significant cardiac safety concerns. Fexofenadine, the active metabolite of terfenadine, was subsequently developed and does not carry this cardiac risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. First generation H₁ antihistamines are useful in drug-induced Parkinsonism:&nbsp;</strong>First generation H₁ antihistamines possess significant anticholinergic properties that make them therapeutically useful in managing drug-induced Parkinsonism and acute muscular dystonia. The anticholinergic activity helps restore the dopamine-acetylcholine balance disrupted by antipsychotic medications. Additionally, these agents find application in common cold symptoms and motion sickness prophylaxis due to their combined antihistaminic and anticholinergic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Second generation H₁ antihistamines are characterized by their inability to cross the BBB, providing effective peripheral antihistaminic action without CNS sedation, unlike first generation agents which have extensive central and anticholinergic effects.</span></p>",
      "correct_choice_id": 387036,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97234/NEET_GT__11_NOV_2025_Pharmacology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97234/NEET_GT__11_NOV_2025_Pharmacology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97042,
      "choices": [
        {
          "id": 386276,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform standard LASIK surgery</span></p>"
        },
        {
          "id": 386277,
          "text": "<p><span style=\"font-size:14.0pt;\">Offer PRK surgery</span></p>"
        },
        {
          "id": 386278,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer for SMILE procedure</span></p>"
        },
        {
          "id": 386279,
          "text": "<p><span style=\"font-size:14.0pt;\">Consider Implantable Collamer Lens (ICL) placement</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old woman with stable myopia for the past 2 years presents for refractive correction. Her current prescription is −10.5D. On examination, her central corneal thickness is 475 microns. She has no history of systemic illness. What is the most appropriate next step in her refractive correction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5476824",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Consider Implantable Collamer Lens (ICL) placement</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">LASIK requires a minimum corneal thickness of &gt;500 microns (with a residual stromal bed ≥270 microns).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A thickness &lt;470 microns is an absolute contraindication. At 475 microns, LASIK and SMILE are relatively contraindicated due to insufficient safety margin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">PRK may be attempted in borderline thin corneas, but at high corrections (−10.5D), it would require ablating over 120 microns (12-15 microns per D), which is unsafe.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thus, ICL, a phakic intraocular lens implanted over the native lens, is safest and preferred for high myopia with thin corneas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Perform standard LASIK surgery:</strong> Unsafe, as the corneal thickness is &lt;500 microns. LASIK requires sufficient tissue for flap creation and ablation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Offer PRK surgery:</strong> PRK is an option in thinner corneas but not preferred for high myopia (−10.5D), due to risk of excessive tissue loss and haze.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Refer for SMILE procedure:</strong> SMILE also removes corneal tissue and would be inappropriate with a borderline thickness and high refractive demand.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">ICL is the preferred correction method for high myopia in patients with thin corneas (&lt;500 µm) where LASIK or PRK are unsafe.</span></p>",
      "correct_choice_id": 386279,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97042/Neet_Gt__11_Nov_2025_Opthalmology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97042/Neet_Gt__11_Nov_2025_Opthalmology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97237,
      "choices": [
        {
          "id": 387048,
          "text": "<p><span style=\"font-size:14.0pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 387049,
          "text": "<p><span style=\"font-size:14.0pt;\">Vildagliptin</span></p>"
        },
        {
          "id": 387050,
          "text": "<p><span style=\"font-size:14.0pt;\">Saxagliptin</span></p>"
        },
        {
          "id": 387051,
          "text": "<p><span style=\"font-size:14.0pt;\">Linagliptin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old patient with chronic kidney disease stage 5 requires treatment for Type 2 diabetes mellitus. Which DPP-4 inhibitor can be safely administered without dose adjustment in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7634573",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)</strong> <strong>Linagliptin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Linagliptin is the only DPP-4 inhibitor that is safe in renal failure without requiring dose adjustment because it is primarily metabolized in the liver rather than being excreted by the kidneys.</span></li><li><span style=\"font-size:14.0pt;\">All other DPP-4 inhibitors (sitagliptin, vildagliptin, saxagliptin, alogliptin, saxagliptin) are contraindicated or require dose adjustment in renal failure.</span></li><li><span style=\"font-size:14.0pt;\">DPP-4 inhibitors work by inhibiting the enzyme dipeptidyl peptidase-4, which normally degrades endogenous GLP-1, thereby potentiating insulin release and decreasing glucagon secretion.</span></li><li><span style=\"font-size:14.0pt;\">These drugs do not cause hypoglycemia or weight gain, and the most common side effect is nasopharyngitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Sitagliptin:</strong> It is incorrect because sitagliptin is primarily excreted unchanged in urine (renal clearance) and requires dose adjustment in CKD. It undergoes non-covalent binding to DPP-4.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vildagliptin:</strong> It is incorrect because vildagliptin undergoes both hepatic and renal clearance and requires dose modification in renal failure. It causes covalent binding to DPP-4.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Saxagliptin:</strong> It is incorrect because saxagliptin is also contraindicated in renal failure and requires dose adjustment. It is partially renally excreted.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Linagliptin is the only DPP-4 inhibitor safe in renal failure without dose adjustment due to hepatic metabolism rather than renal excretion.</span></p>",
      "correct_choice_id": 387051,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97237/NEET_GT__11_NOV_2025_Pharmacology_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97237/NEET_GT__11_NOV_2025_Pharmacology_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96977,
      "choices": [
        {
          "id": 386016,
          "text": "<p><span style=\"font-size:18px;\">Mallory–Denk bodies are composed of cytokeratin intermediate filaments</span></p>"
        },
        {
          "id": 386017,
          "text": "<p><span style=\"font-size:18px;\">It may progress to micronodular cirrhosis&nbsp;</span></p>"
        },
        {
          "id": 386018,
          "text": "<p><span style=\"font-size:18px;\">It is a reversible stage of alcohol-induced injury&nbsp;</span></p>"
        },
        {
          "id": 386019,
          "text": "<p><span style=\"font-size:18px;\">The inflammatory infiltrate is predominantly lymphocytic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 45-year-old chronic alcoholic presents with fatigue and hepatomegaly. Lab tests show elevated AST &gt; ALT (AST:ALT ratio &gt;2:1). Liver biopsy reveals Mallory–Denk bodies and neutrophilic infiltration. All of the following are correct about the lesion except:&nbsp;</span></p>",
      "unique_key": "Q7139804",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) The inflammatory infiltrate is predominantly lymphocytic</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This vignette describes <strong>alcoholic hepatitis</strong> in a <strong>45-year-old chronic alcoholic</strong> with <strong>AST &gt; ALT (typically &gt;2:1)</strong>, <strong>hepatomegaly</strong>, and biopsy showing <strong>Mallory–Denk bodies</strong> with <strong>neutrophilic</strong> infiltration.&nbsp;</span></li><li><span style=\"font-size:18px;\">In alcoholic hepatitis, the inflammatory infiltrate is <strong>predominantly neutrophilic (polymorphonuclear)</strong>, not lymphocytic—therefore <strong>option D is incorrect</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Mallory–Denk bodies are composed of cytokeratin intermediate filaments&nbsp;</strong>True.&nbsp;They are eosinophilic cytoplasmic inclusions formed by <strong>damaged cytokeratin intermediate filaments</strong> within hepatocytes.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. It may progress to micronodular cirrhosis:&nbsp;</strong>True.&nbsp;Chronic alcohol injury can progress from <strong>steatosis → alcoholic hepatitis → micronodular (Laennec) cirrhosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. It is a reversible stage of alcohol-induced injury:&nbsp;</strong>True.<strong>&nbsp;</strong>Unlike cirrhosis, <strong>alcoholic hepatitis</strong> can show <strong>clinical and histologic improvement</strong> with <strong>abstinence</strong> and appropriate therapy, though severe cases carry high short-term mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In <strong>alcoholic hepatitis</strong>, expect <strong>AST:ALT&gt;2</strong>, <strong>Mallory–Denk bodies</strong>, <strong>ballooning degeneration</strong>, and a <strong>predominantly neutrophilic</strong> inflammatory infiltrate; disease may progress to <strong>micronodular cirrhosis</strong> if alcohol use continues.</span></p>",
      "correct_choice_id": 386019,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96977/Neet_Gt__11_Nov_2025_Pathology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96977/Neet_Gt__11_Nov_2025_Pathology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96988,
      "choices": [
        {
          "id": 386060,
          "text": "<p><span style=\"font-size:14.0pt;\">1–a, 2–b, 3–c, 4–d</span></p>"
        },
        {
          "id": 386061,
          "text": "<p><span style=\"font-size:14.0pt;\">1–b, 2–a, 3–c, 4–d</span></p>"
        },
        {
          "id": 386062,
          "text": "<p><span style=\"font-size:14.0pt;\">1–d, 2–a, 3–b, 4–c</span></p>"
        },
        {
          "id": 386063,
          "text": "<p><span style=\"font-size:14.0pt;\">1–b, 2–c, 3–a, 4–d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the automated system with its corresponding detection method. Which of the following is the correct matching?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20100357.jpg\" width=\"835\" height=\"335\"></span></p>",
      "unique_key": "Q5539259",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1–b, 2–a, 3–c, 4–d</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>1–b. BACTEC → Fluorescence detection:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Detects bacterial growth by measuring fluorescence produced when CO₂ generated by microorganisms reacts with a fluorescent dye.</span></li><li><span style=\"font-size:14.0pt;\">Earlier BACTEC models used radioisotopes, but modern systems are non-radioactive and fully automated.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Application</strong>: Blood cultures and mycobacterial detection.</span></li></ul></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>2–a. VITEK MS → Mass spectrometry (MALDI‑TOF):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Uses Matrix‑Assisted Laser Desorption/Ionization – Time of Flight (MALDI‑TOF) mass spectrometry.</span></li><li><span style=\"font-size:14.0pt;\">Identifies bacteria, fungi, and mycobacteria by analyzing their unique protein spectra.</span></li><li><span style=\"font-size:14.0pt;\">Provides identification within minutes and eliminates the need for traditional biochemical tests.</span></li></ul></li></ul><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>3–c. VersaTREK → Manometry (Pressure detection):</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Measures pressure changes caused by gas exchange (CO₂ production or O₂ consumption) in a sealed culture bottle.</span></li><li><span style=\"font-size:14.0pt;\">The pressure alteration is detected by manometric sensors, signaling microbial growth.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Advantage</strong>: Sensitive for both aerobic and anaerobic organisms.</span></li></ul></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>4–d. BacT/ALERT → Colorimetric pH sensor:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Detects microbial growth through color change caused by acid production.</span></li><li><span style=\"font-size:14.0pt;\">CO₂ released by growing microbes diffuses into a color‑sensitive membrane at the bottom of the bottle, turning the sensor from blue‑green to yellow.</span></li><li><span style=\"font-size:14.0pt;\">The system continuously monitors changes, providing real‑time detection without manual intervention.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20100433.jpg\" width=\"1230\" height=\"481\"></strong></span></p>",
      "correct_choice_id": 386061,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96988/NEET_GT__11_NOV_2025_Microbiology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96988/NEET_GT__11_NOV_2025_Microbiology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97045,
      "choices": [
        {
          "id": 386288,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer 4 Factor PCC</span></p>"
        },
        {
          "id": 386289,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer 10 mg oral vitamin K</span></p>"
        },
        {
          "id": 386290,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer fresh frozen plasma</span></p>"
        },
        {
          "id": 386291,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer platelet transfusion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">An 88-year-old woman with coronary artery disease (status post CABG), atrial fibrillation on warfarin, hypertension, heart failure with preserved ejection fraction, and chronic kidney disease presents with altered mental status after a mechanical fall. On examination, she is somnolent but arousable. Noncontrast head CT reveals a 2-cm subdural hematoma with midline shift. Her INR is 3.2. What is the most appropriate next step in her management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2870692",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Administer 4 Factor PCC</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has a life-threatening intracranial hemorrhage while on chronic warfarin therapy. The priority in her management is rapid and effective reversal of warfarin-induced anticoagulation.</span></li><li><span style=\"font-size:14.0pt;\">4F-PCC provides all vitamin K-dependent clotting factors (II, VII, IX, and X) and offers the fastest and most reliable correction of coagulopathy, which is critical in cases of major bleeding like subdural hematoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Administer 10 mg oral vitamin K:</strong> Vitamin K is necessary for sustained reversal but has a delayed onset and does not address the urgent need for hemostasis. It should be administered in conjunction with rapid reversal agents for complete effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Administer fresh frozen plasma:</strong> Fresh frozen plasma is a less effective alternative, as it requires larger volumes, takes longer to administer, and may not achieve the same degree of rapid INR normalization as 4F-PCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Administer platelet transfusion:</strong> Platelet transfusion is only indicated in patients with significant thrombocytopenia or concurrent antiplatelet therapy-not for isolated warfarin-induced coagulopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For acute, major bleeding in a patient receiving warfarin (e.g., intracranial hemorrhage), immediate reversal with 4-factor prothrombin complex concentrate is the recommended therapy to rapidly restore coagulation; vitamin K should be co-administered to ensure sustained reversal. Other agents like FFP or platelets are reserved for specific situations or when PCC is unavailable.</span></p>",
      "correct_choice_id": 386288,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97045/NEET_GT__11_NOV_2025_Medicine_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97045/NEET_GT__11_NOV_2025_Medicine_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97436,
      "choices": [
        {
          "id": 387840,
          "text": "<p><span style=\"font-size:14.0pt;\">Recurrence is negligible and no future screening is needed</span></p>"
        },
        {
          "id": 387841,
          "text": "<p><span style=\"font-size:14.0pt;\">Recurrence risk may be increased; future pregnancies merit targeted renal imaging</span></p>"
        },
        {
          "id": 387842,
          "text": "<p><span style=\"font-size:14.0pt;\">Recurrence is guaranteed if the next fetus is male</span></p>"
        },
        {
          "id": 387843,
          "text": "<p><span style=\"font-size:14.0pt;\">Risk is solely maternal age-dependent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A woman with a previous pregnancy complicated by Potter sequence due to bilateral renal agenesis seeks counseling about recurrence risk. Which of the following statements is most accurate?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1225350",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Recurrence risk may be increased; future pregnancies merit targeted renal imaging</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">While most cases of bilateral renal agenesis leading to Potter sequence occur sporadically, some may have a genetic or familial component (autosomal dominant or recessive renal malformation syndromes).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, future pregnancies carry a small but definite recurrence risk.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early targeted ultrasonography focusing on renal development and amniotic fluid volume is recommended, along with genetic counseling and testing when indicated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Recurrence is negligible and no future screening is needed:</strong> Incorrect. Recurrence is not negligible; proactive screening is essential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Recurrence is guaranteed if the next fetus is male:</strong> Incorrect. Renal agenesis is not sex-linked and does not depend on fetal sex.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Risk is solely maternal age-dependent:</strong> Incorrect. The risk is not related to maternal age but rather to possible hereditary factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">After a fetus is affected by Potter sequence due to bilateral renal agenesis, genetic counseling and targeted renal imaging in subsequent pregnancies are essential to identify possible recurrence early.</span></p>",
      "correct_choice_id": 387841,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97436/NEET_GT__11_NOV_2025_Pediatrics_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97436/NEET_GT__11_NOV_2025_Pediatrics_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97003,
      "choices": [
        {
          "id": 386120,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic aneurysm</span></p>"
        },
        {
          "id": 386121,
          "text": "<p><span style=\"font-size:14.0pt;\">Neurofibromatosis</span></p>"
        },
        {
          "id": 386122,
          "text": "<p><span style=\"font-size:14.0pt;\">Lymphadenopathy</span></p>"
        },
        {
          "id": 386123,
          "text": "<p><span style=\"font-size:14.0pt;\">Cretinism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old man undergoes spinal imaging for evaluation of back pain. A lateral X-ray of the spine reveals posterior scalloping of multiple vertebral bodies. Which of the following conditions is associated with this radiologic finding?&nbsp;</span></p>",
      "unique_key": "Q2367823",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Neurofibromatosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Neurofibromatosis type 1 (NF1)</strong> is the most classically associated condition with <strong>posterior scalloping of vertebral bodies</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This scalloping results from <strong>dural ectasia</strong> and <strong>intraspinal neurofibromas</strong>, which cause chronic pressure against the posterior aspect of the vertebral bodies.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In NF1, additional skeletal manifestations include kyphoscoliosis, vertebral dysplasia, and rib penciling.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aortic aneurysm:&nbsp;</strong>This can cause <strong>anterior</strong> vertebral body erosion due to pulsatile mass effect, not <strong>posterior scalloping</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lymphadenopathy:&nbsp;</strong>Chronic paraspinal lymphadenopathy (e.g., tuberculosis or lymphoma) may affect the vertebral margins, but it more commonly causes <strong>anterior or lateral erosion</strong> rather than posterior scalloping.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cretinism:&nbsp;</strong>Seen in congenital hypothyroidism, it leads to delayed bone maturation, metaphyseal dysplasia, and epiphyseal dysgenesis — <strong>posterior vertebral scalloping is not a feature</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Posterior vertebral body scalloping</strong> is most commonly associated with <strong>neurofibromatosis type 1</strong>, due to intraspinal tumor growth or dural ectasia causing chronic pressure on the vertebrae.</span></p>",
      "correct_choice_id": 386121,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97003/NEET_GT__11_NOV_2025_Radiology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97003/NEET_GT__11_NOV_2025_Radiology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96960,
      "choices": [
        {
          "id": 385948,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 385949,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4</span></p>"
        },
        {
          "id": 385950,
          "text": "<p><span style=\"font-size:14.0pt;\">4 and 5</span></p>"
        },
        {
          "id": 385951,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding the prevertebral fascia, which of the following statements are incorrect?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">It forms the axillary fascia by extending laterally around the subclavian vessels and brachial plexus.</span></li><li><span style=\"font-size:14.0pt;\">It covers the phrenic nerve as it descends on the anterior surface of the scalenus anterior.</span></li><li><span style=\"font-size:14.0pt;\">It contributes to the floor of the posterior triangle of the neck.</span></li><li><span style=\"font-size:14.0pt;\">It forms the false capsule of the thyroid gland.</span></li><li><span style=\"font-size:14.0pt;\">It fuses inferiorly with the pretracheal fascia to form the carotid sheath.</span></li></ol>",
      "unique_key": "Q5204823",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 4 and 5</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>prevertebral fascia</strong> surrounds the prevertebral muscles and extends laterally as the <strong>axillary sheath</strong> enclosing the subclavian vessels and brachial plexus → <strong>Statement 1 is correct.</strong></span></li><li><span style=\"font-size:14.0pt;\">It <strong>covers the phrenic nerve</strong> on the anterior surface of the scalenus anterior → <strong>Statement 2 is correct.</strong></span></li><li><span style=\"font-size:14.0pt;\">It <strong>forms the floor of the posterior triangle</strong> of the neck → <strong>Statement 3 is correct.</strong></span></li><li><span style=\"font-size:14.0pt;\">The <strong>false capsule of the thyroid gland</strong> is formed by the <strong>pretracheal fascia</strong>, not the prevertebral fascia → <strong>Statement 4 is incorrect.</strong></span></li><li><span style=\"font-size:14.0pt;\">The <strong>carotid sheath</strong> receives contributions from all three deep cervical fasciae (investing, pretracheal, and prevertebral), but it is <strong>not formed by fusion inferiorly</strong> → <strong>Statement 5 is incorrect.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111436.jpg\" width=\"1024\" height=\"663\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>prevertebral fascia</strong> forms the <strong>floor of the posterior triangle</strong>, <strong>covers the phrenic nerve</strong>, and <strong>extends laterally to form the axillary sheath</strong>, but <strong>does not form the false capsule of the thyroid gland</strong>, which arises from the <strong>pretracheal fascia</strong>.</span></p>",
      "correct_choice_id": 385950,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96960/NEET_GT__11_NOV_2025_Anatomy_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96960/NEET_GT__11_NOV_2025_Anatomy_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97260,
      "choices": [
        {
          "id": 387136,
          "text": "<p><span style=\"font-size:14.0pt;\">APGAR score</span></p>"
        },
        {
          "id": 387137,
          "text": "<p><span style=\"font-size:14.0pt;\">ASA physical status classification</span></p>"
        },
        {
          "id": 387138,
          "text": "<p><span style=\"font-size:14.0pt;\">Mallampati score</span></p>"
        },
        {
          "id": 387139,
          "text": "<p><span style=\"font-size:14.0pt;\">Aldrete score</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old man has undergone a day care laparoscopic hernia repair. What scoring system is typically used to assess when a patient is ready for discharge from the post-anesthesia care unit (PACU) following day care surgery?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2010553",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Aldrete score</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Aldrete scoring system</strong> is commonly used to assess when a patient has <strong>recovered from the physiological effects of anesthesia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It considers <strong>five parameters</strong>: <strong>consciousness, respiration, circulation, oxygen saturation, and color, mobility and sensation of extremities</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A score of <strong>9 or 10</strong> (out of a maximum of 10) is usually required for a patient to be considered <strong>ready for discharge from the PACU</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A</strong>. <strong>APGAR score:</strong> This is a <strong>quick scoring system</strong> used to <strong>assess the physical status</strong> of a <strong>newborn immediately after birth</strong>. It's not relevant for assessing recovery from anesthesia in adults.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. ASA physical status classification:</strong> This is used to assess a <strong>patient's overall health</strong> status <strong>prior to anesthesia</strong>, but it's not used for assessing recovery from anesthesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>Mallampati score</strong>: This is used to <strong>predict the ease of intubation</strong>, but it's not used for assessing recovery from anesthesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Aldretescore</strong> is a <strong>common scoring system</strong> employed to assess a patient's <strong>readiness</strong> for <strong>discharge</strong> from the <strong>Post-Anesthesia Care Unit (PACU)</strong> after day care surgery, considering parameters such as <strong>consciousness</strong>, <strong>oxygen saturation</strong>, <strong>hemodynamic stability</strong>, <strong>respiratory status</strong>, and <strong>ability</strong> to <strong>move</strong>.</span></p>",
      "correct_choice_id": 387139,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97260/NEET_GT__11_NOV_2025_Anesthesia_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97260/NEET_GT__11_NOV_2025_Anesthesia_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97236,
      "choices": [
        {
          "id": 387044,
          "text": "<p><span style=\"font-size:14.0pt;\">Carbimazole</span></p>"
        },
        {
          "id": 387045,
          "text": "<p><span style=\"font-size:14.0pt;\">Methimazole</span></p>"
        },
        {
          "id": 387046,
          "text": "<p><span style=\"font-size:14.0pt;\">Propylthiouracil</span></p>"
        },
        {
          "id": 387047,
          "text": "<p><span style=\"font-size:14.0pt;\">Radioactive iodine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old pregnant woman at 8 weeks gestation is diagnosed with Graves' disease. She is started on an antithyroid drug. Which drug is preferred during the first trimester of pregnancy?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2249507",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)</strong> <strong>Propylthiouracil</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Propylthiouracil (PTU) is the drug of choice in the first trimester of pregnancy for treating hyperthyroidism because it has less placental transfer compared to carbimazole/methimazole due to higher plasma protein binding.</span></li><li><span style=\"font-size:14.0pt;\">PTU inhibits thyroid peroxidase (blocking iodination and coupling reactions) and additionally inhibits peripheral conversion of T4 to T3 by D1-type 5-deiodinase.</span></li><li><span style=\"font-size:14.0pt;\">While both PTU and carbimazole can cause congenital malformations (choanal atresia and aplasia cutis), PTU is preferred in the first trimester due to reduced fetal exposure.</span></li><li><span style=\"font-size:14.0pt;\">In the second and third trimesters, carbimazole or methimazole can be used as they are more potent and require less frequent dosing.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Carbimazole:</strong> Is incorrect because carbimazole has greater placental transfer than PTU and is thus avoided in the first trimester. It is approximately 5 times more potent than PTU and is preferred in the second and third trimesters.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Methimazole:</strong> Is incorrect because methimazole (the active form of carbimazole) also crosses the placenta more readily than PTU and is avoided in early pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Radioactive iodine:</strong> Is incorrect because radioactive iodine (I-131) is absolutely contraindicated in pregnancy as it crosses the placenta and destroys the fetal thyroid, causing cretinism and other abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Propylthiouracil is the antithyroid drug of choice in the first trimester of pregnancy due to less placental transfer; switch to carbimazole in later trimesters.</span></p>",
      "correct_choice_id": 387046,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97236/NEET_GT__11_NOV_2025_Pharmacology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97236/NEET_GT__11_NOV_2025_Pharmacology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97193,
      "choices": [
        {
          "id": 386872,
          "text": "<p><span style=\"font-size:14.0pt;\">Splenic infarct</span></p>"
        },
        {
          "id": 386873,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute pancreatitis</span></p>"
        },
        {
          "id": 386874,
          "text": "<p><span style=\"font-size:14.0pt;\">Gall stone disease</span></p>"
        },
        {
          "id": 386875,
          "text": "<p><span style=\"font-size:14.0pt;\">Amoebic liver abscess</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 20-year-old female presented to the hospital with a history of recurrent pain in the righ tHypochondrium for 1 week, typically after fatty meals. She is a known case of hereditary spherocytosis. What is the likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q9136606",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Gall stone disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In patients with hemolytic disorders, black pigment stones are seen in the gall bladder, which are likely to block cystic duct and cause biliary colic or cholecystitis.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20112011.jpg\" width=\"714\" height=\"744\"></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Splenic infarct:&nbsp;</strong>May occur in sickle cell disease and will present with LUQ pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Acute pancreatitis:</strong> Patient with Acute Pancreatitis presents with severe epigastric pain radiating to the back. Lab investigations reveal increase serum amylase and lipase levels. Its management is mainly supportive care with adequate analgesia, IV Fluid therapy and oxygen administration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Amoebic liver abscess:</strong> Patients with amoebic liver abscess are mostly asymptomatic. There is usually a history of dysentery with mucus in stools. It is caused by E. histolytica and on aspiration, pus with Anchovy-sauce appearance is obtained.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hemolytic disorders with RUQ pain is likely to be due to gall stones and will be confirmed by USG abdomen.</span></p>",
      "correct_choice_id": 386874,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97193/NEET_GT__11_NOV_2025_Surgery_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97193/NEET_GT__11_NOV_2025_Surgery_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96934,
      "choices": [
        {
          "id": 385844,
          "text": "<p><span style=\"font-size:14.0pt;\">Prospective cohort study</span></p>"
        },
        {
          "id": 385845,
          "text": "<p><span style=\"font-size:14.0pt;\">Case-control study</span></p>"
        },
        {
          "id": 385846,
          "text": "<p><span style=\"font-size:14.0pt;\">Cross-sectional study</span></p>"
        },
        {
          "id": 385847,
          "text": "<p><span style=\"font-size:14.0pt;\">Randomized controlled trial</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher wants to investigate whether prolonged exposure to indoor air pollution from biomass fuel cooking is associated with chronic obstructive pulmonary disease (COPD) in rural women aged 40-60 years. The study needs to be completed within 2 years with limited funding, and the prevalence of COPD in this population is approximately 8%. Which epidemiological study design would be most appropriate for this research question?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3611711",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)&nbsp;Case-control study</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Given the constraints of limited time (2 years), limited funding, and a relatively low disease prevalence (8%), a case-control study is the most appropriate design.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Case-control studies are efficient for studying diseases with low prevalence as they start with diseased individuals (cases) and compare their exposure history with healthy controls.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This design is cost-effective, time-efficient, and suitable for studying chronic diseases like COPD where the outcome has already occurred.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The retrospective nature allows investigation of past exposure to biomass fuel, making it ideal for this research scenario.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Prospective cohort study:</strong> Prospective cohort study would require following subjects over many years to develop COPD, exceeding the 2-year timeline and budget constraints.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cross-sectional study:</strong> Cross-sectional study cannot establish temporal relationship between biomass fuel exposure and COPD development, limiting causal inference.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Randomized controlled trial:</strong> Randomized controlled trial is unethical as it would involve deliberately exposing subjects to harmful biomass fuel pollution.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Case-control studies are optimal for investigating rare diseases or outcomes with low prevalence and for studying chronic diseases where exposure occurred in the past</span></li><li><span style=\"font-size:14.0pt;\">Time and budget constraints significantly influence the choice of epidemiological study design</span></li><li><span style=\"font-size:14.0pt;\">Study design selection must consider ethical feasibility, especially when dealing with harmful exposures</span></li></ul>",
      "correct_choice_id": 385845,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96934/NEET_PG_11_Nov_2025_PSM_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96934/NEET_PG_11_Nov_2025_PSM_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97007,
      "choices": [
        {
          "id": 386136,
          "text": "<p><span style=\"font-size:14.0pt;\">Thumb printing</span></p>"
        },
        {
          "id": 386137,
          "text": "<p><span style=\"font-size:14.0pt;\">Serrated mucosa</span></p>"
        },
        {
          "id": 386138,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased mucosal fold thickness</span></p>"
        },
        {
          "id": 386139,
          "text": "<p><span style=\"font-size:14.0pt;\">Dilution of barium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 68-year-old man undergoes a barium enema for evaluation of lower abdominal pain and rectal bleeding. Which of the following findings is not<strong>&nbsp;</strong>typically associated with ischemic colitis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4848742",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Dilution of barium</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Ischemic colitis</strong> occurs due to reduced blood flow to the colon, leading to mucosal edema, hemorrhage, and ulceration.</span></li><li><span style=\"font-size:14.0pt;\">Typical radiologic findings on barium enema include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Thumb-printing</strong> — due to submucosal edema or hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Serrated or saw-tooth mucosal pattern</strong> — due to mucosal irregularity and ulceration.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Increased mucosal fold thickness</strong> — reflecting submucosal edema and inflammation.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Dilution of barium</strong> is <strong>not</strong> a feature of ischemic colitis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It occurs in <strong>malabsorption syndromes</strong> or conditions with increased intestinal secretions, where the contrast becomes less dense due to dilution by fluid.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recognize that <strong>thumb printing, serrated mucosa, and increased mucosal fold thickness</strong> are characteristic radiologic features of <strong>ischemic colitis</strong>, while <strong>dilution of barium</strong> suggests <strong>malabsorption or secretory intestinal disorders</strong>, not ischemia.</span></p>",
      "correct_choice_id": 386139,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97007/NEET_GT__11_NOV_2025_Radiology_Question_5_L7cmZk4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97007/NEET_GT__11_NOV_2025_Radiology_Question_5_L7cmZk4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97016,
      "choices": [
        {
          "id": 386172,
          "text": "<p><span style=\"font-size:14.0pt;\">Glyceraldehyde-3-phosphate dehydrogenase</span></p>"
        },
        {
          "id": 386173,
          "text": "<p><span style=\"font-size:14.0pt;\">Phosphoglucomutase</span></p>"
        },
        {
          "id": 386174,
          "text": "<p><span style=\"font-size:14.0pt;\">Lactate dehydrogenase</span></p>"
        },
        {
          "id": 386175,
          "text": "<p><span style=\"font-size:14.0pt;\">Glucokinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy is brought to the emergency department with complaints of vomiting, sweating, and dizziness after consuming a large quantity of fruit juice. Biochemical testing shows accumulation of fructose-1-phosphate in the liver, indicating a metabolic block in the fructose catabolic pathway. In a healthy individual, fructose is metabolized in the liver through a series of reactions that ultimately lead to the production of pyruvate. Which of the following enzymes is directly involved in the catabolism of fructose to pyruvate in the liver?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6857542",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Glyceraldehyde-3-phosphate dehydrogenase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the <strong>liver</strong>, fructose is metabolized primarily through the <strong>fructolysis pathway</strong>, which is distinct from glycolysis in its initial steps:</span><ol><li><span style=\"font-size:14.0pt;\"><strong>Fructose → Fructose-1-phosphate</strong></span><br><span style=\"font-size:14.0pt;\">(Enzyme: Fructokinase)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fructose-1-phosphate → Glyceraldehyde + Dihydroxyacetone phosphate (DHAP)</strong></span><br><span style=\"font-size:14.0pt;\">(Enzyme: Aldolase B)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Glyceraldehyde → Glyceraldehyde-3-phosphate (G3P)</strong></span><br><span style=\"font-size:14.0pt;\">(Enzyme: Triose kinase)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Glyceraldehyde-3-phosphate → 1,3-bisphosphoglycerate → ... → Pyruvate</strong></span><br><span style=\"font-size:14.0pt;\">(Enzyme: Glyceraldehyde-3-phosphate dehydrogenase and other glycolytic enzymes)</span></li></ol></li><li><span style=\"font-size:14.0pt;\">Thus, <strong>glyceraldehyde-3-phosphate dehydrogenase</strong> plays a <strong>direct role</strong> in converting <strong>G3P to 1,3-bisphosphoglycerate</strong>, a key step in the <strong>conversion of fructose-derived carbons into pyruvate</strong>.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Phosphoglucomutase:&nbsp;</strong>Catalyzes the interconversion of <strong>glucose-1-phosphate and glucose-6-phosphate</strong> during <strong>glycogen metabolism</strong>, <strong>not involved</strong> in fructose catabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lactate dehydrogenase:&nbsp;</strong>Converts <strong>pyruvate ↔ lactate</strong> during <strong>anaerobic glycolysis</strong>, but acts <strong>after</strong> fructose has already been converted to pyruvate — not in fructose breakdown itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Glucokinase:&nbsp;</strong>Phosphorylates <strong>glucose → glucose-6-phosphate</strong> in the <strong>first step of glycolysis</strong>, <strong>not fructose</strong>.</span><br><span style=\"font-size:14.0pt;\">In the liver, fructose is phosphorylated by <strong>fructokinase</strong>, not glucokinase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hereditary Fructose Intolerance (Aldolase B deficiency)</strong> → accumulation of <strong>fructose-1-phosphate</strong>, leading to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hypoglycemia</strong> (inhibition of glycogenolysis and gluconeogenesis)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Vomiting</strong>, <strong>lactic acidosis</strong>, <strong>liver dysfunction</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">Avoiding fructose, sucrose, and sorbitol in the diet prevents symptoms.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Key Concept Table:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20110303.jpg\" width=\"1165\" height=\"553\"></strong></span></p>",
      "correct_choice_id": 386172,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97016/NEET_GT__11_NOV_2025_Biochemistry_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97016/NEET_GT__11_NOV_2025_Biochemistry_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97030,
      "choices": [
        {
          "id": 386228,
          "text": "<p><span style=\"font-size:14.0pt;\">Prophylactic cervical cerclage at 14 weeks</span></p>"
        },
        {
          "id": 386229,
          "text": "<p><span style=\"font-size:14.0pt;\">Strassman metroplasty before 12 weeks</span></p>"
        },
        {
          "id": 386230,
          "text": "<p><span style=\"font-size:14.0pt;\">Expectant management with regular antenatal follow-up</span></p>"
        },
        {
          "id": 386231,
          "text": "<p><span style=\"font-size:14.0pt;\">Termination of pregnancy and correction of anomaly before attempting conception</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman with known uterine didelphys conceives naturally and is now at 8 weeks gestation. Ultrasound confirms intrauterine pregnancy in the right uterine cavity. What is the most appropriate obstetric management for this patient?&nbsp;</span></p>",
      "unique_key": "Q5886859",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Expectant management with regular antenatal follow-up</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>25-year-old woman</strong> with <strong>known uterine didelphys</strong> who <strong>conceives naturally</strong> and is <strong>now at 8 weeks gestation</strong>, with <strong>ultrasound</strong> confirming <strong>intrauterine pregnancy in the right uterine cavity</strong>, is best managed with <strong>expectant management with regular antenatal follow-up</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In <strong>uterine didelphys</strong>, many pregnancies progress normally; the key is close surveillance for miscarriage, preterm birth, malpresentation, and cervical length, rather than routine intervention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because there is no prior history provided of cervical insufficiency and the pregnancy is already <strong>intrauterine</strong> and viable in the <strong>right uterine cavity</strong>, the <strong>most appropriate obstetric management for this patient</strong> is conservative.</span></li><li><span style=\"font-size:14.0pt;\">Uterine didelphys is associated with a good reproductive outcome and hence normal antenatal care is to be offered. Complications like abortions, preterm and malpresentations are slightly increased in uterine didelphys</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Prophylactic cervical cerclage at 14 weeks:&nbsp;</strong>Incorrect. Routine <strong>prophylactic cervical cerclage at 14 weeks</strong> is <strong>not</strong> indicated solely for <strong>uterine didelphys</strong>; it is reserved for proven or suspected cervical insufficiency (eg, prior mid-trimester losses or a short cervix).&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Strassman metroplasty before 12 weeks:&nbsp;</strong>Incorrect. <strong>Strassman metroplasty before 12 weeks</strong> is a unification surgery used for <strong>bicornuate</strong> uterus and is <strong>not</strong> performed during an established pregnancy; moreover, it is <strong>not</strong> the standard correction for <strong>uterine didelphys</strong>. With a confirmed <strong>intrauterine pregnancy</strong> at <strong>8 weeks gestation</strong> in the <strong>right uterine cavity</strong> after she <strong>conceives naturally</strong>, surgery is contraindicated; proceed with <strong>expectant management with regular antenatal follow-up</strong> as the <strong>most appropriate obstetric management for this patient</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Termination of pregnancy and correction of anomaly before attempting conception: </strong>Incorrect. Routine <strong>termination of pregnancy</strong> to “<strong>correct the anomaly before attempting conception</strong>” is <strong>not</strong> recommended for <strong>uterine didelphys</strong> when a viable <strong>intrauterine pregnancy</strong> exists.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>uterine didelphys</strong> with a confirmed <strong>intrauterine pregnancy</strong> (here, <strong>8 weeks gestation</strong> in the <strong>right uterine cavity</strong>), the <strong>most appropriate obstetric management</strong> is <strong>expectant management with regular antenatal follow-up</strong>; <strong>prophylactic cerclage</strong>, <strong>Strassman metroplasty</strong>, or <strong>termination of pregnancy</strong> are <strong>not</strong> routine.</span></p>",
      "correct_choice_id": 386230,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97030/NEET_GT__11_NOV_2025_OBG_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97030/NEET_GT__11_NOV_2025_OBG_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97248,
      "choices": [
        {
          "id": 387088,
          "text": "<p><span style=\"font-size:14.0pt;\">It reversibly inhibits P2Y12 receptors on platelets&nbsp;</span></p>"
        },
        {
          "id": 387089,
          "text": "<p><span style=\"font-size:14.0pt;\">It acts immediately after oral administration&nbsp;</span></p>"
        },
        {
          "id": 387090,
          "text": "<p><span style=\"font-size:14.0pt;\">Omeprazole enhances its antiplatelet effect</span></p>"
        },
        {
          "id": 387091,
          "text": "<p><span style=\"font-size:14.0pt;\">Its antiplatelet effect persists for 5 days after discontinuation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient on long-term clopidogrel therapy requires urgent surgery. Which of the following statements regarding clopidogrel is true?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4613610",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Its antiplatelet effect persists for 5 days after discontinuation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clopidogrel irreversibly blocks P2Y12 purinergic receptors on the platelet surface, preventing ADP-induced platelet aggregation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Since platelets lack nuclei and cannot synthesize new proteins, the effect of clopidogrel lasts for the entire lifespan of affected platelets (approximately 7-10 days).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, clinically significant antiplatelet effect persists for about 5 days after discontinuation because new platelets are continuously being released from bone marrow.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Complete recovery of platelet function requires generation of sufficient numbers of new unaffected platelets.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, clopidogrel should be discontinued at least 5 days before elective surgery to minimize bleeding risk.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It reversibly inhibits P2Y12 receptors on platelets:&nbsp;</strong>Incorrect. Clopidogrel produces irreversible blockade of P2Y12 receptors, not reversible inhibition. This is in contrast to ticagrelor, which is a newer P2Y12 inhibitor that produces reversible blockade and therefore has faster onset and quicker offset of action (t½ = 12 hours). The irreversible nature of clopidogrel's action explains why its effect persists for days after discontinuation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It acts immediately after oral administration:</strong> Incorrect. Clopidogrel is a prodrug that requires metabolic activation in the liver through a two-step process involving CYP2C19. Only about 50% of absorbed drug is activated, while the rest is inactivated by other enzymes. The antiplatelet action takes about 4 hours to start and develops over several days. A loading dose of 300 mg is often given to achieve faster effect. Prasugrel and ticagrelor are faster-acting alternatives.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Omeprazole enhances its antiplatelet effect:</strong> Incorrect. Omeprazole reduces the antiplatelet action of clopidogrel, not enhances it. Omeprazole is a CYP2C19 inhibitor that decreases the metabolic activation of clopidogrel into its active thiol metabolite. This drug interaction can reduce the cardiovascular protective effects of clopidogrel. Pantoprazole and rabeprazole are safer PPI alternatives that do not significantly inhibit CYP2C19.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clopidogrel irreversibly blocks P2Y12 receptors, requires hepatic activation via CYP2C19 (inhibited by omeprazole), and has persistent antiplatelet effect for 5 days after discontinuation, necessitating planned discontinuation before elective surgery.</span></p>",
      "correct_choice_id": 387091,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97248/NEET_GT__11_NOV_2025_Pharmacology_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97248/NEET_GT__11_NOV_2025_Pharmacology_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97026,
      "choices": [
        {
          "id": 386212,
          "text": "<p><span style=\"font-size:14.0pt;\">Progestasert IUD</span></p>"
        },
        {
          "id": 386213,
          "text": "<p><span style=\"font-size:14.0pt;\">Copper-T 380A</span></p>"
        },
        {
          "id": 386214,
          "text": "<p><span style=\"font-size:14.0pt;\">Mala-N</span></p>"
        },
        {
          "id": 386215,
          "text": "<p><span style=\"font-size:14.0pt;\">Depot injection of norethisterone enanthate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 24-year-old lactating woman with an 18-month-old child presents with irregular heavy menstrual bleeding and requests contraceptive advice. She wishes to continue breastfeeding. Which contraceptive method is most appropriate for her?&nbsp;</span></p>",
      "unique_key": "Q9510184",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Mala-N</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This <strong>24-year-old lactating woman</strong> with an <strong>18-month-old child</strong> has <strong>irregular, heavy menstrual bleeding</strong> and requests <strong>contraceptive advice</strong> while continuing <strong>breastfeeding</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The ideal contraceptive for her should:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Not interfere with lactation</strong> (avoid estrogen-containing methods).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Be effective, convenient, and reversible.</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Help regulate or reduce menstrual bleeding.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mala-N</strong> is a combined OCP that fulfills these requirements.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It can be safely used in <strong>lactating women &gt; 6 months&nbsp;</strong>as after 6 months, the baby is not exclusively breast fed. Combined OCPs should be avoided in women who are breast feeding with infants &lt; 6 months</span></li><li><span style=\"font-size:14.0pt;\">It also <strong>reduces menstrual blood loss</strong> and may help with <strong>irregular heavy bleeding</strong> by inducing endometrial atrophy.</span></li><li><span style=\"font-size:14.0pt;\">It provides <strong>three months of contraception per injection</strong> and is part of the <strong>national family welfare program</strong> in India.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thus, <strong>Combined OCPS&nbsp;</strong>is the <strong>most appropriate contraceptive</strong> choice for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Progestasert IUD:&nbsp;</strong>Incorrect. This is a <strong>progesterone-releasing intrauterine device</strong> that must be <strong>replaced annually</strong> and may cause <strong>irregular spotting</strong>. It is <strong>less suitable</strong> for a woman with heavy bleeding and is <strong>less effective long-term</strong> compared to injectables.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Copper-T 380A:&nbsp;</strong>Incorrect. Although safe for <strong>lactating women</strong>, copper IUDs can <strong>increase menstrual bleeding and cramps</strong>, making them <strong>unsuitable</strong> for a woman who already has <strong>heavy irregular periods</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Depot injection of norethisterone enanthate:&nbsp;</strong>Incorrect. While this progestin-only method is also compatible with lactation, it may <strong>worsen irregular bleeding patterns</strong> in some women. The <strong>national program–approved Mala-N</strong> (norethindrone enanthate) is the <strong>standard, safer choice</strong> in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>lactating women</strong> with <strong>irregular or heavy menstrual bleeding</strong>, the best contraceptive option is Combined OCP<strong>, Mala-N)</strong>, as it is <strong>safe for breastfeeding</strong> &gt; 6 months <strong>reduces menstrual loss</strong>, and provides <strong>effective, reversible contraception</strong>.</span></p>",
      "correct_choice_id": 386214,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97026/NEET_GT__11_NOV_2025_OBG_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97026/NEET_GT__11_NOV_2025_OBG_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96991,
      "choices": [
        {
          "id": 386072,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 386073,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 386074,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 386075,
          "text": "<p><span style=\"font-size:14.0pt;\">All statements are correct&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding eggs and diagnostic clues in parasitology are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Eggs of Capillaria philippinensis resemble those of Trichuris trichiura.</span></li><li><span style=\"font-size:14.0pt;\">Trichostrongylus eggs mimic hookworm eggs but larvae show tail-end bead-like swelling.</span></li><li><span style=\"font-size:14.0pt;\">Necator americanus eggs are bile-stained and float in saturated salt solution.</span></li><li><span style=\"font-size:14.0pt;\">Unfertilized eggs of Ascaris lumbricoides do not float in saturated salt solution.</span></li></ol>",
      "unique_key": "Q3219174",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Eggs of Capillaria philippinensis resemble those of Trichuris trichiura:&nbsp;</strong>Correct. Capillaria philippinensis eggs resemble those of Trichuris trichiura — both are barrel-shaped with bipolar plugs, making microscopic differentiation challenging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20134339.jpg\" width=\"831\" height=\"409\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Trichostrongylus eggs mimic hookworm eggs but larvae show tail-end bead-like swelling:&nbsp;</strong>Correct. Trichostrongylus eggs closely resemble hookworm eggs, but their <strong>rhabditiform larvae</strong> have a <strong>characteristic bead-like swelling at the tail end</strong>, which is a diagnostic clue.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20134404.jpg\" width=\"849\" height=\"468\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Unfertilized eggs of Ascaris lumbricoides do not float in saturated salt solution: </strong>Correct. <strong>Unfertilized eggs of Ascaris lumbricoides</strong> are irregular in shape, heavier, and do <strong>not float</strong> in saturated salt solutions — hence used to differentiate in stool exams. The unfertilized eggs settle down as they are heavier.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Necator americanus eggs are bile-stained and float in saturated salt solution:&nbsp;</strong>False. Eggs of Necator americanus are <strong>not bile-stained</strong> — they are <strong>non–bile-stained</strong> and float in saturated salt solution. This error makes this statement incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Remember the unique features:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Capillaria eggs mimic Trichuris,</span></li><li><span style=\"font-size:14.0pt;\">Trichostrongylus larvae show tail bead swelling,</span></li><li><span style=\"font-size:14.0pt;\">Unfertilized Ascaris eggs sink in saturated salt,</span></li><li><span style=\"font-size:14.0pt;\">Necator eggs are <strong>non–bile-stained</strong>, not bile-stained.</span></li></ul>",
      "correct_choice_id": 386072,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96991/NEET_GT__11_NOV_2025_Microbiology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96991/NEET_GT__11_NOV_2025_Microbiology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97063,
      "choices": [
        {
          "id": 386360,
          "text": "<p><span style=\"font-size:14.0pt;\">Attention</span></p>"
        },
        {
          "id": 386361,
          "text": "<p><span style=\"font-size:14.0pt;\">Abstract thinking</span></p>"
        },
        {
          "id": 386362,
          "text": "<p><span style=\"font-size:14.0pt;\">Judgment</span></p>"
        },
        {
          "id": 386363,
          "text": "<p><span style=\"font-size:14.0pt;\">Intelligence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During a mental status examination, a patient is asked, “What is the similarity between a chair and a table?” What aspect of the patient’s mental functioning is being tested?&nbsp;</span></p>",
      "unique_key": "Q3097904",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Abstract thinking</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Abstract thinking</strong> refers to the ability to form <strong>concepts, generalizations, and relationships</strong> between objects or ideas beyond their literal or concrete features.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">It is commonly tested using:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Proverb interpretation:</strong> e.g., explaining the meaning of “People who live in glass houses shouldn’t throw stones.”</span></li><li><span style=\"font-size:14.0pt;\"><strong>Similarity&nbsp;testing:</strong> e.g., “What is the similarity between a chair and a table?”</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A patient demonstrating <strong>abstract thinking</strong> would respond, “Both are pieces of furniture.”</span></p><p><br><span style=\"font-size:14.0pt;\">A patient showing <strong>concrete thinking</strong> (common in schizophrenia and certain organic brain syndromes) might respond, “Both are kept on the floor,” reflecting a literal, non-abstract association.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Attention:</strong> The ability to focus on a specific stimulus, tested using the <strong>digit repetition test</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Judgment:</strong> The ability to make sound decisions in real or hypothetical situations, tested using scenarios like “What would you do if you saw a house on fire?”</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Intelligence:</strong> Tested by assessing <strong>general information and calculation skills</strong>, not by similarity testing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>similarities test</strong> assesses <strong>abstract thinking</strong>, the capacity to identify conceptual relationships—impaired in conditions such as <strong>schizophrenia</strong> and <strong>frontal lobe dysfunction</strong>.</span></p>",
      "correct_choice_id": 386361,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97063/New_GT_Psychiatry_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97063/New_GT_Psychiatry_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97433,
      "choices": [
        {
          "id": 387828,
          "text": "<p><span style=\"font-size:14.0pt;\">OFC is below normal; head ultrasound is indicated immediately</span></p>"
        },
        {
          "id": 387829,
          "text": "<p><span style=\"font-size:14.0pt;\">OFC is normal; remeasure in 24–48 hours to confirm baseline</span></p>"
        },
        {
          "id": 387830,
          "text": "<p><span style=\"font-size:14.0pt;\">OFC is abnormally large; evaluate for hydrocephalus</span></p>"
        },
        {
          "id": 387831,
          "text": "<p><span style=\"font-size:14.0pt;\">OFC cannot be interpreted without parental head sizes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A term male infant (39 weeks) has an occipitofrontal circumference (OFC) of 33.0 cm at 12 hours of life. Pregnancy and delivery were uncomplicated. Weight is 3.0 kg and length 49 cm. Which interpretation is most accurate?&nbsp;</span></p><p>&nbsp;</p>",
      "unique_key": "Q2356495",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) OFC is normal; remeasure in 24–48 hours to confirm baseline.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">At term, the normal occipitofrontal circumference (OFC) ranges from approximately 33–37 cm, with an average around 34–35 cm.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This infant’s OFC of 33 cm is within the lower limit of normal.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because cranial molding from vaginal delivery may transiently alter head shape, OFC should be remeasured after 24–48 hours to establish the true baseline.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>OFC is below normal; head ultrasound is indicated immediately:</strong> Incorrect. OFC of 33 cm is normal; immediate neuroimaging is unnecessary without other abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>OFC is abnormally large; evaluate for hydrocephalus:</strong> Incorrect. Hydrocephalus presents with OFC &gt;37–38 cm at birth, bulging fontanelle, or dilated scalp veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>OFC cannot be interpreted without parental head sizes:</strong> Incorrect. Parental OFC comparison may be useful in borderline or later cases, but this newborn measurement is interpretable now.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In term neonates, OFC averages 34–35 cm (range 33–37 cm).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Initial measurement should be repeated after molding resolves to confirm baseline head size.</span></li></ul>",
      "correct_choice_id": 387829,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97433/NEET_GT__11_NOV_2025_Pediatrics_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97433/NEET_GT__11_NOV_2025_Pediatrics_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97435,
      "choices": [
        {
          "id": 387836,
          "text": "<p><span style=\"font-size:14.0pt;\">Ectopia lentis downward and inward</span></p>"
        },
        {
          "id": 387837,
          "text": "<p><span style=\"font-size:14.0pt;\">Aortic root dilation on echocardiography</span></p>"
        },
        {
          "id": 387838,
          "text": "<p><span style=\"font-size:14.0pt;\">Positive wrist-thumb sign</span></p>"
        },
        {
          "id": 387839,
          "text": "<p><span style=\"font-size:14.0pt;\">Hindfoot valgus with pes planus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A tall 10-year-old has pectus deformity, long limbs, scoliosis, lens dislocation, and developmental delay. Which feature most points away from Marfan and toward homocystinuria?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-11-10%20at%2012.54.12.jpeg\" width=\"431\" height=\"639\"></p>",
      "unique_key": "Q1981145",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ectopia lentis downward and inward</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Lens displacement is typically superotemporal (upward/outward) in Marfan and inferonasal (downward/inward) in homocystinuria; developmental delay also favors homocystinuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Aortic root dilation on echocardiography:</strong> Incorrect. Aortic root dilation supports Marfan.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Positive wrist-thumb sign:</strong> Incorrect. Wrist-thumb sign occurs in both.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Hindfoot valgus with pes planus:</strong> Incorrect. Foot deformities may occur in Marfan; not discriminative.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Inferonasal ectopia lentis and developmental delay suggest homocystinuria rather than Marfan.</span></p>",
      "correct_choice_id": 387836,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97435/NEET_GT__11_NOV_2025_Pediatrics_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97435/NEET_GT__11_NOV_2025_Pediatrics_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97439,
      "choices": [
        {
          "id": 387852,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperinsulinism due to pancreatic islet cell hyperplasia</span></p>"
        },
        {
          "id": 387853,
          "text": "<p><span style=\"font-size:14.0pt;\">Low cortisol from congenital adrenal hypoplasia</span></p>"
        },
        {
          "id": 387854,
          "text": "<p><span style=\"font-size:14.0pt;\">Transient hypoparathyroidism due to maternal diabetes</span></p>"
        },
        {
          "id": 387855,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased IGF-2 causing hypercalcemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A macrosomic neonate with macroglossia and omphalocele develops jitteriness at 2 hours of life. Which mechanism best explains this complication?</span></p>",
      "unique_key": "Q7689697",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Hyperinsulinism due to pancreatic islet cell hyperplasia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The triad of macrosomia, macroglossia, and omphalocele is characteristic of <strong>Beckwith-Wiedemann syndrome (BWS)</strong>, caused by imprinting abnormalities on chromosome <strong>11p15</strong> affecting genes that regulate growth (e.g., IGF-2).</span></li><li><span style=\"font-size:14.0pt;\">These infants often develop <strong>neonatal hypoglycemia</strong> due to <strong>pancreatic islet cell hyperplasia</strong>, which leads to excessive insulin secretion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hyperinsulinism increases glucose uptake, resulting in symptomatic hypoglycemia manifested by jitteriness or seizures.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Low cortisol from congenital adrenal hypoplasia:</strong> Incorrect. Congenital adrenal hypoplasia leads to cortisol deficiency but not associated with macroglossia or omphalocele.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Transient hypoparathyroidism due to maternal diabetes:</strong> Incorrect. Transient neonatal hypocalcemia due to maternal diabetes is unrelated to this syndrome and presents later.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Increased IGF-2 causing hypercalcemia:</strong> Incorrect. IGF-2 overexpression causes overgrowth and tumor predisposition (e.g., Wilms tumor, hepatoblastoma), not hypercalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Beckwith-Wiedemann syndrome results from imprinting defects on chromosome 11p15 and is characterized by macrosomia, macroglossia, omphalocele, and <strong>neonatal hypoglycemia due to hyperinsulinism</strong> from islet cell hyperplasia.</span></p>",
      "correct_choice_id": 387852,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97439/NEET_GT__11_NOV_2025_Pediatrics_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97439/NEET_GT__11_NOV_2025_Pediatrics_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97442,
      "choices": [
        {
          "id": 387864,
          "text": "<p><span style=\"font-size:14.0pt;\">Abdominal ultrasound every 3 months until 8 years, and AFP every 2–3 months until 4 years</span></p>"
        },
        {
          "id": 387865,
          "text": "<p><span style=\"font-size:14.0pt;\">Yearly abdominal ultrasound until adolescence; no AFP needed</span></p>"
        },
        {
          "id": 387866,
          "text": "<p><span style=\"font-size:14.0pt;\">Chest CT every 6 months until 8 years</span></p>"
        },
        {
          "id": 387867,
          "text": "<p><span style=\"font-size:14.0pt;\">Whole-body MRI annually from birth to 8 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Parents ask about cancer screening for their child diagnosed with Beckwith-Wiedemann syndrome (BWS). Which of the following plan aligns with standard surveillance?</span></p>",
      "unique_key": "Q7827656",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Abdominal ultrasound every 3 months until 8 years, and AFP every 2–3 months until 4 years</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Children with Beckwith-Wiedemann syndrome (BWS) are at increased risk for embryonal tumors—particularly <strong>Wilms tumor</strong> and <strong>hepatoblastoma</strong>. Surveillance aims to detect these malignancies early.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Standard recommendations include <strong>abdominal ultrasound every 3 months</strong> until around <strong>8 years of age</strong> to screen for Wilms tumor, and <strong>serum alpha-fetoprotein (AFP) measurement every 2–3 months</strong> until <strong>4 years of age</strong> to screen for hepatoblastoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Yearly abdominal ultrasound until adolescence; no AFP needed:</strong> Incorrect. Annual imaging is insufficient for early detection, and AFP is essential for hepatoblastoma monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Chest CT every 6 months until 8 years:</strong> Incorrect. Chest CT is not part of standard surveillance; metastasis is detected only after a primary tumor diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Whole-body MRI annually from birth to 8 years:</strong> Incorrect. Whole-body MRI is not routinely indicated and would expose the child to unnecessary interventions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Children with Beckwith-Wiedemann syndrome require <strong>serial abdominal ultrasound and AFP surveillance</strong> to detect Wilms tumor and hepatoblastoma early, following a regular 3-month interval schedule during early childhood.</span></p>",
      "correct_choice_id": 387864,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97442/NEET_GT__11_NOV_2025_Pediatrics_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97442/NEET_GT__11_NOV_2025_Pediatrics_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97011,
      "choices": [
        {
          "id": 386152,
          "text": "<p><span style=\"font-size:14.0pt;\">Isovaleryl-CoA dehydrogenase</span></p>"
        },
        {
          "id": 386153,
          "text": "<p><span style=\"font-size:14.0pt;\">Dihydrolipoamide dehydrogenase</span></p>"
        },
        {
          "id": 386154,
          "text": "<p><span style=\"font-size:14.0pt;\">Branched-chain α-ketoacid dehydrogenase</span></p>"
        },
        {
          "id": 386155,
          "text": "<p><span style=\"font-size:14.0pt;\">Mitochondrial transacylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-week-old neonate presents with severe hypotonia, recurrent seizures, and poor feeding. The parents report a distinct burnt sugar odor in the infant’s urine. Examination reveals lethargy, failure to thrive, and signs of metabolic acidosis. A DNPH (2,4-dinitrophenylhydrazine) test performed on the urine and result is shown in the image below. Which of the following enzyme deficiencies best explains this neonate’s condition?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20105508.jpg\" width=\"408\" height=\"511\"></strong></span></p>",
      "unique_key": "Q9016688",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Branched-chain α-ketoacid dehydrogenase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The clinical picture, odor of burnt sugar in the urine, and metabolic acidosis in a neonate are hallmark features of <strong>Maple Syrup Urine Disease (MSUD)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This rare autosomal recessive disorder results from a deficiency of <strong>branched-chain α-ketoacid dehydrogenase complex (BCKDC)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This enzyme is required for the <strong>oxidative decarboxylation</strong> of branched-chain amino acids—<strong>leucine, isoleucine, and valine</strong>.</span></li><li><span style=\"font-size:14.0pt;\">When BCKDC is deficient, these amino acids and their corresponding ketoacids accumulate, causing neurotoxicity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>DNPH test</strong>, which detects ketoacids, produces a yellow-orange precipitate confirming the presence of branched-chain ketoacids in urine.</span></li><li><span style=\"font-size:14.0pt;\">If left untreated, MSUD can lead to severe neurological damage and death. Treatment includes dietary restriction of branched-chain amino acids and supplementation with thiamine in thiamine-responsive variants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Isovaleryl-CoA dehydrogenase:&nbsp;</strong>Deficiency causes <strong>isovaleric acidemia</strong>, characterized by a sweaty feet odor and metabolic acidosis, but not the burnt sugar odor or DNPH positivity seen in MSUD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Dihydrolipoamide dehydrogenase:</strong>This enzyme is part of multiple enzyme complexes (e.g., PDH, α-KGDH) and is involved in energy metabolism. Its deficiency may result in lactic acidosis but does not cause branched-chain ketoacid buildup.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mitochondrial transacylase:&nbsp;</strong>This is not a specific term for any enzyme involved in branched-chain amino acid metabolism. It is a distractor in this context and not linked to MSUD.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Maple Syrup Urine Disease (MSUD)</strong> is caused by deficiency of <strong>branched-chain α-ketoacid dehydrogenase</strong>, leading to accumulation of branched-chain amino acids and their toxic ketoacids.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It presents in neonates with hypotonia, seizures, metabolic acidosis, and a characteristic burnt sugar urine odor.</span></li></ul>",
      "correct_choice_id": 386154,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97011/NEET_GT__11_NOV_2025_Biochemistry_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97011/NEET_GT__11_NOV_2025_Biochemistry_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96946,
      "choices": [
        {
          "id": 385892,
          "text": "<p><span style=\"font-size:14.0pt;\">Treatment is provided free of cost for BPL patients only</span></p>"
        },
        {
          "id": 385893,
          "text": "<p><span style=\"font-size:14.0pt;\">Treatment is provided free of cost for all patients irrespective of economic status</span></p>"
        },
        {
          "id": 385894,
          "text": "<p><span style=\"font-size:14.0pt;\">Treatment cost is subsidized by 50% for BPL patients</span></p>"
        },
        {
          "id": 385895,
          "text": "<p><span style=\"font-size:14.0pt;\">Treatment is free only for the first 2 months of intensive phase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male diagnosed with pulmonary tuberculosis belongs to Below Poverty Line (BPL) category. He is concerned about the treatment cost under the National Tuberculosis Elimination Program (NTEP). What should be told to the patient regarding the cost of anti-tuberculosis treatment under NTEP?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9644061",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>Treatment is provided free of cost for all patients irrespective of economic status</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Under the National Tuberculosis Elimination Program (NTEP), anti-tuberculosis treatment is provided completely free of cost to all patients regardless of their economic status, whether BPL or APL.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This ensures universal access to TB treatment and removes financial barriers to treatment completion, which is crucial for achieving the goal of TB elimination by 2025.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">NTEP provides completely free anti-tuberculosis treatment to all patients regardless of economic status</span></li><li><span style=\"font-size:14.0pt;\">This universal free treatment policy removes financial barriers and improves treatment completion rates</span></li><li><span style=\"font-size:14.0pt;\">Free treatment includes all drugs, diagnostic tests, and follow-up investigations under NTEP</span></li></ul>",
      "correct_choice_id": 385893,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96946/NEET_PG_11_Nov_2025_PSM_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96946/NEET_PG_11_Nov_2025_PSM_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96983,
      "choices": [
        {
          "id": 386040,
          "text": "<p><span style=\"font-size:18px;\">Giant cell tumor of bone&nbsp;</span></p>"
        },
        {
          "id": 386041,
          "text": "<p><span style=\"font-size:18px;\">Osteosarcoma</span></p>"
        },
        {
          "id": 386042,
          "text": "<p><span style=\"font-size:18px;\">Osteoid osteoma</span></p>"
        },
        {
          "id": 386043,
          "text": "<p><span style=\"font-size:18px;\">Ewing sarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 17-year-old boy presents with progressive pain and swelling around his distal femur for 3 months. Pain is worse at night and partially relieved by NSAIDs. The physical exam shows a tender, firm mass with mild overlying warmth. X-ray shows a well-defined lytic lesion with a sclerotic rim in the metaphysis of the distal femur. Biopsy finding is shown in the image below. Which of the following is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-10%20110040.jpg\" width=\"474\" height=\"371\"></p>",
      "unique_key": "Q7893780",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Osteoid osteoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This <strong>17-year-old boy</strong> with <strong>pain and swelling around the distal femur</strong>, <strong>pain worse at night relieved by NSAIDs</strong>, and <strong>a small, well-defined lytic lesion with a sclerotic rim on X-ray</strong>, has classic features of an <strong>osteoid osteoma</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Key features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Age:</strong> Usually seen in <strong>adolescents and young adults</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Location:&nbsp;</strong>Cortex of long bones (especially <strong>proximal femur</strong> and <strong>tibia</strong>, but may occur in distal femur).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Pain:&nbsp;</strong>Severe nocturnal pain relieved by <strong>NSAIDs or aspirin</strong> due to <strong>prostaglandin E2 production</strong> by the tumor.</span></li><li><span style=\"font-size:14.0pt;\"><strong>X-ray:&nbsp;</strong>Small (&lt;2 cm) radiolucent nidus surrounded by <strong>reactive sclerotic bone</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Histology:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Interlacing trabeculae of woven bone</strong> lined by <strong>osteoblasts</strong> (the key diagnostic finding).</span></li><li><span style=\"font-size:14.0pt;\">Minimal atypia and surrounded by vascular connective tissue stroma.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The benign nature and small size differentiate it from other aggressive bone tumors.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Giant cell tumor of bone:&nbsp;</strong>Incorrect.&nbsp;Occurs in <strong>young adults (20–40 years)</strong>, typically at the <strong>epiphysis</strong> of long bones. Histology shows <strong>numerous multinucleated giant cells</strong> in a stromal background, not osteoid trabeculae lined by osteoblasts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Osteosarcoma: </strong>Incorrect.&nbsp;Occurs in adolescents around the <strong>metaphysis of long bones</strong> (often near the knee) but shows <strong>malignant osteoid production</strong>, <strong>pleomorphic tumor cells</strong>, and <strong>destructive “sunburst” or Codman triangle</strong> appearance on X-ray — not seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Ewing sarcoma:&nbsp;</strong>Incorrect.&nbsp;A <strong>malignant small round blue cell tumor</strong> of bone seen in <strong>children and adolescents</strong>, usually in the <strong>diaphysis</strong>, with <strong>onion-skin periosteal reaction</strong> on imaging and <strong>t(11;22) translocation</strong>. Histology shows sheets of uniform small round cells, not osteoid trabeculae.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Osteoid osteoma</strong> is a <strong>benign bone tumor</strong> of adolescents characterized by <strong>severe nocturnal pain relieved by NSAIDs</strong>, <strong>radiolucent nidus with sclerotic rim</strong>, and <strong>interlacing trabeculae of woven bone lined by osteoblasts</strong> on histology.</span></p>",
      "correct_choice_id": 386042,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96983/Neet_Gt__11_Nov_2025_Pathology_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96983/Neet_Gt__11_Nov_2025_Pathology_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97238,
      "choices": [
        {
          "id": 387052,
          "text": "<p><span style=\"font-size:14.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 387053,
          "text": "<p><span style=\"font-size:14.0pt;\">Betamethasone</span></p>"
        },
        {
          "id": 387054,
          "text": "<p><span style=\"font-size:14.0pt;\">Triamcinolone</span></p>"
        },
        {
          "id": 387055,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrocortisone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following are selective glucocorticoids without having any mineralocorticoid activity except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4189506",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)</strong> <strong>Hydrocortisone</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hydrocortisone is the only option listed that has significant mineralocorticoid activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In fact, hydrocortisone is the glucocorticoid with maximum mineralocorticoid activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The mnemonic \"0M\" (Zero Mineralocorticoid) helps remember selective glucocorticoids: Triamcinolone, Dexamethasone, Betamethasone, and Paramethasone all have zero mineralocorticoid activity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These drugs avoid mineralocorticoid-related side effects like sodium and water retention, edema, hypokalemic alkalosis, and progressive rise in blood pressure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hydrocortisone, being similar in structure and activity to the natural hormone cortisol, retains both glucocorticoid and mineralocorticoid properties, making it suitable for replacement therapy in adrenal insufficiency where both activities are needed.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Dexamethasone:</strong> It is incorrect because dexamethasone is a selective glucocorticoid with zero mineralocorticoid activity. It has maximum glucocorticoid potency and is long-acting (&gt;36 hours).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Betamethasone:</strong> It is incorrect because betamethasone is also a selective glucocorticoid with zero mineralocorticoid activity. It is used antenatally for fetal lung maturation (12 mg IM every 24 hours × 2 doses).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Triamcinolone:</strong> It is incorrect because triamcinolone is a selective glucocorticoid with zero mineralocorticoid activity. It is intermediate-acting (12-36 hours).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hydrocortisone has the highest mineralocorticoid activity among glucocorticoids; dexamethasone, betamethasone, triamcinolone, and paramethasone have zero mineralocorticoid activity.</span></p>",
      "correct_choice_id": 387055,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97238/NEET_GT__11_NOV_2025_Pharmacology_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97238/NEET_GT__11_NOV_2025_Pharmacology_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97019,
      "choices": [
        {
          "id": 386184,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3 and 5 only</span></p>"
        },
        {
          "id": 386185,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 386186,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 5 only</span></p>"
        },
        {
          "id": 386187,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, 4 and 5 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding the indications for an upper segment (classical) cesarean section, consider the following statements:</span></p><ol><li><span style=\"font-size:14.0pt;\">It is preferred in cases of placenta accreta syndrome.</span></li><li><span style=\"font-size:14.0pt;\">It is indicated when a large fibroid occupies the anterior lower uterine segment.</span></li><li><span style=\"font-size:14.0pt;\">It is performed in cases of extensive adhesions in the lower uterine segment.</span></li><li><span style=\"font-size:14.0pt;\">Cervical cancer is a contraindication to performing a classical cesarean section.</span></li><li><span style=\"font-size:14.0pt;\">It may be chosen when the lower uterine segment is underdeveloped, such as in preterm pregnancies.</span></li></ol><p><span style=\"font-size:14.0pt;\">Which of the following statements are correct?&nbsp;</span></p>",
      "unique_key": "Q3572933",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) 1, 2, 3 and 5 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>classical (upper segment) cesarean section</strong> involves a <strong>vertical incision in the upper uterine segment</strong> and is performed only under specific indications where a <strong>lower segment cesarean section (LSCS)</strong> is not feasible or safe.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>1. It is preferred in cases of placenta accreta syndrome:</strong> The placenta is abnormally adherent, and attempting a lower segment incision risks severe hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>2. It is indicated when a large fibroid occupies the anterior lower uterine segment:</strong> Obstructs access to the lower segment, making incision and delivery difficult.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>3. It is performed in cases of extensive adhesions in the lower uterine segment:</strong> Often occur due to previous surgeries or infections, limiting access to the lower uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>5. It may be chosen when the lower uterine segment is underdeveloped, such as in preterm pregnancies:</strong> In very preterm pregnancies, the lower uterine segment may not be well-formed, requiring a classical incision for adequate access.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Cervical cancer is a contraindication to performing a classical cesarean section:</strong> This is incorrect because <strong>cervical cancer</strong> is actually a <strong>contraindication</strong> to performing a cesarean section — surgical delivery can worsen bleeding and dissemination. Such cases require specialized obstetric oncology management.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>classical (upper segment) cesarean section</strong> is indicated when the <strong>lower uterine segment cannot be safely used</strong> — as in <strong>placenta accreta</strong>, <strong>fibroids</strong>, <strong>dense adhesions</strong>, or <strong>an underdeveloped segment</strong> — but <strong>contraindicated in cervical cancer</strong> due to risk of hemorrhage and tumor spread.</span></p>",
      "correct_choice_id": 386184,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97019/NEET_GT__11_NOV_2025_OBG_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97019/NEET_GT__11_NOV_2025_OBG_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97181,
      "choices": [
        {
          "id": 386824,
          "text": "<p><span style=\"font-size:14.0pt;\">Cricothyroid</span></p>"
        },
        {
          "id": 386825,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior cricoarytenoid</span></p>"
        },
        {
          "id": 386826,
          "text": "<p><span style=\"font-size:14.0pt;\">Lateral cricoarytenoid</span></p>"
        },
        {
          "id": 386827,
          "text": "<p><span style=\"font-size:14.0pt;\">Thyroarytenoid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A patient develops hoarseness following thyroid surgery. Laryngoscopy shows a paramedian position of one vocal cord. Which intrinsic laryngeal muscle is not paralyzed?&nbsp;</span></p>",
      "unique_key": "Q9943756",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Cricothyroid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The cricothyroid muscle is supplied by the external branch of the superior laryngeal nerve, a branch of the vagus nerve (cranial nerve X).</span></li><li><span style=\"font-size:14.0pt;\">In thyroid surgery, injury to the recurrent laryngeal nerve (RLN) is the most common cause of postoperative vocal cord palsy.</span></li><li><span style=\"font-size:14.0pt;\">The RLN supplies all intrinsic muscles of the larynx except the cricothyroid.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, when the RLN is injured, all other intrinsic muscles (posterior cricoarytenoid, lateral cricoarytenoid, thyroarytenoid, interarytenoid) are paralyzed, leaving only the cricothyroid functional.</span></li><li><span style=\"font-size:14.0pt;\">The intact cricothyroid muscle tenses the vocal cord, pulling it toward the paramedian position, which explains the laryngoscopic finding.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Posterior cricoarytenoid:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The only abductor of the vocal cords.</span></li><li><span style=\"font-size:14.0pt;\">Paralysis leads to inability to open the glottis → cord remains near midline (paramedian).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lateral cricoarytenoid:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Primary adductor of the vocal cords.</span></li><li><span style=\"font-size:14.0pt;\">Paralysis leads to failure of complete glottic closure during phonation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Thyroarytenoid:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Relaxer of the vocal cords.</span></li><li><span style=\"font-size:14.0pt;\">Paralysis results in loss of fine pitch control and hoarseness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The cricothyroid muscle, supplied by the external branch of the superior laryngeal nerve, is the only intrinsic laryngeal muscle not innervated by the recurrent laryngeal nerve.</span></li><li><span style=\"font-size:14.0pt;\">In recurrent laryngeal nerve palsy, the affected vocal cord assumes a paramedian position, and cricothyroid remains functional.</span></li></ul>",
      "correct_choice_id": 386824,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97181/NEET_GT__11_NOV_2025_ENT_Question_3_CgYDRjD.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97181/NEET_GT__11_NOV_2025_ENT_Question_3_CgYDRjD.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96999,
      "choices": [
        {
          "id": 386104,
          "text": "<p><span style=\"font-size:14.0pt;\">Ixodid tick</span></p>"
        },
        {
          "id": 386105,
          "text": "<p><span style=\"font-size:14.0pt;\">Aedes aegypti</span></p>"
        },
        {
          "id": 386106,
          "text": "<p><span style=\"font-size:14.0pt;\">Phlebotomus argentipes</span></p>"
        },
        {
          "id": 386107,
          "text": "<p><span style=\"font-size:14.0pt;\">Tunga penetrans</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old hiker presents with a recent febrile illness that began 2 weeks after a camping trip in a forested area. He now complains of palpitations and lightheadedness. ECG reveals a first-degree atrioventricular (AV) block. On examination, a faded, annular rash is noted on his left thigh. Which of the following vectors is most likely responsible for transmission of the causative pathogen?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7653754",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Ixodid tick</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The patient exhibits classical signs of <strong>Lyme's disease</strong>, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>History of forest exposure</strong>,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Erythema migrans</strong> (faded annular rash), and</span></li><li><span style=\"font-size:14.0pt;\"><strong>AV conduction abnormality</strong> (carditis).</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Lyme's disease</strong> is caused by the <strong>spirochete Borrelia burgdorferi</strong> and is transmitted by the <strong>Ixodid tick (Ixodes scapularis)</strong>, commonly found in wooded regions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Cardiac involvement</strong>, typically manifesting as <strong>transient AV block</strong>, occurs during the early disseminated phase of the disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Diagnosis is clinical in early stages, and serology supports the diagnosis in later stages.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Treatment involves <strong>IV ceftriaxone</strong> in patients with carditis or neurologic complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Aedes aegypti:&nbsp;</strong>This mosquito species transmits <strong>arboviruses</strong> such as Dengue, Chikungunya, Zika and Yellow fever. These viruses do <strong>not cause AV block</strong>, nor do they present with erythema migrans or cardiac manifestations in the same manner as Lyme disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Phlebotomus argentipes:&nbsp;</strong>This is the <strong>sandfly</strong> vector for Leishmania donovani, the agent of <strong>visceral leishmaniasis (kala-azar)</strong>. It typically causes <strong>fever, hepatosplenomegaly and pancytopenia</strong>, not cardiac conduction abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tunga penetrans:&nbsp;</strong>A parasitic flea causing <strong>tungiasis</strong>, which presents as painful <strong>cutaneous nodules or ulcers</strong>, usually on the feet. It does not transmit systemic infections or cardiac complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Borrelia burgdorferi, the causative agent of Lyme disease, is transmitted by <strong>Ixodes ticks</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Cardiac manifestations such as <strong>transient AV block</strong> can occur in the <strong>early disseminated phase</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Early recognition and treatment are critical to avoid long-term sequelae.</span></li></ul>",
      "correct_choice_id": 386104,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96999/NEET_GT__11_NOV_2025_Microbiology_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96999/NEET_GT__11_NOV_2025_Microbiology_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96941,
      "choices": [
        {
          "id": 385872,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency Medical Services</span></p>"
        },
        {
          "id": 385873,
          "text": "<p><span style=\"font-size:14.0pt;\">Screening and Basic management of Mental health ailment</span></p>"
        },
        {
          "id": 385874,
          "text": "<p><span style=\"font-size:14.0pt;\">Care for Common Ophthalmic and ENT problems</span></p>"
        },
        {
          "id": 385875,
          "text": "<p><span style=\"font-size:14.0pt;\">Bi-weekly super-specialist care in Cardiology and Endocrinology</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Under the Ayushman Bharat Health and Wellness Centre initiative, the expanded package of services at Ayushman Arogya Mandir includes all of the following except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9143214",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)</strong> <strong>Bi-weekly super-specialist care in Cardiology and Endocrinology</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In Ayushman Bharat Health and Wellness Center, under PMJAY</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Health and wellness center (SHC or PHC)</span></li><li><span style=\"font-size:14.0pt;\">5 lakh/ Family/ Year</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Bi-weekly super-specialist care in Cardiology and Endocrinology is not provided at Ayushman Arogya Mandir under AB-HWC.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Expanded range of services</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The expansion of services has been planned in incremental manner</span></li><li><span style=\"font-size:14.0pt;\">As a first step, screening, prevention, control and management of Non communicable diseases and chronic communicable diseases like tuberculosis and leprosy has been introduced at Ayushman Arogya Mandir</span><ol><li><span style=\"font-size:14.0pt;\">Care in pregnancy and childbirth</span></li><li><span style=\"font-size:14.0pt;\">Neonatal and infant health care services</span></li><li><span style=\"font-size:14.0pt;\">Childhood and adolescent health care services</span></li><li><span style=\"font-size:14.0pt;\">Family planning, contraceptive services and other reproductive health care services</span></li><li><span style=\"font-size:14.0pt;\">Management of communicable disease: National Health Programs</span></li><li><span style=\"font-size:14.0pt;\">Management of common communicable diseases and General out-patient care for acute simple illnesses and minor ailments</span></li><li><span style=\"font-size:14.0pt;\">Screening, Prevention, Control and Management of Non-Communicable diseases and chronic communicable diseases like TB and Leprosy</span></li><li><span style=\"font-size:14.0pt;\">Basic Oral health care</span></li><li><span style=\"font-size:14.0pt;\">Care for Common Ophthalmic and ENT problems</span></li><li><span style=\"font-size:14.0pt;\">Elderly and Palliative health care services</span></li><li><span style=\"font-size:14.0pt;\">Emergency Medical Services</span></li><li><span style=\"font-size:14.0pt;\">Screening and Basic management of Mental health ailment</span></li></ol></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Emergency Medical Services:</strong> The expanded package of services includes first-level care for emergencies and trauma (Emergency Medical Services).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B. Screening and Basic management of Mental health ailment:&nbsp;</strong>The expanded package explicitly includes Screening and Basic management of Mental health ailments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Care for Common Ophthalmic and ENT problems:</strong> The expanded package explicitly includes Care for Common Ophthalmic and ENT problems (Eye and ENT care).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The following services were introduced as the expanded range of services at the Ayushman Arogya Mandir apart from the already existing services:</span></p><ol><li><span style=\"font-size:14.0pt;\">Basic Oral health care</span></li><li><span style=\"font-size:14.0pt;\">Care for Common Ophthalmic and ENT problems</span></li><li><span style=\"font-size:14.0pt;\">Elderly and Palliative health care services</span></li><li><span style=\"font-size:14.0pt;\">Emergency Medical Services</span></li><li><span style=\"font-size:14.0pt;\">Screening and Basic management of Mental health ailment</span></li></ol>",
      "correct_choice_id": 385875,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96941/NEET_PG_11_Nov_2025_PSM_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96941/NEET_PG_11_Nov_2025_PSM_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96958,
      "choices": [
        {
          "id": 385940,
          "text": "<p><span style=\"font-size:14.0pt;\">Right superior lobe</span></p>"
        },
        {
          "id": 385941,
          "text": "<p><span style=\"font-size:14.0pt;\">Right middle lobe</span></p>"
        },
        {
          "id": 385942,
          "text": "<p><span style=\"font-size:14.0pt;\">Upper part of right inferior lobe</span></p>"
        },
        {
          "id": 385943,
          "text": "<p><span style=\"font-size:14.0pt;\">Lingula</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 67-year-old man with a history of dysphagia following a stroke aspirates food while lying supine. A subsequent chest X-ray shows lobar consolidation. In the supine position, aspiration pneumonia most commonly involves which lobe of the lung?</span></p>",
      "unique_key": "Q7340190",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Upper part of right inferior lobe</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the <strong>supine position</strong>, aspirated material tends to enter the <strong>posterior segments of the upper lobes</strong> or the <strong>superior segment of the lower lobes</strong>, most commonly on the <strong>right side</strong> due to the <strong>more vertical orientation of the right main bronchus</strong>.</span></li><li><span style=\"font-size:14.0pt;\">When <strong>standing or sitting</strong>, aspiration more often involves the <strong>basal segments of the lower lobes</strong>, especially the <strong>right lower lobe</strong>.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Right superior lobe:&nbsp;</strong>The superior lobe may be involved <strong>only if the patient is sitting upright</strong>, where aspirated material tends to settle in the lower parts of the lung fields. However, in the <strong>supine position</strong>, gravity directs material posteriorly rather than superiorly, so this is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Right middle lobe:&nbsp;</strong>Aspiration into the middle lobe is <strong>less common</strong>, as this segment is not aligned with the main bronchial tree’s gravitational path in either upright or supine positions. The middle lobe is more commonly affected in conditions like <strong>middle lobe syndrome</strong>, not aspiration.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lingula:&nbsp;</strong>The lingula is part of the <strong>left upper lobe</strong> and can be involved in <strong>aspiration on the left side</strong>, but aspiration is far more frequent on the <strong>right</strong>, due to the vertical course of the right main bronchus. Thus, the lingula is an incorrect answer here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111339.jpg\" width=\"733\" height=\"595\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In a <strong>supine patient</strong>, aspirated material most commonly enters the <strong>posterior segment of the upper lobe or superior segment of the lower lobe</strong>, typically of the <strong>right lung</strong>, due to bronchial anatomy.</span></p>",
      "correct_choice_id": 385942,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96958/NEET_GT__11_NOV_2025_Anatomy_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96958/NEET_GT__11_NOV_2025_Anatomy_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97068,
      "choices": [
        {
          "id": 386380,
          "text": "<p><span style=\"font-size:14.0pt;\">Rickets</span></p>"
        },
        {
          "id": 386381,
          "text": "<p><span style=\"font-size:14.0pt;\">Scurvy</span></p>"
        },
        {
          "id": 386382,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteopetrosis</span></p>"
        },
        {
          "id": 386383,
          "text": "<p><span style=\"font-size:14.0pt;\">Metaphyseal dysplasia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old child has a normal bone mineral density. X-ray of his knees is given below. Identify the diagnosis.<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103509.jpg\" width=\"451\" height=\"374\"></strong></span></p>",
      "unique_key": "Q1857215",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Scurvy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">It is the deficiency of vitamin C, causing defect in the osteoid formation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The rosary found in this condition is sharp and tender.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Radiological Features:&nbsp;</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Sclerosed Margins of Epiphysis</span></li><li><span style=\"font-size:14.0pt;\">Osteopenia – ground glass appearance – 1st sign – thinning of cortex (pencil thin cortex).</span></li><li><span style=\"font-size:14.0pt;\">Metaphysis maybe deformed or fractured.</span></li><li><span style=\"font-size:14.0pt;\">Frankel’s line (zone of provisional calcification increases in width and opacity) due to failure of resorption of calcified cartilage and stands out compared to the severely osteopenic metaphysis.</span></li><li><span style=\"font-size:14.0pt;\">Scurvy line or scorbutic zone (Trummerfeld’s zone) – radiolucent transverse band adjacent to the dense provisional zone.</span></li><li><span style=\"font-size:14.0pt;\">Margins of the epiphysis appears sclerotic, termed as ringing of epiphyses or Wimberger’s sign (Ring sign).</span></li><li><span style=\"font-size:14.0pt;\">Lateral metaphyseal spur (Pelkan spur) at ends of metaphysis is produced by outward projection of zone of provisional calcification and periosteal reaction.</span></li><li><span style=\"font-size:14.0pt;\">Corner or angle sign is peripheral metaphyseal cleft.</span></li><li><span style=\"font-size:14.0pt;\">Subperiosteal hemorrhage in lower end of femur and tibia</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103531.jpg\" width=\"567\" height=\"603\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rickets:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In rickets, maturation of osteoid occurs before closure of growth plates, which superimposes the skeletal growth abnormalities i.e., incomplete skeletal calcification and softening of bones.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">There is irregular laying of osteoid with widening of osteoid seam and islets into the diaphysis, and thin and weak new trabeculae.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">On joint loading, juxta-epiphyseal metaphysis becomes broad and cup-shaped.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The characteristic feature of rickets is thickening and widening of growth plate (physis); indistinct and hazy metaphysis abnormally wide (splaying) with cupping or flaring (Brush-like appearance); and bowing of diaphysis, with thinning of cortices.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103547.jpg\" width=\"845\" height=\"413\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Osteopetrosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also called as marble bone disease, it is a diaphyseal dysplasia characterized by failure of bone resorption due to functional deficiency of osteoclast.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Due to functional deficiency of osteoclasts, calcified chondroid (cartilage) and primitive woven bone persists down into metaphysis and diaphysis leading to osteosclerosis and increased brittleness of bones.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It may present with mild anemia, pathological fractures, premature osteoarthritis, and rarely osteomyelitis of mandible.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pancytopenia develops resulting in abnormal bleeding, easy bruising, progressive anemia, and failure to thrive.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">There is severe infection, esp. in Mandible, and Cranial nerve palsies (2nd, 7th and 8th—blindness and deafness).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Laboratory parameters are serum calcium low, serum PTH high, serum phosphate low and serum ALP high. Radiological hallmark is increased radiopacity of bones.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">There is no distinction between cortical and cancellous bone, because intramedullary canal is filled with bone. Rugger jersey spine is seen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103603.jpg\" width=\"873\" height=\"467\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Metaphyseal dysplasia:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also known as Pyle disease, it is a rare autosomal recessive disorder characterized by flaring of the ends of long bones with relative constriction and sclerosis of the diaphysis and mild cranial sclerosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The flared metaphyses are relatively lucent.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patients are often asymptomatic, although genu valgus deformity may be a feature.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Patients present with short-limb dwarfism characterized by coxa vara, and spinal abnormalities. Radiograph reveals bulbous expansion of metaphysis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103617.jpg\" width=\"319\" height=\"490\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The given x-ray image in the question is suggestive of features due to vitamin C deficiency, scurvy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Following are the features seen in a patient with scurvy on a plain radiograph:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103628.jpg\" width=\"872\" height=\"481\"></span></p>",
      "correct_choice_id": 386381,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97068/NEET_GT__11_NOV_2025_Orthopedics_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97068/NEET_GT__11_NOV_2025_Orthopedics_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97015,
      "choices": [
        {
          "id": 386168,
          "text": "<p><span style=\"font-size:14.0pt;\">DNA polymerase&nbsp;</span></p>"
        },
        {
          "id": 386169,
          "text": "<p><span style=\"font-size:14.0pt;\">Ribonuclease P</span></p>"
        },
        {
          "id": 386170,
          "text": "<p><span style=\"font-size:14.0pt;\">Dicer</span></p>"
        },
        {
          "id": 386171,
          "text": "<p><span style=\"font-size:14.0pt;\">RNA polymerase II</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In a study on post-transcriptional gene silencing, an enzyme that processes precursor RNA into short double-stranded fragments was inhibited, leading to gene upregulation. Which of the following enzyme is inhibited?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4924078",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Dicer</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Dicer</strong> is an RNase III endonuclease that processes precursor microRNA (pre-miRNA) and long double-stranded RNA into short ~21–23 nt siRNA/miRNA duplexes, which guide RISC to <strong>silence</strong> target mRNAs post-transcriptionally.</span></li><li><span style=\"font-size:14.0pt;\">Inhibiting Dicer blocks siRNA/miRNA production, reducing silencing and causing <strong>gene upregulation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. DNA polymerase:</strong> DNA replication, not RNA silencing.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ribonuclease P:</strong> Processes tRNA 5′ ends, unrelated to miRNA/siRNA generation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. RNA polymerase II:</strong> Transcribes mRNA and many pri-miRNAs but does not process them into short dsRNAs.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Dicer, an RNase III endonuclease, generates siRNA/miRNA from precursor RNAs; inhibiting Dicer reduces RNA interference and increases target gene expression.</span></p>",
      "correct_choice_id": 386170,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97015/Neet_Gt__11_Nov_2025_Biochemistry_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97015/Neet_Gt__11_Nov_2025_Biochemistry_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97239,
      "choices": [
        {
          "id": 387056,
          "text": "<p><span style=\"font-size:14.0pt;\">Artemisinin-based combination therapy (ACT) for 3 days</span></p>"
        },
        {
          "id": 387057,
          "text": "<p><span style=\"font-size:14.0pt;\">Chloroquine 25 mg/kg over 3 days + primaquine single dose</span></p>"
        },
        {
          "id": 387058,
          "text": "<p><span style=\"font-size:14.0pt;\">Quinine 600 mg TDS for 7 days + clindamycin 300 mg TDS for 7 days</span></p>"
        },
        {
          "id": 387059,
          "text": "<p><span style=\"font-size:14.0pt;\">Mefloquine 15 mg/kg single dose + artesunate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old pregnant woman at 10 weeks gestation presents with confirmed Plasmodium falciparum malaria. She has high-grade fever and parasitemia but no signs of severe/complicated malaria. What is the most appropriate treatment regimen?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7263738",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)</strong> <strong>Quinine 600 mg TDS for 7 days + clindamycin 300 mg TDS for 7 days</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">During the first trimester of pregnancy, falciparum malaria must be treated promptly and aggressively as it has serious implications for both mother and fetus.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The safest and recommended regimen is quinine 600 mg (10 mg/kg) three times daily for 7 days plus clindamycin 300 mg three to four times daily (20 mg/kg/day) for 7 days.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This combination can be used safely during all trimesters of pregnancy and is the preferred option during the first trimester.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Quinine is a rapidly acting erythrocytic schizontocide that has been proven safe in pregnancy, particularly in the first trimester.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Clindamycin, abacteriostatic antibiotic with slow-acting schizontocidal properties, markedly potentiates quinine's antimalarial activity and can be used safely in children and pregnant women, unlike doxycycline which is contraindicated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The combination ensures effective parasite clearance while maintaining fetal safety.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Patients should be monitored for cinchonism (headache, blurred vision, tinnitus, deafness) and hypoglycemia, both known side effects of quinine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Artemisinin-based combination therapy (ACT) for 3 days:</strong> It is incorrect because safety of ACT during the first trimester is unproven. Artemisinin-based combination therapy may be used during second and third trimesters as a better-tolerated 3-day alternative, but should be avoided in the first trimester due to insufficient safety data.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chloroquine 25 mg/kg over 3 days + primaquine single dose:</strong> It is incorrect because chloroquine-resistant P. falciparum is now widespread in India, making chloroquine an inappropriate choice for falciparum malaria regardless of pregnancy status. Additionally, primaquine is contraindicated in pregnancy due to risk of hemolysis in G6PD-deficient fetuses.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Mefloquine 15 mg/kg single dose + artesunate:</strong> It is incorrect because mefloquine can cause neuropsychiatric adverse effects and should not be used in cerebral malaria or during first trimester. The combination with artesunate represents an ACT regimen that lacks sufficient first-trimester safety data.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">First-trimester falciparum malaria in pregnancy requires 7-day treatment with quinine plus clindamycin, which is safe across all trimesters; ACT may be considered only in second and third trimesters.</span></p>",
      "correct_choice_id": 387058,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97239/NEET_GT__11_NOV_2025_Pharmacology_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97239/NEET_GT__11_NOV_2025_Pharmacology_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96989,
      "choices": [
        {
          "id": 386064,
          "text": "<p><span style=\"font-size:14.0pt;\">A positive slide test confirms S. aureus infection without further testing.</span></p>"
        },
        {
          "id": 386065,
          "text": "<p><span style=\"font-size:14.0pt;\">A negative slide test rules out all coagulase-producing organisms.</span></p>"
        },
        {
          "id": 386066,
          "text": "<p><span style=\"font-size:14.0pt;\">A positive slide test should be confirmed with a tube coagulase test.</span></p>"
        },
        {
          "id": 386067,
          "text": "<p><span style=\"font-size:14.0pt;\">Slide coagulase test detects both bound and free coagulase.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements is true regarding interpretation of the slide coagulase test?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20100443.jpg\" width=\"761\" height=\"364\"></strong></span></p>",
      "unique_key": "Q4852900",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) A positive slide test should be confirmed with a tube coagulase test.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>slide coagulase test</strong> detects <strong>bound coagulase</strong> (also known as clumping factor), which causes visible <strong>clumping of bacteria</strong> when mixed with plasma.</span></li><li><span style=\"font-size:14.0pt;\">While a <strong>positive result</strong> (seen on the left side of the image) suggests coagulase production, it <strong>does not definitively confirm Staphylococcus aureus</strong> because other species like S. lugdunensis may also produce bound coagulase.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, a <strong>positive slide coagulase test must always be confirmed</strong> with the <strong>tube coagulase test</strong>, which detects <strong>free coagulase</strong>, the definitive marker for S. aureus identification.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. A positive slide test confirms S. aureus infection without further testing:</strong> Incorrect. While S. aureus is slide coagulase positive, so is S. lugdunensis. Without confirming the presence of <strong>free coagulase via the tube test</strong>, we cannot conclusively identify S. aureus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. A negative slide test rules out all coagulase-producing organisms:&nbsp;</strong>Incorrect. Staphylococcus schleiferi, for example, is <strong>slide coagulase negative</strong> but <strong>tube coagulase positive</strong>. Thus, a negative slide test does <strong>not rule out</strong> coagulase positivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Slide coagulase test detects both bound and free coagulase:</strong> Incorrect. The <strong>slide coagulase test detects only bound coagulase (clumping factor)</strong>. Free coagulase is detected exclusively by the <strong>tube coagulase test</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">S. aureus is coagulase-positive in both tube and slide coagulase tests.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Other Staphylococcus species:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">S. lugdunensis → slide coagulase positive only</span></li><li><span style=\"font-size:14.0pt;\">S. schleiferi → tube coagulase positive only</span></li><li><span style=\"font-size:14.0pt;\">S. epidermidis, S. saprophyticus → coagulase negative</span></li></ul></li></ul>",
      "correct_choice_id": 386066,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96989/NEET_GT__11_NOV_2025_Microbiology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96989/NEET_GT__11_NOV_2025_Microbiology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96973,
      "choices": [
        {
          "id": 386000,
          "text": "<p><span style=\"font-size:18px;\">Acute myeloid leukemia (AML)</span></p>"
        },
        {
          "id": 386001,
          "text": "<p><span style=\"font-size:18px;\">Hairy cell leukemia</span></p>"
        },
        {
          "id": 386002,
          "text": "<p><span style=\"font-size:18px;\">Myelofibrosis</span></p>"
        },
        {
          "id": 386003,
          "text": "<p><span style=\"font-size:18px;\">Chronic myeloid leukemia (CML)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 50-year-old man presents with increasing fatigue, pallor, and splenomegaly. His CBC shows Hb 9.5 g/dL, WBC 3,200/μL, platelets 70,000/μL. A bone marrow aspirate is attempted but results in a dry tap. A biopsy shows a fibrotic marrow with clusters of atypical megakaryocytes. JAK2 mutation is positive. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q9771424",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Myelofibrosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This <strong>50-year-old man</strong> presents with <strong>fatigue, pallor, splenomegaly</strong>, <strong>pancytopenia</strong> (low Hb, WBC, and platelets), a <strong>dry tap on bone marrow aspiration</strong>, and a <strong>fibrotic marrow with atypical megakaryocytes</strong> — all classic features of <strong>primary myelofibrosis</strong>, a <strong>chronic myeloproliferative neoplasm</strong>.</span></li><li><span style=\"font-size:18px;\"><strong>Key diagnostic features of Myelofibrosis:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Clinical:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Progressive <strong>fatigue</strong>, <strong>pallor</strong> (due to anemia), and <strong>massive splenomegaly</strong> (due to extramedullary hematopoiesis).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Laboratory:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\"><strong>Pancytopenia</strong> due to bone marrow failure.</span></li><li><span style=\"font-size:18px;\"><strong>Teardrop-shaped RBCs (dacrocytes)</strong> on peripheral smear.</span></li><li><span style=\"font-size:18px;\"><strong>JAK2 V617F mutation</strong> positive in ~50–60% of cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Bone marrow findings:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\"><strong>Dry tap</strong> due to fibrosis.</span></li><li><span style=\"font-size:18px;\"><strong>Biopsy</strong> shows <strong>marrow fibrosis</strong> and <strong>clusters of atypical megakaryocytes</strong>, which release <strong>fibrogenic growth factors</strong> (e.g., PDGF, TGF-β), leading to <strong>reactive stromal proliferation</strong>.</span></li><li><span style=\"font-size:18px;\">The <strong>splenomegaly</strong> occurs due to <strong>extramedullary hematopoiesis</strong> as the bone marrow becomes progressively fibrotic and unable to produce blood cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Acute myeloid leukemia (AML):&nbsp;</strong>Incorrect.&nbsp;AML typically presents with <strong>pancytopenia</strong> and <strong>blast cells (&gt;20%)</strong> in bone marrow or blood. The marrow is usually <strong>hypercellular</strong>, not fibrotic, and a <strong>dry tap</strong> with <strong>megakaryocytic clusters</strong> is not characteristic.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Hairy cell leukemia:&nbsp;</strong>Incorrect.&nbsp;Also presents with <strong>pancytopenia</strong> and <strong>splenomegaly</strong>, and may cause a <strong>dry tap</strong> due to marrow fibrosis. However, the <strong>bone marrow biopsy</strong> shows <strong>lymphocytes with cytoplasmic projections (“hairy cells”)</strong>, and the immunophenotype is <strong>CD11c+, CD25+, CD103+</strong>. JAK2 mutation is <strong>absent</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Chronic myeloid leukemia (CML):&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>CML shows <strong>marked leukocytosis</strong>, <strong>basophilia</strong>, and <strong>splenomegaly</strong>. The bone marrow is <strong>hypercellular</strong>, not fibrotic, and the <strong>Philadelphia chromosome (BCR-ABL fusion)</strong> is characteristic, not JAK2 mutation.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Primary myelofibrosis</strong> is a <strong>chronic myeloproliferative disorder</strong> characterized by <strong>JAK2 mutation</strong>, <strong>bone marrow fibrosis</strong>, <strong>atypical megakaryocytes</strong>, <strong>pancytopenia</strong>, and <strong>massive splenomegaly</strong> due to <strong>extramedullary hematopoiesis</strong>.</span></li><li><span style=\"font-size:18px;\">A <strong>dry tap</strong> on bone marrow aspiration is a hallmark finding.</span></li></ul>",
      "correct_choice_id": 386002,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96973/Neet_Gt__11_Nov_2025_Pathology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96973/Neet_Gt__11_Nov_2025_Pathology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97072,
      "choices": [
        {
          "id": 386396,
          "text": "<p><span style=\"font-size:14.0pt;\">Stem Cells</span></p>"
        },
        {
          "id": 386397,
          "text": "<p><span style=\"font-size:14.0pt;\">Huxley’s Layer</span></p>"
        },
        {
          "id": 386398,
          "text": "<p><span style=\"font-size:14.0pt;\">Arrector Pili Muscle</span></p>"
        },
        {
          "id": 386399,
          "text": "<p><span style=\"font-size:14.0pt;\">Adamson’s Fringe</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old male presents with patchy hair loss. On trichoscopic examination, segmentation of the hair follicle is noted. Which structure demarcates the upper and lower portions of the hair follicle?&nbsp;</span></p>",
      "unique_key": "Q4901954",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Arrector Pili Muscle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>arrector pili muscle</strong> is a small band of smooth muscle that connects the hair follicle to the dermal tissue.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Its point of attachment divides the follicle into two anatomical zones — the <strong>upper follicle</strong> (above the attachment) associated with the sebaceous gland and pilo-sebaceous unit, and the <strong>lower follicle</strong> (below it), containing the bulb where active hair growth occurs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This muscle also aids thermoregulation by producing ‘goosebumps’ when contracted.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103938.jpg\" width=\"915\" height=\"499\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stem Cells:</strong> Located in the bulge region of the follicle; responsible for regeneration, not segmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Huxley’s Layer:</strong> Part of the inner root sheath; plays no role in dividing follicular segments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Adamson’s Fringe:</strong> Marks the lower border of the keratogenous zone, not the upper-lower follicle junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The <strong>arrector pili muscle</strong> demarcates the <strong>upper and lower portions</strong> of the hair follicle and is key in both structure and thermoregulation.</span></p>",
      "correct_choice_id": 386398,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97072/NEET_GT__11_NOV_2025_Derma_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97072/NEET_GT__11_NOV_2025_Derma_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97204,
      "choices": [
        {
          "id": 386916,
          "text": "<p><span style=\"font-size:14.0pt;\">CBC</span></p>"
        },
        {
          "id": 386917,
          "text": "<p><span style=\"font-size:14.0pt;\">Serum Albumin</span></p>"
        },
        {
          "id": 386918,
          "text": "<p><span style=\"font-size:14.0pt;\">Triglyceride level</span></p>"
        },
        {
          "id": 386919,
          "text": "<p><span style=\"font-size:14.0pt;\">Vit. D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following tests are done weekly to monitor feeding regimens except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3688011",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Vit. D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Monitoring of patients receiving&nbsp;<strong>enteral or parenteral nutrition</strong> is essential to assess adequacy, detect complications, and guide therapy adjustments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The&nbsp;<strong>frequency of investigations</strong> depends on the&nbsp;<strong>phase of feeding</strong> (initiation, stabilization, or maintenance) and the&nbsp;<strong>clinical stability</strong> of the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Weekly Monitoring Parameters:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hematological and metabolic tests:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Complete Blood Count (CBC)</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Electrolytes</strong> (in stable patients, may shift from daily to weekly)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Serum albumin and total proteins</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Calcium, zinc, and copper</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Thiamine, Vitamin B12, and folate</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Serum triglycerides</strong> (important for patients on lipid emulsions)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">These tests help monitor for&nbsp;<strong>nutritional adequacy, infection, inflammation, or metabolic disturbances.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Vitamin D,</strong> however, is&nbsp;<strong>not monitored weekly</strong> — its level reflects&nbsp;<strong>long-term nutritional</strong>&nbsp;<strong>status</strong>, not short-term metabolic changes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20121603.jpg\" width=\"742\" height=\"793\"></strong></span></p>",
      "correct_choice_id": 386919,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97204/NEET_GT__11_NOV_2025_Surgery_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97204/NEET_GT__11_NOV_2025_Surgery_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97020,
      "choices": [
        {
          "id": 386188,
          "text": "<p><span style=\"font-size:14.0pt;\">It is indicated for primary prevention of coronary artery disease</span></p>"
        },
        {
          "id": 386189,
          "text": "<p><span style=\"font-size:14.0pt;\">It decreases the risk of colon cancer</span></p>"
        },
        {
          "id": 386190,
          "text": "<p><span style=\"font-size:14.0pt;\">It decreases the risk of breast cancer with long-term use</span></p>"
        },
        {
          "id": 386191,
          "text": "<p><span style=\"font-size:14.0pt;\">It decreases the risk of endometrial cancer in women with an intact uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding Hormone Replacement Therapy (HRT) is true?&nbsp;</span></p>",
      "unique_key": "Q3494074",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) It decreases the risk of colon cancer</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hormone Replacement Therapy (HRT)</strong> is primarily used to relieve <strong>vasomotor symptoms</strong> (e.g., hot flashes, night sweats) and prevent <strong>postmenopausal osteoporosis</strong>. It is <strong>not recommended</strong> for cardiovascular or cancer prevention due to associated risks.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Protective effect on colon:</strong> Studies, including the <strong>Women’s Health Initiative (WHI)</strong>, show that <strong>combined estrogen–progestin therapy</strong> modestly <strong>reduces the risk of colorectal cancer</strong>. However, this benefit is outweighed by other risks, including breast cancer and thromboembolic events.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is indicated for primary prevention of coronary artery disease:&nbsp;</strong>Incorrect. HRT is <strong>not recommended</strong> for primary or secondary prevention of cardiovascular disease. In fact, it may <strong>increase the risk</strong> of myocardial infarction, stroke, and venous thromboembolism in older postmenopausal women.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It decreases the risk of breast cancer with long-term use:&nbsp;</strong>Incorrect. Prolonged combined HRT (estrogen + progestin) <strong>increases</strong> the risk of <strong>breast cancer</strong>. The risk rises with duration of therapy and declines after discontinuation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It decreases the risk of endometrial cancer in women with an intact uterus:&nbsp;</strong>Incorrect. Estrogen-only therapy <strong>increases</strong> the risk of <strong>endometrial carcinoma</strong> in women with an intact uterus. Adding <strong>progestin</strong> counteracts this risk, so <strong>combined therapy</strong> is required for women who have not undergone hysterectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Hormone Replacement Therapy (HRT)</strong> may <strong>reduce the risk of colorectal cancer</strong>, but it is <strong>not indicated</strong> for preventing cardiovascular disease or cancers.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It <strong>increases breast and endometrial cancer risk</strong> (if unopposed estrogen is used) and should only be used for <strong>short-term symptom relief</strong> in carefully selected postmenopausal women.</span></li></ul>",
      "correct_choice_id": 386189,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97020/NEET_GT__11_NOV_2025_OBG_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97020/NEET_GT__11_NOV_2025_OBG_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97246,
      "choices": [
        {
          "id": 387080,
          "text": "<p><span style=\"font-size:14.0pt;\">Adding bupropion</span></p>"
        },
        {
          "id": 387081,
          "text": "<p><span style=\"font-size:14.0pt;\">Switching to mirtazapine</span></p>"
        },
        {
          "id": 387082,
          "text": "<p><span style=\"font-size:14.0pt;\">Increasing the SSRI dose</span></p>"
        },
        {
          "id": 387083,
          "text": "<p><span style=\"font-size:14.0pt;\">Drug holiday on weekends</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 33-year-old man with major depressive disorder has been on sertraline 100 mg/day for 8 weeks with good response. He now complains of sexual dysfunction. All of the following strategies can help manage this adverse effect except:</span></p>",
      "unique_key": "Q8896836",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Increasing the SSRI dose</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sexual dysfunction (decreased libido, anorgasmia, delayed ejaculation) is a common and dose-related adverse effect of SSRIs, occurring in 30-60% of patients.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It results from increased serotonin at 5-HT2 and 5-HT3 receptors. Increasing the SSRI dose would worsen sexual dysfunction, not improve it, as the effect is dose-dependent.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Management strategies include: (1) Waiting for spontaneous improvement (though often doesn't occur), (2) Dose reduction if clinically feasible, (3) Drug holidays (especially with short-acting SSRIs like sertraline, paroxetine—skipping doses on weekends), (4) Adding bupropion (which increases dopamine/norepinephrine), (5) Switching to antidepressants with lower rates of sexual dysfunction (bupropion, mirtazapine, vilazodone), (6) Adding phosphodiesterase inhibitors (sildenafil) in men.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Adding bupropion</strong>: This is a correct management strategy. Bupropion, which inhibits dopamine and norepinephrine reuptake without affecting serotonin, can counteract SSRI-induced sexual dysfunction. It can be added to the existing SSRI or used as monotherapy. Studies show it improves sexual function in 50-60% of patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Switching to mirtazapine:</strong> This is a correct management strategy. Mirtazapine has lower rates of sexual dysfunction compared to SSRIs (5-10% vs 30-60%). It works by blocking 5-HT2 and 5-HT3 receptors and α2-adrenergic receptors, with a different mechanism than SSRIs. It would be appropriate to switch if sexual dysfunction is intolerable.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Drug holiday on weekends:</strong> This is a CORRECT management strategy. For short half-life SSRIs like sertraline or paroxetine, skipping Friday and Saturday doses can improve sexual function on weekends without significant loss of antidepressant effect. This doesn't work well for long half-life SSRIs like fluoxetine.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">SSRI-induced sexual dysfunction is dose-dependent; management includes dose reduction, drug holidays, adding bupropion, or switching to alternatives like mirtazapine or bupropion, not increasing the SSRI dose.</span></p>",
      "correct_choice_id": 387082,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97246/NEET_GT__11_NOV_2025_Pharmacology_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97246/NEET_GT__11_NOV_2025_Pharmacology_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96981,
      "choices": [
        {
          "id": 386032,
          "text": "<p><span style=\"font-size:18px;\">Perivascular neutrophilic infiltrate with fibrinoid necrosis</span></p>"
        },
        {
          "id": 386033,
          "text": "<p><span style=\"font-size:18px;\">Loss of Schwann cells and segmental demyelination</span></p>"
        },
        {
          "id": 386034,
          "text": "<p><span style=\"font-size:18px;\">Loss of oligodendrocytes with relative preservation of axons</span></p>"
        },
        {
          "id": 386035,
          "text": "<p><span style=\"font-size:18px;\">Neuronal loss with Lewy body inclusions in cytoplasm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 29-year-old woman presents with blurred vision in one eye that developed over a few days. Two months later, she experiences weakness in both lower limbs and urinary urgency. Neurologic examination reveals loss of vision in the right eye and increased tone with brisk reflexes in the lower limbs. MRI brain shows periventricular plaques, and MRI spine shows patchy demyelinating lesions in the cervical cord. CSF analysis reveals elevated IgG index with oligoclonal bands on electrophoresis. Which of the following pathologic features is characteristic of her disease?</span></p>",
      "unique_key": "Q4647171",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. C) Loss of oligodendrocytes with relative preservation of axons</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This <strong>29-year-old woman</strong> with <strong>recurrent episodes of optic neuritis (blurred vision)</strong> and <strong>motor weakness with urinary urgency</strong>, MRI showing <strong>periventricular plaques and spinal demyelination</strong>, and CSF with <strong>oligoclonal IgG bands</strong>, has <strong>Multiple Sclerosis (MS)</strong>.</span></li><li><span style=\"font-size:18px;\"><strong>Multiple Sclerosis</strong> is a <strong>chronic, immune-mediated demyelinating disease of the central nervous system (CNS)</strong> characterized by <strong>autoimmune destruction of myelin and oligodendrocytes</strong> in the brain and spinal cord.</span></li><li><span style=\"font-size:18px;\"><strong>Pathologic features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\"><strong>Loss of oligodendrocytes</strong>, leading to <strong>segmental demyelination</strong>.</span></li><li><span style=\"font-size:18px;\"><strong>Relative preservation of axons</strong> (in early lesions).</span></li><li><span style=\"font-size:18px;\"><strong>Perivascular lymphocytic (T-cell and macrophage) inflammation</strong>.</span></li><li><span style=\"font-size:18px;\">Formation of <strong>gliotic scars (plaques)</strong> in white matter, particularly <strong>periventricular</strong>, <strong>optic nerve</strong>, and <strong>spinal cord</strong> regions.</span></li></ul></li><li><span style=\"font-size:18px;\">This demyelination disrupts nerve conduction, leading to the classic <strong>relapsing-remitting neurologic deficits</strong> (visual, sensory, motor, and autonomic symptoms).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Perivascular neutrophilic infiltrate with fibrinoid necrosis:&nbsp;</strong>Incorrect.&nbsp;This is characteristic of <strong>vasculitis</strong>, such as <strong>polyarteritis nodosa</strong> or <strong>microscopic polyangiitis</strong>, not MS. MS lesions show <strong>lymphocytic (T-cell)</strong>, not <strong>neutrophilic</strong>, inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Loss of Schwann cells and segmental demyelination:&nbsp;</strong>Incorrect.&nbsp;This describes <strong>peripheral nervous system demyelination</strong>, as seen in <strong>Guillain-Barré syndrome (GBS)</strong> or <strong>chronic inflammatory demyelinating polyneuropathy (CIDP)</strong>. MS affects <strong>CNS myelin (oligodendrocytes)</strong>, not <strong>PNS myelin (Schwann cells)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Neuronal loss with Lewy body inclusions in cytoplasm:&nbsp;</strong>Incorrect.&nbsp;This finding is typical of <strong>Parkinson disease</strong> or <strong>Lewy body dementia</strong>, not a demyelinating disorder. MS primarily affects <strong>myelin and oligodendrocytes</strong>, not neuronal cell bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Multiple Sclerosis</strong> is a <strong>CNS demyelinating disorder</strong> characterized by <strong>autoimmune destruction of oligodendrocytes</strong>, resulting in <strong>loss of myelin with relative preservation of axons</strong>, <strong>periventricular plaques</strong>, and <strong>oligoclonal IgG bands in CSF</strong>.</span></p>",
      "correct_choice_id": 386034,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96981/Neet_Gt__11_Nov_2025_Pathology_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96981/Neet_Gt__11_Nov_2025_Pathology_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97075,
      "choices": [
        {
          "id": 386408,
          "text": "<p><span style=\"font-size:14.0pt;\">Nail pitting is of deep irregular and coarse type</span></p>"
        },
        {
          "id": 386409,
          "text": "<p><span style=\"font-size:14.0pt;\">Genetic predisposition HLA-C*06:02</span></p>"
        },
        {
          "id": 386410,
          "text": "<p><span style=\"font-size:14.0pt;\">Joint involvement seen in 5–30% of patients</span></p>"
        },
        {
          "id": 386411,
          "text": "<p><span style=\"font-size:14.0pt;\">Deficient Th1 and Th17 Helper Cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old man presents with silvery scaly plaques on the extensor surfaces and nail pitting. Which of the following statements is not true regarding psoriasis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6398989",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Deficient Th1 and Th17 Helper Cells</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Psoriasis is an <strong>inflammatory, non-infectious</strong> disorder caused by <strong>overactivation of Th1 and Th17 immune pathways</strong>, leading to cytokine-mediated keratinocyte proliferation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is associated with <strong>HLA-C*06:02</strong>, especially in early-onset disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Joint involvement (psoriatic arthritis) occurs in 5–30% of cases.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Nail Pitting</strong> <strong>is of deep irregular and coarse type:</strong> Common finding, typically deep and irregular — true.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Genetic Predisposition</strong> <strong>HLA-C*06:02:</strong> HLA-C*06:02 is well-established — true.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Joint Involvement</strong> <strong>seen in 5–30% of patients:</strong> Psoriatic arthritis is a known association — true.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">Psoriasis involves overactive Th1/Th17 pathways, not deficiency — leading to hyperproliferative inflammatory lesions.</span></p>",
      "correct_choice_id": 386411,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97075/NEET_GT__11_NOV_2025_Derma_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97075/NEET_GT__11_NOV_2025_Derma_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97010,
      "choices": [
        {
          "id": 386148,
          "text": "<p><span style=\"font-size:14.0pt;\">Silent mutation</span></p>"
        },
        {
          "id": 386149,
          "text": "<p><span style=\"font-size:14.0pt;\">Nonsense mutation</span></p>"
        },
        {
          "id": 386150,
          "text": "<p><span style=\"font-size:14.0pt;\">Conserved mutation</span></p>"
        },
        {
          "id": 386151,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-conserved mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A researcher is studying point mutations in the beta-globin gene. She identifies a single nucleotide substitution in the coding sequence where the codon GAC (coding for aspartic acid) is changed to GAG (coding for glutamic acid). Which of the following best describes this type of mutation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8302949",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Conserved mutation</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>conserved mutation</strong> refers to a change in a nucleotide sequence that alters one amino acid to another <strong>with similar biochemical properties</strong> (e.g., charge, polarity, or size), often preserving the function and structure of the resulting protein.</span></li><li><span style=\"font-size:14.0pt;\">In this case:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>GAC</strong> codes for <strong>aspartic acid (Asp)</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>GAG</strong> codes for <strong>glutamic acid (Glu)</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Both Asp and Glu are <strong>acidic amino acids</strong> with similar chemical properties (negatively charged side chains), so this is considered a <strong>conservative (or conserved) substitution</strong>—the protein function is likely retained.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Silent mutation:&nbsp;</strong>A silent mutation does not change the amino acid due to redundancy in the genetic code. Here, the amino acid changes (Asp → Glu), so this is not silent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Nonsense mutation:&nbsp;</strong>A nonsense mutation introduces a premature stop codon, resulting in a truncated protein. That is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Non-conserved mutation:&nbsp;</strong>This would involve a substitution leading to an amino acid with <strong>different biochemical properties</strong>, potentially disrupting protein function. Since Asp and Glu are similar, this is not a non-conserved change.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>conserved mutation</strong> is a nucleotide substitution that changes an amino acid to another with <strong>similar chemical properties</strong>, minimizing functional disruption of the protein. An example is Asp (GAC) to Glu (GAG), both acidic amino acids.</span></p>",
      "correct_choice_id": 386150,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97010/NEET_GT__11_NOV_2025_Biochemistry_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97010/NEET_GT__11_NOV_2025_Biochemistry_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97197,
      "choices": [
        {
          "id": 386888,
          "text": "<p><span style=\"font-size:14.0pt;\">Richter's hernia</span></p>"
        },
        {
          "id": 386889,
          "text": "<p><span style=\"font-size:14.0pt;\">Pantaloon’s hernia</span></p>"
        },
        {
          "id": 386890,
          "text": "<p><span style=\"font-size:14.0pt;\">Littre's hernia</span></p>"
        },
        {
          "id": 386891,
          "text": "<p><span style=\"font-size:14.0pt;\">Maydl’s hernia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which type of hernia is depicted in the following diagram?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20112115.jpg\" width=\"768\" height=\"647\"></strong></span></p>",
      "unique_key": "Q1314219",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Maydl’s hernia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The diagram shows Maydl's hernia/Hernia-en-W/Retrograde hernia, where 2 loops of the bowel remain in the sac with the connecting loop inside the abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Richter's hernia:</strong> In Richter's hernia, a small portion of the antimesenteric wall of the intestine is trapped within the hernia. Strangulation can occur without the presence of intestinal obstruction. Clinically, it mimics gastroenteritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-11-10%20at%2011.08.03.jpeg\" width=\"420\" height=\"279\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pantaloon hernia:</strong> In pantaloon hernia, both direct and indirect hernia occur on the same side.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Littre's hernia:</strong> In Littre's hernia, Meckel's diverticulum is the content.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The diagram illustrates a Maydl’s hernia, a condition where two bowel loops are within a hernial sac with the intervening segment lying within the peritoneal cavity and at risk for strangulation.</span></p>",
      "correct_choice_id": 386891,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97197/NEET_GT__11_NOV_2025_Surgery_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97197/NEET_GT__11_NOV_2025_Surgery_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97199,
      "choices": [
        {
          "id": 386896,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer a hemostatic agent through the chest tube</span></p>"
        },
        {
          "id": 386897,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue resuscitation for the next 6 hours</span></p>"
        },
        {
          "id": 386898,
          "text": "<p><span style=\"font-size:14.0pt;\">Urgent thoracentesis</span></p>"
        },
        {
          "id": 386899,
          "text": "<p><span style=\"font-size:14.0pt;\">Emergency thoracotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 49-year-old male patient was brought to the ER after a road traffic accident. On examination, the following was noted in X-ray. Tube thoracostomy was done and around 1850 ml blood was drained in 1 hour. What is the most appropriate management for this patient?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20112142.jpg\" width=\"547\" height=\"485\"></strong></span></p>",
      "unique_key": "Q3828648",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Emergency thoracotomy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In massive hemothorax, presence of &gt;1500 ml blood in ICD immediately is an indication for thoracotomy.</span></li><li><span style=\"font-size:14.0pt;\">Given the significant blood loss (1850 ml) and the critical condition of the patient, emergency thoracotomy is the most appropriate management.</span></li><li><span style=\"font-size:14.0pt;\">It allows for direct access to the bleeding source for immediate control of bleeding and repair of injuries.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Administer a hemostatic agent through the chest tube:</strong> This is not appropriate when there is a massive blood loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Continue resuscitation for the next 6 hours:</strong> While resuscitation is necessary, immediate control of bleeding is critical in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Urgent thoracentesis:</strong> This is not the suitable intervention for a severe condition like this.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In cases of significant blood loss and critical condition, emergency thoracotomy is essential to control bleeding and repair injuries immediately.</span></p>",
      "correct_choice_id": 386899,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97199/NEET_GT__11_NOV_2025_Surgery_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97199/NEET_GT__11_NOV_2025_Surgery_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96953,
      "choices": [
        {
          "id": 385920,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 385921,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3 and 5 only</span></p>"
        },
        {
          "id": 385922,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 4 and 5 only</span></p>"
        },
        {
          "id": 385923,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In which of the following documentary evidence alone can be allowed as proof without the need of oral evidence in the court?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Victim who died after giving Dying declaration&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Report from Director of Fingerprint Bureau</span></li><li><span style=\"font-size:14.0pt;\">A witness willing to provide a written statement but don’t want to attend court due to anxiety.</span></li><li><span style=\"font-size:14.0pt;\">Deposition recorded in a lower court where cross-examination occurred</span></li><li><span style=\"font-size:14.0pt;\">Injury report by a government medical doctor of a reputed institute</span></li></ol>",
      "unique_key": "Q9555387",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Indian Evidence Act</strong> provides specific exceptions under which documentary evidence is admissible without requiring oral testimony.</span></li><li><span style=\"font-size:14.0pt;\"><strong>These include:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>Victim who died after giving Dying declaration:&nbsp;</strong>Dying declaration is admissible when the person is dead and the statement relates to the cause and circumstances of death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.&nbsp;Report</strong> <strong>from Director of Fingerprint Bureau: Reports from designated government experts</strong> such as the <strong>Director of Fingerprint Bureau</strong> are admissible under Section 293 of CrPC without summoning the expert to court.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Deposition recorded in a lower court where cross-examination occurred: &nbsp;</strong>Depositions from prior court proceedings are allowed, provided cross-examination occurred.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>A witness willing to provide a written statement but don’t want to attend court due to anxiety:&nbsp;</strong>Anxiety does <strong>not qualify</strong> as an exception. Documentary substitution is not allowed unless legally excused (e.g., death, untraceability).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>Injury report by a government medical doctor of a reputed institute:&nbsp;</strong>A medical report is always required to be testified orally by the doctor in the court.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Exception to oral evidence (where document alone is acceptable):</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Dying declaration</span></li><li><span style=\"font-size:14.0pt;\">Expert opinions expressed in a book</span></li><li><span style=\"font-size:14.0pt;\">Deposition of a medical witness taken in&nbsp; a&nbsp; lower court</span></li><li><span style=\"font-size:14.0pt;\">Evidence given by a witness&nbsp; in&nbsp; a&nbsp; previous&nbsp; judicial proceeding</span></li><li><span style=\"font-size:14.0pt;\">Statements by persons who&nbsp; cannot&nbsp; be&nbsp; called&nbsp; as&nbsp; witnesses: e.g. dead, untraceable etc.</span></li><li><span style=\"font-size:14.0pt;\">Report of&nbsp; certain government scientific experts:</span><ol style=\"list-style-type:upper-roman;\"><li><span style=\"font-size:14.0pt;\">Chemical&nbsp; Examiner&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Chief&nbsp; Controller&nbsp; of&nbsp; Explosives,</span></li><li><span style=\"font-size:14.0pt;\">Director&nbsp; of Fingerprint&nbsp; Bureau,</span></li><li><span style=\"font-size:14.0pt;\">Director of a Central Forensic Science Laboratory</span></li></ol></li></ol>",
      "correct_choice_id": 385920,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96953/NEET_GT__11_NOV_2025_FMT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96953/NEET_GT__11_NOV_2025_FMT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97067,
      "choices": [
        {
          "id": 386376,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteoporosis&nbsp;</span></p>"
        },
        {
          "id": 386377,
          "text": "<p><span style=\"font-size:14.0pt;\">Osteomyelitis&nbsp;</span></p>"
        },
        {
          "id": 386378,
          "text": "<p><span style=\"font-size:14.0pt;\">Fibrous Dysplasia</span></p>"
        },
        {
          "id": 386379,
          "text": "<p><span style=\"font-size:14.0pt;\">Paget's Disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old male presents to the clinic with a 6-month history of worsening dull, aching pain in his left thigh and a noticeable bowing of his left leg. He reports a subjective feeling of warmth over the affected area. Physical examination confirms the anterior bowing of the left tibia and palpable warmth over the mid-shaft of the bone. Laboratory tests reveal an elevated serum Alkaline Phosphatase (ALP) level with normal serum calcium and phosphate levels. Which of the following is the most likely diagnosis?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103454.jpg\" width=\"475\" height=\"389\"></span></p>",
      "unique_key": "Q1353771",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Paget's Disease</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Also known as Osteitis Deformans, it is a chronic disorder of the adult skeleton in which localized areas of bone resorption and formation are highly accelerated and disorganized, leading to structurally weak and deformed bone.</span></li><li><span style=\"font-size:14.0pt;\">It typically affects people over the age of 50-55, fitting the 72-year-old male.</span></li><li><span style=\"font-size:14.0pt;\">Dull, aching bone pain and progressive bone deformity are hallmark signs.</span></li><li><span style=\"font-size:14.0pt;\">Increased local warmth is a common sign due to the highly active, rapidly remodelling bone.</span></li><li><span style=\"font-size:14.0pt;\">Isolated, marked elevation of serum Alkaline Phosphatase (ALP) is the classic biochemical signature, reflecting the massive increase in osteoblast activity (bone formation phase) following the initial lytic phase. Serum calcium and phosphate remain normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Osteoporosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to increased bone fragility and fracture risk.</span></li><li><span style=\"font-size:14.0pt;\">Osteoporosis is typically asymptomatic until a fracture occurs. It does not cause local warmth, significant long-bone bowing, or an isolated elevated ALP.</span></li><li><span style=\"font-size:14.0pt;\">ALP is usually normal, unless a recent fracture has occurred. Serum calcium and phosphate are also typically normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Osteomyelitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An infection of the bone, most commonly bacterial.</span></li><li><span style=\"font-size:14.0pt;\">While it causes pain and local warmth, the onset is usually acute or subacute, often accompanied by fever, chills, and other signs of systemic illness. The pain is typically more intense and throbbing.</span></li><li><span style=\"font-size:14.0pt;\">It does not cause the progressive bowing/enlargement deformity described in the case.</span></li><li><span style=\"font-size:14.0pt;\">Though ALP may be slightly elevated, the characteristic lab finding is a marked elevation of inflammatory markers (ESR and CRP), and often an elevated White Blood Cell (WBC) count, which are not mentioned.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Fibrous Dysplasia:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A benign bone disorder where normal bone is replaced by abnormal fibro-osseous tissue.</span></li><li><span style=\"font-size:14.0pt;\">Fibrous dysplasia is a developmental disorder typically diagnosed in children or young adults. Presentation in a 72-year-old is highly unusual.</span></li><li><span style=\"font-size:14.0pt;\">ALP may be mildly elevated if the disease is extensive (polyostotic), but the levels are often not as high as in Paget's disease. The classic clinical triad of the case (pain, bowing, warmth, and isolated high ALP) does not align with a late-onset presentation of this condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The case describes a classic presentation involving bone pain, deformity (bowing), local warmth, and an isolated, significantly elevated Alkaline Phosphatase (ALP) in an elderly patient.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This combination points strongly to a condition involving rapid, disorganized bone turnover.</span></li></ul>",
      "correct_choice_id": 386379,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97067/NEET_GT__11_NOV_2025_Orthopedics_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97067/NEET_GT__11_NOV_2025_Orthopedics_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97017,
      "choices": [
        {
          "id": 386176,
          "text": "<p><span style=\"font-size:14.0pt;\">Competitive inhibition</span></p>"
        },
        {
          "id": 386177,
          "text": "<p><span style=\"font-size:14.0pt;\">Uncompetitive inhibition</span></p>"
        },
        {
          "id": 386178,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-competitive inhibition</span></p>"
        },
        {
          "id": 386179,
          "text": "<p><span style=\"font-size:14.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A team of biochemists is studying an enzyme involved in an essential metabolic pathway to develop a new class of inhibitors for therapeutic use. To determine the type of inhibition, they perform enzyme kinetics experiments and analyze the results using a Lineweaver–Burk plot (double reciprocal plot).The results show two straight lines that are parallel to each other — one representing the enzyme without inhibitor and the other in the presence of the inhibitor. Further analysis reveals that, in the presence of the inhibitor, both the maximum velocity (Vmax) and the Michaelis constant (Km) of the enzyme are decreased. Which type of enzyme inhibition does this pattern represent?&nbsp;</span></p>",
      "unique_key": "Q2066940",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Uncompetitive inhibition</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To interpret enzyme inhibition, we analyze changes in Vmax and Km using enzyme kinetic plots such as the Lineweaver–Burk plot (1/V vs 1/[S]).</span></li><li><span style=\"font-size:14.0pt;\"><strong>In this case:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The two lines are parallel, meaning they never intersect.</span></li><li><span style=\"font-size:14.0pt;\">This indicates that both Vmax decreases and Km decreases proportionally.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the slope (Km/Vmax) remains constant.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This kinetic pattern is characteristic of uncompetitive inhibition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mechanism of Uncompetitive Inhibition:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The inhibitor binds only to the enzyme–substrate (ES) complex, not to the free enzyme.</span></li><li><span style=\"font-size:14.0pt;\">This binding locks the substrate in the enzyme, preventing product formation.</span></li><li><span style=\"font-size:14.0pt;\">As a result:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Vmax decreases → because some enzymes are “trapped” in the ES–inhibitor complex.</span></li><li><span style=\"font-size:14.0pt;\">Km decreases → because substrate binding is stabilized (ES complex is more easily formed).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Hence, both Vmax and Km decrease, giving parallel lines on the Lineweaver–Burk plot.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Competitive inhibition:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inhibitor competes with substrate for the active site.</span></li><li><span style=\"font-size:14.0pt;\">Km increases, Vmax unchanged.</span></li><li><span style=\"font-size:14.0pt;\">Lines intersect on the y-axis (not parallel).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Non-competitive inhibition:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Inhibitor binds both free enzyme and ES complex at an allosteric site.</span></li><li><span style=\"font-size:14.0pt;\">Vmax decreases, Km unchanged.</span></li><li><span style=\"font-size:14.0pt;\">Lines intersect on the x-axis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Uncompetitive inhibition often occurs with multi-substrate enzyme systems, and it’s less common than competitive or non-competitive inhibition.</span></li><li><span style=\"font-size:14.0pt;\">Some drugs that target enzymes in metabolic or signaling pathways act through uncompetitive mechanisms to maintain specificity under certain cellular conditions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Summary Table of Enzyme Inhibition Types:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20110630.jpg\" width=\"1160\" height=\"311\"></strong></span></p>",
      "correct_choice_id": 386177,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97017/NEET_GT__11_NOV_2025_Biochemistry_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97017/NEET_GT__11_NOV_2025_Biochemistry_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97022,
      "choices": [
        {
          "id": 386196,
          "text": "<p><span style=\"font-size:14.0pt;\">Pomeroy technique</span></p>"
        },
        {
          "id": 386197,
          "text": "<p><span style=\"font-size:14.0pt;\">Filshie clips</span></p>"
        },
        {
          "id": 386198,
          "text": "<p><span style=\"font-size:14.0pt;\">Essure device</span></p>"
        },
        {
          "id": 386199,
          "text": "<p><span style=\"font-size:14.0pt;\">Irving technique</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old multiparous woman opts for permanent contraception. Which method of tubal sterilization is most commonly performed during cesarean section?&nbsp;</span></p>",
      "unique_key": "Q2909763",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Pomeroy technique</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This <strong>32-year-old multiparous woman</strong> desires <strong>permanent contraception</strong> and is planned for <strong>tubal sterilization</strong> during a <strong>cesarean section</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Among the available methods, the <strong>Pomeroy technique</strong> is the <strong>most commonly performed</strong> method of <strong>tubal ligation during cesarean delivery</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Procedure summary:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">A <strong>loop</strong> of the <strong>fallopian tube</strong> (usually the isthmic portion) is elevated.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>catgut suture</strong> is tied at the base of the loop to create a knuckle.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>looped segment</strong> is then <strong>excised</strong>, leaving two sealed ends.</span></li><li><span style=\"font-size:14.0pt;\">The cut ends subsequently undergo <strong>fibrosis</strong>, ensuring <strong>permanent occlusion</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Advantages of the Pomeroy technique:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Simple, safe, and quick.</span></li><li><span style=\"font-size:14.0pt;\">Can be performed easily during cesarean section or minilaparotomy.</span></li><li><span style=\"font-size:14.0pt;\">Low failure rate.</span></li><li><span style=\"font-size:14.0pt;\">Easy to identify tube ends if reanastomosis is attempted later.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the <strong>Pomeroy method</strong> is the preferred and most widely used technique for <strong>tubal sterilization during cesarean section</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Filshie clips:&nbsp;</strong>Incorrect. Filshie clips are <strong>mechanical occlusion devices</strong> applied laparoscopically for <strong>interval sterilization</strong>, not commonly during cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Essure device:&nbsp;</strong>Incorrect. The <strong>Essure device</strong> is a <strong>hysteroscopic method</strong> of tubal occlusion placed via the cervix, used for <strong>interval sterilization</strong>. It is <strong>not suitable intraoperatively</strong> or during cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Irving technique:&nbsp;</strong>Incorrect. The <strong>Irving method</strong> involves <strong>burying the proximal cut end of the tube</strong> into the uterine muscle. It is more <strong>complex and time-consuming</strong>, reserved for <strong>repeat sterilization</strong> after failure of a previous method, not routine use during cesarean section.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>Pomeroy technique</strong> is the <strong>most common method</strong> of <strong>tubal sterilization during cesarean section</strong>, as it is <strong>simple, reliable, and effective</strong>, involving <strong>ligation and excision of a loop of the fallopian tube</strong>.</span></p>",
      "correct_choice_id": 386196,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97022/NEET_GT__11_NOV_2025_OBG_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97022/NEET_GT__11_NOV_2025_OBG_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97037,
      "choices": [
        {
          "id": 386256,
          "text": "<p><span style=\"font-size:14.0pt;\">TORCH screening; treat specific infection if positive</span></p>"
        },
        {
          "id": 386257,
          "text": "<p><span style=\"font-size:14.0pt;\">Antiphospholipid antibody panel; aspirin + heparin if positive</span></p>"
        },
        {
          "id": 386258,
          "text": "<p><span style=\"font-size:14.0pt;\">Thyroid function tests; levothyroxine if hypothyroid</span></p>"
        },
        {
          "id": 386259,
          "text": "<p><span style=\"font-size:14.0pt;\">Genetic karyotyping; preimplantation genetic testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old G4A3 presents for preconception counseling. She had first miscarriage at 8 weeks, second at 11 weeks with absent fetal cardiac activity, and third pregnancy loss at 24 weeks due to early-onset severe preeclampsia with fetal demise. She is otherwise healthy. What is the most appropriate investigation and treatment for future pregnancy?</span></p>",
      "unique_key": "Q6047088",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Antiphospholipid antibody panel; aspirin + heparin if positive</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>30-year-old G4A3</strong> seeking <strong>preconception counseling</strong> with losses at <strong>8 weeks</strong>, <strong>11 weeks with absent fetal cardiac activity</strong>, and <strong>24 weeks due to early-onset severe preeclampsia with fetal demise</strong>, while <strong>otherwise healthy</strong>, fits <strong>placental-mediated pregnancy morbidity</strong> from <strong>antiphospholipid syndrome (APS)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Test the <strong>antiphospholipid antibody panel</strong> (<strong>lupus anticoagulant, anticardiolipin IgG/IgM, anti-β2-glycoprotein I IgG/IgM</strong>) and confirm persistence ≥<strong>12 weeks</strong> apart.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In future pregnancy, <strong>low-dose aspirin + heparin (LMWH)</strong> improves live-birth rates and reduces preeclampsia/placental complications.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. TORCH screening; treat specific infection if positive</strong>: Infections are uncommon causes of <strong>recurrent early miscarriage</strong> and do <strong>not</strong> explain <strong>early-onset severe preeclampsia</strong> at <strong>24 weeks</strong> or <strong>fetal demise</strong>; routine TORCH testing is <strong>not recommended</strong> for this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Thyroid function tests; levothyroxine if hypothyroid</strong>: Thyroid disease can contribute to loss, but it does <strong>not</strong> account for the combination of <strong>8- and 11-week miscarriages (absent cardiac activity)</strong> plus a <strong>24-week preeclampsia-related fetal demise</strong>; not the <strong>most appropriate</strong> targeted evaluation here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Genetic karyotyping; preimplantation genetic testing</strong>: Parental karyotyping/PGT may address <strong>chromosomal</strong> causes of early loss (often in IVF contexts) but does <strong>not</strong> address <strong>placental/immune</strong> pathology; it fails to explain <strong>early-onset severe preeclampsia</strong> at <strong>24 weeks</strong> suggestive of <strong>APS</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recurrent early losses plus a second-trimester fetal demise from early-onset severe preeclampsia → evaluate for APS with an antiphospholipid antibody panel and treat future pregnancy with low-dose aspirin + heparin if positive.</span></p>",
      "correct_choice_id": 386257,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97037/NEET_GT__11_NOV_2025_OBG_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97037/NEET_GT__11_NOV_2025_OBG_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97254,
      "choices": [
        {
          "id": 387112,
          "text": "<p><span style=\"font-size:14.0pt;\">Chlordiazepoxide&nbsp;</span></p>"
        },
        {
          "id": 387113,
          "text": "<p><span style=\"font-size:14.0pt;\">Diazepam&nbsp;</span></p>"
        },
        {
          "id": 387114,
          "text": "<p><span style=\"font-size:14.0pt;\">Lorazepam&nbsp;</span></p>"
        },
        {
          "id": 387115,
          "text": "<p><span style=\"font-size:14.0pt;\">Clonazepam&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man with cirrhosis presents 18 hours after his last drink with tremors, sweating, tachycardia, mild confusion, and visual hallucinations. Which drug is most appropriate for managing his alcohol withdrawal?</span></p>",
      "unique_key": "Q4959979",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Lorazepam</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Lorazepam represents the optimal benzodiazepine choice in this cirrhotic patient experiencing alcohol withdrawal.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike other benzodiazepines, lorazepam undergoes direct glucuronide conjugation without forming active metabolites.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This metabolic pathway remains relatively preserved even in advanced liver disease, preventing drug accumulation and enhanced toxicity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient's clinical presentation—tremor, autonomic hyperactivity, mild confusion, and visual hallucinations—indicates moderate alcohol withdrawal syndrome requiring prompt benzodiazepine intervention.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Oxazepam shares similar safety characteristics but has slower, more irregular absorption making lorazepam preferable for acute management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Chlordiazepoxide:</strong> While historically the \"commonest BZD used to cover alcohol withdrawal,\" chlordiazepoxide has a t½ of 6-12 hours with active metabolites that extend duration of action. In cirrhosis, these metabolites accumulate, leading to prolonged sedation and potential hepatic encephalopathy. This option could become a distractor if one ignores cirrhosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Diazepam:</strong> Despite rapid absorption and effectiveness in alcohol withdrawal, diazepam has a biological effect t½ much longer than plasma t½ due to active metabolites. It is contraindicated in liver failure due to metabolite accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Clonazepam:</strong> Though effective as an anticonvulsant, clonazepam forms active metabolites and has prolonged action. It's not the preferred choice for acute alcohol withdrawal management in cirrhotic patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In patients with liver disease requiring benzodiazepine therapy, select agents metabolized by glucuronidation (lorazepam, oxazepam) rather than those forming active metabolites through hepatic oxidation, to prevent drug accumulation and enhanced toxicity.</span></p>",
      "correct_choice_id": 387114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97254/NEET_GT__11_NOV_2025_Pharmacology_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97254/NEET_GT__11_NOV_2025_Pharmacology_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97008,
      "choices": [
        {
          "id": 386140,
          "text": "<p><span style=\"font-size:14.0pt;\">It acts as an anticoagulant</span></p>"
        },
        {
          "id": 386141,
          "text": "<p><span style=\"font-size:14.0pt;\">Prolonged use of antimicrobials leads to its deficiency</span></p>"
        },
        {
          "id": 386142,
          "text": "<p><span style=\"font-size:14.0pt;\">The dietary requirement is 15–20 mg per day</span></p>"
        },
        {
          "id": 386143,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 65-year-old man is admitted to the hospital with complaints of easy bruising, gum bleeding, and blood in stool for the past few days. His past medical history reveals that he has been on broad-spectrum antibiotic therapy for 3 weeks following a severe urinary tract infection. The physician suspects a vitamin deficiency affecting the blood coagulation cascade. Which of the following statements regarding the suspected vitamin is<strong>&nbsp;</strong>true?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5004438",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Prolonged use of antimicrobials leads to its deficiency</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>65-year-old man</strong> admitted with <strong>easy bruising</strong>, <strong>gum bleeding</strong>, and <strong>blood in stool</strong> over <strong>the past few days</strong>, after <strong>broad-spectrum antibiotic therapy for 3 weeks</strong> for a <strong>severe urinary tract infection</strong>, suggests <strong>vitamin K</strong> deficiency affecting the <strong>blood coagulation cascade</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Vitamin K is required for γ-carboxylation (activation) of clotting factors II, VII, IX, X, and proteins C and S.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>Prolonged use of antimicrobials</strong> decreases gut flora that synthesize vitamin K, so <strong>“Prolonged use of antimicrobials leads to its deficiency”</strong> is <strong>true </strong>and explains the bleeding phenotype in this clinical scenario.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It acts as an anticoagulant:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>The suspected vitamin, <strong>vitamin K</strong>, functions as a <strong>procoagulant cofactor</strong> enabling activation of clotting factors; it does <strong>not</strong> act as <strong>an anticoagulant</strong>. Deficiency therefore causes <strong>bleeding</strong> (easy bruising, gum bleeding, blood in stool).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The dietary requirement is 15–20 mg per day:&nbsp;</strong>Incorrect. Daily requirements for vitamin K are in <strong>micrograms</strong> (≈ <strong>90–120 µg/day</strong> in adults), <strong>not 15–20 mg per day</strong>. The patient’s deficiency is driven by <strong>3 weeks</strong> of <strong>broad-spectrum</strong> antimicrobial use rather than inadequate intake alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Vitamin K deficiency commonly follows prolonged broad-spectrum antimicrobial therapy due to loss of gut flora–derived vitamin K, leading to impaired γ-carboxylation of clotting factors and bleeding.</span></p>",
      "correct_choice_id": 386141,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97008/NEET_GT__11_NOV_2025_Biochemistry_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97008/NEET_GT__11_NOV_2025_Biochemistry_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96938,
      "choices": [
        {
          "id": 385860,
          "text": "<p><span style=\"font-size:14.0pt;\">Sensitivity = 75%, Specificity = 90%</span></p>"
        },
        {
          "id": 385861,
          "text": "<p><span style=\"font-size:14.0pt;\">Sensitivity = 60%, Specificity = 95.5%</span></p>"
        },
        {
          "id": 385862,
          "text": "<p><span style=\"font-size:14.0pt;\">Sensitivity = 60%, Specificity = 97.8%</span></p>"
        },
        {
          "id": 385863,
          "text": "<p><span style=\"font-size:14.0pt;\">Sensitivity = 75%, Specificity = 97.8%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A screening test for cervical cancer was conducted on 1000 women. The results showed that 80 women tested positive, out of which 60 actually had cervical cancer. Among the 920 women who tested negative, 40 actually had cervical cancer. What is the sensitivity and specificity of this screening test?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3970426",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)</strong> <strong>Sensitivity = 60%, Specificity = 97.8%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">To calculate sensitivity and specificity, construct a 2x2 table:</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20140047.jpg\" width=\"527\" height=\"403\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20110832.jpg\" width=\"1514\" height=\"373\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sensitivity = TP/(TP+FN) = 60/(60+40) = 60/100 = 60%</span></li><li><span style=\"font-size:14.0pt;\">Specificity = TN/(TN+FP) = 880/(880+20) = 880/900 = 97.8%</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sensitivity measures the ability of a test to correctly identify diseased individuals (TP/(TP+FN))</span></li><li><span style=\"font-size:14.0pt;\">Specificity measures the ability of a test to correctly identify non-diseased individuals (TN/(TN+FP))</span></li></ul>",
      "correct_choice_id": 385862,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96938/NEET_PG_11_Nov_2025_PSM_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96938/NEET_PG_11_Nov_2025_PSM_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96987,
      "choices": [
        {
          "id": 386056,
          "text": "<p><span style=\"font-size:14.0pt;\">Macrophages</span></p>"
        },
        {
          "id": 386057,
          "text": "<p><span style=\"font-size:14.0pt;\">B lymphocytes</span></p>"
        },
        {
          "id": 386058,
          "text": "<p><span style=\"font-size:14.0pt;\">T lymphocytes</span></p>"
        },
        {
          "id": 386059,
          "text": "<p><span style=\"font-size:14.0pt;\">Neutrophils</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man underwent a renal transplant six months ago. He now presents with rising serum creatinine and mild tenderness over the graft site. There are no signs of infection, and urine culture is sterile. Biopsy shows lymphocytic infiltration and vascular endothelial damage.&nbsp;Which of the following immune cells are primarily responsible for this type of graft rejection?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9249397",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) T lymphocytes</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient developed <strong>acute transplant rejection</strong> occurring <strong>within weeks to months (commonly around 6 months)</strong> after transplantation.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>biopsy findings</strong> of <strong>lymphocytic infiltration and vascular endothelial damage</strong> are typical of <strong>acute cellular rejection</strong>, which is <strong>mediated primarily by T lymphocytes</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Mechanism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Acute rejection</strong> may be:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:14.0pt;\"><strong>Cell-mediated (T-cell–mediated):</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\"><strong>CD8⁺ cytotoxic T cells</strong> directly attack graft parenchymal cells and vascular endothelium.</span></li><li><span style=\"font-size:14.0pt;\"><strong>CD4⁺ helper T cells</strong> release cytokines, leading to inflammation and tissue injury.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Humoral (antibody-mediated):</strong></span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:14.0pt;\">Caused by antibodies against donor HLA antigens.</span></li><li><span style=\"font-size:14.0pt;\">Characterized by <strong>vasculitis and C4d complement deposition</strong>.</span></li></ul></li></ol></li><li><span style=\"font-size:14.0pt;\">In this case, the <strong>lymphocytic infiltration</strong> indicates <strong>T-cell–mediated rejection</strong>, which is the <strong>most common form</strong> of acute rejection after several months.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Macrophages:&nbsp;</strong>Incorrect.&nbsp;Macrophages are involved mainly in <strong>chronic rejection</strong> and <strong>type IV hypersensitivity</strong>, but in acute transplant rejection, <strong>T cells</strong> play the central role in initiating graft injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. B lymphocytes:&nbsp;</strong>Incorrect.&nbsp;B cells produce antibodies responsible for <strong>antibody-mediated (humoral) rejection</strong>, which is typically associated with <strong>complement deposition and vasculitis</strong>, not the cellular infiltrate described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Neutrophils:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Neutrophils dominate <strong>hyperacute rejection</strong>, which occurs <strong>within minutes to hours</strong> of transplantation due to <strong>preformed anti-donor antibodies</strong>, not in delayed (6-month) rejections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Acute transplant rejection</strong> occurring <strong>weeks to months after transplantation</strong> is primarily <strong>mediated by T lymphocytes</strong>, leading to <strong>lymphocytic infiltration and endothelial injury</strong> in the graft.</span></p>",
      "correct_choice_id": 386058,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96987/Neet_Gt__11_Nov_2025_Pathology_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96987/Neet_Gt__11_Nov_2025_Pathology_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96986,
      "choices": [
        {
          "id": 386052,
          "text": "<p><span style=\"font-size:14.0pt;\">GFAP</span></p>"
        },
        {
          "id": 386053,
          "text": "<p><span style=\"font-size:14.0pt;\">Synaptophysin</span></p>"
        },
        {
          "id": 386054,
          "text": "<p><span style=\"font-size:14.0pt;\">Calretinin</span></p>"
        },
        {
          "id": 386055,
          "text": "<p><span style=\"font-size:14.0pt;\">Cytokeratin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old man presents with chronic cough and unintentional weight loss. A chest CT scan reveals a well-circumscribed mass in the right lower lobe of the lung. Biopsy of the tumor is shown in the image below. IHC staining is performed to confirm the diagnosis. Which of the following markers is most likely to be positive in this tumor?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20133648.jpg\" width=\"451\" height=\"345\"></strong></span></p>",
      "unique_key": "Q6036805",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Synaptophysin</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s presentation—lung mass composed of <strong>uniform cells with “salt-and-pepper” chromatin</strong>—is consistent with a <strong>neuroendocrine tumor</strong> such as <strong>carcinoid tumor</strong> or <strong>small-cell carcinoma</strong> of the lung.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Synaptophysin</strong> is a <strong>neuroendocrine immunohistochemical marker</strong> found in <strong>presynaptic vesicles of neurons and neuroendocrine cells</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>strongly positive in neuroendocrine tumors</strong>, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Carcinoid tumors</span></li><li><span style=\"font-size:14.0pt;\">Small-cell carcinoma of the lung</span></li><li><span style=\"font-size:14.0pt;\">Pheochromocytoma</span></li><li><span style=\"font-size:14.0pt;\">Medullary thyroid carcinoma</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Other common neuroendocrine markers include <strong>chromogranin A</strong> and <strong>neuron-specific enolase (NSE)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The positivity of synaptophysin supports the <strong>neuroendocrine origin</strong> of the tumor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. GFAP:&nbsp;</strong>Incorrect. Glial fibrillary acidic protein (GFAP) is an <strong>intermediate filament</strong> found in <strong>astrocytes and other glial cells</strong>. It is positive in <strong>astrocytomas, glioblastomas, and ependymomas</strong>, not in neuroendocrine tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Calretinin:&nbsp;</strong>Incorrect.&nbsp;Calretinin is a <strong>calcium-binding protein</strong> expressed in <strong>mesothelial cells</strong>. It is used as a <strong>marker for mesothelioma</strong> and some <strong>neural tumors</strong>, but it is <strong>not characteristic of neuroendocrine tumors</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Cytokeratin:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>Cytokeratin stains <strong>epithelial cells</strong>, so it may be positive in carcinomas of epithelial origin. However, while some neuroendocrine tumors may co-express cytokeratin, it is <strong>not a specific neuroendocrine marker</strong>. <strong>Synaptophysin</strong> is far more specific for confirming neuroendocrine differentiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Synaptophysin is a neuroendocrine immunohistochemical marker</strong> found in presynaptic vesicles of neurons and neuroendocrine cells.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>&nbsp;</strong>It is <strong>positive in neuroendocrine tumors</strong>, including <strong>carcinoid tumors and small-cell carcinoma of the lung</strong>.</span></li></ul>",
      "correct_choice_id": 386053,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96986/Neet_Gt__11_Nov_2025_Pathology_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96986/Neet_Gt__11_Nov_2025_Pathology_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97032,
      "choices": [
        {
          "id": 386236,
          "text": "<p><span style=\"font-size:14.0pt;\">Turner syndrome</span></p>"
        },
        {
          "id": 386237,
          "text": "<p><span style=\"font-size:14.0pt;\">Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome</span></p>"
        },
        {
          "id": 386238,
          "text": "<p><span style=\"font-size:14.0pt;\">Androgen insensitivity syndrome (AIS)</span></p>"
        },
        {
          "id": 386239,
          "text": "<p><span style=\"font-size:14.0pt;\">Imperforate hymen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 14-year-old girl presents with primary amenorrhea. She has normal breast development (Tanner stage IV) but absent pubic and axillary hair. On examination, a blind-ending vaginal pouch is noted. Karyotype shows 46,XY. What is the most likely diagnosis?&nbsp;</span></p>",
      "unique_key": "Q7374397",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Androgen insensitivity syndrome (AIS)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This <strong>14-year-old girl</strong> with <strong>primary amenorrhea</strong>, <strong>normal breast development (Tanner stage IV)</strong>, <strong>absent pubic and axillary hair</strong>, <strong>blind-ending vaginal pouch</strong>, and <strong>46,XY karyotype</strong> has features classic for <strong>Androgen Insensitivity Syndrome (AIS)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In AIS, there is a <strong>mutation in the androgen receptor gene</strong>, leading to <strong>end-organ resistance to androgens</strong>. Despite having a <strong>male (46,XY) karyotype</strong> and <strong>functioning testes</strong> that produce normal or elevated testosterone, the tissues <strong>cannot respond to androgens</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Key findings include:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Normal breast development</strong> → due to peripheral aromatization of androgens to estrogens.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Absent pubic and axillary hair</strong> → due to androgen receptor defect (androgens stimulate hair growth).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Blind vaginal pouch, absent uterus and upper vagina</strong> → due to <strong>anti-Müllerian hormone (AMH)</strong> from Sertoli cells causing Müllerian duct regression.</span></li><li><span style=\"font-size:14.0pt;\"><strong>46,XY karyotype</strong> confirms a genotypic male.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the <strong>most likely diagnosis</strong> is <strong>Androgen Insensitivity Syndrome (AIS)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Turner syndrome:&nbsp;</strong>Incorrect. Turner syndrome (45,XO) presents with <strong>short stature</strong>, <strong>streak ovaries</strong>, <strong>shield chest</strong>, and <strong>primary amenorrhea</strong>, but <strong>no breast development</strong> and <strong>normal pubic hair</strong>. Karyotype differs (45,XO, not 46,XY).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome:&nbsp;</strong>Incorrect<strong>.</strong> MRKH presents with <strong>primary amenorrhea</strong> and a <strong>blind vaginal pouch</strong>, but these patients are <strong>46,XX females</strong> with <strong>normal pubic and axillary hair</strong> and <strong>normal ovarian function</strong>, unlike AIS (46,XY and absent hair).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Imperforate hymen:&nbsp;</strong>Incorrect. Imperforate hymen causes <strong>primary amenorrhea</strong> due to <strong>obstructed menstrual flow</strong>, leading to <strong>cyclical pain</strong> and <strong>hematocolpos</strong>, but the <strong>reproductive tract (uterus, vagina)</strong> and <strong>secondary sexual characteristics</strong> are normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Androgen Insensitivity Syndrome (AIS)</strong> results from a <strong>defect in the androgen receptor</strong> in a <strong>46,XY individual</strong>, leading to <strong>female external genitalia</strong>, <strong>breast development</strong>, <strong>absent pubic/axillary hair</strong>, <strong>blind vagina</strong>, and <strong>absence of uterus and testes in the abdomen or inguinal canal</strong>.</span></p>",
      "correct_choice_id": 386238,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97032/NEET_GT__11_NOV_2025_OBG_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97032/NEET_GT__11_NOV_2025_OBG_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96997,
      "choices": [
        {
          "id": 386096,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 386097,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 3 only</span></p>"
        },
        {
          "id": 386098,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        },
        {
          "id": 386099,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding diagnostic testing for Zika virus are correct?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">IgM ELISA is limited by cross-reactivity with Dengue virus antibodies, reducing its specificity.</span></li><li><span style=\"font-size:14.0pt;\">Real-time multiplex RT-PCR assays available in India target NS5 of ZIKV, nsP4 of Chikungunya, and 3′UTR of Dengue virus.</span></li><li><span style=\"font-size:14.0pt;\">Plaque Reduction Neutralization Test (PRNT) is a more specific assay for Zika virus, particularly in regions endemic for multiple flaviviruses.</span></li><li><span style=\"font-size:14.0pt;\">NS3 protease gene is routinely used as a highly specific PCR target in Zika diagnostics due to its conserved nature.</span></li></ol>",
      "unique_key": "Q2445372",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1, 2 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>IgM ELISA is limited by cross-reactivity with Dengue virus antibodies, reducing its specificity:&nbsp;</strong>Correct.&nbsp; IgM ELISA for Zika virus has poor specificity due to cross-reactivity with other flaviviruses like Dengue, making confirmatory testing essential.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>Real-time multiplex RT-PCR assays available in India target NS5 of ZIKV, nsP4 of Chikungunya, and 3′UTR of Dengue virus:&nbsp;</strong>Correct. In India, multiplex real-time RT-PCR kits detect ZIKV (NS5 region), CHIKV (nsP4), and DENV 1–4 (3′UTR).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Plaque Reduction Neutralization Test (PRNT) is a more specific assay for Zika virus, particularly in regions endemic for multiple flaviviruses:&nbsp;</strong>Correct. PRNT remains the most specific test to differentiate Zika from other flavivirus infections, especially in endemic areas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>NS3 protease gene is routinely used as a highly specific PCR target in Zika diagnostics due to its conserved nature:&nbsp;</strong>Incorrect. NS3 is not the primary PCR target for ZIKV. Instead, NS5 (non-structural protein 5) is used due to its greater specificity and diagnostic utility. NS3 is not widely used due to its variability and less consistent amplification.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In endemic settings, RT-PCR and PRNT are more reliable for diagnosing Zika virus due to the cross-reactivity seen in IgM ELISA with other flaviviruses like Dengue.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">NS5 is the preferred PCR target, not NS3.</span></li></ul>",
      "correct_choice_id": 386097,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96997/NEET_GT__11_NOV_2025_Microbiology_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96997/NEET_GT__11_NOV_2025_Microbiology_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97033,
      "choices": [
        {
          "id": 386240,
          "text": "<p><span style=\"font-size:14.0pt;\">Distance from the lower margin of symphysis pubis to sacral promontory</span></p>"
        },
        {
          "id": 386241,
          "text": "<p><span style=\"font-size:14.0pt;\">Distance from the midpoint of sacral promontory to the uppermost margin of symphysis pubis</span></p>"
        },
        {
          "id": 386242,
          "text": "<p><span style=\"font-size:14.0pt;\">Distance that can be measured clinically on per vaginal examination</span></p>"
        },
        {
          "id": 386243,
          "text": "<p><span style=\"font-size:14.0pt;\">Distance from posterior margin of symphysis pubis to tip of sacrum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 26-year-old primigravida undergoes pelvic assessment. Which of the following represents the true conjugate of the pelvis?&nbsp;</span></p>",
      "unique_key": "Q5040400",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Distance from the midpoint of sacral promontory to the uppermost margin of symphysis pubis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>true conjugate</strong> (also known as the <strong>anatomical conjugate</strong>) is an important anteroposterior diameter of the <strong>pelvic inlet</strong>.</span></li><li><span style=\"font-size:14.0pt;\">It extends from the <strong>sacral promontory</strong> to the <strong>upper (anterosuperior) margin of the symphysis pubis</strong>. This measurement represents the <strong>actual bony dimension</strong> of the pelvic inlet through which the fetal head must pass during labor.</span></li><li><span style=\"font-size:14.0pt;\">Although it cannot be measured directly on physical examination, it is crucial for assessing <strong>pelvic adequacy</strong> and is typically estimated indirectly from the <strong>diagonal conjugate</strong> (measurable on per vaginal examination) by subtracting approximately <strong>1.5–2 cm</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Thus, among the options provided, the <strong>true conjugate</strong> is correctly defined as the <strong>distance from the midpoint of the sacral promontory to the uppermost margin of the symphysis pubis</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Distance from the lower margin of symphysis pubis to sacral promontory:&nbsp;</strong>Incorrect. This represents the <strong>diagonal conjugate</strong>, not the true conjugate. The diagonal conjugate can be <strong>measured clinically</strong> on per vaginal examination and is usually <strong>1.5–2 cm longer</strong> than the true conjugate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Distance that can be measured clinically on per vaginal examination:&nbsp;</strong>Incorrect. This again refers to the <strong>diagonal conjugate</strong>, which is clinically measurable, unlike the true conjugate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Distance from posterior margin of symphysis pubis to tip of sacrum:&nbsp;</strong>Incorrect. This describes the <strong>obstetric conjugate</strong> only partially and inaccurately; the obstetric conjugate actually extends from the <strong>sacral promontory to the nearest point on the posterior surface of the pubic symphysis</strong>. It is the <strong>narrowest fixed diameter</strong> of the pelvic inlet and is smaller than the true conjugate.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>true conjugate</strong> (anatomical conjugate) of the pelvis extends from the <strong>sacral promontory</strong> to the <strong>upper border of the symphysis pubis</strong> and represents a key anteroposterior diameter of the <strong>pelvic inlet</strong> used to assess <strong>pelvic adequacy for childbirth</strong>.</span></p>",
      "correct_choice_id": 386241,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97033/NEET_GT__11_NOV_2025_OBG_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97033/NEET_GT__11_NOV_2025_OBG_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97242,
      "choices": [
        {
          "id": 387064,
          "text": "<p><span style=\"font-size:18px;\">Continue salbutamol and add IV hydrocortisone</span></p>"
        },
        {
          "id": 387065,
          "text": "<p><span style=\"font-size:18px;\">Intramuscular adrenaline 1:1000 (0.5 mL) immediately</span></p>"
        },
        {
          "id": 387066,
          "text": "<p><span style=\"font-size:18px;\">Intravenous adrenaline 1:10,000 via slow infusion</span></p>"
        },
        {
          "id": 387067,
          "text": "<p><span style=\"font-size:18px;\">Intravenous isoprenaline 1-2 mg bolus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 25-year-old asthmatic woman being nebulized with salbutamol suddenly develops facial swelling, urticaria, and BP drops to 70/40 mmHg. She becomes unresponsive. What is the most appropriate immediate intervention?</span></p>",
      "unique_key": "Q3363159",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Intramuscular adrenaline 1:1000 (0.5 mL) immediately</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This is anaphylactic shock (likely from nebulizer preservatives like benzalkonium/EDTA).&nbsp;</span></li><li><span style=\"font-size:18px;\">Adrenaline is DOC for anaphylaxis, and preferred route is IM/SC, NOT IV.&nbsp;</span></li><li><span style=\"font-size:18px;\">Use 1:1000 concentration (0.5 mL = 0.5 mg) into anterolateral thigh.&nbsp;</span></li><li><span style=\"font-size:18px;\">IM provides rapid absorption (5-10 min) while avoiding IV bolus risks (severe hypertension, arrhythmias, cerebral hemorrhage).&nbsp;</span></li><li><span style=\"font-size:18px;\">Repeat at 10 minutes if first dose fails. Only after two failed IM doses consider IV adrenaline 1:10,000 via controlled infusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Continue salbutamol and add IV hydrocortisone:</strong> Continue salbutamol and add IV hydrocortisone: Dangerously delays definitive treatment. This is anaphylaxis, not just asthma. Salbutamol only provides β₂ bronchodilation, doesn't address cardiovascular collapse. Hydrocortisone has delayed onset (hours) and prevents biphasic reactions but plays no role in acute management. Adrenaline must be given immediately.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Intravenous adrenaline 1:10,000 via slow infusion:</strong> Intravenous adrenaline 1:10,000 via slow infusion: IV adrenaline is NOT first-line. Used only when: (1) two IM doses failed, (2) patient in extremis despite initial IM dose, or (3) ICU setting with monitoring. Starting with IV bypasses safer IM route and exposes to unnecessary risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Intravenous isoprenaline 1-2 mg bolus:</strong> Intravenous isoprenaline 1-2 mg bolus: Completely inappropriate and potentially fatal. Isoprenaline is pure β-agonist with NO α activity. Causes profound vasodilation (β₂), worsening hypotension. Anaphylaxis requires α₁ vasoconstriction—isoprenaline cannot provide this. The dose stated is also massive and would cause severe arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Anaphylactic shock requires immediate IM adrenaline 1:1000 (0.5 mL) as first-line; IM route is safer than IV, with repeat dosing at 10-minute intervals before considering IV adrenaline 1:10,000.</span></p>",
      "correct_choice_id": 387065,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97242/NEET_GT__11_NOV_2025_Pharmacology_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97242/NEET_GT__11_NOV_2025_Pharmacology_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97196,
      "choices": [
        {
          "id": 386884,
          "text": "<p><span style=\"font-size:14.0pt;\">T4a</span></p>"
        },
        {
          "id": 386885,
          "text": "<p><span style=\"font-size:14.0pt;\">T3</span></p>"
        },
        {
          "id": 386886,
          "text": "<p><span style=\"font-size:14.0pt;\">T4b</span></p>"
        },
        {
          "id": 386887,
          "text": "<p><span style=\"font-size:14.0pt;\">M1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">According to 8th AJCC classification of colorectal cancers, involvement of the mesorectum in rectal cancer is staged as?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3014657",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) T3</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">The mesorectum refers to the fatty connective tissue surrounding the rectum, which contains lymphatics, blood vessels, and lymph nodes.</span></li><li><span style=\"font-size:14.0pt;\">Involvement of the mesorectum occurs when the tumor penetrates the muscularis propria and extends into the perirectal fat — a defining feature of T3 rectal cancer in the AJCC 8th edition classification.</span></li><li><span style=\"font-size:14.0pt;\">This stage indicates extramural spread but without invasion of adjacent organs or structures, distinguishing it from T4 lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20113702.jpg\" width=\"1163\" height=\"534\"></strong></span></p>",
      "correct_choice_id": 386885,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97196/NEET_GT__11_NOV_2025_Surgery_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97196/NEET_GT__11_NOV_2025_Surgery_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97073,
      "choices": [
        {
          "id": 386400,
          "text": "<p><span style=\"font-size:14.0pt;\">Yellow Dystrophic Nails</span></p>"
        },
        {
          "id": 386401,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased Risk of Malignancy</span></p>"
        },
        {
          "id": 386402,
          "text": "<p><span style=\"font-size:14.0pt;\">Pleural Effusion</span></p>"
        },
        {
          "id": 386403,
          "text": "<p><span style=\"font-size:14.0pt;\">Pitting Edema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old woman presents with nails as shown in the picture below. Which of the following features is false regarding her condition?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103952.jpg\" width=\"687\" height=\"471\"></span></p>",
      "unique_key": "Q3840627",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;D) Pitting Edema</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Yellow Nail Syndrome is characterized by the triad of <strong>yellow dystrophic nails</strong>, <strong>non-pitting lymphedema</strong>, and <strong>pleural effusion</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It results from lymphatic dysfunction. Pitting edema is not seen; rather, the swelling is firm and non-pitting.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The syndrome may also be associated with <strong>bronchiectasis, chronic sinusitis</strong>, and an <strong>increased risk of malignancy</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Yellow Dystrophic Nails:</strong> Thickened, discolored nails due to impaired lymphatic drainage — true.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Increased Risk of Malignancy:</strong> True; associated with lymphoma and bronchogenic carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pleural Effusion:</strong> Common pulmonary feature — true.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Yellow Nail Syndrome</strong> is marked by <strong>non-pitting lymphedema</strong>, <strong>yellow dystrophic nails</strong>, and <strong>pleural effusion</strong> — pitting edema is not a feature.</span></p>",
      "correct_choice_id": 386403,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97073/NEET_GT__11_NOV_2025_Derma_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97073/NEET_GT__11_NOV_2025_Derma_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97005,
      "choices": [
        {
          "id": 386128,
          "text": "<p><span style=\"font-size:14.0pt;\">Dissecting aortic aneurysm</span></p>"
        },
        {
          "id": 386129,
          "text": "<p><span style=\"font-size:14.0pt;\">Jugular venous thrombosis</span></p>"
        },
        {
          "id": 386130,
          "text": "<p><span style=\"font-size:14.0pt;\">Superior sagittal sinus thrombosis</span></p>"
        },
        {
          "id": 386131,
          "text": "<p><span style=\"font-size:14.0pt;\">Deep venous thrombosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old woman presents with headache and seizures. A contrast-enhanced CT scan of the brain reveals empty delta sign. Which of the following conditions is most likely associated with this radiologic sign?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9361358",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Superior sagittal sinus thrombosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>\"Empty delta sign\"</strong> is a <strong>classic radiologic sign</strong> seen on <strong>contrast-enhanced CT</strong> of the brain.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It appears as a <strong>triangular area</strong> of <strong>enhancing dura</strong> surrounding a <strong>central filling defect</strong> within the <strong>superior sagittal sinus</strong>, indicating <strong>thrombosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This sign is most commonly seen in <strong>superior sagittal sinus thrombosis (SSST)</strong>, where the thrombus prevents contrast from filling the central sinus, while the dura mater around it enhances due to engorged collateral veins and inflammation.</span></li><li><span style=\"font-size:14.0pt;\">It’s a hallmark of <strong>cerebral venous sinus thrombosis (CVST)</strong> and can be accompanied by symptoms like <strong>headache, seizures, papilledema</strong>, or focal neurologic deficits.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Dissecting aortic aneurysm</strong>: This is a vascular emergency involving the <strong>aorta</strong>, not the cerebral venous system. It would not produce an empty delta sign on brain imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Jugular venous thrombosis</strong>: While this may present with neck swelling and pain, it does not classically produce the <strong>empty delta sign</strong>, as that sign is specific to the <strong>superior sagittal sinus</strong> on <strong>intracranial imaging</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Deep venous thrombosis (DVT)</strong>: Refers to <strong>limb vein thrombosis</strong>, particularly in the legs. It’s not related to <strong>intracranial venous structures</strong>, and does not appear on <strong>brain CT imaging</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>empty delta sign</strong> is a characteristic finding on contrast CT in <strong>superior sagittal sinus thrombosis</strong> and should be recognized as a diagnostic clue for <strong>cerebral venous sinus thrombosis</strong>.</span></p>",
      "correct_choice_id": 386130,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97005/NEET_GT__11_NOV_2025_Radiology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97005/NEET_GT__11_NOV_2025_Radiology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96984,
      "choices": [
        {
          "id": 386044,
          "text": "<p><span style=\"font-size:18px;\">Only 1, 2, 4 and 5 are correct</span></p>"
        },
        {
          "id": 386045,
          "text": "<p><span style=\"font-size:18px;\">Only 1, 3 and 5 are correct</span></p>"
        },
        {
          "id": 386046,
          "text": "<p><span style=\"font-size:18px;\">Only 2, 3 and 4 are correct</span></p>"
        },
        {
          "id": 386047,
          "text": "<p><span style=\"font-size:18px;\">All five statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Which of the following statements regarding α-1 antitrypsin deficiency are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">It results from mutations in the SERPINA1 gene leading to misfolded AAT protein accumulation in hepatocytes.</span></li><li><span style=\"font-size:18px;\">The PiZZ genotype is associated with severe disease and early-onset panacinar emphysema.</span></li><li><span style=\"font-size:18px;\">Hepatic manifestations occur due to deficiency of circulating AAT leading to unopposed neutrophil elastase activity in the liver.</span></li><li><span style=\"font-size:18px;\">Periodic acid–Schiff (PAS)-positive, diastase-resistant globules in hepatocytes are characteristic on liver biopsy.</span></li><li><span style=\"font-size:18px;\">Smoking accelerates lung damage by oxidizing methionine residues in AAT, reducing its antiprotease activity.</span></li></ol>",
      "unique_key": "Q9269331",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A)</strong> <strong>Only 1, 2, 4 and 5 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Statement 1.&nbsp;It results from mutations in the SERPINA1 gene leading to misfolded AAT protein accumulation in hepatocytes:&nbsp;</strong>Correct.&nbsp;AAT is encoded by the <strong>SERPINA1</strong> gene on chromosome <strong>14q32.1</strong>. Mutant forms (especially <strong>Z allele</strong>) misfold and accumulate in <strong>hepatocytes</strong>, leading to <strong>hepatotoxicity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Statement 2.&nbsp;The PiZZ genotype is associated with severe disease and early-onset panacinar emphysema:&nbsp;</strong>Correct.&nbsp;Homozygous <strong>PiZZ</strong> individuals produce very low AAT → <strong>panacinar emphysema</strong> (especially in <strong>lower lobes</strong>) and <strong>juvenile cirrhosis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Statement 4. Periodic acid–Schiff (PAS)-positive, diastase-resistant globules in hepatocytes are characteristic on liver biopsy:&nbsp;</strong>Correct.&nbsp;Classic biopsy finding due to <strong>accumulated misfolded glycoprotein AAT</strong> in the <strong>endoplasmic reticulum</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Statement 5.&nbsp;Smoking accelerates lung damage by oxidizing methionine residues in AAT, reducing its antiprotease activity:&nbsp;</strong>Correct.&nbsp;Cigarette smoke <strong>oxidizes methionine residues</strong> in AAT, <strong>inactivating</strong> it → <strong>accelerated lung destruction</strong> and earlier onset of emphysema.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Statement 3.&nbsp;Hepatic manifestations occur due to deficiency of circulating AAT leading to unopposed neutrophil elastase activity in the liver:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:18px;\">Hepatic injury is due to <strong>toxic accumulation</strong> of misfolded AAT <strong>within hepatocytes</strong>, <strong>not</strong> due to elastase activity in the liver. Elastase-mediated damage occurs in lungs, not liver.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In AAT deficiency, lung disease is due to lack of antiprotease activity (unopposed elastase), whereas liver disease is due to toxic accumulation of misfolded AAT in hepatocytes (PAS-positive, diastase-resistant globules); PiZZ is severe, and smoking-induced methionine oxidation further impairs AAT.</span></p>",
      "correct_choice_id": 386044,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96984/Neet_Gt__11_Nov_2025_Pathology_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96984/Neet_Gt__11_Nov_2025_Pathology_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97024,
      "choices": [
        {
          "id": 386204,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform urine pregnancy test, then administer DMPA</span></p>"
        },
        {
          "id": 386205,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer DMPA and advise backup contraception for 7 days</span></p>"
        },
        {
          "id": 386206,
          "text": "<p><span style=\"font-size:14.0pt;\">Withhold DMPA and start from next menstrual cycle</span></p>"
        },
        {
          "id": 386207,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer DMPA without any additional precautions</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman on depot medroxyprogesterone acetate (DMPA) presents 14 days late for her scheduled injection. She has been sexually active. What is the most appropriate management?&nbsp;</span></p>",
      "unique_key": "Q6007841",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Administer DMPA without any additional precautions</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Depot Medroxyprogesterone Acetate (DMPA)</strong> is a <strong>progestin-only injectable contraceptive</strong> given <strong>every 12 weeks (3 months)</strong> for effective pregnancy prevention.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>World Health Organization (WHO)</strong> and <strong>CDC (U.S. MEC)</strong> guidelines allow a <strong>grace period of up to 2 weeks (14 days)</strong> beyond the scheduled date for the next DMPA injection.</span></li><li><span style=\"font-size:14.0pt;\">During this <strong>2-week window</strong>, contraceptive efficacy is maintained, and the woman is <strong>still protected</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In this scenario:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The woman is <strong>14 days late</strong>, meaning she is <strong>still within the acceptable grace period</strong>.</span></li><li><span style=\"font-size:14.0pt;\">She has been <strong>sexually active</strong>, but since the contraceptive protection is <strong>maintained during the 2-week window</strong>, <strong>no pregnancy test or backup contraception</strong> is required.</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the <strong>DMPA injection should be administered immediately</strong> without any additional precautions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Perform urine pregnancy test, then administer DMPA:&nbsp;</strong>Incorrect. A pregnancy test is <strong>not necessary</strong> when the woman is within the <strong>14-day grace period</strong>, as ovulation suppression is still effective.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Administer DMPA and advise backup contraception for 7 days:&nbsp;</strong>Incorrect. Backup contraception is needed <strong>only if the woman is more than 2 weeks late (&gt;14 days)</strong> or if there are risk factors for ovulation. In this case, she is <strong>exactly 14 days late</strong>, and contraceptive protection is still intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Withhold DMPA and start from next menstrual cycle:&nbsp;</strong>Incorrect. This would leave the patient <strong>unprotected</strong> and increase the risk of pregnancy. DMPA should not be withheld if within the <strong>permitted time frame</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">When a woman is <strong>≤14 days late</strong> for her <strong>next DMPA injection</strong>, she remains <strong>protected from pregnancy</strong>. The DMPA dose should be given immediately without pregnancy testing or additional contraception.</span></p>",
      "correct_choice_id": 386207,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97024/NEET_GT__11_NOV_2025_OBG_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97024/NEET_GT__11_NOV_2025_OBG_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96996,
      "choices": [
        {
          "id": 386092,
          "text": "<p><span style=\"font-size:14.0pt;\">HPV 16 and 18</span></p>"
        },
        {
          "id": 386093,
          "text": "<p><span style=\"font-size:14.0pt;\">HPV 6 and 11</span></p>"
        },
        {
          "id": 386094,
          "text": "<p><span style=\"font-size:14.0pt;\">HPV 4 and 27</span></p>"
        },
        {
          "id": 386095,
          "text": "<p><span style=\"font-size:14.0pt;\">HPV 31 and 45</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old child presents with progressive hoarseness of voice and episodes of respiratory distress. On laryngoscopic examination, findings are shown in the image. Histopathology reveals koilocytosis. Which of the following HPV types is most commonly associated with this presentation?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20100620.jpg\" width=\"549\" height=\"509\"></strong></span></p>",
      "unique_key": "Q3213810",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) HPV 6 and 11</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image and clinical presentation are classic for <strong>Recurrent Respiratory Papillomatosis (RRP)</strong>, especially in pediatric cases.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This condition is characterized by benign papillomatous lesions on the respiratory epithelium, particularly the larynx.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is caused by <strong>low-risk HPV types 6 and 11</strong>, typically transmitted perinatally from the mother.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. HPV 16 and 18:</strong> These are high-risk oncogenic types associated with cervical, anogenital, and oropharyngeal cancers, not benign respiratory papillomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. HPV 4 and 27:</strong> These types are associated with cutaneous warts (verruca vulgaris), not mucosal papillomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. HPV 31 and 45:</strong> These are also high-risk types linked to cervical dysplasia and malignancy, not laryngeal papillomatosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Recurrent laryngeal papillomatosis presenting with verrucous lesions on laryngoscopy is strongly associated with HPV types <strong>6 and 11</strong>, not the high-risk oncogenic strains.</span></p>",
      "correct_choice_id": 386093,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96996/NEET_GT__11_NOV_2025_Microbiology_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96996/NEET_GT__11_NOV_2025_Microbiology_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96994,
      "choices": [
        {
          "id": 386084,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 4 only</span></p>"
        },
        {
          "id": 386085,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 only</span></p>"
        },
        {
          "id": 386086,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        },
        {
          "id": 386087,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements correctly differentiate Entamoeba histolytica from Entamoeba coli?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">E. histolytica shows unidirectional motility, while E. coli is non-purposeful</span></li><li><span style=\"font-size:14.0pt;\">E. coli contains RBCs in its cytoplasm</span></li><li><span style=\"font-size:14.0pt;\">Nuclear karyosome is central in E. histolytica, eccentric in E. coli</span></li><li><span style=\"font-size:14.0pt;\">Chromatoid bodies are filamentous in E. coli and rounded in E. histolytica</span></li></ol>",
      "unique_key": "Q9917444",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 3 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.</strong> <strong>E. histolytica shows unidirectional motility, while E. coli is non-purposeful:&nbsp;</strong>Correct. Entamoeba histolytica shows very active, purposeful, unidirectional motility using finger-like pseudopodia, whereas E. coli displays sluggish, non-purposeful motility with blunt pseudopodia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>Nuclear</strong> <strong>karyosome is central in E. histolytica, eccentric in E. Coli:</strong> Correct. The karyosome in E. histolytica is small and centrally located; in E. coli, it is large and eccentric.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Chromatoid bodies are filamentous in E. coli and rounded in E. Histolytica:</strong> Correct. Chromatoid bodies of E. histolytica are thick with rounded ends, while those of E. coli are filamentous with thread-like ends.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>E. coli contains RBCs in its cytoplasm:</strong> Incorrect. E. coli does <strong>not</strong> ingest RBCs; this is a key differentiator from E. histolytica, which often does.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Entamoeba histolytica Vs Entamoeba coli:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20100516.jpg\" width=\"1050\" height=\"501\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Cyst Characteristics:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20100554.jpg\" width=\"1220\" height=\"321\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20134710.jpg\" width=\"867\" height=\"571\"></strong></span></p>",
      "correct_choice_id": 386084,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96994/NEET_GT__11_NOV_2025_Microbiology_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96994/NEET_GT__11_NOV_2025_Microbiology_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96982,
      "choices": [
        {
          "id": 386036,
          "text": "<p><span style=\"font-size:18px;\">Loss of myenteric ganglion cells (Auerbach plexus) in the esophageal wall</span></p>"
        },
        {
          "id": 386037,
          "text": "<p><span style=\"font-size:18px;\">Intestinal metaplasia of squamous epithelium at the gastroesophageal junction</span></p>"
        },
        {
          "id": 386038,
          "text": "<p><span style=\"font-size:18px;\">Submucosal fibrosis with eosinophilic infiltration</span></p>"
        },
        {
          "id": 386039,
          "text": "<p><span style=\"font-size:18px;\">Mucosal ulceration with transmural lymphoid aggregates</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 45-year-old man presents with progressive dysphagia, initially to solids and later to liquids, along with regurgitation of undigested food and nocturnal cough. There is no history of weight loss or hematemesis. Barium swallow shows marked dilatation of the esophagus with a distal narrowing (“bird-beak” appearance). Manometry reveals failure of relaxation of the lower esophageal sphincter (LES). Which of the following histopathologic findings is most characteristic of this condition?</span></p>",
      "unique_key": "Q4847503",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Loss of myenteric ganglion cells (Auerbach plexus) in the esophageal wall</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This <strong>45-year-old man</strong> has <strong>progressive dysphagia</strong> (initially to solids, later to liquids), <strong>regurgitation of undigested food</strong>, and <strong>nocturnal cough</strong>, along with <strong>bird-beak narrowing on barium swallow</strong> and <strong>failure of LES relaxation on manometry</strong> — classic features of <strong>achalasia cardia</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Pathogenesis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\"><strong>Achalasia</strong> results from <strong>loss of inhibitory ganglion cells</strong> (that produce nitric oxide and VIP) in the <strong>myenteric (Auerbach) plexus</strong> of the <strong>esophageal wall</strong>.</span></li><li><span style=\"font-size:18px;\">This causes:</span><ol><li><span style=\"font-size:18px;\"><strong>Failure of LES relaxation</strong> → functional obstruction.</span></li><li><span style=\"font-size:18px;\"><strong>Aperistalsis</strong> in the distal esophagus.</span></li><li><span style=\"font-size:18px;\"><strong>Progressive esophageal dilatation</strong> proximally.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Histologic finding:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\"><strong>Loss of myenteric (Auerbach) ganglion cells</strong> between the circular and longitudinal muscle layers of the esophagus.</span></li><li><span style=\"font-size:18px;\">Inflammatory changes may be seen in early stages, followed by fibrosis and muscle hypertrophy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Intestinal metaplasia of squamous epithelium at the gastroesophageal junction:&nbsp;</strong>Incorrect. This describes <strong>Barrett esophagus</strong>, a complication of <strong>chronic gastroesophageal reflux disease (GERD)</strong>, not achalasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Submucosal fibrosis with eosinophilic infiltration:&nbsp;</strong>Incorrect. Seen in <strong>eosinophilic esophagitis</strong>, typically associated with <strong>atopy</strong> and <strong>dysphagia in young adults</strong>, not with LES dysfunction or bird-beak deformity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Mucosal ulceration with transmural lymphoid aggregates:&nbsp;</strong>Incorrect. Characteristic of <strong>Crohn disease</strong>, which can involve the GI tract anywhere from mouth to anus, but not the esophagus in this pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Achalasia cardia</strong> is caused by <strong>loss of myenteric (Auerbach) plexus ganglion cells</strong>, leading to <strong>failure of LES relaxation</strong>, <strong>aperistalsis</strong>, and <strong>esophageal dilatation</strong>, producing the characteristic <strong>bird-beak appearance</strong> on barium swallow.</span></p>",
      "correct_choice_id": 386036,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96982/Neet_Gt__11_Nov_2025_Pathology_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96982/Neet_Gt__11_Nov_2025_Pathology_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97163,
      "choices": [
        {
          "id": 386752,
          "text": "<p><span style=\"font-size:14.0pt;\">Increase in lever ratio due to ossicular chain</span></p>"
        },
        {
          "id": 386753,
          "text": "<p><span style=\"font-size:14.0pt;\">Area ratio between tympanic membrane and stapes footplate</span></p>"
        },
        {
          "id": 386754,
          "text": "<p><span style=\"font-size:14.0pt;\">Phase lag compensation by tensor tympani</span></p>"
        },
        {
          "id": 386755,
          "text": "<p><span style=\"font-size:14.0pt;\">Resonance of the auditory canal enhancing low frequencies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best describes how the middle ear amplifies sound energy to overcome impedance mismatch between air and cochlear fluid?</span></p>",
      "unique_key": "Q1734166",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Area ratio between tympanic membrane and stapes footplate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>middle ear acts as an impedance-matching transformer</strong>, enabling efficient energy transfer from air to cochlear fluid.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key mechanisms are:</span><ol><li><span style=\"font-size:14.0pt;\"><strong>Area ratio advantage</strong> — the tympanic membrane ≈55 mm²) is ~17× larger than the stapes footplate ≈3.2 mm²), concentrating pressure at the oval window.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Lever ratio</strong> — malleus and incus act as a lever 1.3:1).</span><br><span style=\"font-size:14.0pt;\">Together, these give ~20–25 dB amplification.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Increase in lever ratio due to ossicular chain:</strong> The lever ratio contributes partly but is not the main mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Phase lag compensation by tensor tympani:</strong> Tensor tympani modulates vibration to protect from loud sounds, not impedance matching.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Resonance of the auditory canal enhancing low frequencies:</strong> External canal resonance aids frequency selectivity, not impedance conversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The <strong>area ratio between tympanic membrane and stapes footplate</strong> provides the principal pressure gain for efficient sound transmission to the cochlea.</span></p>",
      "correct_choice_id": 386753,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97163/NEET_GT__11_NOV_2025_ENT_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97163/NEET_GT__11_NOV_2025_ENT_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96935,
      "choices": [
        {
          "id": 385848,
          "text": "<p><span style=\"font-size:14.0pt;\">The 2-year-old child due to highest risk of progression to active TB</span></p>"
        },
        {
          "id": 385849,
          "text": "<p><span style=\"font-size:14.0pt;\">The 55-year-old female with chronic cough as a potential secondary case</span></p>"
        },
        {
          "id": 385850,
          "text": "<p><span style=\"font-size:14.0pt;\">The 59-year-old diabetic male due to immunocompromised status</span></p>"
        },
        {
          "id": 385851,
          "text": "<p><span style=\"font-size:14.0pt;\">The 25-year-old pregnant woman due to pregnancy-associated immunosuppression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 31-year-old newly diagnosed pulmonary tuberculosis patient registers at a PHC. During household contact screening, the ASHA worker identifies 4 household contacts, as mentioned in below options. Following current NTEP guidelines for sequential contact investigation, which contact requires the most immediate priority for clinical evaluation and TST/IGRA testing?</span></p>",
      "unique_key": "Q9582379",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>The 55-year-old female with chronic cough as a potential secondary case</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to NTEP guidelines, household contact screening follows a sequential priority approach.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The primary objective is to identify additional active TB cases (secondary cases) rather than just identifying contacts at risk of developing TB.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The 55-year-old female with chronic cough represents the highest immediate priority as she has symptoms suggestive of active tuberculosis and needs urgent evaluation to rule out active disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Once active cases are excluded or treated, then focus shifts to preventive therapy for high-risk contacts like children under 6 years.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The sequential approach prioritizes: 1) Symptomatic contacts for active case detection, 2) Children &lt;6 years for preventive therapy, 3) Other vulnerable groups.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. The 2-year-old child due to highest risk of progression to active TB:</strong> While children &lt;6 years are high priority for TPT, symptomatic contacts take precedence for immediate evaluation to detect active TB cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. The 59-year-old diabetic male due to immunocompromised status:&nbsp;</strong>Diabetic contacts are important but asymptomatic immunocompromised individuals come after symptomatic contacts in the screening sequence.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. The 25-year-old pregnant woman due to pregnancy-associated immunosuppression:</strong> Pregnant women require special consideration but screening symptomatic contacts for active disease takes priority over asymptomatic high-risk groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">NTEP contact screening follows sequential priority: symptomatic contacts first, then children &lt;6 years, then other vulnerable groups.</span></li><li><span style=\"font-size:14.0pt;\">All household contacts of pulmonary TB patients should be screened, but timing and priority follow evidence-based protocols.</span></li></ul>",
      "correct_choice_id": 385849,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96935/NEET_PG_11_Nov_2025_PSM_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96935/NEET_PG_11_Nov_2025_PSM_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97062,
      "choices": [
        {
          "id": 386356,
          "text": "<p><span style=\"font-size:14.0pt;\">ANCA vasculitis</span></p>"
        },
        {
          "id": 386357,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-glomerular basement membrane disease</span></p>"
        },
        {
          "id": 386358,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemolytic uremic syndrome</span></p>"
        },
        {
          "id": 386359,
          "text": "<p><span style=\"font-size:14.0pt;\">IgA nephropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old woman is admitted with a week of abdominal pain and fevers. Her serum creatinine is 4.1 mg/dL (previously 1.0 mg/dL), and urine sediment shows dysmorphic red blood cells. Serologies are pending. Kidney biopsy reveals crescentic glomerulonephritis on light microscopy. What is the least likely diagnosis in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7034691",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Hemolytic uremic syndrome</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Crescentic glomerulonephritis signifies rapidly progressive glomerulonephritis, most often associated with conditions such as ANCA-associated vasculitis and anti-GBM disease, both of which are classic causes and fit this patient’s presentation.</span></li><li><span style=\"font-size:14.0pt;\">IgA nephropathy may infrequently cause crescentic GN, typically after an acute illness, though more often presents with hematuria/proteinuria.</span></li><li><span style=\"font-size:14.0pt;\">Hemolytic uremic syndrome, however, is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and AKI usually due to endothelial injury (often from Shiga toxin-producing E. coli), not by crescentic glomerulonephritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. ANCA vasculitis</strong>: A leading cause of crescentic glomerulonephritis and very consistent with this history and pathology.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Anti-glomerular basement membrane disease</strong>: Frequently causes rapidly progressive GN with crescent formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. IgA nephropathy</strong>: Rarely, aggressive cases result in crescentic GN, so less likely but still possible compared to HUS.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Crescentic glomerulonephritis is a pathological hallmark of rapidly progressive GN, most commonly from ANCA-associated vasculitis and anti-GBM disease, but is not a feature of hemolytic uremic syndrome, which involves a thrombotic microangiopathy mechanism.</span></p>",
      "correct_choice_id": 386358,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97062/Neet_Gt__11_Nov_2025_Medicine_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97062/Neet_Gt__11_Nov_2025_Medicine_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96998,
      "choices": [
        {
          "id": 386100,
          "text": "<p><span style=\"font-size:14.0pt;\">Person-to-person spread has been confirmed in nosocomial outbreaks</span></p>"
        },
        {
          "id": 386101,
          "text": "<p><span style=\"font-size:14.0pt;\">Aspiration is the most common mode of infection</span></p>"
        },
        {
          "id": 386102,
          "text": "<p><span style=\"font-size:14.0pt;\">Contaminated aerosol from air conditioners can be a source</span></p>"
        },
        {
          "id": 386103,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct instillation during respiratory procedures is a known route</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following are true regarding transmission of Legionella except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4822290",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Person-to-person spread has been confirmed in nosocomial outbreaks</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Legionella species are transmitted <strong>via environmental exposure</strong>, primarily from contaminated <strong>water sources</strong> (air conditioners, cooling towers, humidifiers).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Aspiration</strong> of contaminated water is the <strong>most common route</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Aerosol inhalation</strong> and <strong>direct inoculation during respiratory procedures</strong> are also recognized routes.</span></li><li><span style=\"font-size:14.0pt;\"><strong>There is no evidence of human-to-human transmission</strong>, even during hospital outbreaks.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Legionella spreads through <strong>environmental water sources</strong>, not between humans. Hence, infection control focuses on <strong>water system maintenance</strong>, not patient isolation.</span></p>",
      "correct_choice_id": 386100,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96998/NEET_GT__11_NOV_2025_Microbiology_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96998/NEET_GT__11_NOV_2025_Microbiology_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97001,
      "choices": [
        {
          "id": 386112,
          "text": "<p><span style=\"font-size:14.0pt;\">Escherichia coli</span></p>"
        },
        {
          "id": 386113,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudomonas aeruginosa</span></p>"
        },
        {
          "id": 386114,
          "text": "<p><span style=\"font-size:14.0pt;\">Morganella morganii</span></p>"
        },
        {
          "id": 386115,
          "text": "<p><span style=\"font-size:14.0pt;\">Proteus vulgaris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A batch of improperly refrigerated mackerel causes flushing, dizziness, and nausea in several individuals within an hour of consumption. Subsequent microbiological analysis reveals gram-negative bacteria colonizing the fish muscle. Which of the following bacterial species is most commonly associated with this form of foodborne illness?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8298849",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Morganella morganii</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Scombroid fish poisoning is caused by ingestion of <strong>preformed histamine</strong> due to bacterial <strong>decarboxylation of histidine</strong> in fish muscle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This occurs when fish such as tuna or mackerel are not properly refrigerated, allowing bacteria to proliferate.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>most common organism</strong> implicated is <strong>Morganella morganii</strong>, a gram-negative rod known to produce <strong>histidine decarboxylase</strong>, which converts histidine into histamine—leading to allergy-like symptoms despite absence of true IgE-mediated hypersensitivity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Escherichia coli:&nbsp;</strong>Although it is part of the enteric flora and <strong>can contribute</strong> to histamine production, it is not the <strong>most common</strong> bacteria associated with scombroid fish poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pseudomonas aeruginosa:&nbsp;</strong>It may be found in spoiled fish but is <strong>less frequently</strong> implicated in histamine production causing scombroid reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Proteus vulgaris:&nbsp;</strong>Part of the <strong>Proteeae tribe</strong>, like Morganella, but is <strong>less frequently associated</strong> with clinically significant histamine production in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Scombroid&nbsp;fish poisoning is caused by ingestion of histamine in spoiled fish and most commonly linked to Morganella morganii, not by true allergic mechanisms.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Proper refrigeration is essential to prevent this foodborne illness.</span></li></ul>",
      "correct_choice_id": 386114,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97001/NEET_GT__11_NOV_2025_Microbiology_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97001/NEET_GT__11_NOV_2025_Microbiology_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96969,
      "choices": [
        {
          "id": 385984,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior tibial artery</span></p>"
        },
        {
          "id": 385985,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior tibial artery</span></p>"
        },
        {
          "id": 385986,
          "text": "<p><span style=\"font-size:14.0pt;\">Peroneal artery</span></p>"
        },
        {
          "id": 385987,
          "text": "<p><span style=\"font-size:14.0pt;\">Dorsalis pedis artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man with end-stage renal disease requires the creation of an arteriovenous (AV) shunt for hemodialysis access in the lower limb. During preoperative vascular mapping, the surgeon identifies an artery located posterior to the medial malleolus and approximately 2.5 cm anterior to the tendon of the calcaneus, which is suitable for anastomosis with the great saphenous vein. Which artery is most likely used for this AV shunt?&nbsp;</span></p>",
      "unique_key": "Q8100458",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Posterior tibial artery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>posterior tibial artery</strong>, a terminal branch of the <strong>popliteal artery</strong>, is the principal artery of the posterior compartment of the leg.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It travels downward, accompanied by the tibial nerve, and passes <strong>behind the medial malleolus</strong> within the <strong>tarsal tunnel</strong>, lying <strong>2.5 cm anterior to the tendon of the calcaneus (Achilles tendon)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Because of its <strong>superficial and accessible position</strong>, it is often selected for <strong>arteriovenous (AV) shunting</strong> with the <strong>great saphenous vein</strong> in patients requiring hemodialysis access—especially when upper limb veins are unsuitable.</span></li><li><span style=\"font-size:14.0pt;\">The pulse of this artery is also palpated behind the medial malleolus, making it a key landmark in peripheral vascular examination.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20133427.jpg\" width=\"945\" height=\"579\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Anterior tibial artery:&nbsp;</strong>This artery passes through the interosseous membrane between medial &amp; lateral malleolus to enter the anterior compartment of the leg and continues as the <strong>dorsalis pedis artery</strong> on the dorsum of the foot. It lies anteriorly, not posteriorly, and therefore is not used for AV shunt formation behind the medial malleolus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Peroneal artery:&nbsp;</strong>A deep branch of the posterior tibial artery, it supplies the lateral compartment of the leg but lies deep and close to the fibula, making it inaccessible for surgical procedures such as AV shunting.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Dorsalis pedis artery:&nbsp;</strong>This is the continuation of the anterior tibial artery on the dorsum of the foot, located near the tendons of the extensor hallucis longus and extensor digitorum longus. It is <strong>not located posterior to the medial malleolus</strong> and hence not suitable for AV shunt with the great saphenous vein.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>posterior tibial artery</strong>, located <strong>behind the medial malleolus and anterior to the Achilles tendon</strong>, is commonly used for <strong>arteriovenous shunt creation with the great saphenous vein</strong> in hemodialysis patients due to its accessibility and reliable flow.</span></p>",
      "correct_choice_id": 385985,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96969/NEET_GT__11_NOV_2025_Anatomy_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96969/NEET_GT__11_NOV_2025_Anatomy_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97206,
      "choices": [
        {
          "id": 386924,
          "text": "<p><span style=\"font-size:14.0pt;\">Type I</span></p>"
        },
        {
          "id": 386925,
          "text": "<p><span style=\"font-size:14.0pt;\">Type II</span></p>"
        },
        {
          "id": 386926,
          "text": "<p><span style=\"font-size:14.0pt;\">Type III</span></p>"
        },
        {
          "id": 386927,
          "text": "<p><span style=\"font-size:14.0pt;\">Type IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The choledochal cyst that most resembles an accessory gallbladder is:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7643629",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Type II</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">True diverticulum of the CBD.</span></li><li><span style=\"font-size:14.0pt;\">Appears as a saccular outpouching from the CBD—<strong>mimics an accessory gallbladder</strong> in shape and location.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Type I:&nbsp;</strong>Fusiform dilation of the common bile duct (CBD). This is a continuous dilation of the CBD, not a diverticulum-like structure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Type III:</strong> Choledochocele (dilation of distal CBD within duodenal wall). Located intraduodenally, not resembling gallbladder anatomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Type IV:</strong> &nbsp;Multiple cysts, intrahepatic and/or extrahepatic. Complex and diffuse cystic disease—not localized or gallbladder-like.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Type II choledochal cysts</strong> are rare and present as isolated diverticula off the CBD, often mistaken for accessory gallbladders on imaging.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Surgical excision</strong> is typically curative, and differentiation from gallbladder duplication is crucial for operative planning.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-11-10%20at%2012.49.32.jpeg\" width=\"781\" height=\"540\"></span></p>",
      "correct_choice_id": 386925,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97206/NEET_GT__11_NOV_2025_Surgery_Question_14.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97206/NEET_GT__11_NOV_2025_Surgery_Question_14.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96976,
      "choices": [
        {
          "id": 386012,
          "text": "<p><span style=\"font-size:18px;\">The disease increases the risk of colorectal carcinoma&nbsp;</span></p>"
        },
        {
          "id": 386013,
          "text": "<p><span style=\"font-size:18px;\">There is transmural inflammation involving the full thickness of the bowel wall</span></p>"
        },
        {
          "id": 386014,
          "text": "<p><span style=\"font-size:18px;\">Toxic megacolon is a known complication</span></p>"
        },
        {
          "id": 386015,
          "text": "<p><span style=\"font-size:18px;\">Extraintestinal manifestations may include primary sclerosing cholangitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 25-year-old woman presents with chronic bloody diarrhea and abdominal pain. Colonoscopy shows continuous mucosal inflammation starting from the rectum. Biopsy reveals crypt abscesses and pseudopolyps. All of the following statements about her disease are true, except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9524499",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) There is transmural inflammation involving the full thickness of the bowel wall</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">The clinical picture—<strong>chronic bloody diarrhea</strong>, <strong>abdominal pain</strong>, <strong>colonoscopy with continuous mucosal inflammation starting from the rectum</strong>, and <strong>biopsy showing crypt abscesses and pseudopolyps</strong>—is classic for <strong>ulcerative colitis (UC)</strong>.</span></li><li><span style=\"font-size:18px;\">UC is <strong>limited to the mucosa and submucosa</strong>, not <strong>transmural</strong>; therefore, the statement that there is <strong>transmural inflammation involving the full thickness of the bowel wall</strong> is <strong>incorrect</strong> for this disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. The disease increases the risk of colorectal carcinoma:&nbsp;</strong>True.</span><br><span style=\"font-size:18px;\">Long-standing, extensive UC increases <strong>colorectal cancer</strong> risk; surveillance colonoscopy is recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Toxic megacolon is a known complication:&nbsp;</strong>True.<strong> Toxic megacolon</strong> is a life-threatening complication associated with severe UC.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Extraintestinal manifestations may include primary sclerosing cholangitis:&nbsp;</strong>True.&nbsp;UC is linked to <strong>PSC</strong>, along with other extraintestinal features (e.g., arthritis, uveitis, skin disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Ulcerative colitis</strong> shows <strong>continuous, rectum-starting mucosal inflammation with crypt abscesses and pseudopolyps</strong> and is <strong>not transmural</strong>; complications include <strong>toxic megacolon</strong>, <strong>PSC</strong>, and <strong>increased colorectal cancer risk</strong>.</span></p>",
      "correct_choice_id": 386013,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96976/Neet_Gt__11_Nov_2025_Pathology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96976/Neet_Gt__11_Nov_2025_Pathology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97243,
      "choices": [
        {
          "id": 387068,
          "text": "<p><span style=\"font-size:14.0pt;\">It is the drug of choice for paroxysmal supraventricular tachycardia</span></p>"
        },
        {
          "id": 387069,
          "text": "<p><span style=\"font-size:14.0pt;\">It has the shortest half-life (&lt;10 seconds) among antiarrhythmic drugs</span></p>"
        },
        {
          "id": 387070,
          "text": "<p><span style=\"font-size:14.0pt;\">It should be given as a slow intravenous infusion</span></p>"
        },
        {
          "id": 387071,
          "text": "<p><span style=\"font-size:14.0pt;\">It does not fit into Class I to IV classes of Vaughan William’s classification of antiarrhythmic drugs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Regarding adenosine in the treatment of arrhythmias, all are true except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2007655",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) It should be given as a slow intravenous infusion</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adenosine must be given as a rapid IV push (bolus injection) into a central or large peripheral vein, NOT as slow infusion.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Due to its extremely short half-life (&lt;10 seconds), adenosine is rapidly degraded in blood.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Slow infusion would result in complete drug degradation before reaching the heart, making it ineffective.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Rapid bolus injection ensures adequate drug concentration reaches the AV node to terminate PSVT before metabolism occurs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is the drug of choice for paroxysmal supraventricular tachycardia:</strong> Adenosine is the DOC for paroxysmal supraventricular tachycardia (PSVT). It terminates re-entry circuits involving the AV node by causing transient AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It has the shortest half-life (&lt;10 seconds) among antiarrhythmic drugs:</strong> Adenosine has the shortest t½ (&lt;10s) of all antiarrhythmics due to rapid uptake by red blood cells and metabolism. This ultra-short duration is advantageous for safety.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It does not fit into Class I to IV classes of Vaughan William’s classification of antiarrhythmic drugs:&nbsp;</strong>Adenosine is classified separately in Others/miscellaneous drugs along with digoxin, atropine, and magnesium. Doesn't fit into Classes I-IV based on ion channel effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Adenosine must be given as rapid IV push (not slow infusion) due to its ultra-short half-life (&lt;10 seconds) to ensure adequate drug delivery before metabolism.</span></p>",
      "correct_choice_id": 387070,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97243/NEET_GT__11_NOV_2025_Pharmacology_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97243/NEET_GT__11_NOV_2025_Pharmacology_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97070,
      "choices": [
        {
          "id": 386388,
          "text": "<p><span style=\"font-size:14.0pt;\">Transient Synovitis</span></p>"
        },
        {
          "id": 386389,
          "text": "<p><span style=\"font-size:14.0pt;\">Legg-Calvé-Perthes Disease</span></p>"
        },
        {
          "id": 386390,
          "text": "<p><span style=\"font-size:14.0pt;\">Juvenile Idiopathic Arthritis</span></p>"
        },
        {
          "id": 386391,
          "text": "<p><span style=\"font-size:14.0pt;\">Septic Arthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 4-year-old boy is brought to the clinic by his parents due to the acute onset of a painful limp and a complaint of right groin and knee pain that began 24 hours ago. His parents mention he was recovering from a mild viral upper respiratory infection three days prior. He resists passive movement of the right hip, but his pain is significantly worse with internal rotation and abduction. Laboratory tests reveal a normal leukocyte (WBC) count and a minimally elevated erythrocyte sedimentation rate (ESR). A bedside ultrasound shows a small, unilateral hip joint effusion. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7379121",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Transient Synovitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A common, self-limiting inflammation of the hip joint's synovial lining. It is the most frequent cause of acute hip pain and limping in children aged 3 to 10.</span></li><li><span style=\"font-size:14.0pt;\">Fits the typical age range (3-10 years).</span></li><li><span style=\"font-size:14.0pt;\">Often follows a mild viral upper respiratory infection (URI) 1-3 weeks prior, as described.</span></li><li><span style=\"font-size:14.0pt;\">Presents with acute limp and vague pain referred to the groin or knee. Pain is worse with movement, especially internal rotation and abduction.</span></li><li><span style=\"font-size:14.0pt;\">Typically shows a normal or minimally elevated WBC count and a minimally elevated ESR/CRP. These normal or near-normal inflammatory markers are crucial for distinguishing it from Septic Arthritis.</span></li><li><span style=\"font-size:14.0pt;\">Usually shows a small, unilateral hip joint effusion on ultrasound, consistent with simple inflammation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Legg-Calvé-Perthes Disease:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Idiopathic avascular necrosis (death) of the capital femoral epiphysis (the ball of the hip joint).</span></li><li><span style=\"font-size:14.0pt;\">LCPD has a more insidious (gradual) onset and is a chronic condition, often presenting with a gradual, painless limp over months. It is not typically preceded by an acute viral illness.</span></li><li><span style=\"font-size:14.0pt;\">ESR and WBC counts are usually normal, which complicates its differentiation from transient synovitis, but the acute, 24-hour onset in this case argues against the slow progression of LCPD. The definitive diagnosis is made via X-ray (later stage) or MRI (earlier stage).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Juvenile Idiopathic Arthritis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A heterogeneous group of chronic arthritides with onset before age 16.</span></li><li><span style=\"font-size:14.0pt;\">While it can present with an acute flare, JIA is characterized by chronic joint symptoms lasting at least six weeks. A 24-hour history is too short for a definitive diagnosis.</span></li><li><span style=\"font-size:14.0pt;\">JIA usually shows more consistently elevated inflammatory markers (ESR/CRP) and often involves multiple joints over time.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Septic Arthritis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bacterial infection of the joint space (usually Staphylococcus aureus in this age group), a true orthopaedic emergency.</span></li><li><span style=\"font-size:14.0pt;\">While it presents with an acute, painful limp and a severely restricted, painful hip, the systemic signs are key.</span></li><li><span style=\"font-size:14.0pt;\">Septic Arthritis almost always presents with the \"sepsis\" pattern, defined by the Kocher Criteria (high sensitivity for ruling out infection): High Fever (&gt;38.5°C or 101.3°F), inability to bear weight (severe pain).</span></li><li><span style=\"font-size:14.0pt;\">Significantly elevated ESR (usually &gt;40mm/hr) and CRP (usually &gt; 2.0 mg/dL).</span></li><li><span style=\"font-size:14.0pt;\">Significantly elevated WBC count (often &gt; 12,000/mm<sup>3</sup>).</span></li><li><span style=\"font-size:14.0pt;\">Crucially, the patient's normal WBC and minimally elevated ESR rule out Septic Arthritis with high confidence.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The case describes the classic presentation of a transient hip irritation in a young child: acute onset of limp/pain, preceding viral illness, minimal systemic signs, and hip effusion without frank infection.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This scenario requires a careful ruling out of Septic Arthritis, which is a surgical emergency.</span></li></ul>",
      "correct_choice_id": 386388,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97070/NEET_GT__11_NOV_2025_Orthopedics_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97070/NEET_GT__11_NOV_2025_Orthopedics_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97028,
      "choices": [
        {
          "id": 386220,
          "text": "<p><span style=\"font-size:14.0pt;\">IIB</span></p>"
        },
        {
          "id": 386221,
          "text": "<p><span style=\"font-size:14.0pt;\">IIIA</span></p>"
        },
        {
          "id": 386222,
          "text": "<p><span style=\"font-size:14.0pt;\">IIIB</span></p>"
        },
        {
          "id": 386223,
          "text": "<p><span style=\"font-size:14.0pt;\">IVA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old woman presents with persistent postcoital bleeding for 3 months. On speculum examination, a friable cervical growth is noted. Punch biopsy confirms squamous cell carcinoma. Clinical examination reveals a 3 cm cervical lesion with bilateral parametrial involvement extending to the pelvic sidewall. There is no hydronephrosis on imaging. What is the FIGO stage of this patient?&nbsp;</span></p>",
      "unique_key": "Q6219102",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) IIIB</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">On <strong>clinical examination</strong>, there is a <strong>3 cm cervical lesion</strong> with <strong>bilateral parametrial involvement extending to the pelvic sidewall</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In the <strong>FIGO</strong> (2018) cervical cancer staging system, <strong>extension to the pelvic sidewall</strong> places the disease in <strong>Stage IIIB</strong>, regardless of lesion size (e.g., <strong>3 cm</strong>) or histology (<strong>squamous cell carcinoma</strong>).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The statement that <strong>there is no hydronephrosis on imaging</strong> is noted; <strong>hydronephrosis</strong> (or a non-functioning kidney) is another independent criterion for <strong>Stage IIIB</strong>, but <strong>its absence does not downstage</strong> a tumor that already <strong>extends to the pelvic sidewall</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, given <strong>bilateral parametrial involvement</strong> reaching the <strong>pelvic sidewall</strong> on <strong>clinical examination</strong> of a <strong>friable cervical growth</strong> proven by <strong>punch biopsy</strong> to be <strong>squamous cell carcinoma</strong>, the <strong>FIGO stage</strong> is <strong>IIIB</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. IIB:&nbsp;</strong>Incorrect. IIB = <strong>parametrial involvement without pelvic sidewall</strong>; here it <strong>extends to the pelvic sidewall</strong> (and there is <strong>no hydronephrosis on imaging</strong>), so not IIB in this <strong>35-year-old woman</strong> with <strong>squamous cell carcinoma</strong> (<strong>punch biopsy</strong>), <strong>friable cervical growth</strong> (<strong>speculum examination</strong>), <strong>3 cm</strong>, <strong>persistent postcoital bleeding for 3 months</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. IIIA:&nbsp;</strong>Incorrect. IIIA = <strong>lower third of vagina without sidewall</strong>; this case has <strong>bilateral parametrial involvement extending to the pelvic sidewall</strong> on <strong>clinical examination</strong> of a <strong>3 cm</strong> <strong>squamous cell carcinoma</strong> (<strong>punch biopsy</strong>) after <strong>persistent postcoital bleeding for 3 months</strong> and <strong>friable cervical growth</strong>; <strong>no hydronephrosis on imaging</strong> noted.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. IVA:&nbsp;</strong>Incorrect. IVA = <strong>adjacent organ (bladder/rectum) mucosa</strong>; here only <strong>pelvic sidewall</strong> involvement is described with <strong>no hydronephrosis on imaging</strong>, in a <strong>35-year-old woman</strong> with <strong>punch biopsy</strong>–confirmed <strong>squamous cell carcinoma</strong>, <strong>3 cm</strong>, <strong>friable cervical growth</strong> on <strong>speculum examination</strong>, <strong>persistent postcoital bleeding for 3 months</strong> → <strong>IIIB</strong>, not IVA.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">FIGO: extension to the pelvic sidewall (with or without hydronephrosis) defines Stage IIIB.</span></p>",
      "correct_choice_id": 386222,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97028/NEET_GT__11_NOV_2025_OBG_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97028/NEET_GT__11_NOV_2025_OBG_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97251,
      "choices": [
        {
          "id": 387100,
          "text": "<p><span style=\"font-size:14.0pt;\">Aminoglycosides</span></p>"
        },
        {
          "id": 387101,
          "text": "<p><span style=\"font-size:14.0pt;\">Cisplatin</span></p>"
        },
        {
          "id": 387102,
          "text": "<p><span style=\"font-size:14.0pt;\">Vancomycin</span></p>"
        },
        {
          "id": 387103,
          "text": "<p><span style=\"font-size:14.0pt;\">Macrolides</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following drugs cause irreversible ototoxicity except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4664880",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Macrolides</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Macrolides cause reversible ototoxicity, unlike the other options which cause irreversible damage.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Macrolide-induced ototoxicity manifests as tinnitus and hearing loss, usually with high doses or prolonged therapy, particularly with erythromycin and azithromycin.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The ototoxicity is dose-dependent and reversible upon drug discontinuation, typically resolving within days to weeks.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The mechanism involves temporary effects on cochlear outer hair cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Aminoglycosides:</strong> Aminoglycosides cause irreversible ototoxicity affecting both cochlear (auditory) and vestibular function. Amikacin causes maximum cochlear toxicity while streptomycin causes maximum vestibular toxicity. The damage results from accumulation in perilymph and endolymph, generating reactive oxygen species that destroy hair cells. Once damaged, cochlear hair cells do not regenerate, making the toxicity permanent.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Cisplatin:</strong> This platinum-based chemotherapeutic agent causes irreversible bilateral cochlear damage through direct toxicity to outer hair cells and stria vascularis. High-frequency hearing loss is characteristic and cumulative with dose. The ototoxicity is one of the major dose-limiting side effects of cisplatin therapy, and there is no effective preventive treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vancomycin:</strong> Vancomycin causes irreversible ototoxicity, though less frequently than aminoglycosides. The risk increases with high serum levels (&gt;60-80 mg/L), prolonged therapy, concurrent use of other ototoxic drugs, and renal impairment. The mechanism involves direct toxic effects on cochlear hair cells, resulting in permanent hearing loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Macrolides cause reversible ototoxicity, while aminoglycosides, cisplatin, and vancomycin cause irreversible ototoxic damage to cochlear hair cells.</span></p>",
      "correct_choice_id": 387103,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97251/NEET_GT__11_NOV_2025_Pharmacology_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97251/NEET_GT__11_NOV_2025_Pharmacology_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97064,
      "choices": [
        {
          "id": 386364,
          "text": "<p><span style=\"font-size:14.0pt;\">Lumateperone</span></p>"
        },
        {
          "id": 386365,
          "text": "<p><span style=\"font-size:14.0pt;\">Cobenfy (xanomeline + trospium)</span></p>"
        },
        {
          "id": 386366,
          "text": "<p><span style=\"font-size:14.0pt;\">Cariprazine</span></p>"
        },
        {
          "id": 386367,
          "text": "<p><span style=\"font-size:14.0pt;\">Trofinetide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following drugs has been recently approved by the US Food and Drug Administration (FDA) for the management of schizophrenia and works primarily via a cholinergic (muscarinic) mechanism?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9417034",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Cobenfy (xanomeline + trospium)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Cobenfy is the combination of the muscarinic M1/M4 receptor agonist xanomeline and the peripherally acting muscarinic antagonist trospium.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It has been approved by the FDA for the treatment of schizophrenia in adults.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This marks a novel mechanism of action among antipsychotics, shifting from the traditional dopamine D2 receptor blockade toward acetylcholine (cholinergic) pathways.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Lumateperone:</strong> Acts via serotonin and dopamine modulation, not a cholinergic mechanism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Cariprazine:</strong> A dopamine D2/D3 partial agonist; not newly approved for schizophrenia nor cholinergic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Trofinetide:</strong> Approved for Rett syndrome (a neurodevelopmental disorder), not for schizophrenia; mechanism unrelated to cholinergic M1/M4 receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The FDA approval of Cobenfy (xanomeline + trospium) illustrates a paradigm shift in schizophrenia treatment: targeting muscarinic (M1/M4) receptors instead of relying solely on dopamine-D2 receptor antagonism.</span></p>",
      "correct_choice_id": 386365,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97064/New_GT_Psychiatry_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97064/New_GT_Psychiatry_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96933,
      "choices": [
        {
          "id": 385840,
          "text": "<p><span style=\"font-size:14.0pt;\">Primary prevention; highly cost-effective in all populations</span></p>"
        },
        {
          "id": 385841,
          "text": "<p><span style=\"font-size:14.0pt;\">Secondary prevention; cost-effective only in high-prevalence areas&nbsp;</span></p>"
        },
        {
          "id": 385842,
          "text": "<p><span style=\"font-size:14.0pt;\">Primary prevention; cost-effective mainly in high-prevalence populations</span></p>"
        },
        {
          "id": 385843,
          "text": "<p><span style=\"font-size:14.0pt;\">Secondary prevention; universally cost-effective approach</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A community health program implements administration of iron and folic acid tablets to all adolescent girls in schools regardless of their hemoglobin levels to prevent iron deficiency anemia. This intervention is being evaluated for its cost-effectiveness compared to screening-based targeted supplementation. What level of prevention does this intervention represent, and what is typically its cost-effectiveness profile?&nbsp;</span></p>",
      "unique_key": "Q2390909",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Primary prevention; cost-effective mainly in high-prevalence populations</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Universal iron-folic acid supplementation to adolescent girls regardless of hemoglobin status represents primary prevention as it aims to prevent iron deficiency anemia before it occurs.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">However, its cost-effectiveness is mainly justified in populations with high prevalence of iron deficiency, where the number needed to treat is lower, making it more economically viable than targeted screening approaches.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key phrase \"regardless of their hemoglobin levels\" indicates this is primary prevention (no screening/detection involved).&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Primary</strong> <strong>prevention; highly cost-effective in all populations:</strong> While it is primary prevention, universal supplementation is not highly cost-effective in all populations, particularly those with low prevalence of iron deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Secondary prevention; cost-effective only in high-prevalence areas:</strong> This is primary prevention, not secondary prevention, as no screening or early detection is involved in the universal approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Secondary prevention; universally cost-effective approach:</strong> This represents primary prevention, and cost-effectiveness varies significantly based on population prevalence rates.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Universal supplementation without screening represents primary prevention by preventing disease occurrence.</span></li><li><span style=\"font-size:14.0pt;\">Cost-effectiveness of universal interventions depends heavily on disease prevalence in the target population.</span></li></ul>",
      "correct_choice_id": 385842,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96933/NEET_PG_11_Nov_2025_PSM_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96933/NEET_PG_11_Nov_2025_PSM_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97018,
      "choices": [
        {
          "id": 386180,
          "text": "<p><span style=\"font-size:14.0pt;\">To collect endometrial biopsy samples</span></p>"
        },
        {
          "id": 386181,
          "text": "<p><span style=\"font-size:14.0pt;\">To obtain a cervical sample for HPV DNA testing</span></p>"
        },
        {
          "id": 386182,
          "text": "<p><span style=\"font-size:14.0pt;\">To visualize the cervix during colposcopy</span></p>"
        },
        {
          "id": 386183,
          "text": "<p><span style=\"font-size:14.0pt;\">To aspirate uterine contents during dilation and curettage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The instrument shown in the image is used in gynecological procedures. What is its primary purpose?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20111847.jpg\" width=\"470\" height=\"432\"></span></p>",
      "unique_key": "Q7071390",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) To obtain a cervical sample for HPV DNA testing</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The instrument shown in the image is a <strong>Cytobroom</strong> (also called a <strong>cervical cytobrush</strong>).</span></li><li><span style=\"font-size:14.0pt;\">It is primarily used to <strong>collect exfoliated cells from the cervix</strong>, specifically from the <strong>transformation zone</strong>, for <strong>HPV DNA testing</strong> or <strong>Pap smear (cytology)</strong>.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">The <strong>soft nylon bristles</strong> allow gentle scraping of both <strong>ectocervical</strong> and <strong>endocervical cells</strong>, ensuring a high-quality sample without causing trauma or bleeding.</span></li><li><span style=\"font-size:14.0pt;\">This technique increases the detection accuracy of <strong>precancerous cervical lesions</strong> caused by high-risk <strong>Human Papillomavirus (HPV)</strong> strains.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To collect endometrial biopsy samples:&nbsp;</strong>Incorrect. Endometrial biopsy requires a <strong>Pipelle cannula</strong> or <strong>Karman cannula</strong>, not a cytobroom.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. To visualize the cervix during colposcopy:&nbsp;</strong>Incorrect. Visualization is done using a <strong>colposcope</strong>, not a cytological sampling tool.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To aspirate uterine contents during dilation and curettage:&nbsp;</strong>Incorrect. Aspiration is performed using a <strong>suction cannula</strong>, not a brush-type instrument.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>Cytobroom</strong> is used to <strong>collect cervical samples</strong> for <strong>HPV DNA testing</strong> or <strong>Pap smear</strong>, helping in <strong>early detection of cervical cancer and premalignant lesions</strong>.</span></li></ul>",
      "correct_choice_id": 386181,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97018/NEET_GT__11_NOV_2025_OBG_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97018/NEET_GT__11_NOV_2025_OBG_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97049,
      "choices": [
        {
          "id": 386304,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate osilodrostat</span></p>"
        },
        {
          "id": 386305,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform late‑night salivary cortisol</span></p>"
        },
        {
          "id": 386306,
          "text": "<p><span style=\"font-size:14.0pt;\">Refer to neurosurgery for transsphenoidal surgery</span></p>"
        },
        {
          "id": 386307,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform high‑dose dexamethasone suppression test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45‑year‑old woman with central obesity, facial rounding, and easy bruising has elevated 24‑hour urinary cortisol and failure to suppress cortisol on a low‑dose dexamethasone test. Plasma ACTH is 70 pg/mL (normal 5–60), and pituitary MRI is normal. What is the next best step in management?&nbsp;</span></p>",
      "unique_key": "Q8544725",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Perform high‑dose dexamethasone suppression test</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient has confirmed Cushing's syndrome with an elevated plasma ACTH level, indicating ACTH‑dependent disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If pituitary MRI is normal, further testing is required to distinguish between a pituitary (Cushing’s disease) and an ectopic ACTH source because it may not show an abnormality in up to 40% of cases (small tumors may fall below the sensitivity of detection). Characteristically, pituitary corticotrope adenomas fail to enhance following gadolinium administration on T1-weighted MRI images.</span></li><li><span style=\"font-size:14.0pt;\">The high‑dose dexamethasone suppression test (and CRH/desmopressin stimulation test) helps evaluate this by assessing whether cortisol secretion is suppressible.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In Cushing’s disease, high‑dose dexamethasone partially suppresses cortisol levels, whereas ectopic ACTH secretion is resistant to suppression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Initiate osilodrostat</strong>: It is a steroidogenesis inhibitor that is used after the cause of hypercortisolism is established or when surgery is contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Perform late‑night salivary cortisol</strong>: Useful for screening, but this patient already has established hypercortisolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Refer to neurosurgery for transsphenoidal surgery</strong>: Indicated only when Cushing’s disease is confirmed as the source, not before differentiating from ectopic ACTH production.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In ACTH‑dependent Cushing’s syndrome, a normal pituitary MRI does not exclude pituitary disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A high‑dose dexamethasone suppression test or inferior petrosal sinus sampling is necessary to differentiate pituitary from ectopic ACTH secretion before proceeding to surgery.</span></li></ul>",
      "correct_choice_id": 386307,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97049/Neet_Gt__11_Nov_2025_Medicine_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97049/Neet_Gt__11_Nov_2025_Medicine_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97004,
      "choices": [
        {
          "id": 386124,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 5</span></p>"
        },
        {
          "id": 386125,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3 and 5</span></p>"
        },
        {
          "id": 386126,
          "text": "<p><span style=\"font-size:14.0pt;\">4 only</span></p>"
        },
        {
          "id": 386127,
          "text": "<p><span style=\"font-size:14.0pt;\">1 only&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">All of the following statements about iodinated intravascular contrast agents are accurate, except:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">They are used in digital subtraction angiography</span></li><li><span style=\"font-size:14.0pt;\">They are radio-opaque</span></li><li><span style=\"font-size:14.0pt;\">They can cause anaphylactic reactions</span></li><li><span style=\"font-size:14.0pt;\">They are used in magnetic resonance imaging</span></li><li><span style=\"font-size:14.0pt;\">They are excreted mainly by the kidneys</span></li></ol>",
      "unique_key": "Q3872714",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.&nbsp;They are used in magnetic resonance imaging:&nbsp;</strong>False.</span><br><span style=\"font-size:14.0pt;\">Iodinated intravascular contrast media are <strong>not used in MRI</strong>. MRI utilizes <strong>gadolinium-based contrast agents</strong>, which alter magnetic properties of tissues—not X-ray absorption like iodine does. Hence, iodinated contrast is irrelevant in MR imaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.&nbsp;They are used in digital subtraction angiography: </strong>Iodinated contrast is commonly used in <strong>digital subtraction angiography (DSA)</strong> to visualize blood vessels by subtracting pre-contrast images from contrast-enhanced images.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.</strong> <strong>They are radio-opaque:&nbsp;</strong>These agents are <strong>radio-opaque</strong> due to iodine content, enhancing visibility on <strong>X-ray and CT</strong> scans.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>They can cause anaphylactic reactions:</strong> Iodinated contrast can cause <strong>anaphylactoid reactions</strong> (e.g., urticaria, bronchospasm, hypotension), even in patients without prior allergies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>They are excreted mainly by the kidneys:&nbsp;</strong>Iodinated contrast is primarily <strong>excreted via the kidneys</strong>, which is why caution is warranted in patients with <strong>renal impairment</strong> due to risk of <strong>contrast-induced nephropathy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Iodinated contrast agents are not used in MRI</strong>, where gadolinium-based compounds are the contrast of choice.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They are primarily used in <strong>CT and angiographic procedures</strong> and excreted renally.</span></li></ul>",
      "correct_choice_id": 386126,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97004/NEET_GT__11_NOV_2025_Radiology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97004/NEET_GT__11_NOV_2025_Radiology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96947,
      "choices": [
        {
          "id": 385896,
          "text": "<p><span style=\"font-size:14.0pt;\">1-A, 2-B, 3-C, 4-D</span></p>"
        },
        {
          "id": 385897,
          "text": "<p><span style=\"font-size:14.0pt;\">1-B, 2-A, 3-C, 4-D</span></p>"
        },
        {
          "id": 385898,
          "text": "<p><span style=\"font-size:14.0pt;\">1-C, 2-D, 3-A, 4-B</span></p>"
        },
        {
          "id": 385899,
          "text": "<p><span style=\"font-size:14.0pt;\">1-D, 2-C, 3-B, 4-A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Match the syndromes with the appropriate treatment kit and choose the correct combination:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column A</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">1. Vaginal discharge</span></p><p><span style=\"font-size:14.0pt;\">2. Genital Ulcer Disease- Non herpetic for patients allergic to penicillin</span></p><p><span style=\"font-size:14.0pt;\">3. Lower abdominal pain</span></p><p><span style=\"font-size:14.0pt;\">4. Genital Ulcer Disease- Herpetic</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Column B</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111005.jpg\" width=\"1322\" height=\"328\"></span></p>",
      "unique_key": "Q8798245",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 1-B, 2-A, 3-C, 4-D</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>National AIDS Control Organisation (NACO)</strong> and <strong>Government of India</strong> follow a <strong>syndromic management approach</strong> for <strong>sexually transmitted and reproductive tract infections (STIs/RTIs)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Each syndrome is treated empirically using a <strong>color-coded STI/RTI treatment kit</strong> to ensure timely therapy, even before laboratory confirmation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct matches and rationale:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111054.jpg\" width=\"925\" height=\"767\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111127.jpg\" width=\"766\" height=\"796\"></strong></span></p>",
      "correct_choice_id": 385897,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96947/NEET_PG_11_Nov_2025_PSM_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96947/NEET_PG_11_Nov_2025_PSM_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96995,
      "choices": [
        {
          "id": 386088,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2 and 4 only</span></p>"
        },
        {
          "id": 386089,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 386090,
          "text": "<p><span style=\"font-size:14.0pt;\">All of the above</span></p>"
        },
        {
          "id": 386091,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 4 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following correctly matches the mycotoxin to its clinical effect or usage?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Fumonisins — Pulmonary edema in pigs</span></li><li><span style=\"font-size:14.0pt;\">Trichothecenes — Used in biological warfare (Yellow rain)</span></li><li><span style=\"font-size:14.0pt;\">Zearalenone — Cholangiocarcinoma in humans</span></li><li><span style=\"font-size:14.0pt;\">Ochratoxin — Balkan endemic nephropathy</span></li></ol>",
      "unique_key": "Q2199391",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 1, 2 and 4 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1. Fumonisins — Pulmonary edema in pigs:</strong> <strong>Fumonisins</strong> are produced by Fusarium moniliforme and cause <strong>pulmonary edema in pigs</strong>, <strong>equine leukoencephalomalacia</strong>, and esophageal carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;2.</strong> <strong>Trichothecenes — Used in biological warfare (Yellow rain): Trichothecenes</strong>, from Fusarium graminearum, are potent inhibitors of protein synthesis and were used as <strong>biological warfare agents</strong> (notably <strong>yellow rain</strong>).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement&nbsp;4. Ochratoxin — Balkan endemic nephropathy:</strong> <strong>Ochratoxin</strong>, particularly from Aspergillus ochraceus, causes <strong>nephropathy</strong>, including <strong>Balkan endemic nephropathy</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statement:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3. Zearalenone → Cholangiocarcinoma in humans:</strong> Incorrect. Zearalenone is associated with <strong>genital and reproductive disorders in pigs</strong>, not cancer in humans.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Mycotoxins vary in their <strong>source, clinical presentation, and toxic effects</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Linking the correct toxin with its <strong>pathology</strong> helps in accurate diagnosis, especially in zoonotic and toxicology-related cases.</span></li></ul>",
      "correct_choice_id": 386088,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96995/NEET_GT__11_NOV_2025_Microbiology_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96995/NEET_GT__11_NOV_2025_Microbiology_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97006,
      "choices": [
        {
          "id": 386132,
          "text": "<p><span style=\"font-size:14.0pt;\">Klebsiella pneumonia</span></p>"
        },
        {
          "id": 386133,
          "text": "<p><span style=\"font-size:14.0pt;\">Staphylococcal pneumonia</span></p>"
        },
        {
          "id": 386134,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary edema</span></p>"
        },
        {
          "id": 386135,
          "text": "<p><span style=\"font-size:14.0pt;\">Pneumoconiosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55-year-old man presents with high-grade fever, productive cough with thick sputum, and pleuritic chest pain. Chest X-ray shows bulging of the interlobar fissure. Which of the following is the most likely cause?</span></p>",
      "unique_key": "Q2594027",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Klebsiella pneumonia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Klebsiella pneumoniae</strong> classically causes a <strong>lobar pneumonia</strong> with a <strong>bulging fissure sign</strong> on chest radiograph.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This sign results from intense inflammation and <strong>copious exudate production</strong>, leading to <strong>expansion of the affected lobe</strong>, usually the upper lobe.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The thick, mucoid \"currant jelly\" sputum and association with alcoholics or debilitated individuals are classic features.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Staphylococcal pneumonia:&nbsp;</strong>Typically causes <strong>bronchopneumonia</strong> or <strong>necrotizing pneumonia</strong> with cavitation or pneumatoceles, not associated with bulging fissures.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pulmonary edema:&nbsp;</strong>Presents with <strong>bilateral perihilar infiltrates</strong> (\"bat wing\" appearance), not lobar expansion or fissure bulging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pneumoconiosis:&nbsp;</strong>Refers to chronic interstitial lung diseases from inhaled dust particles; radiographic findings include <strong>reticulonodular opacities</strong>, but not lobar consolidation or fissure bulging.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>bulging fissure sign</strong> on chest X-ray is a classic radiological hallmark of <strong>Klebsiella pneumonia</strong>, indicating extensive lobar inflammation and consolidation.</span></p>",
      "correct_choice_id": 386132,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97006/NEET_GT__11_NOV_2025_Radiology_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        17
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97006/NEET_GT__11_NOV_2025_Radiology_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97165,
      "choices": [
        {
          "id": 386760,
          "text": "<p><span style=\"font-size:14.0pt;\">Failure of tubal opening due to tensor veli palatini dysfunction</span></p>"
        },
        {
          "id": 386761,
          "text": "<p><span style=\"font-size:14.0pt;\">Excessive patency of the tube during respiration</span></p>"
        },
        {
          "id": 386762,
          "text": "<p><span style=\"font-size:14.0pt;\">Narrow bony isthmus obstructed by cholesteatoma</span></p>"
        },
        {
          "id": 386763,
          "text": "<p><span style=\"font-size:14.0pt;\">Overactivity of salpingopharyngeus muscle causing reflux</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old boy has recurrent otitis media with effusion. Tympanometry shows type C curve. Which functional abnormality of the Eustachian tube best explains this finding?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7862741",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Failure of tubal opening due to tensor veli palatini dysfunction</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Eustachian tube</strong> equalizes middle ear and nasopharyngeal pressures, ventilating the middle ear.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>tensor veli palatini</strong> is the principal muscle that opens the tube during swallowing or yawning.</span></li><li><span style=\"font-size:14.0pt;\">Failure of opening leads to <strong>negative middle ear pressure</strong> → <strong>retracted tympanic membrane</strong> → <strong>Type C tympanogram</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Excessive patency of the tube during respiration:</strong> Patulous tube causes autophony hearing one’s own breath, not effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Narrow bony isthmus obstructed by cholesteatoma:</strong> Bony obstruction isthmus is rare and unrelated to recurrent effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Overactivity of salpingopharyngeus muscle causing reflux:</strong> Salpingopharyngeus assists opening, not closure; overactivity doesn’t cause this pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Type C tympanogram</strong> indicates negative middle ear pressure due to <strong>failure of Eustachian tube opening</strong>—commonly from <strong>tensor veli palatini dysfunction.</strong></span></p>",
      "correct_choice_id": 386760,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97165/NEET_GT__11_NOV_2025_ENT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97165/NEET_GT__11_NOV_2025_ENT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97034,
      "choices": [
        {
          "id": 386244,
          "text": "<p><span style=\"font-size:14.0pt;\">Salpingectomy&nbsp;</span></p>"
        },
        {
          "id": 386245,
          "text": "<p><span style=\"font-size:14.0pt;\">Total hysterectomy</span></p>"
        },
        {
          "id": 386246,
          "text": "<p><span style=\"font-size:14.0pt;\">Uterine artery ligation only</span></p>"
        },
        {
          "id": 386247,
          "text": "<p><span style=\"font-size:14.0pt;\">B-Lynch compression suture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old G3P2 woman with previous two cesarean sections presents at 38 weeks gestation in active labor with sudden severe suprapubic pain, vaginal bleeding, and fetal bradycardia. On examination, the uterus is tender, fetal parts are easily palpable abdominally, and there is evidence of shock. What is the most appropriate surgical management?&nbsp;</span></p>",
      "unique_key": "Q6206407",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Total hysterectomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This <strong>28-year-old G3P2</strong> woman at <strong>38 weeks gestation</strong> with <strong>previous two cesarean sections</strong> presents in <strong>active labor</strong> with <strong>sudden severe suprapubic pain</strong>, <strong>vaginal bleeding</strong>, <strong>fetal bradycardia</strong>, a <strong>tender uterus</strong>, <strong>fetal parts easily palpable abdominally</strong>, and <strong>evidence of shock</strong>—a classic picture of <strong>uterine rupture</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In the setting of a <strong>large rupture</strong> with <strong>hemodynamic instability (shock)</strong> and likely <strong>extensive lower-segment tear</strong> through a prior cesarean scar, the <strong>MOST appropriate surgical management</strong> is <strong>rapid laparotomy with total hysterectomy</strong>.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>total hysterectomy</strong> (leaving the cervix) is faster, controls hemorrhage promptly, and is favored in <strong>exsanguinating rupture</strong> where <strong>speed</strong> and <strong>hemostasis</strong> are paramount.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This approach directly addresses <strong>uterine rupture</strong>, <strong>vaginal bleeding</strong>, <strong>tender uterus</strong>, <strong>fetal parts palpable</strong>, <strong>fetal bradycardia</strong>, and <strong>shock</strong> in <strong>active labor</strong> after <strong>previous cesarean sections</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Salpingectomy:&nbsp;</strong>Incorrect. This is indicated in a ruptured ectopic pregnancy</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Uterine artery ligation only:&nbsp;</strong>Incorrect. <strong>Uterine artery ligation</strong> may reduce bleeding but <strong>does not treat the uterine rupture</strong> itself. With <strong>vaginal bleeding</strong>, <strong>fetal bradycardia</strong>, a <strong>tender uterus</strong>, and <strong>shock</strong>, definitive surgical management is required. Ligation alone <strong>delays hemostasis</strong> and <strong>fails to address</strong> the <strong>full-thickness tear</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. B-Lynch compression suture:&nbsp;</strong>Incorrect. A <strong>B-Lynch compression suture</strong> is designed for <strong>uterine atony postpartum</strong>, not for a <strong>full-thickness uterine rupture</strong> in <strong>active labor</strong> with <strong>fetal parts palpable</strong> and <strong>hemodynamic instability</strong>. It would <strong>not close the defect</strong> and <strong>not control hemorrhage</strong> adequately in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In <strong>uterine rupture</strong>—especially in <strong>active labor</strong> after <strong>previous cesarean sections</strong> with <strong>shock</strong>, <strong>vaginal bleeding</strong>, <strong>tender uterus</strong>, <strong>fetal bradycardia</strong>, and <strong>fetal parts palpable abdominally</strong>—the <strong>most appropriate, rapid, lifesaving management</strong> is <strong>subtotal hysterectomy</strong> to achieve <strong>definitive hemorrhage control</strong>.</span></p>",
      "correct_choice_id": 386245,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97034/NEET_GT__11_NOV_2025_OBG_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97034/NEET_GT__11_NOV_2025_OBG_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97074,
      "choices": [
        {
          "id": 386404,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 1</span></p>"
        },
        {
          "id": 386405,
          "text": "<p><span style=\"font-size:14.0pt;\">Statement 2</span></p>"
        },
        {
          "id": 386406,
          "text": "<p><span style=\"font-size:14.0pt;\">Both</span></p>"
        },
        {
          "id": 386407,
          "text": "<p><span style=\"font-size:14.0pt;\">Neither</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 19-year-old female with moderate acne is prescribed two recently approved topical agents. One inhibits androgen receptors, while the other is a fourth-generation retinoid. Which of the following statements is true regarding these drugs?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">Trifarotene has been approved for acne.</span></li><li><span style=\"font-size:14.0pt;\">Clascoterone Propionate cream is effective in acne.</span></li></ol>",
      "unique_key": "Q7346432",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Both</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Both statements are correct. <strong>Clascoterone Propionate 1% cream</strong> acts as an <strong>androgen receptor inhibitor</strong>, reducing sebum production and inflammation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Trifarotene</strong> is a <strong>topical fourth-generation retinoid</strong> effective in acne vulgaris, particularly truncal acne.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clascoterone</strong> (androgen receptor blocker) and <strong>Trifarotene</strong> (fourth-generation retinoid) are newly approved agents for acne management.</span></p>",
      "correct_choice_id": 386406,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97074/NEET_GT__11_NOV_2025_Derma_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        18
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97074/NEET_GT__11_NOV_2025_Derma_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97013,
      "choices": [
        {
          "id": 386160,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreases the number of LDL receptors exposed at the cell surface, thus LDL uptake is lowered and blood cholesterol levels rise.</span></p>"
        },
        {
          "id": 386161,
          "text": "<p><span style=\"font-size:14.0pt;\">Inhibits the binding of apo B to the LDL receptor, thus blocking uptake of the lipoprotein and raising blood cholesterol levels.</span></p>"
        },
        {
          "id": 386162,
          "text": "<p><span style=\"font-size:14.0pt;\">Increases the absorption of cholesterol from the intestine.</span></p>"
        },
        {
          "id": 386163,
          "text": "<p><span style=\"font-size:14.0pt;\">Increases the synthesis and secretion of VLDL in the liver, leading to increased LDL formation in the blood.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 54-year-old man with a history of hypertension and hypercholesterolemia comes for routine follow-up. Despite being compliant with a low-fat diet and statin therapy, his LDL cholesterol levels remain elevated. His physician considers adding a newer class of drugs known as PCSK9 inhibitors to his regimen. These monoclonal antibodies act by targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that regulates plasma LDL cholesterol levels. What is the function of PCSK9 on blood cholesterol levels?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1478911",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Decreases the number of LDL receptors exposed at the cell surface, thus LDL uptake is lowered and blood cholesterol levels rise.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">PCSK9 binds the <strong>LDL receptor (LDLR)</strong> on hepatocytes and targets it for <strong>lysosomal degradation</strong> instead of recycling back to the cell surface.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Fewer surface LDLRs → <strong>reduced hepatic LDL uptake</strong> → <strong>higher plasma LDL-cholesterol</strong>. PCSK9 inhibitors (monoclonal antibodies) block this interaction, <strong>preserving LDLRs</strong>, increasing LDL clearance, and lowering LDL-C.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B.</strong> <strong>Inhibits the binding of apo B to the LDL receptor, thus blocking uptake of the lipoprotein and raising blood cholesterol levels:</strong> Incorrect. PCSK9 does <strong>not</strong> inhibit apo B–LDLR binding; it promotes <strong>LDLR degradation</strong> after internalization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C. Increases the absorption of cholesterol from the intestine:</strong> Incorrect. Increased intestinal cholesterol absorption is mediated via <strong>NPC1L1</strong> (target of <strong>ezetimibe</strong>), not PCSK9.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D.</strong>&nbsp;<strong>Increases the synthesis and secretion of VLDL in the liver, leading to increased LDL formation in the blood:</strong> Incorrect. PCSK9 does not directly increase hepatic <strong>VLDL synthesis/secretion</strong>; its principal role is <strong>LDLR degradation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">PCSK9 promotes degradation of hepatic LDL receptors, decreasing LDL clearance and raising plasma LDL; inhibiting PCSK9 preserves LDLRs and lowers LDL-C.</span></p>",
      "correct_choice_id": 386160,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97013/NEET_GT__11_NOV_2025_Biochemistry_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97013/NEET_GT__11_NOV_2025_Biochemistry_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97029,
      "choices": [
        {
          "id": 386224,
          "text": "<p><span style=\"font-size:14.0pt;\">Start progesterone challenge test</span></p>"
        },
        {
          "id": 386225,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform hysteroscopy</span></p>"
        },
        {
          "id": 386226,
          "text": "<p><span style=\"font-size:14.0pt;\">Start combined estrogen-progesterone therapy</span></p>"
        },
        {
          "id": 386227,
          "text": "<p><span style=\"font-size:14.0pt;\">Perform diagnostic laparoscopy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 30-year-old woman presents with secondary amenorrhea for 8 months following a dilatation and curettage for postpartum hemorrhage 10 months ago. She has no vasomotor symptoms. Serum β-hCG is negative. FSH and LH levels are normal. What is the next best step in management?</span></p>",
      "unique_key": "Q7985606",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Perform hysteroscopy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This <strong>30-year-old woman</strong> presents with <strong>secondary amenorrhea</strong> for <strong>8 months</strong> following a <strong>dilatation and curettage (D&amp;C)</strong> for <strong>postpartum hemorrhage</strong>. The absence of <strong>vasomotor symptoms</strong> (e.g., hot flashes) and <strong>normal FSH/LH levels</strong> indicate that <strong>ovarian function and hypothalamic-pituitary axis</strong> are intact.</span></li><li><span style=\"font-size:14.0pt;\">Given the history of <strong>uterine instrumentation after pregnancy</strong>, the most likely diagnosis is <strong>Asherman syndrome (intrauterine adhesions)</strong>. This condition results from <strong>fibrosis of the endometrial lining</strong> following <strong>infection</strong> or <strong>trauma to the basal layer of the endometrium</strong>, commonly after <strong>D&amp;C for postpartum hemorrhage or incomplete abortion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>next best step</strong> in diagnosis is visualization <strong>of the uterine cavity</strong> to confirm intrauterine adhesions. <strong>hysteroscopy</strong> can visualize adhesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Start progesterone challenge test:&nbsp;</strong>Incorrect. The <strong>progesterone challenge test</strong> is used to evaluate <strong>estrogen status and outflow tract patency</strong> in secondary amenorrhea. However, in this case, the most likely cause is <strong>intrauterine adhesions</strong> after D&amp;C, not hormonal imbalance. Moreover, the patient’s <strong>normal FSH/LH</strong> and <strong>lack of withdrawal bleeding</strong> after progesterone would still require imaging — so HSG is more direct.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Start combined estrogen-progesterone therapy:&nbsp;</strong>Incorrect. This therapy is used in <strong>hypoestrogenic states</strong> (e.g., premature ovarian failure, hypothalamic amenorrhea) to restore menstruation. However, the patient has <strong>normal gonadotropins</strong>, indicating normal estrogen levels, and structural uterine damage is the likely cause — so hormone therapy would not resolve the amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Perform diagnostic laparoscopy:&nbsp;</strong>Incorrect. Laparoscopy is useful for evaluating <strong>pelvic pathology</strong> (endometriosis, ovarian cysts, tubal disease), but not for <strong>intrauterine adhesions</strong>. The appropriate investigation for intrauterine pathology is <strong>HSG or hysteroscopy</strong>, not laparoscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Asherman syndrome (intrauterine adhesions) should be suspected in women with secondary amenorrhea after D&amp;C for postpartum hemorrhage or abortion and normal FSH/LH levels. The next best diagnostic step is hysteroscopy to visualize intrauterine adhesions.</span></p>",
      "correct_choice_id": 386225,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97029/NEET_GT__11_NOV_2025_OBG_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97029/NEET_GT__11_NOV_2025_OBG_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96939,
      "choices": [
        {
          "id": 385864,
          "text": "<p><span style=\"font-size:14.0pt;\">Classify as no dehydration and advise home-based ORS therapy with zinc supplementation</span></p>"
        },
        {
          "id": 385865,
          "text": "<p><span style=\"font-size:14.0pt;\">Classify as some dehydration and give ORS 75 ml/kg over 4 hours at the health facility</span></p>"
        },
        {
          "id": 385866,
          "text": "<p><span style=\"font-size:14.0pt;\">Classify as severe dehydration and start IV fluids 100 ml/kg over 3 hours immediately</span></p>"
        },
        {
          "id": 385867,
          "text": "<p><span style=\"font-size:14.0pt;\">Classify as some dehydration and refer urgently to higher center for IV fluid management</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 12-month-old child is brought to the primary health center with a 3-day history of loose stools (8-10 episodes/day) and vomiting (4-5 episodes/day). On examination, the child is irritable, has sunken eyes, skin pinch goes back slowly (2 seconds), and the mother reports decreased urine output. The child weighs 8 kg and appears lethargic but drinks eagerly when offered water. According to IMNCI guidelines, what is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7616293",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>Classify as some dehydration and give ORS 75 ml/kg over 4 hours at the health facility</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to IMNCI guidelines, this child has signs of \"some dehydration\" (moderate dehydration).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The key signs present are: sunken eyes, skin pinch goes back slowly (1-2 seconds), irritable/restless behavior, and drinks eagerly/thirsty.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The child does not have signs of severe dehydration (skin pinch goes back very slowly &gt;2 seconds, lethargic/unconscious, unable to drink).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For a child with some dehydration, IMNCI recommends giving ORS 75 ml/kg over 4 hours at the health facility, along with continued feeding and zinc supplementation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For an 8 kg child, this would be 600 ml of ORS over 4 hours. The child should be monitored during this period and reassessed after 4 hours.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-10%20103934.jpg\" width=\"776\" height=\"740\"></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Oral Rehydration Therapy (First 4 hours: 75 mL/kg):</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20145649.jpg\" width=\"602\" height=\"449\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">(Solution used: WHO Reduced Osmolarity ORS)</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Intravenous Rehydration (Total dose 100 mL/kg):</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20145659.jpg\" width=\"737\" height=\"210\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">(Solution used: Ringer lactate/Hartmann solution, Diarrhoea treatment solution (DTS))</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Maintenance Therapy:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20145709.jpg\" width=\"1002\" height=\"199\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Classify as no dehydration and advise home-based ORS therapy with zinc supplementation:</strong> The presence of sunken eyes and slow skin pinch indicates \"some dehydration,\" not \"no dehydration,\" requiring facility-based ORS therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Classify as severe dehydration and start IV fluids 100 ml/kg over 3 hours immediately:</strong> Signs of severe dehydration (skin pinch &gt;2 seconds, lethargic/unconscious, unable to drink) are not present; IV therapy is not indicated at this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Classify as some dehydration and refer urgently to higher center for IV fluid management:</strong> Children with some dehydration can be managed at PHC level with ORS therapy; referral is only needed if signs worsen or severe dehydration is present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IMNCI classifies dehydration into three categories: no dehydration, some dehydration, and severe dehydration based on specific clinical signs</span></li><li><span style=\"font-size:14.0pt;\">Some dehydration is managed with ORS 75 ml/kg over 4 hours at health facility with close monitoring and reassessment</span></li><li><span style=\"font-size:14.0pt;\">Key signs of some dehydration include sunken eyes, skin pinch 1-2 seconds, irritable/restless, and drinks eagerly/thirsty</span></li><li><span style=\"font-size:14.0pt;\">Zinc supplementation (10-20 mg daily for 10-14 days) should be given along with ORS therapy for all children with diarrhea</span></li></ul>",
      "correct_choice_id": 385865,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96939/NEET_PG_11_Nov_2025_PSM_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96939/NEET_PG_11_Nov_2025_PSM_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96979,
      "choices": [
        {
          "id": 386024,
          "text": "<p><span style=\"font-size:18px;\">Normal zona fasciculata and reticularis in the uninvolved adrenal gland</span></p>"
        },
        {
          "id": 386025,
          "text": "<p><span style=\"font-size:18px;\">Nests of chromaffin cells with salt-and-pepper chromatin</span></p>"
        },
        {
          "id": 386026,
          "text": "<p><span style=\"font-size:18px;\">Diffuse hyperplasia of zona fasciculata and reticularis</span></p>"
        },
        {
          "id": 386027,
          "text": "<p><span style=\"font-size:18px;\">Sheets of large polygonal cells with abundant clear cytoplasm due to lipid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 35-year-old woman presents with weight gain, easy bruising, and irregular menstrual cycles. On examination, she has facial rounding (moon facies), central obesity, and purple striae on the abdomen. Her serum cortisol level is elevated, and ACTH level is suppressed. A CT scan reveals a 3 cm well-circumscribed mass in the left adrenal cortex. Which of the following histologic findings in the lesion is most consistent with her condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8236450",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Sheets of large polygonal cells with abundant clear cytoplasm due to lipid</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This <strong>35-year-old woman</strong> with <strong>Cushing’s syndrome</strong> (moon facies, purple striae, central obesity, menstrual irregularity, and ACTH suppression) has an <strong>adrenal cortical adenoma</strong>, confirmed by <strong>CT showing a well-circumscribed adrenal mass</strong> and <strong>low ACTH</strong>.</span></li><li><span style=\"font-size:18px;\">The histologic hallmark of an <strong>adrenal cortical adenoma</strong> is <strong>sheets or nests of large polygonal cells</strong> with <strong>abundant clear or vacuolated cytoplasm</strong> due to <strong>intracytoplasmic lipid</strong> (cholesterol and steroid precursors).</span></li><li><span style=\"font-size:18px;\">These cells resemble those of the <strong>zona fasciculata</strong> of the adrenal cortex, which is responsible for cortisol production.&nbsp;</span></li><li><span style=\"font-size:18px;\">The adenoma leads to <strong>excess cortisol secretion</strong>, causing <strong>ACTH suppression</strong> and <strong>atrophy of the contralateral adrenal gland</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Atrophic zona fasciculata and reticularis in the uninvolved adrenal:&nbsp;</strong>Incorrect. Although this finding may occur in the <strong>contralateral adrenal gland</strong> due to ACTH suppression, it does <strong>not describe the lesion itself</strong> (the question asks for findings in the tumor). The lesion — the adenoma — is characterized by <strong>lipid-laden polygonal cells</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Nests of chromaffin cells with salt-and-pepper chromatin:&nbsp;</strong>Incorrect.&nbsp;This describes a <strong>pheochromocytoma</strong>, a tumor of the <strong>adrenal medulla</strong> derived from <strong>chromaffin cells</strong> that produce <strong>catecholamines</strong>, not cortisol.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Diffuse hyperplasia of zona fasciculata and reticularis:&nbsp;</strong>Incorrect.&nbsp;Seen in <strong>Cushing disease (pituitary ACTH overproduction)</strong> or <strong>ectopic ACTH syndrome</strong>, where <strong>ACTH levels are high</strong>. This patient’s <strong>ACTH is suppressed</strong>, excluding secondary hyperplasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\"><strong>Adrenal cortical adenomas</strong> causing <strong>ACTH-independent Cushing’s syndrome</strong> are composed of <strong>large, clear, lipid-rich cells</strong> resembling those of the <strong>zona fasciculata</strong>.&nbsp;</span></li><li><span style=\"font-size:18px;\">They produce <strong>excess cortisol</strong>, leading to <strong>ACTH suppression</strong> and <strong>atrophy of the contralateral adrenal gland</strong>.</span></li></ul>",
      "correct_choice_id": 386027,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96979/Neet_Gt__11_Nov_2025_Pathology_Question_7.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96979/Neet_Gt__11_Nov_2025_Pathology_Question_7.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97069,
      "choices": [
        {
          "id": 386384,
          "text": "<p><span style=\"font-size:14.0pt;\">Rheumatoid Arthritis&nbsp;</span></p>"
        },
        {
          "id": 386385,
          "text": "<p><span style=\"font-size:14.0pt;\">Ankylosing Spondylitis</span></p>"
        },
        {
          "id": 386386,
          "text": "<p><span style=\"font-size:14.0pt;\">Lumbar Disc Herniation&nbsp;</span></p>"
        },
        {
          "id": 386387,
          "text": "<p><span style=\"font-size:14.0pt;\">Diffuse Idiopathic Skeletal Hyperostosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 32-year-old male presents with a 3-year history of chronic low back and buttock pain. The pain is insidious in onset and primarily affects the sacroiliac region bilaterally. He reports the pain is significantly worse in the early morning and after periods of rest, often waking him from sleep. Crucially, he notes that the pain improves with exercise and physical activity. He exhibits a positive Schober's test. Blood work reveals a positive HLA-B27 antigen test and an elevated C-reactive protein (CRP). Which of the following is the most likely diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103640.jpg\" width=\"354\" height=\"548\"></strong></span></p>",
      "unique_key": "Q7028585",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ankylosing Spondylitis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The prototypical inflammatory spondyloarthropathy, characterized by inflammation of the axial skeleton, peripheral joints, and entheses.</span></li><li><span style=\"font-size:14.0pt;\">Young male presenting with chronic back pain.</span></li><li><span style=\"font-size:14.0pt;\"><strong>The Inflammatory Pattern:</strong> Insidious Onset and Chronic Duration &gt; 3 months</span></li><li><span style=\"font-size:14.0pt;\">Pain is worse at rest and in the early morning/nocturnal waking.</span></li><li><span style=\"font-size:14.0pt;\">Crucially, improves with exercise/activity (a key differentiator from mechanical pain).</span></li><li><span style=\"font-size:14.0pt;\">Positive Schober's test indicates reduced range of motion due to spinal inflammation/stiffness.</span></li><li><span style=\"font-size:14.0pt;\">Primarily affects the sacroiliac joints and the spine.</span></li><li><span style=\"font-size:14.0pt;\">Positive HLA-B27 (present in over 90% of white AS patients) and elevated CRP (a marker of systemic inflammation).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Rheumatoid Arthritis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A chronic autoimmune inflammatory disorder primarily affecting the lining of the synovial joints (synovitis), leading to joint damage.</span></li><li><span style=\"font-size:14.0pt;\">RA typically affects peripheral, small joints (MCPs, PIPs, wrists) symmetrically. It generally spares the axial skeleton (low back, buttock, sacroiliac joints), except for the upper cervical spine (atlantoaxial joint) in advanced stages.</span></li><li><span style=\"font-size:14.0pt;\">Low back pain in RA is uncommon and not the primary presentation.</span></li><li><span style=\"font-size:14.0pt;\">RA is associated with HLA-DR4 and other HLA alleles, not HLA-B27.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lumbar Disc Herniation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A mechanical cause of low back pain and/or radiculopathy (pain radiating down the leg), caused by protrusion of the intervertebral disc nucleus pulposus.</span></li><li><span style=\"font-size:14.0pt;\"><strong>The Mechanical Pattern:</strong> Pain from LDH is typically acute in onset, often following an injury or strain. The pain is usually worse with activity/movement (especially bending, lifting, or prolonged sitting) and improves with rest—the exact opposite of the case description.</span></li><li><span style=\"font-size:14.0pt;\">While severe LDH can cause pain at rest, the defining feature of improvement with exercise is absent.</span></li><li><span style=\"font-size:14.0pt;\">LDH pain is generally localized to the low back and often unilateral radiculopathy (sciatica), not bilateral sacroiliac pain.</span></li><li><span style=\"font-size:14.0pt;\">LDH is a structural/mechanical problem; HLA-B27 is negative, and the CRP is typically normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Diffuse Idiopathic Skeletal Hyperostosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A non-inflammatory condition characterized by calcification and ossification of ligaments and entheses, primarily along the anterior and right lateral aspects of the spine.</span></li><li><span style=\"font-size:14.0pt;\">DISH is a disease of the elderly (&gt;50-60) and is often discovered incidentally. It typically causes stiffness rather than prominent pain, and the stiffness is less responsive to exercise.</span></li><li><span style=\"font-size:14.0pt;\">Primarily affects the thoracic spine.</span></li><li><span style=\"font-size:14.0pt;\">It is a non-inflammatory process; therefore, HLA-B27 is negative, and the CRP is normal.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The case describes the classic presentation of inflammatory back pain (IBP): onset before age 40, insidious onset, duration &gt; 3 months, morning stiffness, nocturnal pain, and improvement with exercise.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The combination of sacroiliitis, a positive Schober's test, a positive HLA-B27 antigen test, and an elevated CRP is virtually pathognomonic for Ankylosing Spondylitis.</span></li></ul>",
      "correct_choice_id": 386385,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97069/NEET_GT__11_NOV_2025_Orthopedics_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97069/NEET_GT__11_NOV_2025_Orthopedics_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97066,
      "choices": [
        {
          "id": 386372,
          "text": "<p><span style=\"font-size:14.0pt;\">Schizophrenia</span></p>"
        },
        {
          "id": 386373,
          "text": "<p><span style=\"font-size:14.0pt;\">Schizoaffective disorder</span></p>"
        },
        {
          "id": 386374,
          "text": "<p><span style=\"font-size:14.0pt;\">Delusional disorder</span></p>"
        },
        {
          "id": 386375,
          "text": "<p><span style=\"font-size:14.0pt;\">Acute and transient psychotic disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 47-year-old man has had a fixed belief for the past 6 months that his neighbors have hidden cameras in his house to spy on him. He continues his daily work and social life, though he spends time checking walls for these devices. There are no negative symptoms or disorganized behavior. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6518707",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Delusional disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">According to <strong>ICD-11</strong>, <strong>Delusional Disorder</strong> is diagnosed when:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">One or more <strong>persistent delusions</strong> are present for <strong>at least 3 months</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Apart from the direct impact of the delusion, the person’s <strong>behavior, emotions, and speech remain largely normal</strong>. E.g. In this case, where delusion is about neighbours, the behaviour of patient in, say office, is likely to be normal.</span></li><li><span style=\"font-size:14.0pt;\">There are <strong>no negative symptoms, disorganized thinking, or grossly disorganized behavior</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hallucinations may occasionally occur</strong>, but <strong>only if they are brief and match the delusional theme</strong> (for example, feeling insects crawling when one believes they are infested).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This patient’s <strong>long-standing persecutory delusion</strong> preserved overall functioning, and lack of other features are consistent with <strong>Delusional Disorder</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Schizophrenia:</strong> Needs at least two characteristic symptoms (delusions, hallucinations, disorganization, experiences of control, negative symptoms, or catatonia) for ≥ 1 month. Here, only a single fixed delusion is seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Schizoaffective disorder:</strong> Requires concurrent fulfillment of criteria for schizophrenia <strong>and</strong> a <strong>moderate or severe mood episode</strong> (depressive, manic, or mixed), lasting ≥ 1 month. No mood symptoms are mentioned.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Acute and transient psychotic disorder:</strong> Has <strong>sudden onset within 2 weeks</strong>, <strong>rapid changes in symptoms</strong>, <strong>no negative symptoms</strong>, and a <strong>short duration (usually &lt; 1 month, never &gt; 3 months)</strong>. The 6-month course here rules this out.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Delusional Disorder (ICD-11)</strong> involves <strong>persistent delusions lasting ≥ 3 months</strong> with <strong>otherwise stable behavior and personality</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Brief, theme-related hallucinations may occur, but there are <strong>no sustained hallucinations, disorganization, or negative symptoms</strong>.</span></li></ul>",
      "correct_choice_id": 386374,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97066/New_GT_Psychiatry_Question_40.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97066/New_GT_Psychiatry_Question_40.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97021,
      "choices": [
        {
          "id": 386192,
          "text": "<p><span style=\"font-size:14.0pt;\">Anterior Colpotomy</span></p>"
        },
        {
          "id": 386193,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior Colpotomy</span></p>"
        },
        {
          "id": 386194,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparotomy</span></p>"
        },
        {
          "id": 386195,
          "text": "<p><span style=\"font-size:14.0pt;\">Culdocentesis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old woman presents with severe pelvic pain and fever. On examination, a fluctuant mass is palpated in the pouch of Douglas. Which surgical approach is most appropriate for drainage?&nbsp;</span></p>",
      "unique_key": "Q8856630",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Posterior Colpotomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This <strong>28-year-old woman</strong> presents with <strong>severe pelvic pain, fever, and a fluctuant mass in the pouch of Douglas</strong>, suggestive of a <strong>pelvic abscess</strong>—most likely a <strong>tubo-ovarian abscess or pelvic peritonitis</strong> leading to pus collection in the <strong>rectouterine pouch (pouch of Douglas)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In such cases, the <strong>most appropriate and least invasive surgical approach</strong> for drainage is <strong>Posterior Colpotomy</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Posterior colpotomy</strong> involves:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Making an incision through the <strong>posterior vaginal fornix</strong> to access the <strong>rectouterine pouch</strong> directly.</span></li><li><span style=\"font-size:14.0pt;\">Allowing <strong>dependent drainage</strong> of pus or infected fluid.</span></li><li><span style=\"font-size:14.0pt;\">Providing <strong>rapid relief</strong> of symptoms with <strong>minimal morbidity</strong>.</span><br><span style=\"font-size:14.0pt;\">It is the <strong>preferred route</strong> when the abscess is <strong>localized</strong>, <strong>fluctuant</strong>, and <strong>bulging into the posterior fornix</strong>, as in this case.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Anterior Colpotomy:&nbsp;</strong>Incorrect. Anterior colpotomy involves an incision in the <strong>anterior vaginal wall</strong> to access the <strong>bladder or vesicouterine pouch</strong>, used for <strong>bladder stone removal or fistula repair</strong>, not for drainage of a pouch of Douglas abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Laparotomy:&nbsp;</strong>Incorrect. Laparotomy is reserved for <strong>ruptured abscesses</strong>, <strong>diffuse peritonitis</strong>, or <strong>uncertain diagnosis</strong>. It is <strong>more invasive</strong> and not necessary when the abscess is <strong>localized and palpable through the posterior fornix</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Culdocentesis:&nbsp;</strong>Incorrect. Culdocentesis is a <strong>diagnostic procedure</strong>, involving <strong>needle aspiration</strong> of fluid from the pouch of Douglas. While useful for <strong>diagnosis</strong>, it is <strong>not sufficient for complete drainage</strong> of a well-formed abscess.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A <strong>pelvic abscess localized to the pouch of Douglas</strong> and <strong>palpable through the posterior vaginal fornix</strong> should be drained via <strong>posterior colpotomy</strong>, as it provides <strong>dependent drainage</strong>, <strong>rapid relief</strong>, and <strong>minimal surgical morbidity</strong>.</span></p>",
      "correct_choice_id": 386193,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97021/NEET_GT__11_NOV_2025_OBG_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97021/NEET_GT__11_NOV_2025_OBG_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97043,
      "choices": [
        {
          "id": 386280,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-Scl70</span></p>"
        },
        {
          "id": 386281,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-dsDNA</span></p>"
        },
        {
          "id": 386282,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-U1 ribonucleoprotein</span></p>"
        },
        {
          "id": 386283,
          "text": "<p><span style=\"font-size:14.0pt;\">Anti-RNA polymerase III</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old woman with hypertension, hyperlipidemia, type 2 diabetes, and Raynaud disease presents with headache and blurred vision over 8 hours; she is afebrile, with HR 100, BP 170/95, RR 18, and O₂ sat 97%. Skin shows blanching telangiectasias, sclerodactyly, and nailfold capillary changes (dilated loops, dropout). Labs reveal Hb 8.6, platelets 54, creatinine 3.9, BUN 78, total bilirubin 4.5 (direct 0.4), and urinalysis negative for protein, blood, and infection. Which autoantibody places her at highest risk for this complication?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3496095",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Anti-RNA polymerase III</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This presentation (scleroderma features, acute hypertension, renal failure, negative urine, anemia, thrombocytopenia) is classic for scleroderma renal crisis, a complication of systemic sclerosis.</span></li><li><span style=\"font-size:14.0pt;\">Anti-RNA polymerase III antibodies are most closely linked to scleroderma renal crisis, often associated with rapidly progressive renal impairment, severe hypertension, and microangiopathic hemolytic anemia.​</span></li><li><span style=\"font-size:14.0pt;\">These autoantibodies signal increased risk for renal crisis and should prompt vigilance for this complication and early ACE-inhibitor therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Anti-Scl70:</strong>&nbsp;Anti-Scl70 is associated with diffuse cutaneous systemic sclerosis and pulmonary fibrosis, not specifically with renal crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Anti-dsDNA:</strong> Anti-dsDNA is a marker for systemic lupus erythematosus and lupus nephritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Anti-U1 ribonucleoprotein (RNP):</strong> Anti-U1 RNP is seen in mixed connective tissue disease and is not characteristically linked with scleroderma renal crisis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Anti-RNA polymerase III is the autoantibody most strongly associated with the development of scleroderma renal crisis in systemic sclerosis, indicating heightened risk of acute severe hypertension, renal failure, and microangiopathic features; recognize this antibody for prognostication and management.</span></p>",
      "correct_choice_id": 386283,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97043/Neet_Gt__11_Nov_2025_Medicine_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97043/Neet_Gt__11_Nov_2025_Medicine_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96975,
      "choices": [
        {
          "id": 386008,
          "text": "<p><span style=\"font-size:18px;\">It may metastasize early via lymphatics and blood</span></p>"
        },
        {
          "id": 386009,
          "text": "<p><span style=\"font-size:18px;\">Breslow thickness is an important prognostic factor</span></p>"
        },
        {
          "id": 386010,
          "text": "<p><span style=\"font-size:18px;\">It shows junctional activity and pagetoid spread</span></p>"
        },
        {
          "id": 386011,
          "text": "<p><span style=\"font-size:18px;\">It commonly arises in pre-existing seborrheic keratosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 40-year-old woman presents with a darkly pigmented, irregular lesion on her back that has recently increased in size and shape. Biopsy shows atypical melanocytes invading dermis. All of the following statements regarding this lesion are true, except:<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7490068",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) It commonly arises in pre-existing seborrheic keratosis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This <strong>40-year-old woman</strong> has a <strong>darkly pigmented, irregular lesion on the back</strong> that has <strong>recently increased in size and shape</strong>, and <strong>biopsy shows atypical melanocytes invading the dermis</strong>—all classic for <strong>cutaneous melanoma</strong>.&nbsp;</span></li><li><span style=\"font-size:18px;\">Melanoma <strong>does not commonly arise in pre-existing seborrheic keratosis</strong>; instead, it typically arises <strong>de novo</strong> or from a <strong>pre-existing melanocytic nevus</strong>.</span></li><li><span style=\"font-size:18px;\">Therefore, the statement that it “<strong>commonly arises in pre-existing seborrheic keratosis</strong>” is <strong>false</strong> and is the correct choice for the <strong>except</strong> question.</span></li><li><span style=\"font-size:18px;\"><strong>Seborrheic keratosis</strong> is a <strong>benign epidermal tumor</strong>; melanoma <strong>does not commonly arise</strong> from it. (SKs may be numerous in the <strong>Leser–Trélat sign</strong>, but that is unrelated to melanoma origin.)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It may metastasize early via lymphatics and blood:&nbsp;</strong>True.&nbsp;Melanoma is notorious for <strong>early metastasis</strong> through both <strong>lymphatic channels</strong> and <strong>hematogenous spread</strong>, explaining its high mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Breslow thickness is an important prognostic factor:&nbsp;</strong>True<strong>. Breslow thickness</strong> (measured depth of invasion in millimeters) is the <strong>single most important prognostic factor</strong> for localized melanoma; greater depth correlates with worse prognosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It shows junctional activity and pagetoid spread:&nbsp;</strong>True.&nbsp;Melanoma often demonstrates <strong>junctional activity</strong> (atypical melanocytes along the dermoepidermal junction) and <strong>pagetoid spread</strong> (upward scatter of atypical melanocytes within the epidermis), consistent with the biopsy of <strong>atypical melanocytes invading dermis</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">Melanoma prognosis is driven by Breslow thickness; it metastasizes early via lymphatic and hematogenous routes and shows junctional activity with pagetoid spread.</span></li><li><span style=\"font-size:18px;\">It <strong>does not commonly arise from seborrheic keratosis</strong>.</span></li></ul>",
      "correct_choice_id": 386011,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96975/Neet_Gt__11_Nov_2025_Pathology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96975/Neet_Gt__11_Nov_2025_Pathology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97035,
      "choices": [
        {
          "id": 386248,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage I</span></p>"
        },
        {
          "id": 386249,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage II&nbsp;</span></p>"
        },
        {
          "id": 386250,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage III&nbsp;</span></p>"
        },
        {
          "id": 386251,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old multiparous woman presents with a sensation of \"something coming down\" per vaginum. On examination with maximum Valsalva maneuver, the most distal portion of the prolapse is 2 cm beyond the hymenal ring, but the vagina is not completely everted. According to the POP-Q staging system, what stage is this prolapse?</span></p>",
      "unique_key": "Q4406951",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Stage III</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the <strong>POP-Q (Pelvic Organ Prolapse Quantification) staging system</strong>, staging is referenced to the <strong>hymenal ring</strong> during <strong>maximum Valsalva maneuver</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Stage III</strong> is defined as the <strong>most distal portion of the prolapse &gt;1 cm beyond (distal to) the hymen</strong> but <strong>without complete vaginal eversion</strong> (i.e., not Stage IV).</span></li><li><span style=\"font-size:14.0pt;\">In this <strong>58-year-old multiparous woman</strong> with a sensation of <strong>“something coming down” per vaginum</strong>, the exam finding that the <strong>most distal portion is 2 cm beyond the hymenal ring</strong> (i.e., <strong>+2 cm</strong>) and that the <strong>vagina is not completely everted</strong> fits <strong>Stage III</strong> precisely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This directly addresses the scenario’s details: <strong>per vaginum</strong> symptom, <strong>maximum Valsalva</strong> on examination, <strong>2 cm beyond the hymenal ring</strong>, <strong>not completely everted</strong>, and classification per the <strong>POP-Q staging system</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stage I:&nbsp;</strong>Incorrect. Stage I requires the most distal prolapse point to be <strong>&gt;1 cm above (proximal to) the hymen</strong> (i.e., ≤ –1 cm). Our patient is <strong>2 cm beyond</strong> the hymenal ring, not above it.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Stage II:&nbsp;</strong>Incorrect<strong>.</strong> Stage II is when the most distal point lies <strong>within 1 cm proximal or distal to the hymen</strong> (from <strong>–1 cm to +1 cm</strong>). The finding of <strong>+2 cm beyond the hymenal ring</strong> exceeds this range.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Stage IV:&nbsp;</strong>Incorrect. Stage IV denotes <strong>complete vaginal eversion</strong> (or prolapse to within <strong>2 cm of total vaginal length</strong>). The stem explicitly states the <strong>vagina is not completely everted</strong>, ruling out Stage IV.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In <strong>POP-Q</strong>, <strong>Stage III</strong> pelvic organ prolapse = <strong>&gt;1 cm beyond the hymen</strong> on <strong>maximum Valsalva</strong> <strong>without complete vaginal eversion</strong>; e.g., <strong>+2 cm beyond the hymenal ring</strong>.</span></li></ul>",
      "correct_choice_id": 386250,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97035/NEET_GT__11_NOV_2025_OBG_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97035/NEET_GT__11_NOV_2025_OBG_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97440,
      "choices": [
        {
          "id": 387856,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased intraventricular hemorrhage (IVH)</span></p>"
        },
        {
          "id": 387857,
          "text": "<p><span style=\"font-size:14.0pt;\">Reduced need for transfusions and lower IVH rates</span></p>"
        },
        {
          "id": 387858,
          "text": "<p><span style=\"font-size:14.0pt;\">Higher incidence of necrotizing enterocolitis (NEC)</span></p>"
        },
        {
          "id": 387859,
          "text": "<p><span style=\"font-size:14.0pt;\">Increased mortality</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">For a 29-week preterm infant who does not require immediate resuscitation, delayed cord clamping (DCC) of 30–60 seconds is associated with which outcome?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2848031",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Reduced need for transfusions and lower IVH rates</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In preterm infants (especially &lt;32 weeks gestation), delayed cord clamping for 30–60 seconds allows additional placental transfusion, improving <strong>blood volume and hemodynamic stability</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This leads to a <strong>reduced need for blood transfusions</strong>, lower risk of <strong>intraventricular hemorrhage (IVH)</strong>, and less <strong>hypotension</strong> in the early neonatal period.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Increased intraventricular hemorrhage (IVH):</strong> Incorrect. DCC reduces, not increases, IVH incidence by improving cerebral perfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Higher incidence of necrotizing enterocolitis (NEC):</strong> Incorrect. Studies show no increase in necrotizing enterocolitis (NEC) with DCC.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Increased mortality:</strong> Incorrect. Mortality is not increased; some evidence even suggests improved survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">In preterm neonates who are stable at birth, delayed cord clamping (30–60 seconds) decreases the need for transfusions and lowers the risk of intraventricular hemorrhage without increasing adverse outcomes.</span></p>",
      "correct_choice_id": 387857,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97440/NEET_GT__11_NOV_2025_Pediatrics_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97440/NEET_GT__11_NOV_2025_Pediatrics_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96972,
      "choices": [
        {
          "id": 385996,
          "text": "<p><span style=\"font-size:14.0pt;\">It conveys the right bundle branch to the anterior papillary muscle</span></p>"
        },
        {
          "id": 385997,
          "text": "<p><span style=\"font-size:14.0pt;\">It connects the interventricular septum to the posterior papillary muscle</span></p>"
        },
        {
          "id": 385998,
          "text": "<p><span style=\"font-size:14.0pt;\">It is derived from the left ventricular trabeculae carneae</span></p>"
        },
        {
          "id": 385999,
          "text": "<p><span style=\"font-size:14.0pt;\">It is supplied mainly by marginal branches of the right coronary artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the image shown below, which statement about the structure labeled “A” is correct?&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20131816.jpg\" width=\"535\" height=\"428\"></p>",
      "unique_key": "Q3342595",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) It conveys the right bundle branch to the anterior papillary muscle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>moderator band</strong>, also called the <strong>septomarginal trabecula</strong>, is a muscular ridge found in the <strong>right ventricle</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It extends from the <strong>interventricular septum</strong> to the <strong>base of the anterior papillary muscle</strong> and contains part of the <strong>right bundle branch (Purkinje fibers)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This anatomical arrangement ensures <strong>coordinated contraction</strong> of the right ventricle by transmitting the electrical impulse rapidly to the <strong>anterior papillary muscle</strong>, synchronizing it with the rest of the ventricular myocardium.</span></li><li><span style=\"font-size:14.0pt;\">It also helps <strong>prevent overdistension</strong> of the right ventricle during systole.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20133544.jpg\" width=\"873\" height=\"578\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. It connects</strong> <strong>the interventricular septum to the posterior papillary muscle:&nbsp;</strong>Incorrect.&nbsp;The moderator band attaches to the <strong>anterior papillary muscle</strong>, not the posterior one.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. It is derived from left ventricular trabeculae carneae:&nbsp;</strong>Incorrect.<strong>&nbsp;</strong>The moderator band is unique to the <strong>right ventricle</strong>, not found in the left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. It is supplied mainly by marginal branches of the right coronary artery:&nbsp;</strong>Incorrect.&nbsp;It receives blood supply primarily from the <strong>septal branches of the left anterior descending (LAD) artery</strong>, not the right coronary artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>moderator band (septomarginal trabecula)</strong> of the <strong>right ventricle</strong> carries the <strong>right bundle branch fibers</strong> to the <strong>anterior papillary muscle</strong>, ensuring synchronized contraction and efficient right ventricular function.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is supplied by <strong>septal branches of the LAD artery</strong>.</span></li></ul>",
      "correct_choice_id": 385996,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96972/NEET_GT__11_NOV_2025_Anatomy_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96972/NEET_GT__11_NOV_2025_Anatomy_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97014,
      "choices": [
        {
          "id": 386164,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B2 (Riboflavin)&nbsp;</span></p>"
        },
        {
          "id": 386165,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B3 (Niacin)&nbsp;</span></p>"
        },
        {
          "id": 386166,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B5 (Pantothenic acid)&nbsp;</span></p>"
        },
        {
          "id": 386167,
          "text": "<p><span style=\"font-size:14.0pt;\">Vitamin B6 (Pyridoxine)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old patient with peripheral neuropathy is found to have elevated homocysteine levels. Laboratory investigations reveal impaired conversion of serine and homocysteine to cystathionine. Which vitamin deficiency is most likely responsible for this enzymatic dysfunction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1579992",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Vitamin B6 (Pyridoxine)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The reaction <strong>Serine + Homocysteine → Cystathionine + H₂O</strong> is catalyzed by the enzyme <strong>cystathionine β-synthase (CBS)</strong>, which requires <strong>pyridoxal phosphate (PLP)</strong>, the active form of vitamin B6, as a coenzyme.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Clinical Significance:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Vitamin B6 deficiency can lead to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Hyperhomocysteinemia</strong> (increased cardiovascular risk)</span></li><li><span style=\"font-size:14.0pt;\"><strong>Peripheral neuropathy</strong> and seizures</span></li><li><span style=\"font-size:14.0pt;\"><strong>Sideroblastic anemia</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Dermatitis and cheilosis</strong></span></li></ul></li><li><span style=\"font-size:14.0pt;\">This pathway is part of the <strong>transsulfuration pathway</strong>, critical for converting methionine-derived homocysteine to cysteine, maintaining sulfur amino acid homeostasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Vitamin B2 (Riboflavin):</strong> cofactor for flavoproteins (e.g., succinate dehydrogenase); not the key cofactor for this step.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Vitamin B3 (Niacin):</strong> NAD⁺/NADP⁺ cofactor; not required for cystathionine β-synthase.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Vitamin B5 (Pantothenic acid):</strong> component of coenzyme A; unrelated to this reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cystathionine β-synthase (homocysteine + serine → cystathionine) requires pyridoxal phosphate (vitamin B6); B6 deficiency causes impaired transsulfuration and elevated homocysteine.</span></p>",
      "correct_choice_id": 386167,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97014/NEET_GT__11_NOV_2025_Biochemistry_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        1
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97014/NEET_GT__11_NOV_2025_Biochemistry_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97053,
      "choices": [
        {
          "id": 386320,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop clopidogrel at 3 months</span></p>"
        },
        {
          "id": 386321,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop clopidogrel at 6 months</span></p>"
        },
        {
          "id": 386322,
          "text": "<p><span style=\"font-size:14.0pt;\">Stop clopidogrel now and continue aspirin monotherapy</span></p>"
        },
        {
          "id": 386323,
          "text": "<p><span style=\"font-size:14.0pt;\">Take clopidogrel for at least 1 year</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with diabetes is hospitalized for NSTEMI and undergoes drug-eluting stent (DES) placement in the RCA. He is on aspirin, clopidogrel, metoprolol, metformin, and atorvastatin, and has a low risk of bleeding. He asks when he can stop clopidogrel. What is the best recommendation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8699043",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Take clopidogrel for at least 1 year</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">ACC/AHA guidelines recommend that patients with acute coronary syndrome (ACS) treated with a DES receive dual antiplatelet therapy (DAPT) with aspirin and clopidogrel for a minimum of 12 months.</span></li><li><span style=\"font-size:14.0pt;\">This duration reduces the risks of stent thrombosis (a potentially fatal complication) and recurrent MI.</span></li><li><span style=\"font-size:14.0pt;\">Shorter DAPT durations (3 or 6 months) may be considered only for those at high bleeding risk or with stable coronary disease - not for ACS patients at low bleeding risk.</span></li><li><span style=\"font-size:14.0pt;\">Stopping clopidogrel early (before 1 year) significantly increases the risk of stent thrombosis, which is particularly dangerous in ACS patients.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients with ACS who have received a drug-eluting stent should continue clopidogrel and aspirin for at least 1 year to minimize the risk of stent thrombosis and recurrent cardiac events; early discontinuation is reserved only for high-bleeding-risk cases.</span></li></ul>",
      "correct_choice_id": 386323,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97053/Neet_Gt__11_Nov_2025_Medicine_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97053/Neet_Gt__11_Nov_2025_Medicine_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97047,
      "choices": [
        {
          "id": 386296,
          "text": "<p><span style=\"font-size:14.0pt;\">Begin enteral nutrition</span></p>"
        },
        {
          "id": 386297,
          "text": "<p><span style=\"font-size:14.0pt;\">Begin peripheral parenteral nutrition</span></p>"
        },
        {
          "id": 386298,
          "text": "<p><span style=\"font-size:14.0pt;\">Begin total parenteral nutrition</span></p>"
        },
        {
          "id": 386299,
          "text": "<p><span style=\"font-size:14.0pt;\">Continue IV D5/NS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with alcohol use disorder is hospitalized in the ICU for severe pancreatitis, complicated by hypotension requiring vasopressors and prolonged NPO status. After several days of ileus and bowel rest, she now has spontaneous passage of stool and flatus, is off vasopressors, and has a nasogastric tube removed. She has been maintained on IV D5 and NS and the nurse asks about the next step in her nutrition plan. Which of the following is most appropriate?</span></p>",
      "unique_key": "Q3417494",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Begin enteral nutrition</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">With the return of bowel function (passage of stool and flatus), this patient is now able to tolerate enteral nutrition. Early enteral nutrition, even via tube feeding if necessary, is the first-line approach as soon as gut function resumes.</span></li><li><span style=\"font-size:14.0pt;\">Enteral nutrition helps preserve gut integrity, reduces infection risk, and is physiologically superior to parenteral methods in patients with a functioning GI tract.</span></li><li><span style=\"font-size:14.0pt;\">Parenteral nutrition is reserved only for cases where enteral nutrition is not feasible (e.g., persistent ileus, severe malabsorption, bowel obstruction).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Begin peripheral parenteral nutrition:</strong> Peripheral parenteral nutrition is not indicated because GI function has returned and enteral feeding can be tolerated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>C. Begin total parenteral nutrition:</strong> Total parenteral nutrition should be avoided if enteral nutrition is possible, due to increased risk of infection and metabolic complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Continue IV D5/NS:</strong> Continuing IV D5NS alone does not provide sufficient nutrition and should not be continued once the patient can tolerate enteral feedings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Once bowel function has returned after acute pancreatitis or severe illness, early enteral nutrition is preferred over parenteral approaches and should be initiated as soon as tolerated to improve clinical outcomes.</span></p>",
      "correct_choice_id": 386296,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97047/Neet_Gt__11_Nov_2025_Medicine_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97047/Neet_Gt__11_Nov_2025_Medicine_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96952,
      "choices": [
        {
          "id": 385916,
          "text": "<p><span style=\"font-size:14.0pt;\">IMNCI</span></p>"
        },
        {
          "id": 385917,
          "text": "<p><span style=\"font-size:14.0pt;\">RBSK</span></p>"
        },
        {
          "id": 385918,
          "text": "<p><span style=\"font-size:14.0pt;\">NAYAN 2.0</span></p>"
        },
        {
          "id": 385919,
          "text": "<p><span style=\"font-size:14.0pt;\">ICDS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 10-year-old school child presents with the condition shown in the image below. This condition is screened under which of the following national health programs?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111231.jpg\" width=\"548\" height=\"426\"></span></p>",
      "unique_key": "Q4469316",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) RBSK</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">RBSK (Rashtriya Bal Swasthya Karyakram) is a child health screening and early intervention program that specifically focuses on the 4 D's - Defects at birth, Deficiency diseases, Development delays including disability, and Diseases.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The image shows developmental delay/disability which falls under the \"Development delays including disability\" category of RBSK.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This program provides free screening, treatment, and management of these conditions in children from birth to 18 years.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Health conditions screened under this program</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Defects at Birth</strong></span></p><ol><li><span style=\"font-size:14.0pt;\">Neural tube defect</span></li><li><span style=\"font-size:14.0pt;\">Down’s Syndrome</span></li><li><span style=\"font-size:14.0pt;\">Cleft lip &amp; palate /Cleft palate alone<sup>#</sup></span></li><li><span style=\"font-size:14.0pt;\">Talipes (club foot)</span></li><li><span style=\"font-size:14.0pt;\">Developmental dysplasia of the hip</span></li><li><span style=\"font-size:14.0pt;\">Congenital cataract</span></li><li><span style=\"font-size:14.0pt;\">Congenital deafness</span></li><li><span style=\"font-size:14.0pt;\">Congenital heart diseases</span></li><li><span style=\"font-size:14.0pt;\">Retinopathy of prematurity</span></li></ol><p><span style=\"font-size:14.0pt;\"><strong>Deficiencies</strong></span></p><ol><li><span style=\"font-size:14.0pt;\">&nbsp;Anaemia especially severe anaemia</span></li><li><span style=\"font-size:14.0pt;\">Vitamin A deficiency (Bitot spot)</span></li><li><span style=\"font-size:14.0pt;\">Vitamin D deficiency (Rickets)</span></li><li><span style=\"font-size:14.0pt;\">Severe Acute Malnutrition</span></li><li><span style=\"font-size:14.0pt;\">Goiter</span></li></ol><p><span style=\"font-size:14.0pt;\"><strong>Childhood Diseases</strong></span></p><ol><li><span style=\"font-size:14.0pt;\">Skin conditions (Scabies, fungal infection and Eczema)</span></li><li><span style=\"font-size:14.0pt;\">Otitis Media</span></li><li><span style=\"font-size:14.0pt;\">Rheumatic heart disease</span></li><li><span style=\"font-size:14.0pt;\">Reactive airway disease</span></li><li><span style=\"font-size:14.0pt;\">Dental caries</span></li><li><span style=\"font-size:14.0pt;\">Convulsive disorders</span></li></ol><p><span style=\"font-size:14.0pt;\"><strong>Developmental delays</strong></span></p><ol><li><span style=\"font-size:14.0pt;\">Vision impairment</span></li><li><span style=\"font-size:14.0pt;\">Hearing impairment</span></li><li><span style=\"font-size:14.0pt;\">Neuro motor impairment</span></li><li><span style=\"font-size:14.0pt;\">Motor delay</span></li><li><span style=\"font-size:14.0pt;\">Cognitive delay</span></li><li><span style=\"font-size:14.0pt;\">Language delay</span></li><li><span style=\"font-size:14.0pt;\">Behaviour disorder (Autism)</span></li><li><span style=\"font-size:14.0pt;\">Learning disorder</span></li><li><span style=\"font-size:14.0pt;\">Attention deficit hyperactivity disorder</span></li><li><span style=\"font-size:14.0pt;\">Other conditions-sickle cell anaemia, Beta Thalassemia, Congenital Hypothyroidism (optional)</span></li><li><span style=\"font-size:14.0pt;\">Tuberculosis</span></li><li><span style=\"font-size:14.0pt;\">Leprosy</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. IMNCI:</strong> IMNCI (Integrated Management of Neo-natal and Childhood Illnesses): It is essentially not a national health program and it deals with management of neo-natal and childhood illnesses.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. NAYAN 2.0:</strong> NAYAN 2.0 is not a national health program. Nayanamritham 2.0 is&nbsp;the world's first government-led, AI-powered chronic eye screening program launched by the Government of Kerala in collaboration with a private company.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. ICDS:</strong> ICDS (Integrated Child Development Services) provides nutrition and early childhood care but RBSK is the specific program for health screening of the 4 D's</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">RBSK screens for 4 D's: Defects at birth, Deficiency diseases, Development delays including disability, and Diseases</span></li><li><span style=\"font-size:14.0pt;\">The program covers children from birth to 18 years of age</span></li><li><span style=\"font-size:14.0pt;\">It provides comprehensive screening, treatment and management services for identified conditions</span></li></ul>",
      "correct_choice_id": 385917,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96952/NEET_PG_11_Nov_2025_PSM_Question_20.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96952/NEET_PG_11_Nov_2025_PSM_Question_20.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97046,
      "choices": [
        {
          "id": 386292,
          "text": "<p><span style=\"font-size:14.0pt;\">Progression of metastatic disease</span></p>"
        },
        {
          "id": 386293,
          "text": "<p><span style=\"font-size:14.0pt;\">Coronary artery plaque rupture</span></p>"
        },
        {
          "id": 386294,
          "text": "<p><span style=\"font-size:14.0pt;\">Coronary artery vasospasm</span></p>"
        },
        {
          "id": 386295,
          "text": "<p><span style=\"font-size:14.0pt;\">Occult pulmonary embolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with metastatic colon cancer on FOLFOX chemotherapy presents with intermittent shortness of breath and chest pain. Her imaging shows multiple pulmonary metastases but no pulmonary embolism, and ECG reveals sub-millimeter ST depressions in leads II and III. She is not a smoker and physical exam only reveals a soft systolic murmur at the apex. What is the most likely cause of her symptoms?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3230747",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Coronary artery vasospasm</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Chemotherapy agents, especially 5-fluorouracil (part of FOLFOX), are known to cause coronary artery vasospasm, leading to transient ischemia, chest pain, and ECG changes—even in patients without atherosclerotic disease.</span></li><li><span style=\"font-size:14.0pt;\">Vasospasm is a reversible complication that presents with acute chest pain and transient ECG changes but typically lacks evidence of plaque rupture or fixed coronary obstruction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>A. Progression of metastatic disease:</strong> Progression of metastatic disease is unlikely with acute onset chest pain and clear lungs on exam, especially in the absence of new radiographic findings to explain ischemic symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>B. Coronary artery plaque rupture:</strong> Coronary artery plaque rupture would usually present in those with vascular risk factors and produce persistent and often more severe ECG changes indicative of myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option</strong> <strong>D. Occult pulmonary embolism:</strong> Occult pulmonary embolism is not supported by normal CT angiography and lack of hypoxemia or tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Coronary artery vasospasm is a recognized side effect of 5-FU-based chemotherapy and should be suspected in cancer patients presenting with acute chest discomfort and ischemic ECG changes in the absence of classic cardiovascular risk factors or clear infarction.</span></p>",
      "correct_choice_id": 386294,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97046/NEET_GT__11_NOV_2025_Medicine_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97046/NEET_GT__11_NOV_2025_Medicine_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96931,
      "choices": [
        {
          "id": 385832,
          "text": "<p><span style=\"font-size:14.0pt;\">Pulmonary fibrosis</span></p>"
        },
        {
          "id": 385833,
          "text": "<p><span style=\"font-size:14.0pt;\">COPD</span></p>"
        },
        {
          "id": 385834,
          "text": "<p><span style=\"font-size:14.0pt;\">Sarcoidosis</span></p>"
        },
        {
          "id": 385835,
          "text": "<p><span style=\"font-size:14.0pt;\">Bronchiectasis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 64-year-old man with a long history of smoking presents with progressive dyspnea and chronic cough. Spirometry is performed, and is shown below. Which of the following conditions best explains these findings?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20102126.jpg\" width=\"751\" height=\"545\"></span></p>",
      "unique_key": "Q7559930",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) COPD</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>red curve in the abnormal graph</strong> shows:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Reduced slope and prolonged expiratory phase</strong> → classic for <strong>airflow obstruction</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FEV₁ (forced expiratory volume in 1 second)</strong> is markedly reduced.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FVC (forced vital capacity)</strong> is normal or only mildly reduced.</span></li><li><span style=\"font-size:14.0pt;\"><strong>FEV₁/FVC ratio is decreased</strong> (&lt;70%).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">This is the hallmark of <strong>obstructive lung disease</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>COPD (Chronic Obstructive Pulmonary Disease)</strong>, which includes emphysema and chronic bronchitis, is the prototypical cause.</span></li><li><span style=\"font-size:14.0pt;\">Hence, the correct diagnosis is <strong>COPD</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Pulmonary fibrosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Pulmonary fibrosis is a <strong>restrictive lung disease</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In restriction, both <strong>FEV₁ and FVC are reduced</strong>, but the <strong>FEV₁/FVC ratio is normal or increased</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This does not match the given abnormal graph.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Sarcoidosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Sarcoidosis is also a <strong>restrictive disease</strong> affecting lung parenchyma.</span></li><li><span style=\"font-size:14.0pt;\">Like pulmonary fibrosis, both volumes fall proportionally, and the <strong>FEV₁/FVC ratio is preserved or elevated</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is inconsistent with the “scooped-out” obstructive pattern.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Bronchiectasis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bronchiectasis is an <strong>obstructive disease</strong>, but the most classic exam association for this abnormal spirometry curve is <strong>COPD</strong>, particularly in a heavy smoker with chronic symptoms.</span></li><li><span style=\"font-size:14.0pt;\">While both COPD and bronchiectasis cause obstruction, COPD is the correct, best answer in this context.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A decreased FEV₁/FVC ratio with a concave expiratory curve on spirometry indicates obstructive lung disease, most classically COPD.</span></p>",
      "correct_choice_id": 385833,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96931/NEET_GT__11_NOV_2025_Physiology_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96931/NEET_GT__11_NOV_2025_Physiology_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96927,
      "choices": [
        {
          "id": 385816,
          "text": "<p><span style=\"font-size:14.0pt;\">Hemidesmosomes</span></p>"
        },
        {
          "id": 385817,
          "text": "<p><span style=\"font-size:14.0pt;\">Zona occludens</span></p>"
        },
        {
          "id": 385818,
          "text": "<p><span style=\"font-size:14.0pt;\">Gap junctions</span></p>"
        },
        {
          "id": 385819,
          "text": "<p><span style=\"font-size:14.0pt;\">Adherens junctions</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34-year-old man presents with profuse watery diarrhea after returning from a trip abroad. His stools are described as pale and watery, resembling “rice water.” Laboratory testing confirms infection with a toxin-producing organism. Which of the following structures is most likely damaged in this condition?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1997933",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Zona occludens</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Zona occludens (tight junctions)</strong> are specialized cell junctions located at the apical end of epithelial cells.</span></li><li><span style=\"font-size:14.0pt;\">They prevent <strong>paracellular leakage of water and solutes</strong>, maintaining the integrity of epithelial barriers in the gut.</span></li><li><span style=\"font-size:14.0pt;\">Infections such as <strong>cholera</strong> release toxins that disrupt tight junctions, leading to <strong>massive fluid secretion into the intestinal lumen</strong> and the clinical finding of watery, “rice water” stools.</span></li><li><span style=\"font-size:14.0pt;\">Thus, the structure damaged in this case is the <strong>zona occludens</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hemidesmosomes:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Hemidesmosomes anchor epithelial cells to the <strong>basement membrane</strong> through integrins.</span></li><li><span style=\"font-size:14.0pt;\">Their disruption leads to blistering skin diseases (e.g., bullous pemphigoid), not watery diarrhea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Gap junctions:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Gap junctions are channels formed by connexins that permit <strong>intercellular communication</strong> and passage of ions and small molecules.</span></li><li><span style=\"font-size:14.0pt;\">They play no role in maintaining paracellular barrier integrity, so their damage would not explain massive watery diarrhea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Adherens junctions:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Adherens junctions link actin filaments of adjacent cells through cadherins.</span></li><li><span style=\"font-size:14.0pt;\">They provide <strong>mechanical strength</strong> but do not regulate paracellular permeability to fluids, so they are not responsible for the described diarrhea.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Watery diarrhea resembling “rice water stool” occurs in cholera due to disruption of intestinal tight junctions (zona occludens), which normally prevent paracellular fluid leakage<strong>.</strong></span></p>",
      "correct_choice_id": 385817,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96927/NEET_GT__11_NOV_2025_Physiology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96927/NEET_GT__11_NOV_2025_Physiology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96985,
      "choices": [
        {
          "id": 386048,
          "text": "<p><span style=\"font-size:18px;\">Only 2, 3 and 4 are correct</span></p>"
        },
        {
          "id": 386049,
          "text": "<p><span style=\"font-size:18px;\">Only 1, 2 and 5 are correct</span></p>"
        },
        {
          "id": 386050,
          "text": "<p><span style=\"font-size:18px;\">Only 3 and 5 are correct</span></p>"
        },
        {
          "id": 386051,
          "text": "<p><span style=\"font-size:18px;\">All five statements are correct</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">Which of the following statements regarding a breast tumor shown in the image are correct?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20133635.jpg\" width=\"480\" height=\"393\"></strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:18px;\">It arise from the epithelial component of the breast lobules.</span></li><li><span style=\"font-size:18px;\">They are characterized histologically by a leaf-like architecture.</span></li><li><span style=\"font-size:18px;\">The tumor displays both stromal and epithelial elements, with stromal overgrowth being the neoplastic component.</span></li><li><span style=\"font-size:18px;\">Malignant variant of the tumor spread hematogenously to lungs or bones.</span></li><li><span style=\"font-size:18px;\">Axillary lymph node metastasis is common and helps differentiate it from fibroadenoma.</span></li></ol>",
      "unique_key": "Q8793725",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)</strong> <strong>Only 2, 3 and 4 are correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2.&nbsp;They are characterized histologically by a leaf-like architecture:&nbsp;</strong>Correct.&nbsp;The name phyllodes (Greek: “leaf-like”) comes from the <strong>leaf-like clefts</strong> seen histologically due to epithelial-lined projections of cellular stroma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>The tumor displays both stromal and epithelial elements, with stromal overgrowth being the neoplastic component:&nbsp;</strong>Correct.<strong>&nbsp;</strong>Phyllodes tumors are <strong>biphasic</strong>, but only the <strong>stromal component</strong> is <strong>neoplastic</strong> and determines tumor grade (benign, borderline, malignant).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.&nbsp;Malignant variant of the tumor spread hematogenously to lungs or bones:</strong>Correct. When malignant, they behave like <strong>sarcomas</strong> — spreading <strong>hematogenously</strong>, not via lymphatics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.&nbsp;It arise from the epithelial component of the breast lobules:&nbsp;</strong>Incorrect.&nbsp;Phyllodes tumors arise from the <strong>stromal (connective tissue) component</strong>, not epithelial. The epithelium is benign and reactive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.&nbsp;Axillary lymph node metastasis is common and helps differentiate it from fibroadenoma:&nbsp;</strong>Incorrect. Lymph node involvement is <strong>rare</strong>. This feature actually helps <strong>distinguish phyllodes tumor from carcinoma</strong>, <strong>not&nbsp;</strong>fibroadenoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Phyllodes tumors</strong> are <strong>biphasic</strong> (stromal and epithelial elements) breast tumors characterized by a <strong>leaf-like architecture</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their <strong>malignant variant</strong> primarily metastasizes <strong>hematogenously</strong> to sites like the <strong>lungs or bones</strong>, with <strong>axillary lymph node metastasis</strong> being <strong>rare</strong>.</span></li></ul>",
      "correct_choice_id": 386048,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96985/Neet_Gt__11_Nov_2025_Pathology_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96985/Neet_Gt__11_Nov_2025_Pathology_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96949,
      "choices": [
        {
          "id": 385904,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 1 - High birth rate and high death rate</span></p>"
        },
        {
          "id": 385905,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 2 - High birth rate and declining death rate</span></p>"
        },
        {
          "id": 385906,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 3 - Declining birth rate and low death rate</span></p>"
        },
        {
          "id": 385907,
          "text": "<p><span style=\"font-size:14.0pt;\">Stage 4 - Low birth rate and low death rate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The demographic transition model describes the transition from high birth and death rates to low birth and death rates as a country develops economically. In which stage of the demographic transition model does a population experience the maximum growth rate?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8948991",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Stage 2 - High birth rate and declining death rate</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Stage 2 of the demographic transition model is characterized by high birth rates and declining death rates due to improvements in healthcare, sanitation, and nutrition.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This creates the largest gap between birth and death rates, resulting in maximum population growth rate.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Most developing countries are currently in this stage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Stage 1:</strong> Stage 1 has both high birth and death rates, resulting in minimal population growth due to the small gap between births and deaths.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Stage 3:</strong> Stage 3 shows declining birth rates while death rates remain low, leading to reduced population growth compared to Stage 2.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Stage 4:</strong> Stage 4 has both low birth and death rates, resulting in minimal or zero population growth with a stable population size.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Demographic transition model has four distinct stages based on birth and death rate patterns</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-10%20105047.jpg\" width=\"536\" height=\"460\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Stage 2 produces maximum population growth due to the largest gap between high birth rates and declining death rates</span></li></ul>",
      "correct_choice_id": 385905,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96949/NEET_PG_11_Nov_2025_PSM_Question_17.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96949/NEET_PG_11_Nov_2025_PSM_Question_17.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96978,
      "choices": [
        {
          "id": 386020,
          "text": "<p><span style=\"font-size:18px;\">Noncaseating granulomas in alveolar septa</span></p>"
        },
        {
          "id": 386021,
          "text": "<p><span style=\"font-size:18px;\">Diffuse interstitial fibrosis with loss of alveolar architecture</span></p>"
        },
        {
          "id": 386022,
          "text": "<p><span style=\"font-size:18px;\">Eosinophilic infiltrate with Charcot–Leyden crystals</span></p>"
        },
        {
          "id": 386023,
          "text": "<p><span style=\"font-size:18px;\">Patchy organizing pneumonia with Masson bodies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 42-year-old woman presents with progressive shortness of breath and dry cough for 6 months. She also reports skin tightening over the fingers and Raynaud’s phenomenon. On examination, she has sclerodactyly and telangiectasias. HRCT chest shows bilateral interstitial fibrosis with honeycomb pattern. Serologic testing is positive for anti–topoisomerase I (anti–Scl-70) antibodies. Which of the following pathologic features best correlates with this patient’s pulmonary findings?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4740053",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Diffuse interstitial fibrosis with loss of alveolar architecture</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This patient has <strong>systemic sclerosis (scleroderma)</strong> with <strong>diffuse cutaneous features</strong> (sclerodactyly, telangiectasias, Raynaud’s) and <strong>anti–topoisomerase I (anti–Scl-70) antibodies</strong>, which strongly associate with <strong>interstitial lung disease</strong>.&nbsp;</span></li><li><span style=\"font-size:18px;\">Her HRCT showing <strong>bilateral interstitial fibrosis with honeycombing</strong> correlates pathologically with <strong>diffuse interstitial fibrosis and destruction of normal alveolar architecture</strong> (a usual interstitial pneumonia–like pattern common in scleroderma lung).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Noncaseating granulomas in alveolar septa:</strong> Characteristic of <strong>sarcoidosis</strong>, not systemic sclerosis.</span></p><p><br><span style=\"font-size:18px;\"><strong>Option C. Eosinophilic infiltrate with Charcot–Leyden crystals:</strong> Seen in <strong>allergic/eosinophilic lung diseases</strong> (e.g., allergic bronchopulmonary aspergillosis, eosinophilic pneumonia), not scleroderma ILD.</span></p><p><br><span style=\"font-size:18px;\"><strong>Option D. Patchy organizing pneumonia with Masson bodies:&nbsp;</strong>Describes <strong>organizing pneumonia (BOOP/COP)</strong>, which presents with patchy consolidations rather than <strong>honeycombing</strong> typical of fibrosing ILD in scleroderma.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In <strong>systemic sclerosis</strong> (especially <strong>anti–Scl-70 positive</strong>), pulmonary involvement commonly manifests as <strong>fibrosing interstitial lung disease</strong> with <strong>honeycombing</strong> on HRCT and <strong>diffuse interstitial fibrosis with loss of alveolar architecture</strong> on pathology.</span></p>",
      "correct_choice_id": 386021,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96978/Neet_Gt__11_Nov_2025_Pathology_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96978/Neet_Gt__11_Nov_2025_Pathology_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97023,
      "choices": [
        {
          "id": 386200,
          "text": "<p><span style=\"font-size:14.0pt;\">Total Abdominal Hysterectomy</span></p>"
        },
        {
          "id": 386201,
          "text": "<p><span style=\"font-size:14.0pt;\">Vaginal Hysterectomy</span></p>"
        },
        {
          "id": 386202,
          "text": "<p><span style=\"font-size:14.0pt;\">Laparoscopic Hysterectomy</span></p>"
        },
        {
          "id": 386203,
          "text": "<p><span style=\"font-size:14.0pt;\">Radical Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old woman with symptomatic uterine fibroids is planned for hysterectomy. Which type of hysterectomy has the fastest recovery time and least post-operative pain?</span></p>",
      "unique_key": "Q2883302",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Vaginal Hysterectomy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In women undergoing <strong>hysterectomy for benign uterine conditions</strong> such as <strong>symptomatic fibroids</strong>, the <strong>route of surgery</strong> is chosen based on <strong>uterine size</strong>, <strong>mobility</strong>, <strong>presence of adnexal pathology</strong>, <strong>surgeon’s expertise</strong>, and <strong>previous surgeries</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Among all types of hysterectomy, the <strong>vaginal route</strong> is considered the <strong>safest</strong>, with the <strong>shortest recovery time</strong> and <strong>least postoperative pain</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Reasons why vaginal hysterectomy is preferred:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>No abdominal incision</strong> → minimal postoperative discomfort.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Shorter hospital stay</strong> and <strong>faster recovery</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Less blood loss</strong> and <strong>lower risk of infection</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Fewer complications</strong> and <strong>earlier return to daily activities</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Hence, for a <strong>45-year-old woman with benign fibroids</strong>, <strong>vaginal hysterectomy</strong> offers the <strong>best postoperative outcome</strong> when feasible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Total Abdominal Hysterectomy:&nbsp;</strong>Incorrect. Involves a <strong>larger abdominal incision</strong>, resulting in <strong>more pain</strong>, <strong>longer hospital stay</strong>, and <strong>slower recovery</strong> compared with vaginal or laparoscopic approaches.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Laparoscopic Hysterectomy:&nbsp;</strong>Incorrect. Though <strong>minimally invasive</strong> and associated with <strong>faster recovery</strong> than open surgery, it is still generally <strong>slower than vaginal hysterectomy</strong> in terms of recovery and requires <strong>specialized equipment and skills</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Radical Hysterectomy:&nbsp;</strong>Incorrect. Performed for <strong>malignant conditions (e.g., cervical cancer)</strong> and involves removal of <strong>parametrium, upper vagina, and pelvic lymph nodes</strong>, leading to <strong>significant morbidity</strong>, <strong>longer recovery</strong>, and <strong>greater postoperative pain</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">For <strong>benign uterine conditions</strong> such as <strong>fibroids</strong>, <strong>vaginal hysterectomy</strong> provides the <strong>fastest recovery</strong>, <strong>least postoperative pain</strong>, and <strong>lowest complication rate</strong>, making it the <strong>preferred route</strong> when feasible.</span></p>",
      "correct_choice_id": 386201,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97023/NEET_GT__11_NOV_2025_OBG_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97023/NEET_GT__11_NOV_2025_OBG_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97038,
      "choices": [
        {
          "id": 386260,
          "text": "<p><span style=\"font-size:14.0pt;\">Non-ischemic CRVO; chronic cystoid macular edema</span></p>"
        },
        {
          "id": 386261,
          "text": "<p><span style=\"font-size:14.0pt;\">Ischemic CRVO; neovascular glaucoma</span></p>"
        },
        {
          "id": 386262,
          "text": "<p><span style=\"font-size:14.0pt;\">Diabetic retinopathy; vitreous hemorrhage</span></p>"
        },
        {
          "id": 386263,
          "text": "<p><span style=\"font-size:14.0pt;\">Branch retinal vein occlusion; macular edema</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 62-year-old diabetic and hypertensive male presents with sudden painless loss of vision in his right eye since morning. Visual acuity is counting fingers at 2 meters. Relative afferent pupillary defect (RAPD) is present. Fundus photograph of the affected eye is shown below. Fundus fluorescein angiography reveals &nbsp;extensive areas of capillary non-perfusion measuring more than 10 disc areas. What is the most likely diagnosis and the most feared complication within the next 3 months?</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-04%20112034.jpg\" width=\"551\" height=\"377\"></span></p>",
      "unique_key": "Q1845217",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Ischemic CRVO; neovascular glaucoma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The fundus photograph demonstrates classic features of Ischemic Central Retinal Vein Occlusion (CRVO).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The pathognomonic finding is the 'splashed-tomato' appearance due to massive hemorrhages throughout all four quadrants.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Key distinguishing features include marked venous engorgement with severe tortuosity, numerous cotton wool spots (usually more than 6-10), disc edema and hyperemia, and extensive macular involvement.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The presence of RAPD and severely reduced visual acuity (counting fingers or worse) further confirms ischemic CRVO.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Fundus fluorescein angiography showing extensive areas of capillary non-perfusion (more than 10 disc areas) is diagnostic of the ischemic type.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The most feared complication is rubeosis iridis leading to neovascular glaucoma (NVG), which occurs in approximately 20% of ischemic CRVO cases within 3 months (hence called 90-day glaucoma or 100-day glaucoma).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This occurs due to release of VEGF from the ischemic retina, causing neovascularization of the iris (NVI) and angle (NVA), ultimately leading to intractable glaucoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Incorrect Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Non-ischemic CRVO; chronic cystoid macular edema:</strong> &nbsp;Unlikely. Non-ischemic CRVO shows mild venous dilatation, scattered peripheral hemorrhages, few cotton wool spots, and no RAPD. Vision loss is moderate (6/12–6/60), and neovascular glaucoma is rare (2–3%). The fundus here shows extensive hemorrhages and numerous cotton wool spots, typical of ischemic CRVO.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Diabetic retinopathy; vitreous hemorrhage:</strong> Less likely. Diabetic retinopathy is usually bilateral with dot-blot hemorrhages, microaneurysms, and circinate hard exudates. It shows venous beading, not the diffuse venous engorgement and tortuosity seen in CRVO. The acute, unilateral onset favors CRVO over diabetic retinopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Branch retinal vein occlusion; macular edema:</strong> &nbsp;Incorrect. BRVO involves one quadrant, usually superotemporal, with localized hemorrhages and edema. The present case shows all four quadrants affected with the classic “blood and thunder” (splashed-tomato) appearance of CRVO. Neovascular glaucoma is far more common in ischemic CRVO (≈20%) than in BRVO (2–3%).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ischemic CRVO is characterized by massive hemorrhages in all quadrants ('splashed-tomato' appearance), marked venous tortuosity, numerous cotton wool spots, RAPD positivity, and capillary non-perfusion &gt;10 disc areas on FFA; the most serious complication is neovascular glaucoma occurring in 20% cases within 3 months, requiring urgent panretinal photocoagulation when neovascularization develops.</span></p>",
      "correct_choice_id": 386261,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97038/NEET_GT__11_NOV_2025_Opthalmology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97038/NEET_GT__11_NOV_2025_Opthalmology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97060,
      "choices": [
        {
          "id": 386348,
          "text": "<p><span style=\"font-size:14.0pt;\">Diabetic nephropathy</span></p>"
        },
        {
          "id": 386349,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypertensive nephropathy</span></p>"
        },
        {
          "id": 386350,
          "text": "<p><span style=\"font-size:14.0pt;\">Oxalate nephropathy</span></p>"
        },
        {
          "id": 386351,
          "text": "<p><span style=\"font-size:14.0pt;\">Recurrent AKI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 47-year-old man with Crohn disease and a history of recurrent severe diarrhea presents with elevated serum creatinine. His current S.Cr is 2.3 (previous 1.8). He has a diet-controlled diabetes (HbA1c 6.6%), and a controlled hypertension (on amlodipine). His urine PCR is 0.2 g/dL and renal ultrasound is relatively normal. What is the most likely etiology of his kidney disease?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6742884",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Oxalate nephropathy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Patients with chronic inflammatory bowel disease (like Crohn’s) are at risk for enteric hyperoxaluria due to malabsorption. Unabsorbed fatty acids in the gut bind calcium, leaving more oxalate available to be absorbed, leading to hyperoxaluria, nephrolithiasis, and ultimately oxalate nephropathy.</span></li><li><span style=\"font-size:14.0pt;\">Typical features include CKD with minimal proteinuria and normal appearing renal parenchyma in ultrasonography. Progression of creatinine over time reflects ongoing tubular and interstitial damage, not glomerular disease.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Diabetic nephropathy:</strong> Diabetic nephropathy usually presents with progressively worsening creatinine and significant proteinuria, neither seen in this well-controlled diabetic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hypertensive nephropathy:</strong> Hypertensive nephropathy generally develops over many years of poorly controlled hypertension, which is not reflected here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Recurrent AKI:</strong> Recurrent AKI causes acute-on-chronic changes and fluctuating creatinine, but this patient’s trend supports steady progression rather than repetitive acute insults.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Oxalate nephropathy is an important cause of CKD in patients with malabsorptive disorders; it results from increased oxalate absorption and is associated with kidney stones, tubular injury, and minimal proteinuria. Dietary modifications and hydration are key to management.</span></p>",
      "correct_choice_id": 386350,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97060/Neet_Gt__11_Nov_2025_Medicine_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97060/Neet_Gt__11_Nov_2025_Medicine_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97061,
      "choices": [
        {
          "id": 386352,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyperglycemia</span></p>"
        },
        {
          "id": 386353,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyporeninemic hypoaldosteronism</span></p>"
        },
        {
          "id": 386354,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudohyperkalemia</span></p>"
        },
        {
          "id": 386355,
          "text": "<p><span style=\"font-size:14.0pt;\">Renal failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 72-year-old man with chronic lymphocytic leukemia and no complaints - is found to have Na - 132 mEq/L, K - 8.2 mEq/L (and, after calcium gluconate, insulin, and dextrose, repeat K is 8.5 mEq/L). His HCO₃ is 26 mEq/L, BUN 28 mg/dL, Cr 1.2 mg/dL, glucose 220 mg/dL and his WBC count is 372000/µL; ECG shows normal sinus rhythm without peaked T waves, and repeat ECG remains unchanged. What is the most likely etiology of his hyperkalemia?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8399903",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Pseudohyperkalemia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Persistently high serum potassium with no ECG changes or improvement after treatment, in the context of extreme leukocytosis due to chronic lymphocytic leukemia, strongly suggests pseudohyperkalemia.</span></li><li><span style=\"font-size:14.0pt;\">Pseudohyperkalemia results from in vitro lysis of fragile leukemic cells during blood sample handling, leading to falsely elevated serum potassium; true hyperkalemia would be expected to respond to treatment and produce ECG changes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hyperglycemia:</strong> Hyperglycemia may cause mild hyperkalemia but would typically respond to insulin therapy and may show some ECG findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Hyporeninemic hypoaldosteronism:</strong> Hyporeninemic hypoaldosteronism may cause hyperkalemia in chronic kidney disease, but usually with altered renal function and clinical response to therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Renal failure:</strong> Renal failure may lead to hyperkalemia, but this patient has normal creatinine and potassium is unresponsive to treatment, making it unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Pseudohyperkalemia is a lab artifact that occurs in patients with extreme leukocytosis and fragile cell membranes, leading to falsely elevated serum potassium; it is recognized by a normal ECG, lack of symptoms, and failure of potassium levels to decrease with typical treatments. Correct identification prevents unnecessary interventions.</span></p>",
      "correct_choice_id": 386354,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97061/Neet_Gt__11_Nov_2025_Medicine_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97061/Neet_Gt__11_Nov_2025_Medicine_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97058,
      "choices": [
        {
          "id": 386340,
          "text": "<p><span style=\"font-size:14.0pt;\">Myasthenia gravis</span></p>"
        },
        {
          "id": 386341,
          "text": "<p><span style=\"font-size:14.0pt;\">CIDP</span></p>"
        },
        {
          "id": 386342,
          "text": "<p><span style=\"font-size:14.0pt;\">Guillain-Barré syndrome</span></p>"
        },
        {
          "id": 386343,
          "text": "<p><span style=\"font-size:14.0pt;\">Multiple sclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 46-year-old woman presents with a 5-month history of progressive limb weakness and sensory loss. She reports difficulty climbing stairs and frequent falls, and examination shows symmetric proximal and distal limb weakness, reduced reflexes, and diminished vibration and pinprick sensation in all four extremities. She has no bladder or bowel involvement, and cranial nerve function is intact. CSF analysis reveals elevated protein and normal cell count. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9600068",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) CIDP</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Subacute to chronic progression of symmetric sensorimotor weakness and sensory loss over ≥2 months, with reduced reflexes and albuminocytologic dissociation on CSF, is highly characteristic of CIDP.</span></li><li><span style=\"font-size:14.0pt;\">Unlike GBS, CIDP evolves over months (not days to weeks) and often presents with both proximal and distal weakness with sensory involvement but without cranial nerve or autonomic findings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Myasthenia gravis:</strong> Myasthenia gravis typically presents with fluctuating weakness, especially affecting ocular and bulbar muscles, without sensory loss or reduced reflexes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Guillain-Barré syndrome:</strong> Guillain-Barré syndrome presents with similar features but evolves acutely (days to 4 weeks) not chronically over months.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Multiple sclerosis:</strong> Multiple sclerosis predominantly affects the CNS (brain and spinal cord) with features of central demyelination.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">CIDP should be suspected in patients with progressive, symmetric weakness and sensory changes over at least 2 months, diminished reflexes, and albuminocytologic dissociation on CSF; timely diagnosis is essential as immunomodulatory therapies can prevent long-term disability.</span></p>",
      "correct_choice_id": 386341,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97058/Neet_Gt__11_Nov_2025_Medicine_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97058/Neet_Gt__11_Nov_2025_Medicine_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96937,
      "choices": [
        {
          "id": 385856,
          "text": "<p><span style=\"font-size:14.0pt;\">1-Q, 2-S, 3-P, 4-R</span></p>"
        },
        {
          "id": 385857,
          "text": "<p><span style=\"font-size:14.0pt;\">1-P, 2-Q, 3-R, 4-S</span></p>"
        },
        {
          "id": 385858,
          "text": "<p><span style=\"font-size:14.0pt;\">1-S, 2-P, 3-Q, 4-R</span></p>"
        },
        {
          "id": 385859,
          "text": "<p><span style=\"font-size:14.0pt;\">1-R, 2-S, 3-P, 4-Q</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A public health officer is reviewing air quality data from an urban monitoring station that shows AQI values of 55, 155, 255, and 355 on different days. Match the following NAQI ranges with their appropriate health effects and recommendations:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20110750.jpg\" width=\"1262\" height=\"476\"></strong></span></p>",
      "unique_key": "Q1270524",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A)</strong> <strong>1-Q, 2-S, 3-P, 4-R</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The National Air Quality Index (NAQI) of India classifies air quality into six categories.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">NAQI is given by CPCB. It is based on 8 parameters.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">PM 2.5 – CO, NO<sub>2</sub>, Lead</span></li><li><span style=\"font-size:14.0pt;\">PM 10 – SO<sub>2</sub>, O<sub>3</sub>, NH<sub>3</sub></span></li></ul></li><li><span style=\"font-size:14.0pt;\">The correct matching is: AQI 51-100 (Satisfactory) causes minor breathing discomfort to sensitive people; AQI 101-200 (Moderate) causes breathing discomfort to people with lung disease such as asthma; AQI 201-300 (Poor) causes breathing discomfort to most people on prolonged exposure; and AQI 301-400 (Very Poor) causes respiratory illness on prolonged exposure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This systematic classification helps in providing appropriate health advisories to the public.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20135932.jpg\" width=\"1328\" height=\"550\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">NAQI ranges from 0-50 (Good) to 401-500 (Severe) with specific health advisories for each category</span></li><li><span style=\"font-size:14.0pt;\">Higher AQI values correspond to more severe health effects, progressing from sensitive individuals to general population</span></li></ul>",
      "correct_choice_id": 385856,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96937/NEET_PG_11_Nov_2025_PSM_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96937/NEET_PG_11_Nov_2025_PSM_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97240,
      "choices": [
        {
          "id": 387060,
          "text": "<p><span style=\"font-size:14.0pt;\">High plasma protein binding leading to displacement resulting in free drug accumulation&nbsp;</span></p>"
        },
        {
          "id": 387061,
          "text": "<p><span style=\"font-size:14.0pt;\">First-order elimination kinetics with linear dose-response relationship</span></p>"
        },
        {
          "id": 387062,
          "text": "<p><span style=\"font-size:14.0pt;\">Zero-order kinetics at therapeutic concentrations</span></p>"
        },
        {
          "id": 387063,
          "text": "<p><span style=\"font-size:14.0pt;\">Enzyme auto-induction increasing metabolism over time</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old patient with newly diagnosed epilepsy is started on phenytoin. After achieving therapeutic levels (15 μg/mL) on 300 mg/day, the dose is increased to 350 mg/day due to persistent seizures. Three weeks later, the patient develops ataxia, nystagmus, and confusion. Serum phenytoin level is now 35 μg/mL. What pharmacokinetic principle explains this disproportionate increase in drug levels?</span></p>",
      "unique_key": "Q5360577",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C)&nbsp;Zero-order kinetics at therapeutic concentrations</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Phenytoin exhibits zero-order kinetics at therapeutic concentrations where hepatic enzymes (CYP2C9/CYP2C19) become saturated.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Once saturated, a constant amount (not fraction) is eliminated per unit time, causing small dose increases (17% from 300→350 mg) to produce disproportionately large plasma level increases (133% from 15→35 μg/mL), explaining the toxicity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. High plasma protein binding</strong> <strong>leading to displacement resulting in free drug accumulation:&nbsp;</strong>High plasma protein binding may result in more drug interactions when given with other drugs having high plasma protein binding. Altered binding changes free-to-bound ratio but here no other drug is being given with phenytoin.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;First-order elimination kinetics with linear dose-response relationship:</strong> In first-order kinetics, a constant fraction is eliminated per unit time with linear dose-proportional increases. A 17% dose increase would produce only ~17% concentration increase (15→17.5 μg/mL), not the 133% increase observed—this disproportionate rise is pathognomonic of saturation kinetics.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.&nbsp;Enzyme auto-induction increasing metabolism over time:</strong> Auto-induction increases CYP450 enzyme synthesis over 2-3 weeks, causing decreasing plasma levels at constant doses (requiring dose increases to maintain levels). This scenario shows increasing levels after dose escalation—the opposite effect of auto-induction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Phenytoin's saturation kinetics at therapeutic levels requires small dose increments (25-30 mg) with careful monitoring, as modest dose increases produce disproportionate plasma level rises once enzymes are saturated.</span></p>",
      "correct_choice_id": 387062,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97240/NEET_GT__11_NOV_2025_Pharmacology_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97240/NEET_GT__11_NOV_2025_Pharmacology_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96936,
      "choices": [
        {
          "id": 385852,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer only rabies vaccine (4-dose regimen) on days 0, 3, 7, and 14</span></p>"
        },
        {
          "id": 385853,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer rabies immunoglobulin (RIG) around the wound site followed by intradermal rabies vaccine at 8 sites on day 0</span></p>"
        },
        {
          "id": 385854,
          "text": "<p><span style=\"font-size:14.0pt;\">Administer rabies immunoglobulin (RIG) around the wound site and distally, followed by intramuscular rabies vaccine on days 0, 3, 7, 14 and 28</span></p>"
        },
        {
          "id": 385855,
          "text": "<p><span style=\"font-size:14.0pt;\">Observe for 10 days for signs of rabies in the dog before initiating any prophylaxis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old child is brought to the emergency department 8 hours after being bitten by a stray dog who escaped and could not be found. The bite wound appears as in the image below. The child has no prior history of rabies vaccination. After thorough wound washing and tetanus prophylaxis, what is the most appropriate next step in rabies post-exposure prophylaxis according to current guidelines under the National Rabies Control Program?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20110716_e33Dshu.jpg\" width=\"518\" height=\"348\"></strong></span></p>",
      "unique_key": "Q6364133",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Administer rabies immunoglobulin (RIG) around the wound site and distally, followed by intramuscular rabies vaccine on days 0, 3, 7, 14 and 28</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This case represents a Category III exposure (single or multiple transdermal bites on head, neck, face, hands, or genitals; or licks on broken skin/mucous membranes) by an unknown dog.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">According to WHO and current Indian guidelines, Category III exposure requires both passive immunization with rabies immunoglobulin (RIG) and active immunization with rabies vaccine.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">RIG (HRIG 20 IU/Kg) should be infiltrated around and into the wound site as much as anatomically feasible, with any remaining RIG given intramuscularly at a distant site.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Rabies vaccine -&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">ESSEN regimen – i.m. 5 doses on Day 0, 3, 7, 14 and 28 (1-1-1-1-1)</span></li><li><span style=\"font-size:14.0pt;\">Updated THAI red cross regimen – i.m. 4 doses on Day 0, 3, 7 and 28 (2-2-2-0-2)</span></li></ul></li><li><span style=\"font-size:14.0pt;\">The updated WHO recommendation (2018) now favors a 4-dose intramuscular vaccine schedule (days 0, 3, 7, 14) over the previous 5-dose regimen for post-exposure prophylaxis in immunocompetent individuals.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20135725.jpg\" width=\"1009\" height=\"653\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Administer only rabies vaccine (4-dose regimen) on days 0, 3, 7, and 14:</strong> Vaccine alone is insufficient for Category III exposure; RIG is mandatory as passive immunization due to high risk of transmission from facial bites.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Administer rabies immunoglobulin (RIG) around the wound site followed by intradermal rabies vaccine at 8 sites on day 0:&nbsp;</strong>Intradermal route with 8-site regimen is used for pre-exposure prophylaxis, not post-exposure; intramuscular route is preferred for post-exposure prophylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Observe for 10 days for signs of rabies in the dog before initiating any prophylaxis:</strong> 10-day observation is only applicable when the biting animal can be observed and confined; since the dog escaped, immediate prophylaxis is indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Category III rabies exposure (facial/head bites, deep wounds) mandates both RIG and vaccine administration regardless of animal observation possibility</span></li><li><span style=\"font-size:14.0pt;\">Current program guidelines recommend 5-dose intramuscular vaccine schedule (0, 3, 7, 14 and 28 days) for post-exposure prophylaxis in immunocompetent individuals</span></li><li><span style=\"font-size:14.0pt;\">RIG must be infiltrated around wound sites with any remaining dose given intramuscularly at distant site on day 0</span></li><li><span style=\"font-size:14.0pt;\">When the biting animal cannot be observed, immediate prophylaxis should never be delayed pending animal surveillance</span></li></ul>",
      "correct_choice_id": 385854,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96936/NEET_PG_11_Nov_2025_PSM_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96936/NEET_PG_11_Nov_2025_PSM_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97187,
      "choices": [
        {
          "id": 386848,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior belly of digastric muscle</span></p>"
        },
        {
          "id": 386849,
          "text": "<p><span style=\"font-size:14.0pt;\">Stylohyoid ligament</span></p>"
        },
        {
          "id": 386850,
          "text": "<p><span style=\"font-size:14.0pt;\">Retromandibular vein</span></p>"
        },
        {
          "id": 386851,
          "text": "<p><span style=\"font-size:14.0pt;\">Greater auricular nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During superficial parotidectomy, a surgeon identifies the main trunk of the facial nerve at its emergence from the stylomastoid foramen. Which landmark best aids in locating this nerve intraoperatively?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8069605",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Posterior belly of digastric muscle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>facial nerve</strong> exits the <strong>stylomastoid foramen</strong>, then passes <strong>just deep to the posterior belly of digastric</strong> and <strong>stylohyoid muscles</strong> before entering the parotid gland.</span></li><li><span style=\"font-size:14.0pt;\">This muscle serves as a reliable surgical landmark for identifying the facial nerve trunk during <strong>parotid surgery</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Stylohyoid ligament:&nbsp;</strong>The stylohyoid ligament is variable and not a reliable guide.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Retromandibular vein:&nbsp;</strong>The retromandibular vein lies deep to the facial branches; used later for orientation, not initial identification.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Greater auricular nerve:</strong> The greater auricular nerve crosses the SCM superficially and is a sensory nerve, not a landmark for the facial trunk.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">In <strong>superficial parotidectomy</strong>, the <strong>posterior belly of the digastric muscle</strong> is the most consistent landmark to locate the <strong>facial nerve trunk</strong>.</span></p>",
      "correct_choice_id": 386848,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97187/NEET_GT__11_NOV_2025_ENT_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97187/NEET_GT__11_NOV_2025_ENT_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97262,
      "choices": [
        {
          "id": 387144,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">ASA-PS I</span></p>"
        },
        {
          "id": 387145,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">ASA-PS II</span></p>"
        },
        {
          "id": 387146,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">ASA-PS III</span></p>"
        },
        {
          "id": 387147,
          "text": "<p><span style=\"color:black;font-size:14.0pt;\">ASA-PS IV</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:14.0pt;\">A 45-year-old male with Type II Diabetes is posted for surgery. His HbA1c is 6 gm %. What is his ASA-physical status classification is</span><span style=\"font-size:14.0pt;\">?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1407201",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) ASA-PS II</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\">In the case presented, the patient is a 45-year-old male with Type II Diabetes, and his HbA1c level is 6%.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A HbA1c level of 6% suggests that his diabetes is reasonably <strong>well-controlled</strong>, and it <strong>does not indicate severe systemic disease</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Therefore, the appropriate ASA-PS classification for this patient would be:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>ASA-PS II (American Society of Anesthesiologists Physical Status II)</strong> category includes patients with <strong>mild to moderate systemic diseases</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These conditions are well-controlled and <strong>do not limit the patient's daily activities</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For example, <strong>controlled hypertension, well-managed diabetes</strong>, or <strong>mild asthma</strong> would fall into this category.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>American Society of Anesthesiologists Physical Status classification:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A</strong>. <strong>ASA-PS I (American Society of Anesthesiologists Physical Status I):</strong> This category represents a <strong>normal healthy patient</strong> with <strong>no underlying medical conditions</strong>. Patients in ASA-PS I have an excellent chance of a <strong>successful outcome after surgery</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C</strong>. <strong>ASA-PS III (American Society of Anesthesiologists Physical Status III):</strong> Patients in this category have <strong>severe systemic diseases</strong> that <strong>limit their daily activities</strong>. These conditions may <strong>not be well-controlled</strong> and could <strong>pose significant risks</strong> during surgery. Examples include patients with <strong>poorly controlled diabetes</strong>, <strong>significant heart disease</strong>, or <strong>severe lung disease</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D</strong>. <strong>ASA-PS IV (American Society of Anesthesiologists Physical Status IV):</strong> This category is reserved for patients with <strong>severe systemic diseases</strong> that are a <strong>constant threat</strong> to <strong>their life</strong>. Patients in this category are often <strong>unstable</strong> and may require <strong>immediate medical attention</strong>. Examples include patients with <strong>decompensated heart failure</strong>, <strong>severe respiratory failure</strong>, or <strong>end-stage organ failure</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Note:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>ASA-PS V (American Society of Anesthesiologists Physical Status V):</strong> This category represents patients who are in a <strong>moribund state</strong> and are <strong>not expected to survive without the surgery</strong>. The surgery may be performed as a <strong>last resort to prolong life</strong>, even though the chances of survival are <strong>extremely low</strong>. Patients in ASA-PS V often have <strong>severe, life-threatening conditions</strong> and may be <strong>comatose or near death</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>ASA-PS VI (American Society of Anesthesiologists Physical Status VI):</strong> This category includes patients who have been declared <strong>brain-dead</strong> but are being kept on <strong>life support</strong> for the <strong>purpose of organ donation</strong>. These patients are <strong>not expected to recover</strong>, and their <strong>organs</strong> are being <strong>preserved for transplantation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:#0F0F0F;font-size:14.0pt;\"><strong>American Society of Anesthesiologists (ASA) Physical Status Classification System</strong></span></p><p>&nbsp;</p><p><span style=\"color:#0F0F0F;font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-07%20101606.jpg\" width=\"894\" height=\"708\"></strong></span></p>",
      "correct_choice_id": 387145,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97262/NEET_GT__11_NOV_2025_Anesthesia_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97262/NEET_GT__11_NOV_2025_Anesthesia_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96945,
      "choices": [
        {
          "id": 385888,
          "text": "<p><span style=\"font-size:14.0pt;\">1 Community Health Officer (CHO) + 1 ANM + 1 ASHA&nbsp;</span></p>"
        },
        {
          "id": 385889,
          "text": "<p><span style=\"font-size:14.0pt;\">2 ANM + 1 MPW (male)</span></p>"
        },
        {
          "id": 385890,
          "text": "<p><span style=\"font-size:14.0pt;\">2 ANMs only</span></p>"
        },
        {
          "id": 385891,
          "text": "<p><span style=\"font-size:14.0pt;\">1 Community Health Officer (CHO) + 1 ANM + 1 MPW&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">According to IPHS 2022 guidelines, what is the minimum staffing pattern required for a Health and Wellness Center- Sub-Health center serving a population of 6000 in the plains area?</span></p>",
      "unique_key": "Q9957959",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D)</strong> <strong>1 Community Health Officer (CHO) + 1 ANM + 1 MPW</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to IPHS 2022 guidelines, an HWC-SHC requires one Community Health Officer (CHO), an Auxiliary Nurse Midwife (ANM) and a Multi-Purpose Worker (MPW) (Male) or two ANMs, and support staff as the minimum staffing pattern.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The trap in this question lies in the phrase \"serving a population of 6000\" - many candidates might think this requires additional staff or confuse it with larger population norms.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ASHA workers are community volunteers and not part of the formal staffing pattern of Sub-centers.&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">IPHS 2022 specifies 1 ANM as the sole staffing requirement for Sub-centers in plains areas</span></li><li><span style=\"font-size:14.0pt;\">Sub-centers serve 3000-5000 population in plains and 3000 population in tribal/hilly areas</span></li><li><span style=\"font-size:14.0pt;\">ASHA workers are community volunteers, not formal healthcare staff at Sub-centers</span></li></ul>",
      "correct_choice_id": 385891,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96945/NEET_PG_11_Nov_2025_PSM_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96945/NEET_PG_11_Nov_2025_PSM_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97050,
      "choices": [
        {
          "id": 386308,
          "text": "<p><span style=\"font-size:14.0pt;\">Graves disease</span></p>"
        },
        {
          "id": 386309,
          "text": "<p><span style=\"font-size:14.0pt;\">Painless thyroiditis</span></p>"
        },
        {
          "id": 386310,
          "text": "<p><span style=\"font-size:14.0pt;\">Toxic adenoma</span></p>"
        },
        {
          "id": 386311,
          "text": "<p><span style=\"font-size:14.0pt;\">TSH‑producing pituitary adenoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 55‑year‑old man presents for evaluation of hyperthyroidism discovered during an evaluation for palpitations. Laboratory testing shows undetectable TSH and elevated free T4 of 3.8 ng/dL (normal 0.9-1.8). A radioiodine uptake scan demonstrates absent uptake. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9114550",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Painless thyroiditis</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Painless (silent) thyroiditis is a transient hyperthyroid phase of autoimmune thyroid inflammation, typically associated with Hashimoto thyroiditis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It results from leakage of preformed thyroid hormone into the circulation rather than increased synthesis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Because new hormone synthesis is suppressed, radioiodine uptake is absent or very low.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The hyperthyroid phase is self‑limited and may be followed by hypothyroidism before recovery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Graves disease:</strong> Characterized by diffuse increased radioiodine uptake due to excessive hormone synthesis driven by TSH‑receptor–stimulating antibodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Toxic adenoma:</strong> A single overactive thyroid nodule autonomously produces thyroid hormone, showing focal increased radioiodine uptake.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. TSH‑producing pituitary adenoma:</strong> Causes elevated TSH and high thyroid hormone levels, not suppressed TSH, and does not show absent radioiodine uptake.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Absent radioiodine uptake in the setting of hyperthyroidism indicates release of preformed thyroid hormone, as seen in painless or subacute thyroiditis, rather than increased synthesis as occurs in Graves disease or toxic adenoma.</span></p>",
      "correct_choice_id": 386309,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97050/NEET_GT__11_NOV_2025_Medicine_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97050/NEET_GT__11_NOV_2025_Medicine_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97437,
      "choices": [
        {
          "id": 387844,
          "text": "<p><span style=\"font-size:14.0pt;\">Immediate endocrine workup for hypothyroidism</span></p>"
        },
        {
          "id": 387845,
          "text": "<p><span style=\"font-size:14.0pt;\">Reassurance; normal eruption can be as late as 10–12 months</span></p>"
        },
        {
          "id": 387846,
          "text": "<p><span style=\"font-size:14.0pt;\">Start vitamin D therapy for rickets</span></p>"
        },
        {
          "id": 387847,
          "text": "<p><span style=\"font-size:14.0pt;\">Genetic testing for amelogenesis imperfecta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 9-month-old infant has no erupted teeth but is otherwise growing normally and meeting developmental milestones. What is the most appropriate next step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2991164",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Reassurance; normal eruption can be as late as 10–12 months</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Tooth eruption is highly variable among infants.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The first teeth—usually the lower central incisors—typically appear around 6 months of age, but eruption can occur anytime up to 10–12 months and still be considered normal.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">In a child with normal growth, nutrition, and developmental milestones, delayed tooth eruption alone is not concerning and requires only observation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Immediate endocrine workup for hypothyroidism:</strong> Incorrect. Hypothyroidism may delay tooth eruption, but it would also present with poor growth, lethargy, hypotonia, and constipation—none of which are present.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Start vitamin D therapy for rickets:</strong> Incorrect. Rickets causes delayed eruption with bony deformities, widened wrists, and hypotonia, which are absent here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Genetic testing for amelogenesis imperfect:</strong> Incorrect. Amelogenesis imperfecta affects enamel formation (quality), not the timing of eruption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In healthy infants, absence of tooth eruption at 9 months is often a normal variant.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Eruption may be delayed up to 12 months without underlying pathology, requiring only reassurance and continued observation.</span></li></ul>",
      "correct_choice_id": 387845,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97437/NEET_GT__11_NOV_2025_Pediatrics_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97437/NEET_GT__11_NOV_2025_Pediatrics_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97071,
      "choices": [
        {
          "id": 386392,
          "text": "<p><span style=\"font-size:14.0pt;\">Juvenile Idiopathic Arthritis&nbsp;</span></p>"
        },
        {
          "id": 386393,
          "text": "<p><span style=\"font-size:14.0pt;\">Pigmented Villonodular Synovitis</span></p>"
        },
        {
          "id": 386394,
          "text": "<p><span style=\"font-size:14.0pt;\">Septic Arthritis&nbsp;</span></p>"
        },
        {
          "id": 386395,
          "text": "<p><span style=\"font-size:14.0pt;\">Haemophiliac Arthropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old boy with a known history of severe haemophilia A presents to the clinic with progressively worsening pain, stiffness, and recurrent swelling in his left knee over the past three years. The episodes of swelling often occur after minor trauma and take several days to resolve completely. On physical examination, left knee is visibly enlarged, warm, and has flexion contracture. He has a noticeable limp. What is the most likely diagnosis?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-05%20103706.jpg\" width=\"477\" height=\"402\"></strong></span></p>",
      "unique_key": "Q2181343",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Haemophiliac Arthropathy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A destructive joint disease that results from hemarthrosis into the joint space, most commonly the knees, elbows, and ankles.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The blood irritates the synovium, causing synovitis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Chronic synovitis leads to thickening, joint cartilage destruction, bone erosion, and ultimately, a fixed deformity.</span></li><li><span style=\"font-size:14.0pt;\">Patient is known as severe Haemophilia A.</span></li><li><span style=\"font-size:14.0pt;\">Recurrent hemarthrosis is the initiating event.</span></li><li><span style=\"font-size:14.0pt;\">Recurrent swelling after minor trauma, progressively worsening pain and stiffness, and eventual development of a fixed flexion contracture and joint enlargement. The knee is the most common joint affected.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Juvenile Idiopathic Arthritis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A chronic inflammatory arthritis with onset before age 16.</span></li><li><span style=\"font-size:14.0pt;\">The primary cause of the joint damage in this patient is his bleeding disorder, not an autoimmune process.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">While JIA can cause chronic synovitis, pain, and contractures, the patient's existing severe Haemophilia A provides a more direct and definitive explanation for the joint destruction through recurrent bleeding.</span></li><li><span style=\"font-size:14.0pt;\">JIA would not explain the history of recurrent swelling occurring after minor trauma (i.e., haemarthrosis).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Pigmented Villonodular Synovitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A rare, benign, and proliferative disorder of the synovium characterized by villous and nodular overgrowth. It often contains deposits of haemosiderin (iron from old blood).</span></li><li><span style=\"font-size:14.0pt;\">While PVNS often presents with recurrent swelling and pain, it is idiopathic. In this patient, the cause of the recurrent blood is clearly the severe Haemophilia A, making Haemophiliac Arthropathy the more specific and appropriate diagnosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Septic Arthritis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Bacterial infection of the joint space.</span></li><li><span style=\"font-size:14.0pt;\">Septic arthritis presents as an acute, critical emergency with severe pain, fever, chills, and significantly elevated inflammatory markers (WBC, ESR, CRP).</span></li><li><span style=\"font-size:14.0pt;\">The patient's three-year history of chronic, recurrent swelling and progressive deformity does not fit the acute, destructive course of an untreated infection.</span></li><li><span style=\"font-size:14.0pt;\">While haemophiliacs are not immune to infection, the chronic course is not characteristic of septic arthritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The case describes a young male with a known history of severe Haemophilia A who develops chronic, progressive joint damage in a single joint.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This clinical picture is the classic presentation of a haemophiliac complication known as Haemophiliac Arthropathy.</span></li></ul>",
      "correct_choice_id": 386395,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97071/NEET_GT__11_NOV_2025_Orthopedics_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        15
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97071/NEET_GT__11_NOV_2025_Orthopedics_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96932,
      "choices": [
        {
          "id": 385836,
          "text": "<p><span style=\"font-size:14.0pt;\">6</span></p>"
        },
        {
          "id": 385837,
          "text": "<p><span style=\"font-size:14.0pt;\">1/6</span></p>"
        },
        {
          "id": 385838,
          "text": "<p><span style=\"font-size:14.0pt;\">5</span></p>"
        },
        {
          "id": 385839,
          "text": "<p><span style=\"font-size:14.0pt;\">1/5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 38-year-old man begins treadmill exercise testing to assess functional capacity. After he reaches steady state during moderate exertion, his measured oxygen consumption is 1500 ml/min. Baseline resting oxygen consumption is estimated to be 250 ml/min. What is the patient’s approximate MET (metabolic equivalent of task) score during this exercise?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q2534378",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) 6</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>MET (Metabolic Equivalent of Task)</strong> is a physiological unit that expresses the <strong>energy cost of physical activities</strong>.</span></li><li><span style=\"font-size:14.0pt;\">By definition, <strong>1 MET = oxygen consumption at rest = ~250 ml/min (or 3.5 ml O₂/kg/min)</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20102152_YpxeppL.jpg\" width=\"1638\" height=\"582\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">1 MET equals resting oxygen consumption (approximately 250 ml/min or 3.5 ml/kg/min).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">MET scores during exercise are calculated by dividing activity oxygen consumption by resting oxygen consumption.&nbsp;</span></li></ul>",
      "correct_choice_id": 385836,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96932/NEET_GT__11_NOV_2025_Physiology_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96932/NEET_GT__11_NOV_2025_Physiology_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97051,
      "choices": [
        {
          "id": 386312,
          "text": "<p><span style=\"font-size:14.0pt;\">Small cell cancer</span></p>"
        },
        {
          "id": 386313,
          "text": "<p><span style=\"font-size:14.0pt;\">Squamous cell cancer</span></p>"
        },
        {
          "id": 386314,
          "text": "<p><span style=\"font-size:14.0pt;\">Large cell cancer</span></p>"
        },
        {
          "id": 386315,
          "text": "<p><span style=\"font-size:14.0pt;\">Adenocarcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 70-year-old man with hypertension, and a 25-pack-year smoking history presents with fatigue, thirst, frequent urination, weight loss, and confusion. He drinks several liters of water daily. Which diagnosis is most likely?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3851483",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Squamous cell cancer</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Symptoms including fatigue, confusion, excessive thirst, polyuria, and weight loss are classic manifestations of hypercalcemia.</span></li><li><span style=\"font-size:14.0pt;\">Hypercalcemia in a patient with lung cancer is most commonly caused by a paraneoplastic syndrome mediated by parathyroid hormone-related peptide (PTHrP).</span></li><li><span style=\"font-size:14.0pt;\">Squamous cell carcinoma of the lung is the type most strongly associated with hypercalcemia via PTHrP production, making it the most likely diagnosis in a smoker presenting with these symptoms and a new syndrome of polyuria and polydipsia.​</span></li><li><span style=\"font-size:14.0pt;\">Additional findings such as neuropsychiatric changes (confusion) and renal symptoms (polyuria, polydipsia) further support the hypercalcemia diagnosis.​</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Small cell cancer</strong>: Typically associated with paraneoplastic syndromes like SIADH (causing hyponatremia) and ectopic ACTH production (leading to Cushing’s syndrome), not hypercalcemia.​</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Large cell cancer:</strong> Rarely linked with paraneoplastic syndromes; hypercalcemia may occur but is much less common compared to squamous cell carcinoma.​</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Adenocarcinoma:</strong> Not classically linked with hypercalcemia of malignancy, and does not frequently produce PTHrP or cause these metabolic effects.​</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Squamous cell carcinoma of the lung is the classic lung malignancy causing hypercalcemia through PTHrP secretion and should be strongly suspected in smoking patients with symptoms of dehydration, confusion, and polyuria.</span></p>",
      "correct_choice_id": 386313,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97051/NEET_GT__11_NOV_2025_Medicine_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97051/NEET_GT__11_NOV_2025_Medicine_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96974,
      "choices": [
        {
          "id": 386004,
          "text": "<p><span style=\"font-size:18px;\">Caused by immune complex deposition after streptococcal infection</span></p>"
        },
        {
          "id": 386005,
          "text": "<p><span style=\"font-size:18px;\">Electron microscopy shows subepithelial “hump-like” deposits</span></p>"
        },
        {
          "id": 386006,
          "text": "<p><span style=\"font-size:18px;\">It is an example of type III hypersensitivity reaction</span></p>"
        },
        {
          "id": 386007,
          "text": "<p><span style=\"font-size:18px;\">There is linear deposition of IgG and C3 on immunofluorescence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 12-year-old boy presents with cola-colored urine, periorbital edema, and mild hypertension 2 weeks after a throat infection. Urine analysis shows RBC casts, mild proteinuria with reduced serum C3. Which of the following statements regarding his condition is incorrect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6960655",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D)&nbsp;There is linear deposition of IgG and C3 on immunofluorescence</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A 12-year-old boy who presents 2 weeks after a throat infection (post-streptococcal pharyngitis) with cola-colored urine, periorbital edema, and mild hypertension, plus urine analysis showing RBC casts, mild proteinuria, and reduced serum C3, has acute post-streptococcal (post-infectious) glomerulonephritis (PSGN).</span></li><li><span style=\"font-size:18px;\">PSGN is caused by immune complex deposition after streptococcal infection and is an example of type III hypersensitivity reaction.&nbsp;</span></li><li><span style=\"font-size:18px;\">On electron microscopy, PSGN characteristically shows subepithelial “hump-like” deposits formed by immune complexes.&nbsp;</span></li><li><span style=\"font-size:18px;\">On immunofluorescence, PSGN classically demonstrates granular (“lumpy-bumpy”) deposition of IgG and C3, not linear deposition.&nbsp;</span></li><li><span style=\"font-size:18px;\">Therefore, the statement “There is linear deposition of IgG and C3 on immunofluorescence” is incorrect in this condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Caused by immune complex deposition after streptococcal infection:&nbsp;</strong>Correct. PSGN follows a streptococcal infection (often throat infection) by about 2 weeks and is caused by immune complex deposition in glomeruli, explaining reduced serum C3, RBC casts, mild proteinuria, periorbital edema, mild hypertension, and cola-colored urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Electron microscopy shows subepithelial “hump-like” deposits:&nbsp;</strong>Correct. On electron microscopy, PSGN shows subepithelial “hump-like” deposits of immune complexes, consistent with the urine analysis findings (RBC casts, mild proteinuria) and the post-streptococcal timing (2 weeks after a throat infection) with reduced serum C3.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. It is an example of type III hypersensitivity reaction:&nbsp;</strong>Correct. PSGN is mediated by type III hypersensitivity due to circulating immune complexes (IgG with streptococcal antigens) depositing in the glomerular basement membrane and mesangium, activating complement (reduced serum C3) and producing cola-colored urine, periorbital edema, mild hypertension, and RBC casts with mild proteinuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">In acute post-streptococcal glomerulonephritis, occurring ~2 weeks after a streptococcal throat infection, expect low C3, RBC casts, mild proteinuria, and granular (not linear) IgG/C3 deposition with subepithelial “hump-like” deposits.</span></p>",
      "correct_choice_id": 386007,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96974/Neet_Gt__11_Nov_2025_Pathology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96974/Neet_Gt__11_Nov_2025_Pathology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97233,
      "choices": [
        {
          "id": 387032,
          "text": "<p><span style=\"font-size:14.0pt;\">Thiazides increase lithium absorption from the gastrointestinal tract</span></p>"
        },
        {
          "id": 387033,
          "text": "<p><span style=\"font-size:14.0pt;\">Thiazides decrease lithium metabolism in the liver</span></p>"
        },
        {
          "id": 387034,
          "text": "<p><span style=\"font-size:14.0pt;\">Thiazides increase renal tubular reabsorption of lithium</span></p>"
        },
        {
          "id": 387035,
          "text": "<p><span style=\"font-size:14.0pt;\">Thiazides displace lithium from intracellular binding sites</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with bipolar disorder stable on lithium therapy for 3 years develops hypertension. His physician starts hydrochlorothiazide 25 mg daily. Two weeks later, he presents with coarse tremors, confusion, vomiting, and ataxia. Serum lithium level is 2.8 mEq/L (therapeutic: 0.6-1.2 mEq/L). What is the most likely mechanism of this drug interaction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4047880",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Thiazides increase renal tubular reabsorption of lithium</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thiazide diuretics increase lithium toxicity by enhancing renal tubular reabsorption.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Lithium is handled like sodium—freely filtered at the glomerulus and 80% reabsorbed in the proximal tubule.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Thiazides cause volume depletion, triggering compensatory increased proximal tubular reabsorption of both sodium and lithium.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This reduces lithium clearance by 25-40%, causing accumulation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Lithium has a narrow therapeutic index (0.6-1.2 mEq/L), making this interaction dangerous.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Thiazides increase lithium absorption from the gastrointestinal tract:</strong> Lithium has &gt;95% oral bioavailability and is completely absorbed from the GI tract regardless of thiazide use. Diuretics don't affect GI absorption. The toxicity mechanism involves renal elimination, not absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;B.</strong> <strong>Thiazides decrease lithium metabolism in the liver:</strong> Lithium is not metabolized at all—it's eliminated entirely unchanged by the kidneys. As a simple ion, it undergoes no hepatic biotransformation. Drug interactions involving metabolism don't apply to lithium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Thiazides displace lithium from intracellular binding sites:</strong> Lithium doesn't bind to proteins; it exists as a free ion. Displacement interactions only occur with highly protein-bound drugs (&gt;90%). The toxicity results from reduced renal excretion, not displacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Thiazides increase lithium toxicity by enhancing proximal tubular reabsorption due to volume depletion; reduce lithium dose by 50% when starting thiazides and monitor levels frequently.</span></p>",
      "correct_choice_id": 387034,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97233/NEET_GT__11_NOV_2025_Pharmacology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97233/NEET_GT__11_NOV_2025_Pharmacology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96921,
      "choices": [
        {
          "id": 385792,
          "text": "<p><span style=\"font-size:14.0pt;\">Respiratory minute volume refers to the total volume of air inspired (or expired) per minute.</span></p>"
        },
        {
          "id": 385793,
          "text": "<p><span style=\"font-size:14.0pt;\">Residual volume is the amount of air remaining in the lungs after a maximal forceful expiration.</span></p>"
        },
        {
          "id": 385794,
          "text": "<p><span style=\"font-size:14.0pt;\">Vital capacity is the maximum volume of air that can be exhaled following a normal tidal inspiration.</span></p>"
        },
        {
          "id": 385795,
          "text": "<p><span style=\"font-size:14.0pt;\">Physiological dead space is the portion of inspired air that does not participate in gas exchange with blood.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following definitions is incorrect regarding respiratory physiology?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9554097",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Vital capacity is the maximum volume of air that can be exhaled following a normal tidal inspiration.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Vital capacity (VC)</strong> is defined as the <strong>maximum amount of air that can be exhaled after a maximal inspiration</strong>, not after a normal tidal inspiration.</span></li><li><span style=\"font-size:14.0pt;\">It represents the sum of <strong>tidal volume (TV) + inspiratory reserve volume (IRV) + expiratory reserve volume (ERV)</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The option in the question incorrectly limits vital capacity to exhalation after only a normal inspiration, which underestimates its true definition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Respiratory minute volume refers to the total volume of air inspired (or expired) per minute:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is correct.</span></li><li><span style=\"font-size:14.0pt;\">Respiratory minute volume (also called minute ventilation) is calculated as:&nbsp;</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\">Minute&nbsp;ventilation= Tidal&nbsp;volume&nbsp;(TV) × Respiratory&nbsp;rate&nbsp;(RR)&nbsp;</span></li></ul></li><li><span style=\"font-size:14.0pt;\">It represents the amount of air inspired (or expired) per minute.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Residual volume is the amount of air remaining in the lungs after a maximal forceful expiration:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is correct.</span></li><li><span style=\"font-size:14.0pt;\">Residual volume cannot be expelled, even with maximum expiratory effort.</span></li><li><span style=\"font-size:14.0pt;\">It maintains alveolar patency and prevents lung collapse.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Physiological dead space is the portion of inspired air that does not participate in gas exchange with blood:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This is correct.</span></li><li><span style=\"font-size:14.0pt;\">Physiological dead space = anatomical dead space (conducting airways) + alveolar dead space (alveoli that are ventilated but not perfused).</span></li><li><span style=\"font-size:14.0pt;\">By definition, it is the amount of air not equilibrating with blood.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Vital capacity is the maximum volume of air that can be exhaled after a maximal inspiration, not after a normal tidal inspiration.</span></p>",
      "correct_choice_id": 385794,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96921/NEET_GT__11_NOV_2025_Physiology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96921/NEET_GT__11_NOV_2025_Physiology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97434,
      "choices": [
        {
          "id": 387832,
          "text": "<p><span style=\"font-size:14.0pt;\">Café-au-lait macules and axillary freckling</span></p>"
        },
        {
          "id": 387833,
          "text": "<p><span style=\"font-size:14.0pt;\">Laryngomalacia with omega-shaped epiglottis on laryngoscopy</span></p>"
        },
        {
          "id": 387834,
          "text": "<p><span style=\"font-size:14.0pt;\">Hypoplastic orbital fissures and single palmar crease</span></p>"
        },
        {
          "id": 387835,
          "text": "<p><span style=\"font-size:14.0pt;\">Micrognathia with round face and wide nasal bridge</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 3-month-old girl has high-pitched cat-like cry, microcephaly, hypotonia, epicanthal folds, and developmental delay. Which additional finding most strongly supports the diagnosis?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3778656",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Micrognathia with round face and wide nasal bridge.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cri du chat (5p deletion) features: high-pitched cry, microcephaly, hypotonia, micrognathia, round face, hypertelorism/wide nasal bridge, and developmental delay.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Café-au-lait macules and axillary freckling:&nbsp;</strong>Incorrect. These are suggestive of Neurofibromatosis type 1.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Laryngomalacia with omega-shaped epiglottis on laryngoscopy:</strong> Incorrect. Laryngomalacia can cause stridor but the characteristic cry arises from laryngeal/neurologic immaturity specific to 5p deletion; omega epiglottis is not a hallmark of cri du chat.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Hypoplastic orbital fissures and single palmar crease:</strong> Incorrect. Single palmar crease is nonspecific; hypoplastic orbital fissures do not define cri du chat.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cri du chat (5p−) classically presents with cat-like cry plus facial features including micrognathia, round face, and wide nasal bridge.</span></p>",
      "correct_choice_id": 387835,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97434/NEET_GT__11_NOV_2025_Pediatrics_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        13
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97434/NEET_GT__11_NOV_2025_Pediatrics_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96992,
      "choices": [
        {
          "id": 386076,
          "text": "<p><span style=\"font-size:14.0pt;\">18S ribosomal RNA gene</span></p>"
        },
        {
          "id": 386077,
          "text": "<p><span style=\"font-size:14.0pt;\">NADH dehydrogenase subunit 2 (nad2) gene</span></p>"
        },
        {
          "id": 386078,
          "text": "<p><span style=\"font-size:14.0pt;\">β-tubulin gene</span></p>"
        },
        {
          "id": 386079,
          "text": "<p><span style=\"font-size:14.0pt;\">K13 propeller gene</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 39-year-old man who frequently consumes undercooked freshwater fish presents with vague upper abdominal discomfort. His stool sample is submitted for real-time PCR to confirm the suspected diagnosis of liver fluke infection. Which of the following gene targets is most specific for detecting Clonorchis sinensis?</span></p>",
      "unique_key": "Q8946230",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) NADH dehydrogenase subunit 2 (nad2) gene</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>NADH dehydrogenase subunit 2 (nad2) gene</strong> is a <strong>mitochondrial DNA element</strong> specifically targeted by real-time PCR assays for the detection of Clonorchis sinensis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This gene offers <strong>high sensitivity and specificity</strong> in molecular diagnostics and is commonly used in surveillance and confirmation, especially when stool microscopy is inconclusive.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It distinguishes C. sinensis from other similar flukes such as Opisthorchis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. 18S ribosomal RNA gene:&nbsp;</strong>Although the 18S rRNA gene is widely conserved and used in parasitology for genus-level detection, it <strong>lacks species-specificity</strong>, especially for differentiating between closely related trematodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. β-tubulin gene:&nbsp;</strong>This gene is more commonly associated with <strong>helminth resistance studies</strong>, particularly for <strong>benzimidazole resistance</strong>, not for species detection or confirmation of Clonorchis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. K13 propeller gene:&nbsp;</strong>This gene is specific to <strong>Plasmodium falciparum</strong> and is used to detect <strong>artemisinin resistance</strong> in malaria. It has no role in fluke or helminth detection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Real-time PCR targeting the <strong>nad2 mitochondrial gene</strong> is a highly specific molecular diagnostic tool used for <strong>confirmation of Clonorchis sinensis</strong> in stool specimens, especially in endemic areas or when microscopic findings are ambiguous.</span></p>",
      "correct_choice_id": 386077,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96992/NEET_GT__11_NOV_2025_Microbiology_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96992/NEET_GT__11_NOV_2025_Microbiology_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97057,
      "choices": [
        {
          "id": 386336,
          "text": "<p><span style=\"font-size:14.0pt;\">Auto-PEEP</span></p>"
        },
        {
          "id": 386337,
          "text": "<p><span style=\"font-size:14.0pt;\">Excessive secretions</span></p>"
        },
        {
          "id": 386338,
          "text": "<p><span style=\"font-size:14.0pt;\">Pneumothorax</span></p>"
        },
        {
          "id": 386339,
          "text": "<p><span style=\"font-size:14.0pt;\">Vent asynchrony</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A&nbsp;patient with recent onset of acute desaturation in the hospital is found to have a sudden rise in ventilator peak inspiratory pressure to 46 cm H2O (from 27 cm H2O previously) while plateau pressure remains unchanged at 22 cm H2O. What is the most likely etiology of this change?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8645202",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>B) Excessive secretions</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">An acute increase in peak inspiratory pressure with unchanged plateau pressure suggests increased airway resistance rather than reduced lung compliance.</span></li><li><span style=\"font-size:14.0pt;\">Excessive secretions in the airway obstruct airflow, raising resistance and thereby increasing peak pressures, but do not affect plateau pressure, which reflects compliance.</span></li><li><span style=\"font-size:14.0pt;\">This finding, along with acute desaturation, is classic for airway obstruction due to secretions that should be managed promptly to restore effective ventilation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Auto-PEEP:</strong> Auto-PEEP would typically increase both peak and plateau pressures due to air trapping and reduced compliance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Pneumothorax:</strong> Pneumothorax increases both peak and plateau pressures as it impairs lung compliance.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Vent asynchrony:</strong> Vent asynchrony may cause inefficient ventilation but would not selectively and significantly elevate peak pressure without affecting plateau pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">A sudden rise in peak pressure with unchanged plateau pressure on the ventilator indicates increased airway resistance, most commonly due to excessive secretions; prompt airway management is essential to prevent hypoxemia.</span></p>",
      "correct_choice_id": 386337,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97057/Neet_Gt__11_Nov_2025_Medicine_Question_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97057/Neet_Gt__11_Nov_2025_Medicine_Question_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97245,
      "choices": [
        {
          "id": 387076,
          "text": "<p><span style=\"font-size:14.0pt;\">Propofol</span></p>"
        },
        {
          "id": 387077,
          "text": "<p><span style=\"font-size:14.0pt;\">Thiopentone sodium</span></p>"
        },
        {
          "id": 387078,
          "text": "<p><span style=\"font-size:14.0pt;\">Ketamine</span></p>"
        },
        {
          "id": 387079,
          "text": "<p><span style=\"font-size:14.0pt;\">Midazolam</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old trauma patient in hypotension requires emergency surgery. Which intravenous anaesthetic agent would be most appropriate for induction?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8254281",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Ketamine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Ketamine is the agent of choice for hypovolemic patients because of its unique cardiovascular profile.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Unlike other intravenous anaesthetics that cause cardiovascular depression, ketamine produces sympathetic stimulation leading to increased heart rate, cardiac output, and blood pressure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This makes it invaluable in patients who have bled or are in shock.</span></li><li><span style=\"font-size:14.0pt;\">The mechanism involves stimulation of the sympathetic nervous system, which counteracts the hypotension that would otherwise worsen with other anaesthetic agents.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">ketamine has been specifically good for hypovolemic patients.</span></li><li><span style=\"font-size:14.0pt;\">Ketamine produces what is termed \"dissociative anaesthesia\" characterized by profound analgesia, immobility, and amnesia with only light sleep.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">At doses of 1-2 mg/kg IV or 3-5 mg/kg IM, it acts rapidly within one minute.</span></li><li><span style=\"font-size:14.0pt;\">Additional advantages include maintained respiration, bronchodilatation, and preserved airway reflexes.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Propofol:</strong> Causes profound fall in blood pressure primarily due to vasodilatation with less marked cardiac depression. This hypotension is \"more profound than that with thiopentone\" and would be particularly dangerous in hypovolemic patients. The baroreflex is suppressed, preventing compensatory tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Thiopentone sodium:</strong> Causes immediate fall in BP after injection, mainly due to vasodilatation. cardiovascular collapse may occur if hypovolemia, shock or sepsis are present.\" It reduces cardiac contractility and would severely compromise an already unstable circulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Midazolam:</strong> While producing less cardiovascular depression than barbiturates, midazolam causes \"somewhat greater\" fall in BP than diazepam. In a hypovolemic patient, even this modest hypotensive effect could be detrimental. Additionally, BZDs are poor analgesics and would require opioids, further compromising cardiovascular stability.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Ketamine's sympathomimetic properties making it increase BP and cardiac output render it uniquely suitable for anaesthesia in hypovolemic and shocked patients, unlike all other IV anaesthetics which cause cardiovascular depression.</span></p>",
      "correct_choice_id": 387078,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97245/NEET_GT__11_NOV_2025_Pharmacology_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97245/NEET_GT__11_NOV_2025_Pharmacology_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97065,
      "choices": [
        {
          "id": 386368,
          "text": "<p><span style=\"font-size:14.0pt;\">A patient says that his internal organs have been stolen by aliens who have fitted machinery in place of his internal organs.</span></p>"
        },
        {
          "id": 386369,
          "text": "<p><span style=\"font-size:14.0pt;\">A patient says that aliens control the movement of his hand.</span></p>"
        },
        {
          "id": 386370,
          "text": "<p><span style=\"font-size:14.0pt;\">A patient reports that he can hear two aliens talking to each other and discussing about him.</span></p>"
        },
        {
          "id": 386371,
          "text": "<p><span style=\"font-size:14.0pt;\">A patient says that he experiences burning sensations in his stomach caused by UV rays being thrown at him by the aliens.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following is not a Schneider’s First-Rank Symptom (SFRS)?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4669925",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) A patient says that his internal organs have been stolen by aliens who have fitted machinery in place of his internal organs.</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Schneider’s First-Rank Symptoms (SFRS) are specific psychotic experiences that are highly characteristic of <strong>schizophrenia</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">They primarily involve disturbances of thought, perception, and the sense of self-agency.</span></li><li><span style=\"font-size:14.0pt;\">Option <strong>A</strong> describes a <strong>somatic delusion</strong> — a false belief about bodily changes (organs stolen or replaced), not an SFRS. It reflects a <strong>delusional belief</strong>, not a first-rank symptom.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. A patient says that aliens control the movement of his hand:</strong> This represents <strong>made volition</strong>, where the patient feels that an external force is controlling his actions — a classic <strong>SFRS</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. A patient reports that he can hear two aliens talking to each other and discussing about him:</strong> This is <strong>voices heard arguing</strong>, another classical <strong>SFRS</strong> related to auditory hallucinations.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. A patient says that he experiences burning sensations in his stomach caused by UV rays being thrown at him by the aliens:</strong> This represents <strong>somatic passivity</strong>, where sensations are experienced as being externally imposed — also an <strong>SFRS</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Somatic or bodily delusions</strong> (e.g., “my organs have been replaced”) are <strong>not SFRS</strong>, while phenomena such as <strong>made volition</strong>, <strong>voices arguing</strong>, and <strong>somatic passivity</strong> are typical <strong>Schneider’s First-Rank Symptoms</strong> of schizophrenia.</span></p>",
      "correct_choice_id": 386368,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97065/New_GT_Psychiatry_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        16
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97065/New_GT_Psychiatry_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96962,
      "choices": [
        {
          "id": 385956,
          "text": "<p><span style=\"font-size:14.0pt;\">3, 1, 4, 2</span></p>"
        },
        {
          "id": 385957,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 4, 1, 3</span></p>"
        },
        {
          "id": 385958,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 385959,
          "text": "<p><span style=\"font-size:14.0pt;\">4, 3, 2, 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In the floor of the fourth ventricle, the afferent nuclear columns of the brainstem are arranged in a specific sequence from medial to lateral. Which of the following correctly represents this order?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">General somatic&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">General visceral&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Special somatic&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Special visceral</span></li></ol>",
      "unique_key": "Q6521959",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 2, 4, 1, 3</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>sensory (afferent) nuclei</strong> of the brainstem are organized <strong>lateral to the sulcus limitans</strong>, while the <strong>motor (efferent) nuclei</strong> lie medial to it.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Among the <strong>afferent columns</strong>, the arrangement from <strong>medial to lateral</strong> is as follows:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>2. General Visceral Afferent (GVA):</strong> Receives sensory impulses from visceral organs such as the pharynx, larynx, and thoracic and abdominal viscera.</span></li><li><span style=\"font-size:14.0pt;\"><strong>4. Special Visceral Afferent (SVA):</strong> Carries taste sensations (via cranial nerves VII, IX, X).</span></li><li><span style=\"font-size:14.0pt;\"><strong>1. General Somatic Afferent (GSA):</strong> Conveys general sensory information like touch, pain, and temperature from the face.</span></li><li><span style=\"font-size:14.0pt;\"><strong>3. Special Somatic Afferent (SSA):</strong> Transmits special sensory input related to hearing and balance (from cranial nerve VIII).</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Hence, the correct <strong>medial to lateral sequence</strong> is: <strong>General Visceral → Special Visceral → General Somatic → Special Somatic </strong>or numerically: <strong>2, 4, 1, 3.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In the <strong>floor of the fourth ventricle</strong>, the <strong>afferent (sensory) columns</strong> are arranged <strong>from medial to lateral</strong> as: <strong>General Visceral → Special Visceral → General Somatic → Special Somatic (2, 4, 1, 3).</strong></span></p>",
      "correct_choice_id": 385957,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96962/NEET_GT__11_NOV_2025_Anatomy_Question_5.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96962/NEET_GT__11_NOV_2025_Anatomy_Question_5.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97036,
      "choices": [
        {
          "id": 386252,
          "text": "<p><span style=\"font-size:14.0pt;\">No anti-D is needed as she already received prophylaxis at 28 weeks&nbsp;</span></p>"
        },
        {
          "id": 386253,
          "text": "<p><span style=\"font-size:14.0pt;\">Give anti-D within 72 hours of delivery&nbsp;</span></p>"
        },
        {
          "id": 386254,
          "text": "<p><span style=\"font-size:14.0pt;\">Give anti-D only if DCT becomes positive&nbsp;</span></p>"
        },
        {
          "id": 386255,
          "text": "<p><span style=\"font-size:14.0pt;\">No anti-D is needed as the baby's blood group is B positive</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 28-year-old primigravida with O negative blood group and husband with B positive blood group delivered a baby at term. She had received anti-D prophylaxis at 28 weeks of gestation. The baby's blood group is B positive with a negative Direct Coombs Test (DCT). What is the appropriate management regarding anti-D administration?&nbsp;</span></p>",
      "unique_key": "Q4485937",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Give anti-D within 72 hours of delivery</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">A <strong>28-year-old primigravida</strong> with <strong>O negative</strong> blood group <strong>delivered at term</strong>; the <strong>husband is B positive</strong> and the <strong>baby is B positive</strong> with a <strong>negative Direct Coombs Test (DCT)</strong> after <strong>anti-D prophylaxis at 28 weeks of gestation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Because the mother is <strong>Rh(D)-negative</strong> and the infant is <strong>Rh(D)-positive</strong>, she <strong>must receive postpartum anti-D within 72 hours</strong> to prevent alloimmunization from delivery-related fetomaternal hemorrhage.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>28-week</strong> antenatal prophylaxis <strong>does not replace</strong> the <strong>postpartum</strong> dose.</span></li><li><span style=\"font-size:14.0pt;\">A <strong>negative DCT</strong> in the baby <strong>does not affect</strong> the indication for <strong>maternal</strong> anti-D.</span></li><li><span style=\"font-size:14.0pt;\"><strong>O mother/B positive baby</strong> (possible ABO mismatch) may reduce but <strong>does not eliminate</strong> Rh sensitization risk—<strong>anti-D is still required</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. No anti-D is needed as she already received prophylaxis at 28 weeks</strong>: Incorrect. the <strong>28-week</strong> dose is <strong>antepartum</strong>; a <strong>postpartum</strong> dose is still required <strong>within 72 hours</strong> when the <strong>baby is B positive</strong> and the mother is <strong>O negative</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Give anti-D only if DCT becomes positive</strong>: Incorrect. <strong>DCT</strong> reflects antibodies on the <strong>newborn’s</strong> RBCs; <strong>maternal</strong> prophylaxis is indicated <strong>regardless of a negative DCT</strong> when an <strong>Rh-negative</strong> mother delivers an <strong>Rh-positive</strong> infant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. No anti-D is needed as the baby's blood group is B positive</strong>: Incorrect: <strong>“B positive”</strong> confirms <strong>Rh positivity</strong>, which <strong>triggers</strong> postpartum <strong>anti-D</strong> in the <strong>Rh-negative</strong> (O negative) <strong>primigravida</strong> who <strong>delivered at term</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">An Rh-negative mother who delivers an Rh-positive (e.g., B positive) baby must receive anti-D immunoglobulin within 72 hours postpartum—even if she received 28-week prophylaxis and the newborn’s DCT is negative.</span></p>",
      "correct_choice_id": 386253,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97036/NEET_GT__11_NOV_2025_OBG_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97036/NEET_GT__11_NOV_2025_OBG_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97231,
      "choices": [
        {
          "id": 387024,
          "text": "<p><span style=\"font-size:14.0pt;\">Furosemide at bedtime&nbsp;</span></p>"
        },
        {
          "id": 387025,
          "text": "<p><span style=\"font-size:14.0pt;\">Desmopressin at bedtime&nbsp;</span></p>"
        },
        {
          "id": 387026,
          "text": "<p><span style=\"font-size:14.0pt;\">Hydrochlorothiazide in the morning&nbsp;</span></p>"
        },
        {
          "id": 387027,
          "text": "<p><span style=\"font-size:14.0pt;\">Spironolactone at bedtime&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-year-old child with primary nocturnal enuresis (bedwetting) has not responded to behavioral interventions. The parents are seeking pharmacological treatment. The child has no other medical conditions and normal daytime voiding patterns. Which medication would be most appropriate for this condition?&nbsp;</span></p>",
      "unique_key": "Q8631904",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Desmopressin at bedtime</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Intranasal or oral desmopressin at bedtime controls primary nocturia by reducing urine volume.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It stimulates the B2 receptors and increases the urine output&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">For bedwetting in children, the dose is 5-10 μg intranasally at bedtime. Desmopressin is a selective V₂ receptor agonist that increases water reabsorption in the collecting ducts.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Fluid intake must be restricted 1 hour before and till 8 hours after the dose to avoid fluid retention.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p style=\"margin-left:0in;\"><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;A. Furosemide at bedtime:</strong> Furosemide would increase urine production, worsening bedwetting</span></p><p style=\"margin-left:0in;\">&nbsp;</p><p style=\"margin-left:0in;\"><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;C.</strong> <strong>Hydrochlorothiazide in the morning:</strong> Hydrochlorothiazide in morning would not help nighttime urine production</span></p><p style=\"margin-left:0in;\">&nbsp;</p><p style=\"margin-left:0in;\"><span style=\"font-size:14.0pt;\"><strong>Option&nbsp;D. Spironolactone at bedtime:</strong> Spironolactone has no role in treating bedwetting</span></p><p style=\"margin-left:0in;\">&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Desmopressin at bedtime reduces nocturnal urine volume and is effective for primary nocturnal enuresis in children.</span></p>",
      "correct_choice_id": 387025,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97231/NEET_GT__11_NOV_2025_Pharmacology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97231/NEET_GT__11_NOV_2025_Pharmacology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97205,
      "choices": [
        {
          "id": 386920,
          "text": "<p><span style=\"font-size:14.0pt;\">Hair clipping is preferred over shaving to reduce surgical site infection risk</span></p>"
        },
        {
          "id": 386921,
          "text": "<p><span style=\"font-size:14.0pt;\">Alcohol-based hand rubs are superior to soap and water for routine hand hygiene</span></p>"
        },
        {
          "id": 386922,
          "text": "<p><span style=\"font-size:14.0pt;\">Preoperative skin hair removal should be done in the ward the night before surgery</span></p>"
        },
        {
          "id": 386923,
          "text": "<p><span style=\"font-size:14.0pt;\">Minimising preoperative hospital stay helps reduce nosocomial infection risk</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding preoperative preparation is incorrect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3363605",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Preoperative skin hair removal should be done in the ward the night before surgery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Hair removal</strong>, if necessary, should be done <strong>immediately before surgery in the operating theatre</strong>, not the night before, to reduce microbial colonization.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hair clipping is preferred over shaving to reduce surgical site infection risk:&nbsp;</strong>Hair clipping is the recommended method for preoperative hair removal — it causes less skin trauma than shaving.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.&nbsp;Alcohol-based hand rubs are superior to soap and water for routine hand hygiene:&nbsp;</strong>Alcohol-based hand rubs are more effective than soap and water for routine hand hygiene, unless hands are visibly soiled.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Minimising preoperative hospital stay helps reduce nosocomial infection risk:&nbsp;</strong>Shorter preoperative hospital stays reduce the risk of hospital-acquired infections and improve surgical outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hair clipping on OT table is associated with least risk of SSI (surgical site infections).</span></p>",
      "correct_choice_id": 386922,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97205/NEET_GT__11_NOV_2025_Surgery_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97205/NEET_GT__11_NOV_2025_Surgery_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97040,
      "choices": [
        {
          "id": 386268,
          "text": "<p><span style=\"font-size:14.0pt;\">To improve cosmetic appearance</span></p>"
        },
        {
          "id": 386269,
          "text": "<p><span style=\"font-size:14.0pt;\">To reduce intraocular pressure early</span></p>"
        },
        {
          "id": 386270,
          "text": "<p><span style=\"font-size:14.0pt;\">To allow formation of the foveal fixation reflex</span></p>"
        },
        {
          "id": 386271,
          "text": "<p><span style=\"font-size:14.0pt;\">To prevent development of nystagmus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 6-week-old infant is diagnosed with a dense unilateral congenital cataract. The ophthalmologist recommends urgent surgery. What is the most important reason for early surgical intervention in this case?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1753807",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) To allow formation of the foveal fixation reflex</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In infants, <strong>visual development is highly time-sensitive</strong>. The <strong>critical period for the development of the foveal fixation reflex</strong> and <strong>normal visual pathways</strong> occurs in the first few months of life.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">If <strong>a dense congenital cataract is not removed early</strong>, <strong>visual input is blocked</strong>, and the brain fails to develop the proper <strong>cortical connections for vision</strong> in that eye — a condition known as <strong>stimulus-deprivation amblyopia</strong>.</span></li><li><span style=\"font-size:14.0pt;\">In <strong>unilateral cataract</strong>, early surgical correction (typically by 6–8 weeks) is especially important because the other eye can dominate, worsening the amblyopia in the affected eye.</span></li><li><span style=\"font-size:14.0pt;\">This intervention <strong>allows proper light stimulus to reach the retina</strong>, promoting development of <strong>central vision and foveal fixation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. To improve cosmetic appearance:</strong> While appearance may improve after cataract removal, <strong>this is not the primary indication</strong>. Early surgery is aimed at <strong>preventing irreversible vision loss</strong>, not cosmetic benefit.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. To reduce intraocular pressure early:</strong> Congenital cataracts are not primarily associated with <strong>increased intraocular pressure (IOP)</strong>. This is more relevant to <strong>congenital glaucoma</strong>, not cataracts.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. To prevent development of nystagmus:</strong> Nystagmus can develop from sensory deprivation, but it is a <strong>secondary outcome</strong>. The <strong>primary goal</strong> is to allow <strong>visual input</strong> and proper <strong>cortical development</strong>, which will incidentally reduce the risk of nystagmus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In infants with <strong>unilateral congenital cataracts</strong>, <strong>early surgical removal</strong> is critical to allow <strong>visual pathway development</strong> and <strong>prevent amblyopia</strong> — the <strong>formation of the foveal fixation reflex</strong> is time-sensitive and must not be delayed.</span></p>",
      "correct_choice_id": 386270,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97040/Neet_Gt__11_Nov_2025_Opthalmology_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97040/Neet_Gt__11_Nov_2025_Opthalmology_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96993,
      "choices": [
        {
          "id": 386080,
          "text": "<p><span style=\"font-size:14.0pt;\">Tropical traveler with ring forms inside RBCs and pigment</span></p>"
        },
        {
          "id": 386081,
          "text": "<p><span style=\"font-size:14.0pt;\">Temperate-region patient with pear-shaped organisms forming a cross pattern</span></p>"
        },
        {
          "id": 386082,
          "text": "<p><span style=\"font-size:14.0pt;\">Patient from Africa presenting with high-grade fever and cerebral signs</span></p>"
        },
        {
          "id": 386083,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood smear showing gametocytes and Maurer’s dots</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In which of the following scenarios is artemisinin combination therapy not the drug of choice?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q8597140",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Temperate-region patient with pear-shaped organisms forming a cross pattern</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The scenario described <strong>Babesiosis</strong>, a tick-borne infection caused by Babesia species, most commonly seen in <strong>temperate regions like the northeastern United States</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">On peripheral smear, Babesia often presents with <strong>pear-shaped intraerythrocytic parasites</strong> arranged in <strong>Maltese cross (tetrad) formation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The treatment of choice for babesiosis is <strong>atovaquone + azithromycin</strong> (or clindamycin + quinine in severe cases), <strong>not artemisinin combination therapy</strong>, which is reserved for malaria caused by Plasmodium falciparum.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tropical traveler with ring forms inside RBCs and pigment:</strong> This description is classic for Plasmodium falciparum infection. ACT is the treatment of choice here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Patient from Africa presenting with high-grade fever and cerebral signs:&nbsp;</strong>Suggests <strong>cerebral malaria</strong> caused by P. falciparum. ACT is first-line therapy, especially in endemic regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Blood smear showing gametocytes and Maurer’s dots:</strong> These are classic features of P. falciparum. Maurer’s clefts (dots) and banana-shaped gametocytes are hallmark features. ACT is the drug of choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Artemisinin-based combination therapy (ACT) is the first-line treatment for <strong>falciparum malaria</strong>, especially in endemic regions.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Babesiosis</strong>, though morphologically similar to malaria, is treated with <strong>atovaquone and azithromycin</strong>, not ACT.</span></li></ul>",
      "correct_choice_id": 386081,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96993/NEET_GT__11_NOV_2025_Microbiology_Question_6_VgHXqRd.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96993/NEET_GT__11_NOV_2025_Microbiology_Question_6_VgHXqRd.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97184,
      "choices": [
        {
          "id": 386836,
          "text": "<p><span style=\"font-size:14.0pt;\">Frontal sinus</span></p>"
        },
        {
          "id": 386837,
          "text": "<p><span style=\"font-size:14.0pt;\">Sphenoid sinus</span></p>"
        },
        {
          "id": 386838,
          "text": "<p><span style=\"font-size:14.0pt;\">Maxillary sinus</span></p>"
        },
        {
          "id": 386839,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior ethmoidal sinus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which sinus drains into the middle meatus through the hiatus semilunaris and is most commonly infected due to its dependent drainage pathway?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6972471",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Maxillary sinus</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>maxillary sinus</strong> drains via the <strong>ostium in the middle meatus</strong> hiatus (semilunaris).</span></li><li><span style=\"font-size:14.0pt;\">The ostium lies <strong>high on the medial wall</strong>, above the sinus floor, resulting in poor gravity-assisted drainage.</span></li><li><span style=\"font-size:14.0pt;\">Hence, it is the <strong>most frequently infected sinus</strong> in sinusitis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-11-10%20at%2011.06.11.jpeg\" width=\"428\" height=\"442\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Frontal sinus:</strong> Frontal sinus drains via frontonasal duct into the <strong>infundibulum</strong> of middle meatus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Sphenoid sinus:</strong> Sphenoid sinus drains into <strong>sphenoethmoidal recess</strong> superior meatus).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Posterior ethmoidal sinus:</strong> Posterior ethmoids drain into <strong>superior meatus</strong>, not middle meatus.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:14.0pt;\">The <strong>maxillary sinus</strong>, with an ostium high on its medial wall, drains poorly and is <strong>most prone to infection.</strong></span></p>",
      "correct_choice_id": 386838,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97184/NEET_GT__11_NOV_2025_ENT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        9
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97184/NEET_GT__11_NOV_2025_ENT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97044,
      "choices": [
        {
          "id": 386284,
          "text": "<p><span style=\"font-size:14.0pt;\">Blood cultures</span></p>"
        },
        {
          "id": 386285,
          "text": "<p><span style=\"font-size:14.0pt;\">Echocardiogram</span></p>"
        },
        {
          "id": 386286,
          "text": "<p><span style=\"font-size:14.0pt;\">Complement levels</span></p>"
        },
        {
          "id": 386287,
          "text": "<p><span style=\"font-size:14.0pt;\">Kidney biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old man with a history of IV drug use, hepatitis C and cirrhosis presents with 2 days of new palpable purpura on his lower extremities. He reports a week of malaise, arthralgias, and lower leg paresthesia with mild weakness. His blood pressure is 93/64 mmHg and heart rate is 97 beats/min. Exam shows a systolic murmur in tricuspid area with reduced power and sensation in both lower legs. Labs reveal anemia, thrombocytopenia, proteinuria, and positive rheumatoid factor. Which of the following is not an appropriate immediate next step in his evaluation?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9570370",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Kidney biopsy</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s presentation is suggestive of infection-associated or cryoglobulinemic vasculitis. Contributing factors include hepatitis C, recent endocarditis, IV drug use, palpable purpura, arthritis, neuropathy, and proteinuria.</span></li><li><span style=\"font-size:14.0pt;\">Kidney biopsy is not indicated acutely in the setting of active infection and likely vasculitis; management should initially focus on infectious and vasculitic assessment and treatment. Biopsy is reserved for cases where the diagnosis remains uncertain or if renal pathology worsens despite appropriate therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Blood cultures:&nbsp;</strong>Blood cultures are necessary to assess for persistent bacteremia, especially considering his history of IV drug use and a murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B</strong>. <strong>Echocardiogram:</strong> Echocardiogram is indicated to detect active endocarditis or new valvular lesions, which could explain ongoing systemic emboli or vasculitic phenomena.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Complement levels:&nbsp;</strong>Complement levels can help evaluate for cryoglobulinemia - common in hepatitis C -with low complement supporting the diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Initial evaluation of possible systemic vasculitis in a high-risk patient should prioritize laboratory and cardiac investigations over invasive procedures like kidney biopsy, unless renal involvement is rapidly progressive or diagnosis is unclear after standard work-up.</span></p>",
      "correct_choice_id": 386287,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97044/Neet_Gt__11_Nov_2025_Medicine_Question_16.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97044/Neet_Gt__11_Nov_2025_Medicine_Question_16.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96954,
      "choices": [
        {
          "id": 385924,
          "text": "<p><span style=\"font-size:14.0pt;\">Photobacterium and Armillaria help to release stored light in the putrefying tissue&nbsp;</span></p>"
        },
        {
          "id": 385925,
          "text": "<p><span style=\"font-size:14.0pt;\">Putrefying tissue provides ideal conditions for microbial luciferase to act on luciferin, producing light&nbsp;</span></p>"
        },
        {
          "id": 385926,
          "text": "<p><span style=\"font-size:14.0pt;\">Decomposition gases react with air to emit light&nbsp;</span></p>"
        },
        {
          "id": 385927,
          "text": "<p><span style=\"font-size:14.0pt;\">As there body liquefies, it reflects more light</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following best explains the cause of postmortem luminescence?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9652839",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Putrefying tissue provides ideal conditions for microbial luciferase to act on luciferin, producing light</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Postmortem luminescence (also called bioluminescence of decomposition) occurs due to the action of bioluminescent bacteria, such as Photobacterium and Vibrio species, that colonize putrefying tissue.</span></li><li><span style=\"font-size:14.0pt;\">These bacteria produce light through a biochemical reaction involving: Luciferase (enzyme) acting on Luciferin (substrate),in the presence of oxygen, forming an excited intermediate that releases visible light when it returns to its ground state.</span></li><li><span style=\"font-size:14.0pt;\">The warm, moist, nutrient-rich, and anaerobic environment of decomposing tissue provides ideal conditions for this reaction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Photobacterium and Armillaria help to release stored light in the putrefying tissue:</strong> light is not “stored”; it’s&nbsp;<strong>produced chemically</strong>&nbsp;through a luciferase–luciferin reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Decomposition gases react with air to emit light:</strong> Gases from decomposition don’t emit light; they only cause bloating and odor.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. As there body liquefies, it reflects more light:</strong> Reflection of light increases visibility but doesn’t&nbsp;<strong>generate</strong>&nbsp;light.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Postmortem luminescence is caused by <strong>bioluminescent bacteria</strong> that colonize <strong>decomposing tissue</strong>.</span></li><li><span style=\"font-size:14.0pt;\">They produce light through the <strong>luciferase–luciferin enzymatic reaction</strong>, a hallmark of microbial bioluminescence under suitable postmortem conditions.</span></li></ul>",
      "correct_choice_id": 385925,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96954/NEET_GT__11_NOV_2025_FMT_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96954/NEET_GT__11_NOV_2025_FMT_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96963,
      "choices": [
        {
          "id": 385960,
          "text": "<p><span style=\"font-size:14.0pt;\">Median nerve</span></p>"
        },
        {
          "id": 385961,
          "text": "<p><span style=\"font-size:14.0pt;\">Ulnar nerve</span></p>"
        },
        {
          "id": 385962,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior interosseous nerve</span></p>"
        },
        {
          "id": 385963,
          "text": "<p><span style=\"font-size:14.0pt;\">Musculocutaneous nerve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 42-year-old man sustains a deep laceration to the posterior aspect of his forearm. On examination, he is unable to straighten his fingers, but wrist extension is preserved, though slightly weak and deviated to the radial side. Pronation and supination remain normal. Which of the following nerves is most likely injured?</span></p>",
      "unique_key": "Q5994077",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Posterior interosseous nerve</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>posterior interosseous nerve (PIN)</strong>, a deep branch of the <strong>radial nerve</strong>, supplies most of the <strong>extensor muscles of the forearm</strong>—including <strong>extensor digitorum, extensor digiti minimi, and extensor indicis</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">These muscles extend the metacarpophalangeal joints of the fingers.</span></li><li><span style=\"font-size:14.0pt;\">Injury to the PIN results in:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Loss of finger extension</strong> at the metacarpophalangeal joints,</span></li><li><span style=\"font-size:14.0pt;\"><strong>Weak wrist extension</strong> (due to intact extensor carpi radialis longus), and</span></li><li><span style=\"font-size:14.0pt;\"><strong>No sensory deficit</strong>, since the PIN is a purely <strong>motor nerve</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">Thus, the patient’s inability to extend fingers with preserved wrist motion is diagnostic of <strong>posterior interosseous nerve palsy</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111553.jpg\" width=\"868\" height=\"716\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Median nerve:&nbsp;</strong>Injury leads to loss of thumb opposition, weakened wrist flexion, and sensory loss over the lateral palm — not finger extension weakness.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Ulnar nerve:&nbsp;</strong>Causes claw hand deformity, weakness in finger abduction/adduction, and sensory loss over the medial hand — again, not loss of finger extension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Musculocutaneous nerve:&nbsp;</strong>Affects elbow flexion (biceps, brachialis) and forearm sensation on the lateral side — unrelated to finger extension.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>posterior interosseous nerve</strong> (a motor branch of the radial nerve) injury leads to <strong>loss of finger extension with preserved wrist extension</strong>. It is commonly injured in forearm trauma or radial head dislocation.</span></p>",
      "correct_choice_id": 385962,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96963/NEET_GT__11_NOV_2025_Anatomy_Question_6.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96963/NEET_GT__11_NOV_2025_Anatomy_Question_6.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97263,
      "choices": [
        {
          "id": 387148,
          "text": "<p><span style=\"font-size:14.0pt;\">Extubate the patient</span></p>"
        },
        {
          "id": 387149,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat Muscle Relaxant</span></p>"
        },
        {
          "id": 387150,
          "text": "<p><span style=\"font-size:14.0pt;\">Deepen the Plane of Anesthesia</span></p>"
        },
        {
          "id": 387151,
          "text": "<p><span style=\"font-size:14.0pt;\">Give Reversal Agent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 36-year-old female is posted for Modified radical mastectomy under general anesthesia. Halfway through the surgery, this is her capnograph. What should be the next step?<strong>&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-07%20101619.jpg\" width=\"702\" height=\"340\"></strong></span></p>",
      "unique_key": "Q1034712",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Repeat Muscle Relaxant</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This capnograph shows a ‘Curare Cleft’.</span></li><li><span style=\"font-size:14.0pt;\"><strong>The ‘Curare Cleft’ is an indication&nbsp;</strong>that the patient is<strong> out of neuromuscular blockade&nbsp;</strong>and is <strong>making an attempt to breathe spontaneously.</strong></span></li><li><span style=\"font-size:14.0pt;\">As they are <strong>halfway</strong> through the surgery, a <strong>top up dose of muscle relaxant</strong> needs to be given to <strong>paralyze the patient again.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-07%20101631.jpg\" width=\"584\" height=\"254\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Extubate the patient:</strong> Patient <strong>cannot be extubated</strong> as they are <strong>halfway</strong> through the surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Deepen the Plane of Anesthesia:&nbsp;</strong>Deepening anaesthesia <strong>will not paralyze</strong> the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D.</strong> <strong>Give Reversal Agent:</strong> Patient <strong>cannot be reversed from neuromuscular blockade</strong> as they are <strong>halfway through the surgery</strong>, surgery is not over.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In cases where the <strong>capnograph waveform</strong> shows a <strong>curare cleft</strong> in the capnograph during <strong>surgery</strong>, the appropriate next step may be to <strong>repeat</strong> the <strong>muscle relaxant</strong> to <strong>ensure adequate muscle paralysis</strong> for the procedure.</span></p>",
      "correct_choice_id": 387149,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97263/NEET_GT__11_NOV_2025_Anesthesia_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97263/NEET_GT__11_NOV_2025_Anesthesia_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97200,
      "choices": [
        {
          "id": 386900,
          "text": "<p><span style=\"font-size:14.0pt;\">Hyoid bone</span></p>"
        },
        {
          "id": 386901,
          "text": "<p><span style=\"font-size:14.0pt;\">Posterior belly of digastric</span></p>"
        },
        {
          "id": 386902,
          "text": "<p><span style=\"font-size:14.0pt;\">Mylohyoid muscle</span></p>"
        },
        {
          "id": 386903,
          "text": "<p><span style=\"font-size:14.0pt;\">Horizontal line through the angle of the mandible</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old woman presents to the clinic with a lump under her jaw. On examination, the lump is found to be associated with the submandibular gland. Which structure separates the superficial and deep lobes of the submandibular gland?</span></p>",
      "unique_key": "Q2242320",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Mylohyoid muscle</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The mylohyoid muscle separates the superficial and deep lobes of the submandibular gland.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The submandibular gland wraps around the posterior edge of the mylohyoid muscle, forming its superficial and deep parts.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Hyoid bone:&nbsp;</strong>The hyoid bone is located in the anterior neck and does not play a role in separating the lobes of the submandibular gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Posterior belly of digastric:&nbsp;</strong>The posterior belly of the digastric muscle is located near the submandibular gland, but it does not separate the superficial and deep lobes of the gland.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Horizontal line through the angle of mandible:&nbsp;</strong>A horizontal line through the angle of the mandible is an anatomical reference but does not separate the superficial and deep lobes of the gland</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The mylohyoid muscle separates the superficial and deep lobes of the submandibular gland.</span></p>",
      "correct_choice_id": 386902,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97200/NEET_GT__11_NOV_2025_Surgery_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97200/NEET_GT__11_NOV_2025_Surgery_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96980,
      "choices": [
        {
          "id": 386028,
          "text": "<p><span style=\"font-size:18px;\">Direct osteolytic metastasis causing bone resorption</span></p>"
        },
        {
          "id": 386029,
          "text": "<p><span style=\"font-size:18px;\">Secretion of parathyroid hormone–related peptide (PTHrP) by tumor cells</span></p>"
        },
        {
          "id": 386030,
          "text": "<p><span style=\"font-size:18px;\">Ectopic secretion of intact parathyroid hormone</span></p>"
        },
        {
          "id": 386031,
          "text": "<p><span style=\"font-size:18px;\">Increased synthesis of 1,25-dihydroxyvitamin D (calcitriol) by tumor macrophages</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 65-year-old man, chronic smoker, presents with persistent cough, hemoptysis, and weight loss for 3 months. Chest X-ray shows a hilar mass in the right lung. Biopsy of the lesion shows polygonal cells with intercellular bridges and keratin pearls. Serum studies reveal hypercalcemia, but PTH levels are suppressed. Which of the following is the cause of hypercalcemia in this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3054976",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Secretion of parathyroid hormone–related peptide (PTHrP) by tumor cells</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\">This <strong>65-year-old chronic smoker</strong> with <strong>persistent cough, hemoptysis, weight loss</strong>, and a <strong>right hilar mass</strong> showing <strong>polygonal cells with intercellular bridges and keratin pearls</strong> has <strong>squamous cell carcinoma of the lung</strong>.</span></li><li><span style=\"font-size:18px;\"><strong>Squamous cell carcinoma</strong> is strongly associated with <strong>paraneoplastic hypercalcemia</strong> due to <strong>ectopic production of parathyroid hormone–related peptide (PTHrP)</strong> by tumor cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Mechanism:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:18px;\"><strong>PTHrP</strong> mimics the actions of <strong>PTH</strong> on <strong>bone and kidney</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\">Increases <strong>bone resorption</strong> → releases calcium into circulation.</span></li><li><span style=\"font-size:18px;\">Increases <strong>renal calcium reabsorption</strong> and <strong>phosphate excretion</strong>.</span></li></ul></li><li><span style=\"font-size:18px;\">Unlike true PTH, <strong>PTHrP does not increase 1,25-dihydroxyvitamin D (calcitriol)</strong> synthesis in the kidney.</span></li><li><span style=\"font-size:18px;\">As a result, <strong>serum calcium is elevated</strong>, but <strong>PTH is suppressed</strong> due to feedback inhibition.</span></li><li><span style=\"font-size:18px;\">Thus, the <strong>hypercalcemia</strong> in this case is <strong>paraneoplastic</strong>, caused by <strong>tumor secretion of PTHrP</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Direct osteolytic metastasis causing bone resorption:&nbsp;</strong>Incorrect.&nbsp;This mechanism is seen in <strong>breast cancer, multiple myeloma, and renal cell carcinoma</strong>, where <strong>bone metastases</strong> cause <strong>local bone destruction</strong>. In this case, the <strong>hilar mass</strong> (primary lung lesion) with <strong>keratin pearls</strong> suggests <strong>squamous cell carcinoma</strong>, not osteolytic metastasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Ectopic secretion of intact parathyroid hormone:&nbsp;</strong>Incorrect. Ectopic production of <strong>intact PTH</strong> is extremely rare in malignancy. PTH levels are <strong>suppressed</strong> in this patient, ruling this out.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Increased synthesis of 1,25-dihydroxyvitamin D (calcitriol) by tumor macrophages:&nbsp;</strong>Incorrect.&nbsp;This occurs in <strong>lymphomas (especially Hodgkin lymphoma)</strong>, where macrophages express <strong>1α-hydroxylase</strong>, increasing <strong>calcitriol</strong> and promoting <strong>calcium absorption</strong> from the gut. Not seen in lung squamous carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Squamous cell carcinoma of the lung</strong> causes <strong>paraneoplastic hypercalcemia</strong> via <strong>ectopic secretion of PTH-related peptide (PTHrP)</strong>, leading to <strong>increased bone resorption and renal calcium reabsorption</strong> with <strong>suppressed PTH levels</strong>.</span></p>",
      "correct_choice_id": 386029,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96980/Neet_Gt__11_Nov_2025_Pathology_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        5
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96980/Neet_Gt__11_Nov_2025_Pathology_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96951,
      "choices": [
        {
          "id": 385912,
          "text": "<p><span style=\"font-size:14.0pt;\">Tab Chloroquine 600mg stat, then 300mg after 6 hours, followed by 300mg daily for 2 days</span></p>"
        },
        {
          "id": 385913,
          "text": "<p><span style=\"font-size:14.0pt;\">Tab Paracetamol 500mg TDS, adequate fluid intake, and platelet monitoring</span></p>"
        },
        {
          "id": 385914,
          "text": "<p><span style=\"font-size:14.0pt;\">Tab Doxycycline 100mg BD for 7 days with supportive care</span></p>"
        },
        {
          "id": 385915,
          "text": "<p><span style=\"font-size:14.0pt;\">Tab Artemether- Lumefantrine therapy for 3 days&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 25-year-old woman from a village in tribal area of Madhya Pradesh presents with high-grade fever, headache, and myalgia for 5 days. Local health workers have identified the mosquito larvae shown in the image breeding in water storage containers around her house. What is the most appropriate first-line treatment for the likely condition?</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111207_3t6nTWF.jpg\" width=\"521\" height=\"364\"></p>",
      "unique_key": "Q4626369",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Tab Paracetamol 500mg TDS, adequate fluid intake, and platelet monitoring</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image shows Aedes aegypti larvae, identifiable by their characteristic siphon tube and tendency to hang from the water surface at an angle.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The clinical presentation of fever, headache, and myalgia in an endemic area with confirmed Aedes breeding strongly suggests dengue fever.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Treatment for dengue is supportive, including paracetamol for fever (avoiding aspirin due to bleeding risk), adequate hydration, and monitoring for complications like thrombocytopenia and plasma leakage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20154841.jpg\" width=\"958\" height=\"332\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Tab Chloroquine 600mg stat, then 300mg after 6 hours, followed by 300mg daily for 2 days:</strong> Chloroquine is antimalarial therapy, inappropriate for dengue fever caused by Aedes aegypti</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Tab Doxycycline 100mg BD for 7 days with supportive care:&nbsp;</strong>Doxycycline is used for rickettsial diseases or scrub typhus, not dengue fever</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Tab Artemether- Lumefantrine therapy for 3 days:</strong> Artemether-Lumefantrine is antimalarial combination therapy, not indicated for dengue</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Aedes aegypti larvae are identified by their siphon tube and surface-hanging behavior in clean water collections</span></li><li><span style=\"font-size:14.0pt;\">Dengue fever requires supportive treatment with paracetamol, hydration, and monitoring for complications</span></li></ul>",
      "correct_choice_id": 385913,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96951/NEET_PG_11_Nov_2025_PSM_Question_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96951/NEET_PG_11_Nov_2025_PSM_Question_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96956,
      "choices": [
        {
          "id": 385932,
          "text": "<p><span style=\"font-size:14.0pt;\">Discharge with symptomatic treatment and follow-up</span></p>"
        },
        {
          "id": 385933,
          "text": "<p><span style=\"font-size:14.0pt;\">Platelet transfusion and intravenous antibiotics</span></p>"
        },
        {
          "id": 385934,
          "text": "<p><span style=\"font-size:14.0pt;\">Report to child protective services and admit for neuro-monitoring</span></p>"
        },
        {
          "id": 385935,
          "text": "<p><span style=\"font-size:14.0pt;\">Lumbar puncture followed by anticonvulsants</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 2-month-old baby is brought by the parents with history of seizures. CT scan reveals subdural hemorrhage without any skull fracture. A bloody cerebrospinal fluid tap is obtained, and MRI reveals delayed white matter myelination. Ophthalmic exam confirms retinal hemorrhages. Which of the following is the most appropriate next step in management?&nbsp;</span></p>",
      "unique_key": "Q5535497",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) Report to child protective services and admit for neuro-monitoring</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This clinical scenario is <strong>highly suspicious for non-accidental trauma (NAT)</strong>, specifically <strong>Shaken Baby Syndrome (SBS)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>classic triad</strong> includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Subdural hemorrhage</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Retinal hemorrhages</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Neurologic symptoms (e.g., seizures, altered consciousness)</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111304.jpg\" width=\"476\" height=\"494\"></strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The absence of external trauma with intracranial bleeding and retinal hemorrhages—especially in a non-mobile infant—warrants <strong>mandatory reporting to child protective services</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Immediate <strong>inpatient care with neuro-monitoring</strong> is essential due to the risk of ongoing or worsening brain injury.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Discharge with symptomatic treatment and follow-up:</strong> Dangerous and inappropriate. This ignores the signs of potential abuse and could place the child at risk for further harm or death.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Platelet transfusion and intravenous antibiotics:</strong> No evidence supports thrombocytopenia or infection. The etiology is traumatic, not infectious or hematologic.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Lumbar puncture followed by anticonvulsants:</strong> LP is contraindicated in suspected raised intracranial pressure (ICP), and seizures must be managed, but that’s <strong>secondary</strong> to addressing the cause (abuse).</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In any infant presenting with <strong>seizures</strong>, <strong>subdural hemorrhage</strong>, and <strong>retinal hemorrhages</strong>, always <strong>suspect Shaken Baby Syndrome</strong>. Immediate reporting to child protection services and <strong>hospital admission</strong> is a <strong>medicolegal and ethical obligation</strong>.</span></p>",
      "correct_choice_id": 385934,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96956/NEET_GT__11_NOV_2025_FMT_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96956/NEET_GT__11_NOV_2025_FMT_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97025,
      "choices": [
        {
          "id": 386208,
          "text": "<p><span style=\"font-size:14.0pt;\">Mifepristone plus misoprostol</span></p>"
        },
        {
          "id": 386209,
          "text": "<p><span style=\"font-size:14.0pt;\">Manual vacuum aspiration</span></p>"
        },
        {
          "id": 386210,
          "text": "<p><span style=\"font-size:14.0pt;\">Dilatation and evacuation</span></p>"
        },
        {
          "id": 386211,
          "text": "<p><span style=\"font-size:14.0pt;\">Extra-amniotic instillation of ethacridine lactate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 34 year old woman at 8 weeks of gestation requests medical termination of pregnancy. Which of the following methods is not appropriate for first-trimester MTP?&nbsp;</span></p>",
      "unique_key": "Q9749638",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>D) Extra-amniotic instillation of ethacridine lactate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">This <strong>34-year-old woman</strong> at <strong>8 weeks of gestation</strong> is seeking <strong>medical termination of pregnancy (MTP)</strong> in the <strong>first trimester</strong>.</span><br><span style=\"font-size:14.0pt;\">According to the <strong>Medical Termination of Pregnancy (MTP) Act</strong> and standard obstetric guidelines, the recommended methods for <strong>first-trimester MTP (up to 12 weeks)</strong> include:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\"><strong>Medical methods:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Mifepristone (antiprogestin) + Misoprostol (prostaglandin E1 analogue)</strong></span><br><span style=\"font-size:14.0pt;\">→ Effective, safe, and widely used for termination up to <strong>9–12 weeks</strong>.</span></li></ul></li><li><span style=\"font-size:14.0pt;\"><strong>Surgical methods:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Manual Vacuum Aspiration (MVA)</strong> or</span></li><li><span style=\"font-size:14.0pt;\"><strong>Dilatation and Evacuation (D&amp;E) </strong>→ Both suitable and effective up to <strong>12 weeks of gestation</strong>.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>extra-amniotic instillation of ethacridine lactate</strong> is obsolete and <strong>not appropriate for first-trimester MTP</strong>.</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It is used for <strong>second-trimester terminations (13–20 weeks)</strong> because it requires an adequately enlarged uterine cavity to instill the solution.</span></li><li><span style=\"font-size:14.0pt;\">At <strong>8 weeks</strong>, the uterine cavity is too small, increasing the risk of <strong>uterine perforation and incomplete evacuation</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Hence, the <strong>most appropriate answer</strong> is <strong>D. Extra-amniotic instillation of ethacridine lactate</strong> — it is <strong>not suitable for first-trimester termination</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Mifepristone plus misoprostol:&nbsp;</strong>Correct method (for first trimester). Combination of <strong>200 mg mifepristone orally</strong>, followed 24–48 hours later by <strong>800 µg misoprostol vaginally or orally</strong>, is safe and effective for medical abortion up to <strong>9–12 weeks</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Manual vacuum aspiration:&nbsp;</strong>Correct method (for first trimester).</span><br><span style=\"font-size:14.0pt;\">MVA is a <strong>safe surgical technique</strong> used for termination up to <strong>12 weeks</strong>, with minimal complications and rapid recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Dilatation and evacuation:&nbsp;</strong>Correct method (for first trimester). D&amp;E is a <strong>surgical method</strong> also used up to <strong>12 weeks</strong>, though gradually being replaced by MVA due to fewer complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Extra-amniotic instillation of ethacridine lactate</strong> is used for <strong>second-trimester MTP (13–20 weeks)</strong> and <strong>not appropriate for first-trimester termination</strong>, where <strong>mifepristone + misoprostol, MVA, or D&amp;C</strong> are preferred safe methods.</span></p>",
      "correct_choice_id": 386211,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97025/NEET_GT__11_NOV_2025_OBG_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        14
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97025/NEET_GT__11_NOV_2025_OBG_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97202,
      "choices": [
        {
          "id": 386908,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 386909,
          "text": "<p><span style=\"font-size:14.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 386910,
          "text": "<p><span style=\"font-size:14.0pt;\">5, 6, 7, 8</span></p>"
        },
        {
          "id": 386911,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 2, 3, 4, 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A<strong>&nbsp;</strong>patient has a tumor in his right lobe of liver. A right hemi-hepatectomy is planned. What segments will be resected in this procedure?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6791653",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 5, 6, 7, 8</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In a <strong>right hemi-hepatectomy</strong>, the <strong>entire right anatomical lobe of the liver</strong> is resected.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This corresponds to <strong>Couinaud segments 5, 6, 7, and 8</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-06%20115409.jpg\" width=\"993\" height=\"582\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Couinaud’s classification</strong> divides the liver into 8 functionally independent segments based on vascular inflow, outflow, and biliary drainage.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Right hemi-hepatectomy</strong> removes segments <strong>5–8</strong>, preserving the left lobe (segments 2–4) and often segment 1 (caudate), unless specifically involved.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-11-10%20at%2012.46.25.jpeg\" width=\"692\" height=\"482\"></span></p>",
      "correct_choice_id": 386910,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97202/NEET_GT__11_NOV_2025_Surgery_Question_10.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97202/NEET_GT__11_NOV_2025_Surgery_Question_10.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97203,
      "choices": [
        {
          "id": 386912,
          "text": "<p><span style=\"font-size:14.0pt;\">Give colloids</span></p>"
        },
        {
          "id": 386913,
          "text": "<p><span style=\"font-size:14.0pt;\">Wait for 2 hours and reassess</span></p>"
        },
        {
          "id": 386914,
          "text": "<p><span style=\"font-size:14.0pt;\">Give a bolus of 10ml/kg Hartmann solution</span></p>"
        },
        {
          "id": 386915,
          "text": "<p><span style=\"font-size:14.0pt;\">Give normal saline in the remaining period</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A child with 20% burns is resuscitated as per Parklands equation. After 6 hours his urine output is 0.3ml/kg/hour, and his vitals are unstable with cool extremities. What is the next step?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q1146712",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Give a bolus of 10 mL/kg Hartmann solution</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In this scenario, the child is <strong>under-resuscitated</strong>: low urine output (&lt;0.5 mL/kg/hr), unstable vitals, and cool extremities suggest <strong>hypoperfusion</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This is a standard response to inadequate perfusion during burn resuscitation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Hartmann’s (Ringer’s lactate) is preferred for volume expansion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Give colloids:</strong> Not first-line in the first 24 hours post-burn. Capillary leak is ongoing; colloids may extravasate and worsen edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Wait for 2 hours and reassess:</strong> Delaying resuscitation in a child with signs of shock is dangerous. Immediate action is needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Give normal saline in the remaining period:</strong> NS is not preferred due to risk of hyperchloremic acidosis. Also, this doesn’t address the acute hypoperfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Urine output &lt;0.5 mL/kg/hr</strong> in a burn patient signals inadequate fluid resuscitation.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Hartmann’s solution</strong> is the fluid of choice for bolus resuscitation in burns, especially in the first 24 hours.</span></li></ul>",
      "correct_choice_id": 386914,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97203/NEET_GT__11_NOV_2025_Surgery_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97203/NEET_GT__11_NOV_2025_Surgery_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96955,
      "choices": [
        {
          "id": 385928,
          "text": "<p><span style=\"font-size:14.0pt;\">In differentiating between suicidal and homicidal cuts</span></p>"
        },
        {
          "id": 385929,
          "text": "<p><span style=\"font-size:14.0pt;\">In estimating postmortem interval based on drying pattern of wounds</span></p>"
        },
        {
          "id": 385930,
          "text": "<p><span style=\"font-size:14.0pt;\">In confirming site of impact in vehicular collision trauma</span></p>"
        },
        {
          "id": 385931,
          "text": "<p><span style=\"font-size:14.0pt;\">In diagnosing thermal injuries in explosion victims</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">In which forensic context would the presence of flaying injuries on the legs be most significant?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q4579687",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;C) In confirming site of impact in vehicular collision trauma</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Flaying injuries are a <strong>specific type of avulsion injury</strong> involving <strong>extensive removal of skin</strong>, most commonly seen on the <strong>legs</strong> in road traffic accidents.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-10%20105255.jpg\" width=\"717\" height=\"483\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">These injuries occur when the <strong>limbs strike or are dragged across rough surfaces</strong>, such as road pavement, during high-speed collisions.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their <strong>location and pattern</strong> can help forensic experts <strong>confirm the point and side of impact</strong>, direction of force, and even potential contact with vehicle surfaces like bumpers or wheels.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. In differentiating between suicidal and homicidal cuts:&nbsp;</strong>Suicidal and homicidal cuts are typically incised wounds, not avulsion-type. Flaying injuries have no diagnostic value in assessing intent (suicide vs homicide), as they result from mechanical trauma, not self-infliction.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. In estimating postmortem interval based on drying pattern of wounds:&nbsp;</strong>While certain wound changes can assist in estimating time since death, flaying injuries do not play a significant role in this. The drying pattern of lacerations or abrasions is more relevant.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. In diagnosing thermal injuries in explosion victims:&nbsp;</strong>Flaying injuries are <strong>mechanical</strong>, not thermal. Burn injuries involve charring, blistering, or tissue necrosis due to heat exposure, not skin detachment from forceful trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\"><strong>Flaying injuries</strong> are large skin avulsions most frequently observed on the <strong>legs</strong> in <strong>road traffic accidents</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Their presence and pattern can provide critical information in <strong>reconstructing the mechanism and site of impact</strong> during forensic analysis.</span></li></ul>",
      "correct_choice_id": 385930,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96955/NEET_GT__11_NOV_2025_FMT_Question_3.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        10
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96955/NEET_GT__11_NOV_2025_FMT_Question_3.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97000,
      "choices": [
        {
          "id": 386108,
          "text": "<p><span style=\"font-size:14.0pt;\">Burkholderia pseudomallei</span></p>"
        },
        {
          "id": 386109,
          "text": "<p><span style=\"font-size:14.0pt;\">Burkholderia cepacia</span></p>"
        },
        {
          "id": 386110,
          "text": "<p><span style=\"font-size:14.0pt;\">Acinetobacter baumannii</span></p>"
        },
        {
          "id": 386111,
          "text": "<p><span style=\"font-size:14.0pt;\">Pseudomonas aeruginosa</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following non‑fermenting Gram‑negative bacilli is lysine decarboxylase positive?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3101452",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Burkholderia cepacia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Burkholderia cepacia is a <strong>non‑fermenting, oxidase‑positive, lysine‑positive</strong> Gram‑negative bacillus.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It belongs to the <strong>Burkholderia cepacia complex (BCC)</strong>, a group of opportunistic pathogens known for causing infections in <strong>immunocompromised patients</strong> and <strong>those with cystic fibrosis or chronic granulomatous disease</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The organism can <strong>decarboxylate lysine</strong> due to the presence of <strong>lysine decarboxylase enzyme</strong>, which differentiates it biochemically from several other non‑fermenters.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Burkholderia pseudomallei:</strong> Though biochemically similar, B. pseudomallei (causative agent of melioidosis) is <strong>lysine‑negative</strong> and can be differentiated from B. cepacia by its distinct colony morphology and bipolar “safety‑pin” appearance on microscopy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Acinetobacter baumannii:</strong> This organism is <strong>oxidase‑negative</strong> and <strong>non‑motile</strong>, typically <strong>lysine‑negative</strong>. It is an important <strong>nosocomial pathogen</strong> causing ventilator‑associated pneumonia and bacteremia, especially in ICU settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Pseudomonas aeruginosa:</strong> Although a classic non‑fermenter, P. aeruginosa does <strong>not decarboxylate lysine</strong>. It is <strong>arginine‑positive</strong> and produces <strong>pyocyanin pigment</strong>—key diagnostic features used in differentiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Among the non‑fermenting Gram‑negative bacilli, <strong>only Burkholderia cepacia</strong> is <strong>lysine decarboxylase positive</strong>, a feature that aids its laboratory identification and distinction from other opportunistic pathogens like Pseudomonas and Acinetobacter.</span></p>",
      "correct_choice_id": 386109,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97000/NEET_GT__11_NOV_2025_Microbiology_Question_13.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97000/NEET_GT__11_NOV_2025_Microbiology_Question_13.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97056,
      "choices": [
        {
          "id": 386332,
          "text": "<p><span style=\"font-size:14.0pt;\">COPD</span></p>"
        },
        {
          "id": 386333,
          "text": "<p><span style=\"font-size:14.0pt;\">Heart failure</span></p>"
        },
        {
          "id": 386334,
          "text": "<p><span style=\"font-size:14.0pt;\">Idiopathic pulmonary arterial hypertension</span></p>"
        },
        {
          "id": 386335,
          "text": "<p><span style=\"font-size:14.0pt;\">ILD&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 52-year-old woman who has not seen a doctor in over 20 years presents with dyspnea on exertion and is found to have an oxygen saturation of 92%. Her chest X-ray, PFTs and CT scan are normal. Echocardiogram demonstrates an EF of 54% with normal valves and RVSP of 55 mmHg, and right heart catheterization reveals a PCWP of 13 mmHg and mean pulmonary artery pressure of 35 mmHg. What is the most likely cause of her dyspnea?&nbsp;</span></p>",
      "unique_key": "Q5991784",
      "difficulty_level": "difficult",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>C) Idiopathic pulmonary arterial hypertension</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Elevated RVSP and mean pulmonary artery pressure with normal PCWP and echocardiogram findings are characteristic features of pre-capillary pulmonary hypertension, most consistent with idiopathic PAH.</span></li><li><span style=\"font-size:14.0pt;\">The absence of imaging or PFT findings for interstitial lung disease and a normal ejection fraction exclude ILD and heart failure as causes.</span></li><li><span style=\"font-size:14.0pt;\">COPD typically shows obstructive patterns on PFTs, which are not present here, and would not account for the hemodynamic findings noted on right heart catheterization.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. COPD</strong>: Would show obstructive changes on PFTs, not found in this patient, and would not account for her normal imaging and right heart findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Heart failure</strong>: Generally causes an elevated PCWP and may show a reduced EF or left-sided filling pressures, which are normal in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. ILD</strong>: Would usually present with significant restrictive findings on PFTs and radiographic interstitial changes; both are absent here.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Idiopathic PAH is identified by elevated pulmonary artery pressures on right heart catheterization, normal left-sided heart pressures, and exclusion of left heart and lung disease on imaging and PFTs; right heart catheterization is essential for diagnosis.</span></p>",
      "correct_choice_id": 386334,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97056/Neet_Gt__11_Nov_2025_Medicine_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97056/Neet_Gt__11_Nov_2025_Medicine_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97265,
      "choices": [
        {
          "id": 387156,
          "text": "<p><span style=\"font-size:14.0pt;\">S and C technique&nbsp;</span></p>"
        },
        {
          "id": 387157,
          "text": "<p><span style=\"font-size:14.0pt;\">C and E technique</span></p>"
        },
        {
          "id": 387158,
          "text": "<p><span style=\"font-size:14.0pt;\">D and E technique</span></p>"
        },
        {
          "id": 387159,
          "text": "<p><span style=\"font-size:14.0pt;\">Jaw thrust</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">What is the name of this technique of mask ventilation?&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-11-10%20at%2012.53.15.jpeg\" width=\"626\" height=\"478\"></p>",
      "unique_key": "Q1902666",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) C and E technique&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The image depicts a technique commonly used in medical settings <strong>during bag and mask ventilation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The technique illustrated is known as the \"<strong>C and E Technique</strong>,\" which is a method employed during <strong>Bag-Valve-Mask (BVM) ventilation</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This approach is utilized to maintain an <strong>open airway</strong> and <strong>ensure effective ventilation</strong> in patients who are <strong>not breathing adequately</strong> or at all.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\"><strong>The \"C and E\" refers to the hand placement:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>\"C\"</strong> represents the <strong>shape formed</strong> by the <strong>thumb and index finger</strong>, which are placed on the <strong>mask</strong> to create an <strong>airtight seal</strong> against the <strong>patient's face</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>\"E\"</strong> signifies the <strong>remaining fingers</strong> (<strong>middle, ring, and little fingers</strong>) that are positioned under the <strong>mandible (jawbone)</strong> to <strong>lift</strong> and <strong>thrust the jaw forward</strong>.</span></li><li><span style=\"font-size:14.0pt;\">This maneuver helps in <strong>keeping the airway open</strong> by <strong>preventing</strong> the <strong>tongue</strong> from <strong>occluding the oropharynx</strong>.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>thumb and index fingers</strong> pressing <strong>against the mask</strong> while the other fingers <strong>lift the jaw</strong> forms the <strong>distinctive \"C\" and \"E\" shapes</strong>, hence the name.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The <strong>jaw thrust</strong> achieved by the <strong>\"E\" fingers is vital</strong> as it <strong>elevates the tongue off</strong> the <strong>back wall</strong> of the <strong>throat</strong>, <strong>reducing airway obstruction</strong> and <strong>facilitating better airflow</strong> during <strong>artificial ventilation</strong>.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The technique depicted in the image is known as the '<strong>C and E technique</strong>' for <strong>mask ventilation</strong> during <strong>bag-valve-mask (BVM) ventilation</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This technique involves forming a <strong>'C' shape</strong> with the <strong>thumb</strong> and <strong>index finger</strong> to <strong>create</strong> an <strong>airtight mask seal</strong> and using the <strong>remaining fingers</strong> to <strong>lift</strong> and <strong>thrust</strong> the <strong>jaw forward</strong> (<strong>'E' shape</strong>) to <strong>maintain</strong> an <strong>open airway</strong>, <strong>preventing tongue obstruction</strong> during <strong>artificial ventilation</strong>.</span></li></ul>",
      "correct_choice_id": 387157,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97265/NEET_GT__11_NOV_2025_Anesthesia_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        19
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97265/NEET_GT__11_NOV_2025_Anesthesia_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97232,
      "choices": [
        {
          "id": 387028,
          "text": "<p><span style=\"font-size:14.0pt;\">Downregulation of GnRH receptors leading to decreased gonadotropin release</span></p>"
        },
        {
          "id": 387029,
          "text": "<p><span style=\"font-size:14.0pt;\">Direct inhibition of testosterone synthesis</span></p>"
        },
        {
          "id": 387030,
          "text": "<p><span style=\"font-size:14.0pt;\">Decreased sensitivity of target organs to gonadotropins</span></p>"
        },
        {
          "id": 387031,
          "text": "<p><span style=\"font-size:14.0pt;\">Competitive antagonism at gonadotropin receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Gonadotropin-releasing hormone (GnRH) when administered in continuous fashion versus pulsatile fashion has different therapeutic effects. What is the primary mechanism behind continuous GnRH administration?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q5015729",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Downregulation of GnRH receptors leading to decreased gonadotropin release</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Continuous GnRH administration causes receptor downregulation and desensitization, leading to paradoxical suppression of gonadotropin release.</span></li><li><span style=\"font-size:14.0pt;\">This mechanism is therapeutically exploited in conditions requiring sex hormone suppression like prostate cancer, breast cancer, and endometriosis.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Pulsatile administration maintains normal receptor sensitivity and hormone release.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Continuous GnRH administration paradoxically suppresses the reproductive axis through receptor desensitization.</span></p>",
      "correct_choice_id": 387028,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97232/NEET_GT__11_NOV_2025_Pharmacology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97232/NEET_GT__11_NOV_2025_Pharmacology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97059,
      "choices": [
        {
          "id": 386344,
          "text": "<p><span style=\"font-size:14.0pt;\">Whole body PET scan</span></p>"
        },
        {
          "id": 386345,
          "text": "<p><span style=\"font-size:14.0pt;\">Chest CT with contrast</span></p>"
        },
        {
          "id": 386346,
          "text": "<p><span style=\"font-size:14.0pt;\">EEG</span></p>"
        },
        {
          "id": 386347,
          "text": "<p><span style=\"font-size:14.0pt;\">Repeat brain MRI with contrast</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 58-year-old man presents with subacute onset of cognitive dysfunction, confusion, and intractable seizures. He has multiple abnormal movements and rapid neurological deterioration. Anti-Hu antibodies are detected in his serum and CSF. Brain MRI is unremarkable. What is the next best step in management?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q7947685",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.</strong> <strong>A) Whole body PET scan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Anti-Hu antibody–associated autoimmune encephalitis is strongly paraneoplastic, most commonly linked to small cell lung cancer, but can be associated with other occult malignancies.​</span></li><li><span style=\"font-size:14.0pt;\">After confirming anti-Hu positivity, whole body PET is the most sensitive test for cancer screening to identify occult malignancy not evident on standard imaging.</span></li><li><span style=\"font-size:14.0pt;\">The results guide both cancer-directed therapy and immunosuppression.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Chest CT with contrast:</strong> Chest CT with contrast may miss non-pulmonary malignancies; PET scan is more comprehensive.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. EEG:</strong> EEG can support diagnosis of encephalitis but does not guide the search for underlying cancer at this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Repeat brain MRI with contrast:</strong> Repeat MRI is usually not helpful when prior MRI is unremarkable and anti-Hu confirmed.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">In anti-Hu–mediated autoimmune encephalitis, comprehensive cancer screening with a whole body PET scan is critical after antibody confirmation, due to the high risk of underlying malignancy; timely detection allows for treatment of both the tumor and encephalitic syndrome.</span></p>",
      "correct_choice_id": 386344,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97059/Neet_Gt__11_Nov_2025_Medicine_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        11
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97059/Neet_Gt__11_Nov_2025_Medicine_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96943,
      "choices": [
        {
          "id": 385880,
          "text": "<p><span style=\"font-size:14.0pt;\">Conduct vulnerability assessment and hazard mapping</span></p>"
        },
        {
          "id": 385881,
          "text": "<p><span style=\"font-size:14.0pt;\">Initiate recovery and rehabilitation activities</span></p>"
        },
        {
          "id": 385882,
          "text": "<p><span style=\"font-size:14.0pt;\">Develop early warning systems</span></p>"
        },
        {
          "id": 385883,
          "text": "<p><span style=\"font-size:14.0pt;\">Establish disaster preparedness training programs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A district health officer is reviewing the disaster management preparedness following recent flash floods in a rural area. The immediate response phase has been completed with rescue operations and emergency medical care. The community now requires restoration of basic health services and temporary shelter arrangements. What would be the next best step in the disaster management cycle?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9900776",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B)</strong> <strong>Initiate recovery and rehabilitation activities</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">In the disaster management cycle, after the immediate response phase (rescue, emergency medical care, evacuation), the next logical step is recovery and rehabilitation.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This phase focuses on restoring essential services, providing temporary shelter, rehabilitating health infrastructure, and helping the community return to normalcy.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Recovery activities include restoration of healthcare facilities, ensuring safe water supply, temporary housing arrangements, and psychological support.</span></li><li><span style=\"font-size:14.0pt;\">The other options represent activities from different phases: vulnerability assessment (preparedness phase), early warning systems (mitigation/preparedness phase), and training programs (preparedness phase).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-11-06%20at%2014%2C05%2C03-Picsart-AiImageEnhancer_ulRhCmq.jpg\" width=\"1380\" height=\"1282\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Conduct vulnerability assessment and hazard mapping:&nbsp;</strong>Vulnerability assessment and hazard mapping are components of the preparedness phase, conducted before disasters occur to identify risks and plan mitigation strategies.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Develop early warning systems:</strong> Early warning systems are established during the mitigation and preparedness phases to provide advance notice of potential disasters, not after the immediate response.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Establish disaster preparedness training programs:</strong> Disaster preparedness training programs are part of the preparedness phase, aimed at building capacity before disasters strike, not during post-disaster recovery.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The disaster management cycle consists of four phases: mitigation, preparedness, response, and recovery/rehabilitation</span></li><li><span style=\"font-size:14.0pt;\">Recovery phase immediately follows the response phase and focuses on restoring normalcy and essential services</span></li><li><span style=\"font-size:14.0pt;\">Each phase has specific objectives and activities that must be implemented in proper sequence for effective disaster management</span></li><li><span style=\"font-size:14.0pt;\">Understanding the cyclical nature helps in appropriate resource allocation and timely intervention during different disaster phases</span></li></ul>",
      "correct_choice_id": 385881,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96943/NEET_PG_11_Nov_2025_PSM_Question_11.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96943/NEET_PG_11_Nov_2025_PSM_Question_11.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97194,
      "choices": [
        {
          "id": 386876,
          "text": "<p><span style=\"font-size:14.0pt;\">Radioiodine scan</span></p>"
        },
        {
          "id": 386877,
          "text": "<p><span style=\"font-size:14.0pt;\">Post-operative calcitonin and CEA</span></p>"
        },
        {
          "id": 386878,
          "text": "<p><span style=\"font-size:14.0pt;\">Lugol’s iodine supplementation</span></p>"
        },
        {
          "id": 386879,
          "text": "<p><span style=\"font-size:14.0pt;\">Chemotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 50-year-old female has recently undergone total thyroidectomy for a thyroid mass. The histopathological examination shows papillary thyroid cancer. What would be the further management of this patient?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q9489368",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Radioiodine scan</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">After a total thyroidectomy for papillary thyroid cancer, the usual next step is a radio-iodine scan to look for metastasis.</span></li><li><span style=\"font-size:14.0pt;\">After total thyroidectomy for papillary thyroid cancer, a radioiodine scan (also known as I-123 or RAI scan) is often used to detect any remaining thyroid tissue or metastatic disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It can also aid in planning for subsequent radioactive iodine therapy, if necessary, to ablate residual tissue or treat metastatic disease.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The patient is usually given a dose of radioactive iodine, which is taken up by any remaining thyroid cells, and then imaging is done to determine the distribution of the radioactivity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Post-operative calcitonin and CEA:</strong> Incorrect. They are performed in medullary thyroid cancer. In PTC, serum Thyroglobulin is done.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Lugol’s iodine supplement:</strong> Incorrect. This is used in preoperative preparation of patients with thyrotoxicosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Chemotherapy:</strong> Incorrect for early and most intermediate stages. Chemotherapy isn't a standard treatment for most thyroid cancers. However, it might be recommended for people who don't respond to standard treatments and for certain types of aggressive thyroid cancers.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Radioiodine scan to detect any remaining thyroid tissue and potential metastasis usually after 3-6 weeks.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Based on the findings, further therapeutic radioactive iodine might be administered.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Regular follow-up, including blood tests and imaging studies, will be necessary to monitor for any recurrence or metastasis.</span></li></ul>",
      "correct_choice_id": 386876,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97194/NEET_GT__11_NOV_2025_Surgery_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        12
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97194/NEET_GT__11_NOV_2025_Surgery_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97002,
      "choices": [
        {
          "id": 386116,
          "text": "<p><span style=\"font-size:14.0pt;\">It is the most common cause of gas gangrene</span></p>"
        },
        {
          "id": 386117,
          "text": "<p><span style=\"font-size:14.0pt;\">The organism shows a positive Nagler reaction</span></p>"
        },
        {
          "id": 386118,
          "text": "<p><span style=\"font-size:14.0pt;\">The most common toxin is hyaluronidase</span></p>"
        },
        {
          "id": 386119,
          "text": "<p><span style=\"font-size:14.0pt;\">Food poisoning strains produce heat-resistant spores</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the Clostridium perfringens is incorrect?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q3680314",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) The most common toxin is hyaluronidase</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clostridium perfringens is the <strong>most common cause of gas gangrene (clostridial myonecrosis)</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is a <strong>gram-positive, spore-forming, anaerobic bacillus</strong> found in soil and the intestinal tract.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>major toxin</strong> responsible for tissue destruction and systemic toxicity is the <strong>α-toxin (lecithinase or phospholipase C)</strong>, which hydrolyzes cell membrane phospholipids, leading to <strong>massive hemolysis, vascular injury, and necrosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Hyaluronidase is indeed produced by C. perfringens, but it is a <strong>spreading factor</strong>, <strong>not the main toxin</strong> responsible for gas gangrene pathology.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>Nagler reaction</strong>, a test for α-toxin (lecithinase), is characteristically <strong>positive</strong> for C. perfringens.</span></li><li><span style=\"font-size:14.0pt;\">Food poisoning strains (Type A) form <strong>heat-resistant spores</strong>, which survive cooking and germinate in inadequately reheated food.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. It is the most common cause of gas gangrene:</strong> True. C. perfringens, especially Type A strain, is the <strong>major cause</strong> of traumatic gas gangrene and soft tissue infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. The organism shows a positive Nagler reaction:&nbsp;</strong>True. The <strong>Nagler reaction</strong> detects <strong>α-toxin (lecithinase)</strong> on egg yolk agar; neutralization with specific antitoxin confirms the result.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Food poisoning strains produce heat-resistant spores:&nbsp;</strong>True. The <strong>enterotoxin-producing strains (Type A)</strong> cause <strong>food poisoning</strong> due to survival of <strong>heat-resistant spores</strong> in cooked meat or gravy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>α-toxin (lecithinase)</strong> is the <strong>principal virulence factor</strong> of Clostridium perfringens in gas gangrene, causing <strong>cell lysis, hemolysis, and tissue necrosis</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Hyaluronidase acts only as a spreading factor and is <strong>not the main toxin</strong>.</span></li></ul>",
      "correct_choice_id": 386118,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97002/NEET_GT__11_NOV_2025_Microbiology_Question_15.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        6
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97002/NEET_GT__11_NOV_2025_Microbiology_Question_15.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96940,
      "choices": [
        {
          "id": 385868,
          "text": "<p><span style=\"font-size:14.0pt;\">Relative risk = 8.0; There is 8 times higher risk of acute kidney injury in exposed children</span></p>"
        },
        {
          "id": 385869,
          "text": "<p><span style=\"font-size:14.0pt;\">Relative risk = 5.3; There is 5.3 times higher risk of acute kidney injury in exposed children&nbsp;</span></p>"
        },
        {
          "id": 385870,
          "text": "<p><span style=\"font-size:14.0pt;\">Relative risk = 0.4; There is 60% lower risk of acute kidney injury in exposed children</span></p>"
        },
        {
          "id": 385871,
          "text": "<p><span style=\"font-size:14.0pt;\">Relative risk = 2.67; There is 2.67 times higher risk of acute kidney injury in exposed children</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">During an outbreak investigation of acute kidney injury in children, epidemiologists found that among 200 children who consumed contaminated cough syrup, 80 developed acute kidney injury. Among 300 children who did not consume the contaminated cough syrup, 15 developed acute kidney injury. What is the relative risk of developing acute kidney injury among children who consumed contaminated cough syrup compared to those who did not, and how should this be interpreted?</span></p>",
      "unique_key": "Q2917133",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A) Relative risk = 8.0; There is 8 times higher risk of acute kidney injury in exposed children</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">To calculate relative risk (RR), we use the formula: RR = (Risk in exposed group)/(Risk in unexposed group).&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Risk in exposed group = 80/200 = 0.4 (40%)</span></li><li><span style=\"font-size:14.0pt;\">Risk in unexposed group = 15/300 = 0.05 (5%)</span></li><li><span style=\"font-size:14.0pt;\">Relative Risk = 0.4/0.05 = 8.0</span></li><li><span style=\"font-size:14.0pt;\">This means children who consumed contaminated cough syrup have 8 times higher risk of developing acute kidney injury compared to those who did not consume it.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">A relative risk of 8.0 indicates a very strong association between exposure (contaminated cough syrup) and outcome (acute kidney injury), which is consistent with a causative relationship in an outbreak scenario.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Relative risk quantifies the strength of association between exposure and disease outcome in cohort studies and outbreak investigations</span></li><li><span style=\"font-size:14.0pt;\">RR &gt; 1 indicates increased risk in exposed group, RR = 1 indicates no association, and RR &lt; 1 indicates protective effect</span></li><li><span style=\"font-size:14.0pt;\">In outbreak investigations, high relative risk values (&gt;5) suggest strong causal relationship between exposure and disease</span></li><li><span style=\"font-size:14.0pt;\">Proper calculation requires clear identification of exposed/unexposed groups and accurate attack rates in both groups</span></li></ul>",
      "correct_choice_id": 385868,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96940/NEET_PG_11_Nov_2025_PSM_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        7
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96940/NEET_PG_11_Nov_2025_PSM_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96961,
      "choices": [
        {
          "id": 385952,
          "text": "<p><span style=\"font-size:14.0pt;\">Great auricular and lesser occipital nerves</span></p>"
        },
        {
          "id": 385953,
          "text": "<p><span style=\"font-size:14.0pt;\">Ventral rami of C1 to C3 spinal nerves</span></p>"
        },
        {
          "id": 385954,
          "text": "<p><span style=\"font-size:14.0pt;\">Glossopharyngeal nerve and vagus nerve</span></p>"
        },
        {
          "id": 385955,
          "text": "<p><span style=\"font-size:14.0pt;\">Small sensory branches from the dorsal rami of C1 to C3 spinal nerves</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">The foramen indicated by the arrow in the image is surrounded by structures receiving sensory innervation from which of the following nerves?&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111452.jpg\" width=\"621\" height=\"705\"></span></p>",
      "unique_key": "Q5096678",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. D) Small sensory branches from the dorsal rami of C1 to C3 spinal nerves</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>foramen magnum</strong> (shown by the arrow) is the large opening at the base of the skull through which the <strong>medulla oblongata</strong>, <strong>meninges</strong>, <strong>vertebral arteries</strong>, and <strong>spinal roots of the accessory nerves</strong> pass.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>skin around the foramen magnum</strong> receives sensory innervation from <strong>small branches of the dorsal rami of the C1–C3 spinal nerves</strong> (suboccipital, greater occipital, and third occipital nerves).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20111508.jpg\" width=\"1023\" height=\"574\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Great auricular and lesser occipital nerves:</strong> The <strong>great auricular</strong> and <strong>lesser occipital nerves</strong> supply the <strong>parotid region and posterior ear</strong>, not the posterior scalp near the foramen magnum.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B.</strong> <strong>Ventral rami of C1 to C3 spinal nerves:</strong> The <strong>ventral rami</strong> of C1–C3 form the <strong>cervical plexus</strong>, which supplies the <strong>anterior and lateral neck</strong>, not the region around the foramen magnum.</span></p><p><br><span style=\"font-size:14.0pt;\"><strong>Option C.</strong> <strong>Glossopharyngeal nerve and vagus nerve:</strong> The <strong>glossopharyngeal</strong> and <strong>vagus nerves</strong> supply mucosa of the pharynx and larynx, not the external occipital or suboccipital skin.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">The <strong>posterior scalp and skin surrounding the foramen magnum</strong> are innervated by <strong>small sensory branches from the dorsal rami of C1–C3 spinal nerves</strong>.</span></p>",
      "correct_choice_id": 385955,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96961/NEET_GT__11_NOV_2025_Anatomy_Question_4.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96961/NEET_GT__11_NOV_2025_Anatomy_Question_4.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97039,
      "choices": [
        {
          "id": 386264,
          "text": "<p><span style=\"font-size:14.0pt;\">Right superior oblique</span></p>"
        },
        {
          "id": 386265,
          "text": "<p><span style=\"font-size:14.0pt;\">Right superior rectus</span></p>"
        },
        {
          "id": 386266,
          "text": "<p><span style=\"font-size:14.0pt;\">Left inferior rectus</span></p>"
        },
        {
          "id": 386267,
          "text": "<p><span style=\"font-size:14.0pt;\">Left inferior oblique</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 35-year-old male presents with vertical diplopia following a motor vehicle accident. On examination, there is hypertropia of the right eye in primary gaze. The vertical deviation increases when the patient looks to the left. On performing the Bielschowsky head tilt test, the hypertropia worsens when the head is tilted to the right shoulder. Which extraocular muscle is most likely paretic?</span></p>",
      "unique_key": "Q6159621",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. A) Right superior oblique</strong>&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This patient’s vertical strabismus can be analyzed using Parks three-step test to identify the paretic muscle:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:14.0pt;\"><strong>Step 1</strong> – Identify hypertropic eye: The right eye is higher, suggesting weakness of a right depressor (Rt inferior rectus or Rt superior oblique) or left elevators (Lt superior rectus or Lt inferior oblique).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Step 2</strong> – Assess horizontal gaze: Hypertropia worsens on left gaze (opposite gaze), indicating weakness of a muscle whose vertical action is maximal in adduction (Rt superior oblique) or indicating weakness of a muscle whose vertical action is maximal in abduction (Lt superior rectus).</span></li><li><span style=\"font-size:14.0pt;\"><strong>Step 3</strong> – Bielschowsky head tilt test (BHTT): Hypertropia worsens on right head tilt (same side as hypertropic eye), consistent with right superior oblique weakness, as the unopposed extorters exaggerate the deviation.</span></li></ul></li><li><span style=\"font-size:14.0pt;\">So, Right hypertropia + worse on opposite gaze + worse on same-side head tilt = right superior oblique palsy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Right superior rectus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Elevates the eye in <strong>abduction</strong>, not adduction.</span></li><li><span style=\"font-size:14.0pt;\">Hypertropia would <strong>worsen on right gaze</strong>, not left.</span></li><li><span style=\"font-size:14.0pt;\">Head tilt to the <strong>opposite side (left)</strong> would worsen diplopia — inconsistent with findings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Left inferior rectus:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Depresses the <strong>left eye in abduction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">If weak, left hypertropia (not right) would result, and deviation would worsen on <strong>right gaze</strong> — opposite of this case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Left inferior oblique:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Elevates the <strong>left eye in adduction</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Weakness would cause <strong>left hypotropia</strong> (not right hypertropia) and worsen on <strong>left head tilt</strong> — again opposite of findings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:14.0pt;\"><strong>Superior oblique palsy</strong> produces <strong>vertical diplopia</strong>, <strong>hypertropia</strong>, and <strong>excyclotorsion</strong> of the affected eye.</span></li><li><span style=\"font-size:14.0pt;\">The <strong>Bielschowsky head tilt test</strong> helps localize the lesion — hypertropia worsens on <strong>ipsilateral head tilt</strong>.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Mnemonic: SIN RAD SOLID –</strong> Superiors are Intorters, Recti are Adductors, Superior Oblique: Lateral, Intorsion, Depression.</span></li></ul>",
      "correct_choice_id": 386264,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97039/Neet_Gt__11_Nov_2025_Opthalmology_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        8
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97039/Neet_Gt__11_Nov_2025_Opthalmology_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96970,
      "choices": [
        {
          "id": 385988,
          "text": "<p><span style=\"font-size:14.0pt;\">1 and 2 are incorrect</span></p>"
        },
        {
          "id": 385989,
          "text": "<p><span style=\"font-size:14.0pt;\">3 and 5 are incorrect</span></p>"
        },
        {
          "id": 385990,
          "text": "<p><span style=\"font-size:14.0pt;\">1, 3, and 4 are incorrect</span></p>"
        },
        {
          "id": 385991,
          "text": "<p><span style=\"font-size:14.0pt;\">2 and 4 are incorrect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which of the following statements regarding the Lisfranc ligament is incorrect?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:14.0pt;\">It connects the medial cuneiform to the base of the second metatarsal.</span></li><li><span style=\"font-size:14.0pt;\">It is one of the cuneometatarsal interosseous ligaments.</span></li><li><span style=\"font-size:14.0pt;\">It is the weakest among the three cuneometatarsal interosseous ligaments.</span></li><li><span style=\"font-size:14.0pt;\">Its disruption can lead to instability and deformity of the tarsometatarsal joint.</span></li><li><span style=\"font-size:14.0pt;\">It extends from the lateral cuneiform to the base of the fifth metatarsal.</span></li></ol>",
      "unique_key": "Q9377639",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) 3 and 5 are incorrect</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Lisfranc ligament</strong> is a <strong>strong interosseous cuneometatarsal ligament</strong> that extends from the <strong>medial cuneiform</strong> to the <strong>base of the second metatarsal</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is <strong>the strongest</strong> of the cuneometatarsal interosseous ligaments and provides essential stability to the <strong>tarsometatarsal (Lisfranc) joint complex</strong>.</span></li><li><span style=\"font-size:14.0pt;\">Disruption or injury to this ligament—often called a <strong>Lisfranc injury</strong>—results in <strong>instability, pain, and deformity of the midfoot</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Such injuries commonly occur following twisting trauma, falls, or crush injuries to the foot.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20133450.jpg\" width=\"809\" height=\"661\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 3.</strong> <strong>It</strong> <strong>is the weakest among the three cuneometatarsal interosseous ligaments:</strong> Incorrect. The Lisfranc ligament is the <strong>strongest</strong>, not the weakest.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 5.</strong> <strong>It extends from the lateral cuneiform to the base of the fifth metatarsal:&nbsp;</strong>Incorrect. The ligament does <strong>not</strong> extend from the <strong>lateral cuneiform to the fifth metatarsal</strong>; that description is anatomically false.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Correct Statements:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 1.&nbsp;It connects the medial cuneiform to the base of the second metatarsal:</strong> Correct. It truly connects the medial cuneiform to the base of the second metatarsal.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 2. It is one of the cuneometatarsal interosseous ligaments:</strong> Correct. It belongs to the group of cuneometatarsal interosseous ligaments.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Statement 4.</strong> <strong>Its disruption can lead to instability and deformity of the tarsometatarsal joint:</strong> Correct. Its injury causes <strong>tarsometatarsal joint instability and deformity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">The <strong>Lisfranc ligament</strong> is a <strong>strong interosseous ligament</strong> connecting the <strong>medial cuneiform to the base of the second metatarsal</strong>, providing crucial <strong>midfoot stability</strong>.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It is the <strong>strongest</strong> cuneometatarsal ligament, and its rupture leads to <strong>tarsometatarsal instability and deformity</strong> known as <strong>Lisfranc injury</strong>.</span></li></ul>",
      "correct_choice_id": 385989,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96970/NEET_GT__11_NOV_2025_Anatomy_Question_8.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        3
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96970/NEET_GT__11_NOV_2025_Anatomy_Question_8.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97244,
      "choices": [
        {
          "id": 387072,
          "text": "<p><span style=\"font-size:14.0pt;\">Enalapril + Telmisartan</span></p>"
        },
        {
          "id": 387073,
          "text": "<p><span style=\"font-size:14.0pt;\">Verapamil + Metoprolol</span></p>"
        },
        {
          "id": 387074,
          "text": "<p><span style=\"font-size:14.0pt;\">Digoxin + Spironolactone</span></p>"
        },
        {
          "id": 387075,
          "text": "<p><span style=\"font-size:14.0pt;\">Furosemide + Epleronone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">Which drug combination is contraindicated in the management of heart failure due to risk of severe bradycardia and AV block?</span></p>",
      "unique_key": "Q5242109",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. B) Verapamil + Metoprolol</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Verapamil (or diltiazem) plus beta-blockers (e.g. metoprolol) is contraindicated due to additive negative effects on heart rate and AV conduction.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both slow SA node firing and AV conduction, risking severe bradycardia, high-degree AV block, or asystole.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Both also have negative inotropic effects that can worsen heart failure.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">This combination is absolutely contraindicated.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A.</strong> <strong>Enalapril + Telmisartan:</strong> Although generally not recommended, but this combination increases risk of hyperkalemia and hypotension. It does not cause bradycardia/AV block.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Digoxin + Spironolactone:</strong> Commonly used combination; not contraindicated. Complementary mechanisms - digoxin for inotropy, spironolactone for mortality reduction. Monitor potassium.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Furosemide + Epleronone:</strong> Standard beneficial combination. Loop diuretics with aldosterone antagonists are routinely combined with potassium monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Verapamil/diltiazem should NEVER be combined with beta-blockers due to additive negative chronotropic and dromotropic effects.</span></p>",
      "correct_choice_id": 387073,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97244/NEET_GT__11_NOV_2025_Pharmacology_Question_12.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97244/NEET_GT__11_NOV_2025_Pharmacology_Question_12.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96919,
      "choices": [
        {
          "id": 385784,
          "text": "<p><span style=\"font-size:14.0pt;\">3.0 L/min</span></p>"
        },
        {
          "id": 385785,
          "text": "<p><span style=\"font-size:14.0pt;\">4.0 L/min</span></p>"
        },
        {
          "id": 385786,
          "text": "<p><span style=\"font-size:14.0pt;\">5.0 L/min&nbsp;</span></p>"
        },
        {
          "id": 385787,
          "text": "<p><span style=\"font-size:14.0pt;\">6.5 L/min</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 60-year-old man with a history of coronary artery disease is admitted for evaluation of cardiac performance. His oxygen consumption (VO₂) is measured at 250 mL O₂/min. The oxygen content of his pulmonary vein (systemic arterial blood) is 0.20 mL O₂/mL blood, and the oxygen content of his pulmonary artery (mixed venous blood) is 0.15 mL O₂/mL blood. What is this patient’s cardiac output?&nbsp;</span></p>",
      "unique_key": "Q5947085",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) 5.0 L/min</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">This problem is based on the <strong>Fick Principle</strong>, which states that:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20101923.jpg\" width=\"997\" height=\"144\"></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20102039.jpg\" width=\"1517\" height=\"600\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Thus, the <strong>cardiac output is 5 L/min</strong>, which is within the <strong>normal physiologic range</strong> for an adult at rest.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">According to the <strong>Fick Principle</strong>, <strong>cardiac output</strong> is calculated as:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-11-03%20102051.jpg\" width=\"951\" height=\"139\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">It reflects the relationship between total body oxygen consumption and the oxygen extraction difference between arterial and venous blood.</span></li><li><span style=\"font-size:14.0pt;\"><strong>Increased oxygen extraction</strong> (wider A–V O₂ difference) → <strong>low cardiac output</strong></span></li><li><span style=\"font-size:14.0pt;\"><strong>Decreased oxygen extraction</strong> (narrow A–V O₂ difference) → <strong>high cardiac output</strong></span></li><li><span style=\"font-size:14.0pt;\">This principle is fundamental for <strong>hemodynamic assessment</strong> in critical care and cardiology.</span></li></ul>",
      "correct_choice_id": 385786,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96919/NEET_GT__11_NOV_2025_Physiology_Question_1.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        2
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/96919/NEET_GT__11_NOV_2025_Physiology_Question_1.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 97253,
      "choices": [
        {
          "id": 387108,
          "text": "<p><span style=\"font-size:14.0pt;\">Fluconazole monotherapy intravenously</span></p>"
        },
        {
          "id": 387109,
          "text": "<p><span style=\"font-size:14.0pt;\">Itraconazole oral therapy</span></p>"
        },
        {
          "id": 387110,
          "text": "<p><span style=\"font-size:14.0pt;\">Amphotericin B with 5-Flucytosine&nbsp;</span></p>"
        },
        {
          "id": 387111,
          "text": "<p><span style=\"font-size:14.0pt;\">Voriconazole oral therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:14.0pt;\">A 45-year-old immunocompromised patient develops cryptococcal meningitis. Which of the following represents the most appropriate initial treatment regimen?<strong>&nbsp;</strong></span></p>",
      "unique_key": "Q6690134",
      "difficulty_level": "intermediate",
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans. C) Amphotericin B with 5-Flucytosine</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Amphotericin B is the drug of choice for cryptococcal meningitis during the acute induction phase, often combined with flucytosine for synergistic effect and to reduce total AMB dose requirements.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Amphotericin B is a polyene antifungal that binds to ergosterol in fungal cell membranes, creating pores that lead to cell death, making it fungicidal.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">It represents the gold standard of antifungal therapy with effectiveness against practically all types of systemic mycoses.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">When combined with flucytosine, the therapy is typically limited to the first 2 weeks to avoid flucytosine's bone marrow toxicity.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">The major adverse effects of amphotericin B include nephrotoxicity (most important dose-related toxicity causing azotemia, reduced GFR, acidosis, hypokalemia), infusion-related reactions (chills, fever—most common immediate side effect), and anemia from bone marrow depression.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">Liposomal amphotericin B formulations are less nephrotoxic but significantly more expensive.&nbsp;</span></li><li><span style=\"font-size:14.0pt;\">After the acute phase is controlled with AMB, long-term maintenance therapy with oral fluconazole is used in AIDS patients to prevent relapse, as fluconazole has excellent CNS penetration and is preferred for fungal meningitis continuation therapy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option A. Fluconazole monotherapy intravenously: &nbsp;</strong>Is incorrect because while fluconazole is the preferred azole for fungal meningitis due to good CNS penetration, it is used for maintenance therapy after initial AMB treatment, not as first-line monotherapy for acute cryptococcal meningitis. Starting with fluconazole alone would be inadequate for severe infection in immunocompromised patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Itraconazole oral therapy:</strong> Is incorrect because itraconazole has poor CSF penetration and is not the drug of choice for cryptococcosis. Itraconazole is preferred for histoplasmosis, blastomycosis, sporotrichosis, and paracoccidioidomycosis, but amphotericin B is superior for cryptococcal infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Voriconazole oral therapy:</strong> Is incorrect because voriconazole is a second-generation triazole that is the drug of choice for invasive aspergillosis, not cryptococcal meningitis. Its indications include disseminated fluconazole-resistant Candida infections, Fusarium infections, and febrile neutropenia not responding to antibacterial therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Cryptococcal meningitis requires initial treatment with amphotericin B (±flucytosine) followed by long-term fluconazole maintenance therapy; amphotericin B is the gold standard but causes significant nephrotoxicity.</span></p>",
      "correct_choice_id": 387110,
      "question_audio": null,
      "question_video": null,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97253/NEET_GT__11_NOV_2025_Pharmacology_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [],
      "subjects_id": [
        4
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/97253/NEET_GT__11_NOV_2025_Pharmacology_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}